# Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)

EU Regulation 2018/669 · adopted 16 April 2018

Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)

## Introductory text

Commission Regulation (EU) 2018/669
of 16 April 2018
amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006, and in particular Article 53(1) thereof,
Whereas:
(1)
Tables 3.1 and 3.2 of Annex VI to Regulation (EC) No 1272/2008 contain the list of harmonised classification and labelling of hazardous substances but only in English for all language versions of that Regulation.
(2)
On 2 December 2008 the Commission committed itself to ensure that the chemical names corresponding to the International Chemical Identifications in Tables 3.1 and 3.2 of Annex VI to Regulation (EC) No 1272/2008 are published in the same language as the language versions in which that Regulation has been published.
(3)
Table 3.1 of Annex VI to Regulation (EC) No 1272/2008 has been amended several times to reflect technical and scientific progress, by adding, deleting or modifying substances or their classification. To take account of those changes and to ensure that all the chemical names in Table 3.1 of Annex VI to Regulation (EC) No 1272/2008 are in the same language as the language versions in which that Regulation has been published, Table 3.1 needs to be replaced partially.
(4)
In view of the derogation which applies to the translation into Irish of acts which are not adopted jointly by the European Parliament and the Council, the chemical names in Table 3.1 of Annex VI should not be translated into Irish.
(5)
Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC, which has been repealed with effect from 1 June 2015. As a consequence, Table 3.2 is to be deleted in accordance with Article 1(2) of Commission Regulation (EU) 2016/1179 with effect from 1 June 2017. That table should therefore not be changed. As a result Table 3.1 has been renamed to Table 3 in accordance with Article 2(2) of Commission Regulation (EU) 2017/776 with effect from 1 June 2017.
(6)
Suppliers should be given sufficient time to adapt the labelling and packaging of substances and mixtures to the new translation provisions and to sell existing stocks.
(7)
Suppliers should have the possibility of applying this Regulation before its date of application to ensure a high level of protection of human health and of the environment and to provide sufficient flexibility to suppliers.
(8)
The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council,
HAS ADOPTED THIS REGULATION:

## 1 

The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in the Annex to this Regulation are replaced by the entries set out in the Annex to this Regulation.

## 2 

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
It shall apply from 1 December 2019.
By way of derogation from the second subparagraph, substances and mixtures may before 1 December 2019 be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008, as amended by this Regulation.

## Signature

This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 16 April 2018.
For the Commission
The President
Jean-Claude Juncker

## 

Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Specific Conc. Limits, M-factors
Notes
Hazard Class andCategory Code(s)
Hazard statement Code(s)
Pictogram, Signal Word Code(s)
Hazard statement Code(s)
Suppl. Hazard statement Code(s)
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
001-001-00-9
hydrogen
215-605-7
1333-74-0
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
001-002-00-4
aluminium lithium hydride
240-877-9
16853-85-3
Water-react. 1
Skin Corr. 1A
H260
H314
GHS02
GHS05
Dgr
H260
H314
001-003-00-X
sodium hydride
231-587-3
7646-69-7
Water-react. 1
H260
GHS02
Dgr
H260
001-004-00-5
calcium hydride
232-189-2
7789-78-8
Water-react. 1
H260
GHS02
Dgr
H260
003-001-00-4
lithium
231-102-5
7439-93-2
Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014
003-002-00-X
n-hexyllithium
404-950-0
21369-64-2
Water-react. 1
Pyr. Sol. 1
Skin Corr. 1A
H260
H250
H314
GHS02
GHS05
Dgr
H260
H250
H314
EUH014
003-003-00-5
(2-methylpropyl)lithium; isobutyllithium
440-620-2
920-36-5
Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H314
H336
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H260
H250
H314
H336
H410
EUH014
004-001-00-7
beryllium
231-150-7
7440-41-7
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H350i
H330
H301
H372 **
H319
H335
H315
H317
GHS06
GHS08
Dgr
H350i
H330
H301
H372 **
H319
H335
H315
H317
004-002-00-2
beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex
—
—
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350i
H330
H301
H372 **
H319
H335
H315
H317
H411
GHS06
GHS08
GHS09
Dgr
H350i
H330
H301
H372 **
H319
H335
H315
H317
H411
A
004-003-00-8
beryllium oxide
215-133-1
1304-56-9
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H350i
H330
H301
H372 **
H319
H335
H315
H317
GHS06
GHS08
Dgr
H350i
H330
H301
H372 **
H319
H335
H315
H317
005-001-00-X
boron trifluoride
231-569-5
7637-07-2
Press. Gas
Acute Tox. 2 *
Skin Corr. 1A
H330
H314
GHS04
GHS06
GHS05
Dgr
H330
H314
EUH014
U
005-002-00-5
boron trichloride
233-658-4
10294-34-5
Press. Gas
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1B
H330
H300
H314
GHS04
GHS06
GHS05
Dgr
H330
H300
H314
EUH014
U
005-003-00-0
boron tribromide
233-657-9
10294-33-4
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
H330
H300
H314
GHS06
GHS05
Dgr
H330
H300
H314
EUH014
005-004-00-6
trialkylboranes, solid
—
—
Pyr. Sol. 1
Skin Corr. 1B
H250
H314
GHS02
GHS05
Dgr
H250
H314
A
005-004-01-3
trialkylboranes, liquid
—
—
Pyr. Liq. 1
Skin Corr. 1B
H250
H314
GHS02
GHS05
Dgr
H250
H314
A
005-005-00-1
trimethyl borate
204-468-9
121-43-7
Flam. Liq. 3
Acute Tox. 4 *
H226
H312
GHS02
GHS07
Wng
H226
H312
005-006-00-7
dibutyltin hydrogen borate
401-040-5
75113-37-0
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360FD
H341
H372**
H312
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H360FD
H341
H372**
H312
H302
H318
H317
H410
005-007-00-2
boric acid; [1]
boric acid; [2]
233-139-2 [1]
234-343-4 [2]
10043-35-3 [1]
11113-50-1 [2]
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr.1B;
H360FD: C ≥ 5,5 %
005-008-00-8
diboron trioxide;
boric oxide
215-125-8
1303-86-2
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr.1B;
H360FD:C ≥ 3,1 %
005-009-00-3
tetrabutylammonium butyltriphenylborate
418-080-4
120307-06-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
005-010-00-9
N, N-dimethylanilinium tetrakis(pentafluorophenyl)borate
422-050-6
118612-00-3
Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H351
H302
H315
H318
GHS08
GHS05
GHS07
Dgr
H351
H302
H315
H318
005-011-00-4
disodium tetraborate, anhydrous; boric acid, disodium salt; [1]
tetraboron disodium heptaoxide, hydrate; [2]
orthoboric acid, sodium salt [3]
215-540-4 [1]
235-541-3 [2]
237-560-2 [3]
1330-43-4 [1]
12267-73-1 [2]
13840-56-7 [3]
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr. 1B; H360FD: C ≥4,5 %
005-011-01-1
disodium tetraborate decahydrate;
borax decahydrate
215-540-4
1303-96-4
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr.1B; H360FD: C ≥ 8,5 %
005-011-02-9
disodium tetraborate pentahydrate;
borax pentahydrate
215-540-4
12179-04-3
Repr. 1B
H360FD
GHS08
Dgr
H360FD
Repr.B; H360FD: C ≥ 6,5 %
005-012-00-X
diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate
418-070-1
141714-54-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
005-013-00-5
diethylmethoxyborane
425-380-9
7397-46-8
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H250
H332
H312
H302
H373**
H314
H317
H413
GHS02
GHS05
GHS08
GHS07
Dgr
H250
H332
H312
H302
H373**
H314
H317
H413
005-014-00-0
4-formylphenylboronic acid
438-670-5
87199-17-5
Skin Sens. 1
H317
GHS07
Wng
H317
005-015-00-6
1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
414-380-4
140681-55-6
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
005-016-00-1
tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate
431-370-5
—
Aquatic Chronic 4
H413
—
H413
005-017-00-7
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Ox. Sol. 2
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr.1B; H360Df: C ≥9 % Repr.1B; H360 D: 6,5 % ≤ C <9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-017-01-4
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1] 231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Ox. Sol. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-018-00-2
perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
STOT SE 3
Eye Dam. 1
H360Df
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H335
H318
Repr. 1B;
H360Df: C ≥ 14 % Repr. 1B;
H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2;
H319: 22 % ≤ C < 36 %
005-018-01-X
perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H360Df
H332
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H332
H335
H318
Repr. 1B; H360
Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-019-00-8
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Ox. Sol. 3
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-019-01-5
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate;[3]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Ox. Sol. 3
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥
9 %
Repr. 1B; H360D: 6,5 %
≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
006-001-00-2
carbon monoxide
211-128-3
630-08-0
Flam. Gas 1
Press. Gas
Repr. 1A
Acute Tox. 3 *
STOT RE 1
H220
H360D ***
H331
H372 **
GHS02
GHS04
GHS06
GHS08
Dgr
H220
H360D *** H331
H372 **
U
006-002-00-8
phosgene; carbonyl chloride
200-870-3
75-44-5
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
H330
H314
GHS04
GHS06
GHS05
Dgr
H330
H314
U
006-003-00-3
carbon disulphide
200-843-6
75-15-0
Flam. Liq. 2
Repr. 2
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
H225
H361fd
H372 **
H319
H315
GHS02
GHS08
GHS07
Dgr
H225
H361fd
H372 **
H319
H315
Repr. 2; H361fd: C ≥ 1 %
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 %
≤ C < 1 %
006-004-00-9
calcium carbide
200-848-3
75-20-7
Water-react. 1
H260
GHS02
Dgr
H260
T
006-005-00-4
thiram (ISO);
tetramethylthiuram disulphide
205-286-2
137-26-8
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H373 **
H319
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H332
H302
H373 **
H319
H315
H317
H410
M = 10
006-006-00-X
hydrogen cyanide;
hydrocyanic acid
200-821-6
74-90-8
Flam. Liq. 1
Acute Tox. 2 * Aquatic Acute 1
Aquatic Chronic 1
H224
H330
H400
H410
GHS02
GHS06
GHS09
Dgr
H224
H330
H410
006-006-01-7
hydrogen cyanide … %;
hydrocyanic acid … %
200-821-6
74-90-8
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
B
006-007-00-5
salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
EUH032
A
006-008-00-0
antu (ISO);
1-(1-naphthyl)-2-thiourea
201-706-3
86-88-4
Acute Tox. 2 *
Carc. 2
H300
H351
GHS06
GHS08
Dgr
H300
H351
006-009-00-6
1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;
isolan
204-318-2
119-38-0
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
006-010-00-1
5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate; dimetan
204-525-8
122-15-6
Acute Tox. 3 *
H301
GHS06
Dgr
H301
006-011-00-7
carbaryl (ISO);
1-naphthyl methylcarbamate
200-555-0
63-25-2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H351
H332
H302
H400
GHS08
GHS07
GHS09
Wng
H351
H332
H302
H400
M=100
006-012-00-2
ziram (ISO);
zinc bis dimethyldithiocarbamate
205-288-3
137-30-4
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H373 **
H335
H318
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H330
H302
H373 **
H335
H318
H317
H410
M = 100
006-013-00-8
metam-sodium (ISO);
sodium methyldithiocarbamate
205-293-0
137-42-8
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
EUH031
006-014-00-3
nabam (ISO);
disodium ethylenebis(N, N'-dithiocarbamate)
205-547-0
142-59-6
Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H335
H317
H410
GHS07
GHS09
Wng
H302
H335
H317
H410
006-015-00-9
diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4
330-54-1
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H373** H410
M = 10
006-016-00-4
propoxur (ISO);
2-isopropyloxyphenyl N-methylcarbamate;
2-isopropoxyphenyl methylcarbamate
204-043-8
114-26-1
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
006-017-00-X
aldicarb (ISO);
2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime
204-123-2
116-06-3
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H400
H410
GHS06
GHS09
Dgr
H330
H300
H311
H410
006-018-00-5
aminocarb (ISO);
4-dimethylamino-3-tolyl methylcarbamate
217-990-7
2032-59-9
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
006-019-00-0
di-allate (ISO);
S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate
218-961-1
2303-16-4
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410
006-020-00-6
barban (ISO);
4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate
202-930-4
101-27-9
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
006-021-00-1
linuron (ISO);
3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea
206-356-5
330-55-2
Repr. 1B Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H351
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H360Df
H351
H302
H373 **
H410
006-022-00-7
decarbofuran (ISO);
2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate
—
1563-67-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
006-023-00-2
mercaptodimethur (ISO);
methiocarb (ISO);
3,5-dimethyl-4-methylthiophenyl N-methylcarbamate
217-991-2
2032-65-7
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
006-024-00-8
proxan-sodium (ISO);
sodium O-isopropyldithiocarbonate
205-443-5
140-93-2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H302
H315
H411
GHS07
GHS09
Wng
H302
H315
H411
006-025-00-3
allethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]
S-bioallethrin; [3]
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]
esbiothrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]
209-542-4 [1]
249-013-5 [2]-[3]
584-79-2 [1]
28434-00-6 [2]
84030-86-4 [3]
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410
C
006-026-00-9
carbofuran (ISO);
2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate
216-353-0
1563-66-2
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410
006-028-00-X
dinobuton (ISO);
2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate
213-546-1
973-21-7
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
006-029-00-5
dioxacarb (ISO);
2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate
230-253-4
6988-21-2
Acute Tox. 3 * Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411
006-030-00-0
EPTC (ISO);
S-ethyl dipropylthiocarbamate
212-073-8
759-94-4
Acute Tox. 4 *
H302
GHS07
Wng
H302
006-031-00-6
formetanate (ISO);
3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate
244-879-0
22259-30-9
Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H317
H400
H410
GHS06
GHS09
Dgr
H330
H300
H317
H410
006-032-00-1
monolinuron (ISO);
3-(4-chlorophenyl)-1-methoxy-1-methylurea
217-129-5
1746-81-2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H410
006-033-00-7
metoxuron (ISO);
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea
243-433-2
19937-59-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
006-034-00-2
pebulate (ISO);
N-butyl-N-ethyl-S-propylthiocarbamate
214-215-4
1114-71-2
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
006-036-00-3
benzthiazuron (ISO);
1-benzothiazol-2-yl-3-methylurea
217-685-9
1929-88-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
006-037-00-9
promecarb (ISO);
3-isopropyl-5-methylphenyl N-methylcarbamate
220-113-0
2631-37-0
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
006-038-00-4
sulfallate (ISO);
2-chloroallyl N, N-dimethyldithiocarbamate
202-388-9
95-06-7
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
006-039-00-X
tri-allate (ISO);
S-2,3,3-trichloroallyl diisopropylthiocarbamate
218-962-7
2303-17-5
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410
006-040-00-5
3-methylpyrazol-5-yl-dimethylcarbamate; monometilan
—
2532-43-6
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
006-041-00-0
dimethylcarbamoyl chloride
201-208-6
79-44-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H350
H331
H302
H319
H335
H315
GHS06
GHS08
Dgr
H350
H331
H302
H319
H335
H315
Carc. 1B;
H350: C ≥ 0,001 %
006-042-00-6
monuron (ISO);
3-(4-chlorophenyl)-1,1-dimethylurea
205-766-1
150-68-5
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410
006-043-00-1
3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;
monuron-TCA
—
140-41-0
Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H319
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H319
H315
H410
006-044-00-7
isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea
251-835-4
34123-59-6
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
M = 10
006-045-00-2
methomyl (ISO);
1-(methylthio)ethylideneamino N-methylcarbamate
240-815-0
16752-77-5
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H410
M=100
006-047-00-3
bufencarb (ISO);
reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
—
8065-36-9
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
006-048-00-9
ethiofencarb (ISO);
2-(ethylthiomethyl)phenyl N-methylcarbamate
249-981-9
29973-13-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
006-049-00-4
dixanthogen;
O, O-diethyl dithiobis(thioformate)
207-944-4
502-55-6
Acute Tox. 4 *
H302
GHS07
Wng
H302
006-050-00-X
1,1-dimethyl-3-phenyluronium trichloroacetate;
fenuron-TCA
—
4482-55-7
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
006-051-00-5
ferbam (ISO);
iron tris(dimethyldithiocarbamate)
238-484-2
14484-64-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410
006-052-00-0
formetanate hydrochloride;
3-(N, N-dimethylaminomethyleneamino)phenyl N-methylcarbamate
245-656-0
23422-53-9
Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H317
H400
H410
GHS06
GHS09
Dgr
H330
H300
H317
H410
006-053-00-6
isoprocarb (ISO);
2-isopropylphenyl N-methylcarbamate
220-114-6
2631-40-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
006-054-00-1
mexacarbate (ISO);
3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate
206-249-3
315-18-4
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Dgr
H300
H312
H410
006-055-00-7
xylylcarb (ISO);
3,4-dimethylphenyl N-methylcarbamate;
3,4-xylyl methylcarbamate;
MPMC
219-364-9
2425-10-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
006-056-00-2
metolcarb (ISO);
m-tolyl methylcarbamate;
MTMC
214-446-0
1129-41-5
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
006-057-00-8
nitrapyrin (ISO);
2-chloro-6-trichloromethylpyridine
217-682-2
1929-82-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
006-058-00-3
noruron (ISO);
1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea
—
2163-79-3
Acute Tox. 4 *
H302
GHS07
Wng
H302
006-059-00-9
oxamyl (ISO);
N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;
245-445-3
23135-22-0
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Chronic 2
H330
H300
H312
H411
GHS06
GHS09
Dgr
H330
H300
H312
H411
006-060-00-4
oxycarboxin (ISO);
2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide
226-066-2
5259-88-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
006-061-00-X
S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;
prothiocarb hydrochloride
243-193-9
19622-19-6
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
006-062-00-5
methyl 3,4-dichlorophenylcarbanilate;
SWEP.
—
1918-18-9
Acute Tox. 4 *
H302
GHS07
Wng
H302
006-063-00-0
thiobencarb (ISO);
S-4-chlorobenzyl diethylthiocarbamate
248-924-5
28249-77-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
006-064-00-6
thiofanox (ISO);
3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime
254-346-4
39196-18-4
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
006-065-00-1
3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;
triamid
—
15271-41-7
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Chronic 2
H300
H311
H411
GHS06
GHS09
Dgr
H300
H311
H411
006-066-00-7
vernolate (ISO);
S-propyl dipropylthiocarbamate
217-681-7
1929-77-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
006-067-00-2
XMC;
3,5-xylyl methylcarbamate
—
2655-14-3
Acute Tox. 4 *
H302
GHS07
Wng
H302
006-068-00-8
diazomethane
206-382-7
334-88-3
Carc. 1B
H350
GHS08
Dgr
H350
006-069-00-3
thiophanate-methyl (ISO);
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene
245-740-7
23564-05-8
Muta. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H332
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H332
H317
H410
006-070-00-9
furmecyclox (ISO);
N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide
262-302-0
60568-05-0
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
006-071-00-4
cyclooct-4-en-1-yl methyl carbonate
401-620-8
87731-18-8
Skin Sens. 1
H317
GHS07
Wng
H317
006-072-00-X
prosulfocarb (ISO);
S-benzyl N, N-dipropylthiocarbamate
401-730-6
52888-80-9
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
006-073-00-5
3-(dimethylamino)propylurea
401-950-2
31506-43-1
Eye Dam. 1
H318
GHS05
Dgr
H318
006-074-00-0
2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate
402-440-2
2094-99-7
Acute Tox. 2 *
Skin Corr. 1B
STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H314
H373 **
H334
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H330
H314
H373 **
H334
H317
H410
006-076-00-1
mancozeb (ISO);
manganese
ethylenebis(dithiocarbamate)
(polymeric) complex with zinc salt
—
8018-01-7
Repr. 2
Skin Sens. 1
Aquatic Acute 1
H361d***
H317
H400
GHS08
GHS07
GHS09
Wng
H361d***
H317
H400
M=10
006-077-00-7
maneb (ISO);
manganese
ethylenebis(dithiocarbamate)
(polymeric)
235-654-8
12427-38-2
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d***
H332
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d***
H332
H319
H317
H410
M=10
006-078-00-2
zineb (ISO);
zinc ethylenebis(dithiocarbamate) (polymeric)
235-180-1
12122-67-7
STOT SE 3
Skin Sens. 1
H335
H317
GHS07
Wng
H335
H317
006-079-00-8
disulfiram;
tetraethylthiuramdisulfide
202-607-8
97-77-8
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410
006-080-00-3
tetramethylthiuram monosulphide
202-605-7
97-74-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
006-081-00-9
zinc bis(dibutyldithiocarbamate)
205-232-8
136-23-2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H317
H410
006-082-00-4
zinc bis(diethyldithiocarbamate)
238-270-9
14324-55-1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H317
H410
006-083-00-X
butocarboxim (ISO);
3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime
252-139-3
34681-10-2
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H226
H331
H311
H301
H319
H400
H410
GHS02
GHS06
GHS09
Dgr
H226
H331
H311
H301
H319
H410
006-084-00-5
carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate
259-565-9
55285-14-8
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H317
H400
H410
GHS06
GHS09
Dgr
H330
H301
H317
H410
006-085-00-0
fenobucarb (ISO);
2-butylphenyl methylcarbamate
223-188-8
3766-81-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
006-086-00-6
fenoxycarb (ISO);
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate
276-696-7
72490-01-8
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
M = 1
M = 10 000
006-087-00-1
furathiocarb (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate
265-974-3
65907-30-4
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H373**
H319
H315
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H301
H373**
H319
H315
H317
H410
M = 100
006-088-00-7
benfuracarb (ISO);
ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate
—
82560-54-1
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H331
H302
H400
H410
GHS06
GHS08
GHS09
Dgr
H361f***
H331
H302
H410
006-090-00-8
2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate
408-010-0
88558-41-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H332
H318
H412
GHS05
GHS07
Dgr
H332
H318
H412
006-091-00-3
propineb (ISO);
polymeric zinc propylenebis(dithiocarbamate)
—
9016-72-2
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H332
H373**
H317
H400
GHS08
GHS07
GHS09
Wng
H332
H373**
H317
H400
006-092-00-9
tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate
425-420-5
98737-29-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
006-093-00-4
2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)
427-180-7
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
006-094-00-X
O-isobutyl-N-ethoxy carbonylthiocarbamate
434-350-4
103122-66-3
Flam. Liq. 3
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H226
H350
H340
H302
H373**
H317
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H350
H340
H302
H373**
H317
H411
006-095-00-5
fosetyl-aluminium (ISO);
aluminium triethyl triphosphonate
254-320-2
39148-24-8
Eye Dam. 1
H318
GHS05
Dgr
H318
006-096-00-0
chlorpropham (ISO);
isopropyl 3-chlorocarbanilate
202-925-7
101-21-3
Carc. 2
STOT RE 2 *
Aquatic Chronic 2
H351
H373**
H411
GHS08
GHS09
Wng
H351
H373**
H411
006-097-00-6
1-phenyl-3-(p-toluenesulfonyl)urea
424-620-1
13909-63-2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
006-098-00-1
tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
429-170-8
134575-17-0
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
006-099-00-7
N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-][(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl4-methylbenzenesulfonate
520-2
232938-43-1
Aquatic Chronic 2
H411
GHS09
H411
006-101-00-6
reaction mass of: N, N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;
N, N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]
423-070-8
—
Aquatic Chronic 4
H413
—
H413
006-102-00-1
O-hexyl-N-ethoxycarbonylthiocarbamate
432-750-3
—
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H340
H302
H373**
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H340
H302
H373**
H317
H411
006-103-00-7
N, N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea
445-760-8
—
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H334
H400
H410
GHS05
GHS08
GHS09
Dgr
H318
H334
H410
M=100
007-001-00-5
ammonia, anhydrous
231-635-3
7664-41-7
Flam. Gas 2
Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H221
H331
H314
H400
GHS04
GHS06
GHS05
GHS09
Dgr
H221
H331
H314
H400
U
007-001-01-2
ammonia ….%
215-647-6
1336-21-6
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
STOT SE 3; H335: C ≥ 5 %
B
007-002-00-0
nitrogen dioxide; [1]
dinitrogen tetraoxide [2]
233-272-6 [1]
234-126-4 [2]
10102-44-0 [1]
10544-72-6 [2]
Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B
H270
H330
H314
GHS04
GHS03
GHS06
GHS05
Dgr
H270
H330
H314
*
STOT SE 3; H335: C ≥0,5 %
5
007-003-00-6
chlormequat chloride (ISO);
2-chloroethyltrimethylammonium chloride
213-666-4
999-81-5
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
007-006-00-2
ethyl nitrite
203-722-6
109-95-5
Flam. Gas 1
Press. Gas
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H220
H332
H312
H302
GHS02
GHS04
GHS07
Dgr
H220
H332
H312
H302
U
007-007-00-8
ethyl nitrate
210-903-3
625-58-1
Unst. Expl.
H200
GHS01
Dgr
H200
007-008-00-3
hydrazine
206-114-9
302-01-2
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H350
H331
H311
H301
H314
H317
H400
H410
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H226
H350
H331
H311
H301
H314
H317
H410
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 3 % ≤ C < 10 %
007-009-00-9
dicyclohexylammonium nitrite
221-515-9
3129-91-7
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
*
007-010-00-4
sodium nitrite
231-555-9
7632-00-0
Ox. Sol. 3
Acute Tox. 3 *
Aquatic Acute 1
H272
H301
H400
GHS03
GHS06
GHS09
Dgr
H272
H301
H400
*
007-011-00-X
potassium nitrite
231-832-4
7758-09-0
Ox. Sol. 2
Acute Tox. 3 *
Aquatic Acute 1
H272
H301
H400
GHS03
GHS06
GHS09
Dgr
H272
H301
H400
*
007-012-00-5
N,N-dimethylhydrazine
200-316-0
57-14-7
Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H225
H350
H331
H301
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H331
H301
H314
H411
007-013-00-0
1,2-dimethylhydrazine
—
540-73-8
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H350
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H411
Carc. 1B; H350: C ≥ 0,01 %
007-014-00-6
salts of hydrazine
—
—
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H311
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H317
H410
A
007-015-00-1
O-ethylhydroxylamine
402-030-3
624-86-2
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H225
H331
H311
H301
H372 **
H319
H317
H400
GHS02
GHS06
GHS08
GHS09
Dgr
H225
H331
H311
H301
H372 **
H319
H317
H400
007-016-00-7
butyl nitrite
208-862-1
544-16-1
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
H225
H331
H301
GHS02
GHS06
Dgr
H225
H331
H301
007-017-00-2
isobutyl nitrite
208-819-7
542-56-3
Flam. Liq. 2
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H350
H341
H332
H302
GHS02
GHS08
GHS07
Dgr
H225
H350
H341
H332
H302
007-018-00-8
sec-butyl nitrite
213-104-8
924-43-6
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Dgr
H225
H332
H302
007-019-00-3
tert-butyl nitrite
208-757-0
540-80-7
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Dgr
H225
H332
H302
007-020-00-9
pentyl nitrite; [1]
‘amyl nitrite’, mixed isomers [2]
207-332-7 [1]
203-770-8 [2]
463-04-7 [1]
110-46-3 [2]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Dgr
H225
H332
H302
007-021-00-4
hydrazobenzene;
1,2-diphenylhydrazine
204-563-5
122-66-7
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
007-022-00-X
hydrazine bis(3-carboxy-4-hydroxybenzensulfonate)
405-030-1
—
Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H350
H302
H314
H317
H412
GHS08
GHS05
GHS07
Dgr
H350
H302
H314
H317
H412
007-023-00-5
sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate
405-510-0
—
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
007-024-00-0
2-(decylthio)ethylammonium chloride
405-640-8
36362-09-1
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H315
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H373 **
H315
H318
H410
007-025-00-6
(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride
406-090-1
81880-96-8
Muta. 2
Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H301
H372 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H301
H372 **
H317
H410
007-026-00-1
oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide
413-230-5
122035-71-6
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
007-027-00-7
1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane
420-190-2
771478-66-1
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 **
H314
H317
H410
007-028-00-2
hydroxylammonium nitrate
236-691-2
13465-08-2
Expl. 1.1 ****
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H311
H302
H373**
H319
H315
H317
H400
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H351
H311
H302
H373**
H319
H315
H317
H400
007-029-00-8
diethyldimethylammonium hydroxide
419-400-5
95500-19-9
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
008-001-00-8
oxygen
231-956-9
7782-44-7
Ox. Gas 1
Press. Gas
H270
GHS03
GHS04
Dgr
H270
U
008-003-00-9
hydrogen peroxide solution… %
231-765-0
7722-84-1
Ox. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H271
H332
H302
H314
GHS03
GHS05
GHS07
Dgr
H271
H332
H302
H314
Ox. Liq. 1; H271: C ≥70 %****
Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****
*
Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 %
Skin Irrit. 2; H315: 35 % ≤ C < 50 %
Eye Dam. 1; H318: 8 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 %
B
009-001-00-0
fluorine
231-954-8
7782-41-4
Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1A
H270
H330
H314
GHS04
GHS03
GHS06
GHS05
Dgr
H270
H330
H314
009-002-00-6
hydrogen fluoride
231-634-8
7664-39-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A
H330
H310
H300
H314
GHS06
GHS05
Dgr
H330
H310
H300
H314
009-003-00-1
hydrofluoric acid … %
231-634-8
7664-39-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A
H330
H310
H300
H314
GHS06
GHS05
Dgr
H330
H310
H300
H314
Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1 % ≤C < 1 %
B
009-004-00-7
sodium fluoride
231-667-8
7681-49-4
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
H301
H319
H315
GHS06
Dgr
H301
H319
H315
EUH032
009-005-00-2
potassium fluoride
232-151-5
7789-23-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
009-006-00-8
ammonium fluoride
235-185-9
12125-01-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
009-007-00-3
sodium bifluoride;
sodium hydrogen difluoride
215-608-3
1333-83-1
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314
*Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < % Eye Irrit. 2;
H319: 0,1 % ≤
C < 1 %
009-008-00-9
potassium bifluoride;
potassium hydrogen difluoride
232-156-2
7789-29-9
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314
*
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-009-00-4
ammonium bifluoride;
ammonium hydrogen difluoride
215-676-4
1341-49-7
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314
*
Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-010-00-X
fluoroboric acid … %
240-898-3
16872-11-0
Skin Corr. 1B
H314
GHS05
Dgr
H314
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤
C < 25 %
B
009-011-00-5
fluorosilicic acid … %
241-034-8
16961-83-4
Skin Corr. 1B
H314
GHS05
Dgr
H314
B
009-012-00-0
alkali fluorosilicates(Na); [1]
alkali fluorosilicates(K); [2]
alkali fluorosilicates(NH4) [3]
240-934-8 [1]
240-896-2 [2]
240-968-3 [3]
16893-85-9 [1]
16871-90-2 [2]
16919-19-0 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
*
A
009-013-00-6
fluorosilicates, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302
*
A
009-014-00-1
lead hexafluorosilicate
247-278-1
25808-74-6
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H360Df
H332
H302
H373 **
H410
1
009-015-00-7
sulphuryl difluoride
220-281-5
2699-79-8
Press. Gas
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H331
H373 **
H400
GHS04
GHS06
GHS08
GHS09
Dgr
H331
H373 **
H400
U
009-016-00-2
trisodium hexafluoroaluminate [1]
trisodium hexafluoroaluminate(cryolite) [2]
237-410-6 [1]
239-148-8 [2]
13775-53-6 [1]
15096-52-3 [2]
STOT RE 1
Acute Tox. 4
Aquatic Chronic 2
H372
H332
H411
GHS07
GHS08
GHS09
Dgr
H372
H332
H411
009-017-00-8
potassium mu-fluoro-bis(triethylaluminium)
400-040-2
12091-08-6
Flam. Sol. 1
Water-react. 1
Skin Corr. 1A
Acute Tox. 4 *
H228
H270
H314
H332
GHS02
GHS05
GHS07
Dgr
H228
H270
H314
H332
EUH014
T
009-018-00-3
magnesium hexafluorosilicate
241-022-2
16949-65-8
Acute Tox. 3 *
H301
GHS06
Dgr
H301
*
011-001-00-0
sodium
231-132-9
7440-23-5
Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014
011-002-00-6
sodium hydroxide;
caustic soda
215-185-5
1310-73-2
Skin Corr. 1A
H314
GHS05
Dgr
H314
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit.2; H319: 0,5 % ≤ C < 2 %
011-003-00-1
sodium peroxide
215-209-4
1313-60-6
Ox. Sol. 1
Skin Corr. 1A
H271
H314
GHS03
GHS05
Dgr
H271
H314
011-004-00-7
sodium azide
247-852-1
26628-22-8
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H400
H410
EUH032
011-005-00-2
sodium carbonate
207-838-8
497-19-8
Eye Irrit. 2
H319
GHS07
Wng
H319
011-006-00-8
sodium cyanate
213-030-6
917-61-3
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
011-007-00-3
propoxycarbazone-sodium
—
181274-15-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M = 10
012-001-00-3
magnesium powder (pyrophoric)
231-104-6
7439-95-4
Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Dgr
H260
H250
T
012-002-00-9
magnesium, powder or turnings
231-104-6
—
Flam. Sol. 1
Water-react. 2
Self-heat. 1
H228
H261
H252
GHS02
Dgr
H228
H261
H252
T
012-003-00-4
magnesium alkyls
—
—
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Dgr
H250
H260
H314
EUH014
A
012-004-00-X
aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate
422-150-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
013-001-00-6
aluminium powder (pyrophoric)
231-072-3
7429-90-5
Water-react. 2
Pyr. Sol. 1
H261
H250
GHS02
Dgr
H261
H250
T
013-002-00-1
aluminium powder (stabilised)
231-072-3
7429-90-5
Water-react. 2
Flam. Sol. 1
H261
H228
GHS02
Dgr
H261
H228
T
013-003-00-7
aluminium chloride, anhydrous
231-208-1
7446-70-0
Skin Corr. 1B
H314
GHS05
Dgr
H314
013-004-00-2
aluminium alkyls
—
—
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Dgr
H250
H260
H314
EUH014
A
013-005-00-8
diethyl(ethyldimethylsilanolato) aluminium
401-160-8
55426-95-4
Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
H260
H250
H314
GHS02
GHS05
Dgr
H260
H250
H314
EUH014
013-006-00-3
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised
402-370-2
—
Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Dgr
H226
H318
013-007-00-9
poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)
403-430-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318
013-008-00-4
di-n-octylaluminium iodide
408-190-0
7585-14-0
Pyr. Liq. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H314
H400
H410
GHS02
GHS05
GHS09
Dgr
H250
H314
H410
EUH014
013-009-00-X
sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y =1,5
418-720-2
—
Flam. Sol. 1
Water-react. 1
Pyr. Sol. 1
Acute Tox. 4 *
Skin Corr. 1A
H228
H260
H250
H332
H314
GHS02
GHS05
GHS07
Dgr
H228
H260
H250
H332
H314
EUH014
T
013-010-00-5
hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d, g][1.3.2]dioxaphosphocin-6-oxide)
430-650-4
151841-65-5
Aquatic Chronic 2
H411
GHS09
H411
014-001-00-9
trichlorosilane
233-042-5
10025-78-2
Flam. Liq. 1
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H224
H250
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H224
H250
H332
H302
H314
EUH014
EUH029
*
STOT SE 3; H335: C ≥ 1 %
T
014-002-00-4
silicon tetrachloride
233-054-0
10026-04-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
EUH014
014-003-00-X
dimethyldichlorosilane
200-901-0
75-78-5
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315
014-004-00-5
trichloro(methyl)silane; methyltrichlorosilane
200-902-6
75-79-6
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315
EUH014
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %
014-005-00-0
tetraethyl silicate;
ethyl silicate
201-083-8
78-10-4
Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H226
H332
H319
H335
GHS02
GHS07
Wng
H226
H332
H319
H335
014-006-00-6
bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride
401-380-4
—
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
014-007-00-1
triethoxyisobutylsilane
402-810-3
17980-47-1
Skin Irrit. 2
H315
GHS07
Wng
H315
014-008-00-7
(chloromethyl)bis(4-fluorophenyl)methylsilane
401-200-4
85491-26-5
Aquatic Chronic 2
H411
GHS09
H411
014-009-00-2
isobutylisopropyldimethoxysilane
402-580-4
111439-76-0
Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2
H226
H332
H315
GHS02
GHS07
Wng
H226
H332
H315
014-010-00-8
disodium metasilicate
229-912-9
6834-92-0
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
014-011-00-3
cyclohexyldimethoxymethylsilane
402-140-1
17865-32-6
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
014-012-00-9
bis(3-(trimethoxysilyl)propyl)amine
403-480-3
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
014-013-00-4
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)
404-920-7
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H312
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H411
014-014-00-X
etacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane
253-704-7
37894-46-5
Repr. 1B
Acute Tox. 4 *
STOT RE 2 *
H360D *** H302
H373 **
GHS08
GHS07
Dgr
H360D *** H302
H373 **
014-015-00-5
α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane))
406-420-4
69430-40-6
Aquatic Chronic 4
H413
—
H413
014-016-00-0
reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane
406-490-6
—
Aquatic Chronic 2
H411
GHS09
H411
014-017-00-6
flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane
—
85509-19-9
Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D *** H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D *** H302
H411
014-018-00-1
octamethylcyclotetrasiloxane
209-136-7
556-67-2
Repr. 2
Aquatic Chronic 4
H361f *** H413
GHS08
Wng
H361f *** H413
014-019-00-7
reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole
403-250-2
—
Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D *** H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D *** H302
H411
014-020-00-2
bis(1,1-dimethyl-2-propynyloxy)dimethylsilane
414-960-7
53863-99-3
Acute Tox. 4 *
H332
GHS07
Wng
H332
014-021-00-8
tris(isopropenyloxy)phenyl silane
411-340-8
52301-18-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H400
H410
014-022-00-3
reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)
401-530-9
—
Flam. Sol. 1
STOT SE 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H228
H370 **
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H228
H370 **
H332
H312
H302
T
014-023-00-9
α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole
408-160-7
125613-45-8
Aquatic Chronic 2
H411
GHS09
H411
014-024-00-4
1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene
412-620-2
121626-74-2
Aquatic Chronic 2
H411
GHS09
H411
014-025-00-X
4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine
411-400-3
102089-33-8
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H373 **
H315
H318
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H315
H318
H412
014-026-00-5
dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane
407-180-3
770722-36-6
Skin Corr. 1A
H314
GHS05
Dgr
H314
014-027-00-0
chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane
410-270-5
770722-46-8
Skin Corr. 1A
H314
GHS05
Dgr
H314
014-028-00-6
α-[3-(1-oxoprop-2-enyl)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)
415-290-8
193159-06-7
Skin Sens. 1
H317
GHS07
Wng
H317
014-029-00-1
O, O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]
421-870-1
156145-66-3
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
H361f *** H302
H373 **
GHS08
GHS07
Wng
H361f *** H302
H373 **
014-030-00-7
[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium
422-060-0
137390-08-0
Acute Tox. 2 *
H300
GHS06
Dgr
H300
014-031-00-2
bis(1-methylethyl)-dimethoxysilane
421-540-7
18230-61-0
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H226
H315
H317
H412
GHS02
GHS07
Wng
H226
H315
H317
H412
014-032-00-8
dicyclopentyldimethoxysilane
404-370-8
126990-35-0
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
014-033-00-3
2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica
419-030-4
125804-20-8
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
014-034-00-9
3-hexylheptamethyltrisiloxane
428-700-5
1873-90-1
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
014-035-00-4
2-(3,4-epoxycyclohexyl)ethyltriethoxy silane
425-050-4
10217-34-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
014-036-00-X
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane
405-020-7
105024-66-6
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F*** H400
H410
GHS08
GHS09
Dgr
H360F*** H410
M=1000
014-037-00-5
2-butanone-O, O',O''-(phenylsilylidyne)trioxime
433-360-6
34036-80-1
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373**
H317
H412
GHS08
GHS07
Wng
H373**
H317
H412
014-038-00-0
S-(3-(triethoxysilyl)propyl)octanethioate
436-690-9
220727-26-4
Skin Sens. 1
H317
GHS07
Wng
H317
014-039-00-6
(2,3-dimethylbut-2-yl)-trimethoxysilane
439-360-2
142877-45-0
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
014-041-00-7
N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane
445-890-5
201290-01-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
014-042-00-2
reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-010-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318
014-043-00-8
reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)
432-200-2
—
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H335
H315
H318
H412
GHS05
GHS07
Dgr
H335
H315
H318
H412
014-044-00-3
3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane
433-050-0
—
Aquatic Chronic 2
H411
GHS09
H411
014-045-00-9
magnesium sodium fluoride silicate
442-650-1
—
STOT RE 2 *
H373**
GHS08
Wng
H373**
015-001-00-1
white phosphorus
231-768-7
12185-10-3
Pyr. Sol. 1
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H250
H330
H300
H314
H400
GHS02
GHS06
GHS05
GHS09
Dgr
H250
H330
H300
H314
H400
015-002-00-7
red phosphorus
231-768-7
7723-14-0
Flam. Sol. 1
Aquatic Chronic 3
H228
H412
GHS02
Dgr
H228
H412
015-004-00-8
aluminium phosphide
244-088-0
20859-73-8
Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Aquatic Acute 1
H260
H300
H311
H330
H400
GHS02
GHS06
GHS09
Dgr
H260
H300
H311
H330
H400
EUH029
EUH032
M = 100
015-005-00-3
magnesium phosphide;
trimagnesium diphosphide
235-023-7
12057-74-8
Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Aquatic Acute 1
H260
H300
H311
H330
H400
GHS02
GHS06
GHS09
Dgr
H260
H300
H311
H330
H400
EUH029
EUH032
M = 100
015-006-00-9
trizinc diphosphide;
zinc phosphide
215-244-5
1314-84-7
Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H260
H300
H400
H410
GHS02
GHS06
GHS09
Dgr
H260
H300
H410
EUH029
EUH032
M=100
T
015-007-00-4
phosphorus trichloride
231-749-3
7719-12-2
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Skin Corr. 1A
H330
H300
H373 **
H314
GHS06
GHS08
GHS05
Dgr
H330
H300
H373 **
H314
EUH014
EUH029
015-008-00-X
phosphorus pentachloride
233-060-3
10026-13-8
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
H330
H302
H373 **
H314
GHS06
GHS08
GHS05
Dgr
H330
H302
H373 **
H314
EUH014
EUH029
015-009-00-5
phosphoryl trichloride
233-046-7
10025-87-3
Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1A
H330
H372 **
H302
H314
GHS06
GHS08
GHS05
Dgr
H330
H372 **
H302
H314
EUH014
EUH029
015-010-00-0
phosphorus pentoxide
215-236-1
1314-56-3
Skin Corr. 1A
H314
GHS05
Dgr
H314
015-011-00-6
phosphoric acid . %, orthophosphoric acid . %
231-633-2
7664-38-2
Skin Corr. 1B
H314
GHS05
Dgr
H314
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
015-012-00-1
tetraphosphorus trisulphide;
phosphorus sesquisulphid
215-245-0
1314-85-8
Flam. Sol. 2
Water-react. 1
Acute Tox. 4 *
Aquatic Acute 1
H228
H260
H302
H400
GHS02
GHS07
GHS09
Dgr
H228
H260
H302
H400
T
015-013-00-7
triethyl phosphate
201-114-5
78-40-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
015-014-00-2
tributyl phosphate
204-800-2
126-73-8
Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
H351
H302
H315
GHS08
GHS07
Wng
H351
H302
H315
015-015-00-8
tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
201-103-5
78-30-8
STOT SE 1
Aquatic Chronic 2
H370 **
H411
GHS08
GHS09
Dgr
H370 **
H411
STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 %
C
015-016-00-3
tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
201-105-6
78-32-0
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H312
H302
H411
GHS07
GHS09
Wng
H312
H302
H411
*
C
015-019-00-X
dichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate
200-547-7
62-73-7
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
H330
H311
H301
H317
H400
GHS06
GHS09
Dgr
H330
H311
H301
H317
H400
M=1000
015-020-00-5
mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate
232-095-1
7786-34-7
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
M = 10000
015-021-00-0
trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate
200-149-3
52-68-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H400
H410
M = 1000
015-022-00-6
phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate
236-116-5
13171-21-6
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H300
H311
H410
015-023-00-1
pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate
—
108-34-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300
015-024-00-7
triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N, N,N',N'-tetramethylphosphonic diamide
—
1031-47-6
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-025-00-2
TEPP (ISO);
tetraethyl pyrophosphate
203-495-3
107-49-3
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400
015-026-00-8
schradan (ISO); octamethylpyrophosphoramide
205-801-0
152-16-9
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-027-00-3
sulfotep (ISO);
O, O,O, O-tetraethyl dithiopyrophosphate
222-995-2
3689-24-5
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
M = 1000
015-028-00-9
demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate
206-053-8
298-03-3
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400
015-029-00-4
demeton-S (ISO);
diethyl-S-2-ethylthioethyl phosphorothioate
204-801-8
126-75-0
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-030-00-X
demeton-O-methyl (ISO);
O-2-ethylthioethyl O,O-dimethyl phosphorothioate
212-758-1
867-27-6
Acute Tox. 3 *
H301
GHS06
Dgr
H301
015-031-00-5
demeton-S-methyl (ISO);
S-2-ethylthioethyl dimethyl phosphorothioate
213-052-6
919-86-8
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H311
H301
H411
GHS06
GHS09
Dgr
H311
H301
H411
015-032-00-0
prothoate (ISO);
O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate
218-893-2
2275-18-5
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 3
H310
H300
H412
GHS06
Dgr
H310
H300
H412
015-033-00-6
phorate (ISO);
O,O-diethyl ethylthiomethyl phosphorodithioate
206-052-2
298-02-2
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
M = 1000
015-034-00-1
parathion (ISO);
O,O-diethyl O-4-nitrophenyl phosphorothioate
200-271-7
56-38-2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H300
H311
H372 **
H410
M = 100
015-035-00-7
parathion — methyl (ISO);
O,O-dimethyl O-4-nitrophenyl phosphorothioate
206-050-1
298-00-0
Flam. Liq. 3
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H226
H330
H300
H311
H373 **
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H226
H330
H300
H311
H373 **
H410
M = 100
015-036-00-2
O-ethyl O-4-nitrophenyl phenylphosphonothioate;
EPN
218-276-8
2104-64-5
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
015-037-00-8
phenkapton (ISO);
S-(2,5-dichlorophenylthiomethyl) O, O-diethyl phosphorodithioate
218-892-7
2275-14-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
015-038-00-3
coumaphos (ISO);
O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate
200-285-3
56-72-4
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Dgr
H300
H312
H410
015-039-00-9
azinphos-methyl (ISO);
O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate
201-676-1
86-50-0
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H317
H400
H410
GHS06
GHS09
Dgr
H330
H300
H311
H317
H410
015-040-00-4
diazinon (ISO);
O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate
206-373-8
333-41-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H400
H410
015-041-00-X
malathion (ISO);
1,2-bis(ethoxycarbonyl)ethyl O, O-dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion]
204-497-7
121-75-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=1000
015-042-00-5
chlorthion O-(3-chloro-4-nitrophenyl) O, O-dimethyl phosphorothioate
207-902-5
500-28-7
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
M = 100
015-043-00-0
phosnichlor (ISO);
O-4-chloro-3-nitrophenyl O, O-dimethyl phosphorothioate
—
5826-76-6
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302
015-044-00-6
carbophenothion (ISO);
4-chlorophenylthiomethyl O, O-diethyl phosphorodithioate
212-324-1
786-19-6
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
015-045-00-1
mecarbam (ISO);
N-ethoxycarbonyl-N-methylcarbamoylmethyl O, O-diethyl phosphorodithioate
219-993-9
2595-54-2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H400
H410
015-046-00-7
oxydemeton-methyl;
S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate
206-110-7
301-12-2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
H311
H301
H400
GHS06
GHS09
Dgr
H311
H301
H400
015-047-00-2
ethion (ISO);
O, O,O',O'-tetraethyl S, S'-methylenedi (phosphorodithioate);
diethion
209-242-3
563-12-2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
M = 10000
015-048-00-8
fenthion (ISO);
O, O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate
200-231-9
55-38-9
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H312
H302
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H312
H302
H372** H410
M=100
015-049-00-3
endothion (ISO);
S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate
220-472-3
2778-04-3
Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Dgr
H311
H301
015-050-00-9
thiometon (ISO);
S-2-ethylthioethyl O,O-dimethyl phosphorodithioate
211-362-6
640-15-3
Acute Tox. 3 *
Acute Tox. 4 *
H301
H312
GHS06
Dgr
H301
H312
015-051-00-4
dimethoate (ISO);
O, O-dimethyl methylcarbamoylmethyl phosphorodithioate
200-480-3
60-51-5
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
015-052-00-X
fenchlorphos (ISO);
O, O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate
206-082-6
299-84-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
015-053-00-5
menazon (ISO);
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate
201-123-4
78-57-9
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
015-054-00-0
fenitrothion (ISO);
O, O-dimethyl O-4-nitro-m-tolyl phosphorothioate
204-524-2
122-14-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
015-055-00-6
naled (ISO);
1,2-dibromo-2,2-dichloroethyl dimethyl phosphate
206-098-3
300-76-5
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
H312
H302
H319
H315
H400
GHS07
GHS09
Wng
H312
H302
H319
H315
H400
M = 1000
015-056-00-1
azinphos-ethyl (ISO);
O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate
220-147-6
2642-71-9
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
M=100
015-057-00-7
formothion (ISO);
N-formyl-N-methylcarbamoylmethyl O, O-dimethyl phosphorodithioate
219-818-6
2540-82-1
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
015-058-00-2
morphothion (ISO);
O, O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate
205-628-0
144-41-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
015-059-00-8
vamidothion (ISO);
O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate
218-894-8
2275-23-2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
H301
H312
H400
GHS06
GHS09
Dgr
H301
H312
H400
015-060-00-3
disulfoton (ISO);
O,O-diethyl 2-ethylthioethyl phosphorodithioate
206-054-3
298-04-4
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
015-061-00-9
dimefox (ISO); tetramethylphosphorodiamidic fluoride
204-076-8
115-26-4
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-062-00-4
mipafox (ISO);
N,N'-di-isopropylphosphorodiamidic fluoride
206-742-3
371-86-8
STOT SE 1
H370 **
GHS08
Dgr
H370 **
015-063-00-X
dioxathion (ISO);
1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)
201-107-7
78-34-2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H400
H410
GHS06
GHS09
Dgr
H330
H300
H311
H410
M = 1000
015-064-00-5
bromophos-ethyl (ISO);
O-4-bromo-2,5-dichlorophenyl
O,O-diethyl phosphorothioate
225-399-0
4824-78-6
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
015-065-00-0
S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate
—
2703-37-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H330
H310
H300
H411
GHS06
GHS09
Dgr
H330
H310
H300
H411
015-066-00-6
omethoate (ISO);
O, O-dimethyl S-methylcarbamoylmethyl phosphorothioate
214-197-8
1113-02-6
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
H301
H312
H400
GHS06
GHS09
Dgr
H301
H312
H400
015-067-00-1
phosalone (ISO);
S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O, O-diethyl phosphorodithioate
218-996-2
2310-17-0
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H312
H317
H400
H410
GHS06
GHS09
Dgr
H301
H332
H312
H317
H410
M=1000
015-068-00-7
dichlofenthion (ISO);
O—2,4-dichlorophenyl O,O-diethyl phosphorothioate
202-564-5
97-17-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H400
H410
015-069-00-2
methidathion (ISO);
2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate
213-449-4
950-37-8
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Dgr
H300
H312
H410
015-070-00-8
cyanthoate (ISO);
S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate
223-099-4
3734-95-0
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311
015-071-00-3
chlorfenvinphos (ISO);
2-chloro-1-(2,4 dichlorophenyl)vinyl diethyl phosphate
207-432-0
470-90-6
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
015-072-00-9
monocrotophos (ISO);
dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate
230-042-7
6923-22-4
Muta. 2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H330
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H330
H300
H311
H410
015-073-00-4
dicrotophos (ISO);
(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
205-494-3
141-66-2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
015-074-00-X
crufomate (ISO);
4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate
206-083-1
299-86-5
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
015-075-00-5
S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate
—
2635-50-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
015-076-00-0
potasan;
O, O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
—
299-45-6
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
M = 1000
015-077-00-6
2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate
—
7076-53-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
015-078-00-1
demeton-S-methylsulphon(ISO);
S-2-ethylsulphonylethyl dimethyl phosphorothioate
241-109-5
17040-19-6
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2
H301
H312
H411
GHS06
GHS09
Dgr
H301
H312
H411
015-079-00-7
acephate (ISO);
O, S-dimethyl acetylphosphoramidothioate
250-241-2
30560-19-1
Acute Tox. 4 *
H302
GHS07
Wng
H302
015-080-00-2
amidithion (ISO);
2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
—
919-76-6
Acute Tox. 4 *
H302
GHS07
Wng
H302
015-081-00-8
O,O,O',O'-tetrapropyl dithiopyrophosphate
221-817-0
3244-90-4
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
015-082-00-3
azothoate (ISO);
O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate
227-419-3
5834-96-8
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
015-083-00-9
bensulide (ISO);
O, O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate
212-010-4
741-58-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
015-084-00-4
chlorpyrifos (ISO);
O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
220-864-4
2921-88-2
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H400
H410
M = 10000
015-085-00-X
chlorphonium chloride (ISO);
tributyl (2,4-dichlorobenzyl) phosphonium chloride
204-105-4
115-78-6
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H301
H312
H319
H315
GHS06
Dgr
H301
H312
H319
H315
015-086-00-5
coumithoate (ISO);
O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate
—
572-48-5
Acute Tox. 3 *
H301
GHS06
Dgr
H301
015-087-00-0
cyanophos (ISO);
O-4-cyanophenyl O,O-dimethyl phosphorothioate
220-130-3
2636-26-2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
015-088-00-6
dialifos (ISO);
2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate
233-689-3
10311-84-9
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H400
H410
015-089-00-1
ethoate-methyl (ISO); ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
204-121-1
116-01-8
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
015-090-00-7
fensulfothion (ISO);
O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate
204-114-3
115-90-2
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
015-091-00-2
fonofos (ISO);
O-ethyl phenyl ethylphosphonodithioate
213-408-0
944-22-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
015-092-00-8
phosacetim (ISO);
O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate
223-874-7
4104-14-7
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
015-093-00-3
leptophos (ISO);
O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate
244-472-8
21609-90-5
Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H370 **
H312
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H370 **
H312
H410
015-094-00-9
mephosfolan (ISO);
diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate
213-447-3
950-10-7
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H310
H300
H411
GHS06
GHS09
Dgr
H310
H300
H411
015-095-00-4
methamidophos (ISO);
O,S-dimethyl phosphoramidothioate
233-606-0
10265-92-6
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
H330
H300
H311
H400
GHS06
GHS09
Dgr
H330
H300
H311
H400
015-096-00-X
oxydisulfoton (ISO);
O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
219-679-1
2497-07-6
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
M = 10
015-097-00-5
phenthoate (ISO);
ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate
219-997-0
2597-03-7
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
M = 100
015-098-00-0
trichloronate (ISO);
O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate
206-326-1
327-98-0
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
015-099-00-6
pirimiphos-ethyl (ISO);
O, O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate
245-704-0
23505-41-1
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
015-100-00-X
phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile
238-887-3
14816-18-3
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f*** H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f*** H302
H317
H410
M=1000
015-101-00-5
phosmet (ISO);
O, O-dimethyl phthalimidomethyl S-phosphorodithioate
211-987-4
732-11-6
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
M = 100
015-102-00-0
tris(2-chloroethyl)phosphate
204-118-5
115-96-8
Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360F*** H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360F*** H302
H411
015-103-00-6
phosphorus tribromide
232-178-2
7789-60-8
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014
015-104-00-1
diphosphorus pentasulphide;
phosphorus pentasulphide
215-242-4
1314-80-3
Flam. Sol. 1
Water-react. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H228
H260
H332
H302
H400
GHS02
GHS07
GHS09
Dgr
H228
H260
H332
H302
H400
EUH029
T
015-105-00-7
triphenyl phosphite
202-908-4
101-02-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 %
015-106-00-2
hexamethylphosphoric triamide; hexamethylphosphoramide
211-653-8
680-31-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
Carc. 1B;
H350: C ≥ 0,01 %
015-107-00-8
ethoprophos (ISO);
ethyl-S,S-dipropyl phosphorodithioate
236-152-1
13194-48-4
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H301
H317
H400
H410
GHS06
GHS09
Dgr
H330
H310
H301
H317
H410
015-108-00-3
bromophos (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate
218-277-3
2104-96-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M = 100
015-109-00-9
crotoxyphos (ISO);
1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate
231-720-5
7700-17-6
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
M = 10
015-110-00-4
cyanofenphos (ISO);
O-4-cyanophenyl O-ethyl phenylphosphonothioate
—
13067-93-1
Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H301
H370 **
H312
H319
H411
GHS06
GHS08
GHS09
Dgr
H301
H370 **
H312
H319
H411
015-111-00-X
phosfolan (ISO);
diethyl 1,3-dithiolan-2-ylidenephosphoramidate
213-423-2
947-02-4
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-112-00-5
thionazin (ISO);
O,O-diethyl O-pyrazin-2-yl phosphorothioate;
206-049-6
297-97-2
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-113-00-0
tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate
260-515-3
57018-04-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
015-114-00-6
chlormephos (ISO);
S-chloromethyl O,O-diethyl phosphorodithioate
246-538-1
24934-91-6
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
M = 10
015-115-00-1
chlorthiophos (ISO);
[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O, O-diethyl phosphorothioate predominates]
244-663-6
21923-23-9
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
M = 1000
015-116-00-7
demephion-O (ISO);
O, O-dimethyl O-2-methylthioethyl phosphorothioate
211-666-9
682-80-4
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311
015-117-00-2
demephion-S (ISO);
O, O-dimethyl S-2-methylthioethyl phosphorothioate
219-971-9
2587-90-8
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311
015-118-00-8
demeton
—
8065-48-3
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400
015-119-00-3
dimethyl 4-(methylthio)phenyl phosphate
—
3254-63-5
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-120-00-9
ditalimfos (ISO);
O, O-diethyl phthalimidophosphonothioate
225-875-8
5131-24-8
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
015-121-00-4
edifenphos (ISO);
O-ethyl S, S-diphenyl phosphorodithioate
241-178-1
17109-49-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H317
H400
H410
GHS06
GHS09
Dgr
H331
H301
H312
H317
H410
015-122-00-X
etrimfos (ISO);
O-6-ethoxy-2-ethylpyrimidin-4-yl O, O-dimethylphosphorothioate
253-855-9
38260-54-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M = 10
015-123-00-5
fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-1
22224-92-6
Acute Tox. 2
Acute Tox. 2
Acute Tox. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H300
H310
H330
H319
H400
H410
GHS06
GHS09
Dgr
H300
H310
H330
H319
H410
M = 100
M = 100
015-124-00-0
fosthietan (ISO);
diethyl 1,3-dithietan-2-ylidenephosphoramidate
244-437-7
21548-32-3
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
015-125-00-6
glyphosine (ISO);
N,N-bis(phosphonomethyl)glycine
219-468-4
2439-99-8
Eye Dam. 1
H318
GHS05
Dgr
H318
015-126-00-1
heptenophos (ISO);
7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate
245-737-0
23560-59-0
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
M = 100
015-127-00-7
iprobenfos(ISO);
S-benzyl diisopropyl phosphorothioate
247-449-0
26087-47-8
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
015-128-00-2
IPSP;
S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate
—
5827-05-4
Acute Tox. 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H301
H400
H410
GHS06
GHS09
Dgr
H310
H301
H410
M = 100
015-129-00-8
isofenphos (ISO);
O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate
246-814-1
25311-71-1
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
M = 100
015-130-00-3
isothioate (ISO);
S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;
—
36614-38-7
Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Dgr
H311
H301
015-131-00-9
isoxathion (ISO);
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate
242-624-8
18854-01-8
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
015-132-00-4
S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate; methylcarbophenothione
—
953-17-3
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
M = 1000
015-133-00-X
piperophos (ISO);
S-2-methylpiperidinocarbonylmethyl-O, O-dipropyl phosphorodithioate
—
24151-93-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M = 10
015-134-00-5
pirimiphos-methyl (ISO);
O-(2-diethylamino-6-methylpyrimidin-4-yl) O, O-dimethyl phosphorothioate
249-528-5
29232-93-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
015-135-00-0
profenofos (ISO)O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate;
255-255-2
41198-08-7
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
M = 1000
015-136-00-6
trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;
isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO)
250-517-2
31218-83-4
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
M = 100
015-137-00-1
pyrazophos (ISO);
O, O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate
236-656-1
13457-18-6
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410
015-138-00-7
quinalphos (ISO);
O, O-diethyl-O-quinoxalin-2-yl phosphorothioate
237-031-6
13593-03-8
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
M = 1000
015-139-00-2
terbufos (ISO);
S-tert-butylthiomethyl O, O-diethylphosphorodithioate;
235-963-8
13071-79-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
M = 1000
015-140-00-8
triazophos (ISO);
O, O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate
245-986-5
24017-47-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H400
H410
GHS06
GHS09
Dgr
H331
H301
H312
H410
M=100
015-141-00-3
ethylenediammonium O, O-bis(octyl) phosphorodithioate, mixed isomers
400-520-1
—
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H410
015-142-00-9
butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate
401-100-0
—
Flam. Liq. 2
Eye Irrit. 2
Aquatic Chronic 2
H225
H319
H411
GHS02
GHS07
GHS09
Dgr
H225
H319
H411
T
015-143-00-4
reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers
401-740-0
—
Acute Tox. 4 *
H302
GHS07
Wng
H302
015-144-00-X
reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate
402-090-0
87025-52-3
Skin Corr. 1B
H314
GHS05
Dgr
H314
015-145-00-5
reaction mass of copper(I) O, O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O, O-bis(4-methylpent-2-yl) phosphorodithioate
401-520-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
015-146-00-0
S-(tricyclo(5.2.1.0 2,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate
401-850-9
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
015-147-00-6
reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)
400-930-0
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H411
015-148-00-1
2-(diphosphonomethyl)succinic acid
403-070-4
51395-42-7
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
015-149-00-7
reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide
403-470-9
—
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
015-150-00-2
(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide
404-940-6
86608-70-0
Acute Tox. 4 *
Eye Dam. 1
STOT RE 2 *
Aquatic Chronic 3
H302
H318
H373 **
H412
GHS08
GHS05
GHS07
Dgr
H302
H318
H373 **
H412
015-151-00-8
tris(isopropyl/tert-butylphenyl)phosphate
405-010-2
—
Aquatic Chronic 2
H411
GHS09
H411
015-152-00-3
dioxabenzofos (ISO);
2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide
223-292-3
3811-49-2
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
Aquatic Chronic 2
H311
H301
H370 **
H411
GHS06
GHS08
GHS09
Dgr
H311
H301
H370 **
H411
015-153-00-9
isazofos (ISO);
O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O, O-diethyl phosphorothioate
255-863-8
42509-80-8
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H301
H373 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H311
H301
H373 **
H317
H410
015-154-00-4
ethephon;
2-chloroethylphosphonic acid
240-718-3
16672-87-0
Acute Tox. 3
Acute Tox. 4
Acute Tox. 4
Skin Corr. 1C
Aquatic Chronic 2
H311
H332
H302
H314
H411
GHS06
GHS05
GHS09
Dgr
H311
H332
H302
H314
H411
EUH071
015-155-00-X
glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
278-636-5
77182-82-2
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
H360Fd
H332
H312
H302
H373**
GHS08
GHS07
Dgr
H360Fd
H332
H312
H302
H373**
015-156-00-5
methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]
methacrifos (ISO);
methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]
250-366-9 [1]-[2]
30864-28-9 [1]
62610-77-9 [2]
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
015-157-00-0
phosphonic acid; [1]
phosphorous acid [2]
237-066-7 [1]
233-663-1 [2]
13598-36-2 [1]
10294-56-1 [2]
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314
015-158-00-6
(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)
402-340-9
32760-80-8
Aquatic Chronic 3
H412
—
H412
015-159-00-1
hydroxyphosphonoacetic acid
405-710-8
23783-26-8
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
H302
H373 **
H314
H317
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H314
H317
015-160-00-7
vanadyl pyrophosphate
406-260-5
58834-75-6
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
015-161-00-2
divanadyl pyrophosphate
407-130-0
65232-89-5
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
015-162-00-8
vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped
407-350-7
—
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H332
H373 **
H318
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H332
H373 **
H318
H411
015-163-00-3
bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide
412-010-6
145052-34-2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
015-164-00-9
calcium P, P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate
400-480-5
36669-85-9
Aquatic Chronic 3
H412
—
H412
015-165-00-4
reaction mass of: thiobis(4,1-phenylene)-S, S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate
404-986-7
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
015-166-00-X
3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
410-290-4
80693-00-1
Aquatic Chronic 4
H413
—
H413
015-167-00-5
3-(hydroxyphenylphosphinyl)propanoic acid
411-200-6
14657-64-8
Eye Dam. 1
H318
GHS05
Dgr
H318
015-168-00-0
fosthiazate (ISO);
(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate
—
98886-44-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H317
H400
H410
GHS06
GHS09
Dgr
H331
H301
H312
H317
H410
EUH070
015-169-00-6
tributyltetradecylphosphonium tetrafluoroborate
413-520-1
—
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 ** H314
H317
H410
015-170-00-1
reaction mass of: di-(1-octane-N, N,N-trimethylammonium) octylphosphate; 1-octane-N, N,N-trimethylammonium di-octylphosphate; 1-octane-N, N,N-trimethylammonium octylphosphate
407-490-9
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
015-171-00-7
O, O,O-tris(2(or 4)-C 9-10-isoalkylphenyl) phosphorothioate
406-940-1
—
Aquatic Chronic 2
H411
GHS09
H411
015-172-00-2
reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;
isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate
406-240-6
—
Flam. Liq. 3
Skin Corr. 1B
Aquatic Chronic 2
H226
H314
H411
GHS02
GHS05
GHS09
Dgr
H226
H314
H411
015-173-00-8
methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate
414-080-3
117291-73-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
015-174-00-3
1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine
411-370-1
82857-68-9
Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 2
H301
H318
H411
GHS06
GHS05
GHS09
Dgr
H301
H318
H411
015-175-00-9
tert-butyl (triphenylphosphoranylidene) acetate
412-880-7
35000-38-5
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H301
H373 **
H319
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H373 ** H319
H317
H411
015-176-00-4
P, P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine
413-430-2
116163-96-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
015-177-00-X
((4-phenylbutyl)hydroxyphosphoryl)acetic acid
412-170-7
83623-61-4
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H373 **
H318
H317
GHS08
GHS05
Dgr
H373 ** H318
H317
015-178-00-5
(R)-α-phenylethylammonium(-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate
418-570-8
25383-07-7
Repr. 2
Aquatic Chronic 2
H361f *** H411
GHS08
GHS09
Wng
H361f *** H411
015-179-00-0
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine
422-720-8
166242-53-1
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H351
H302
H373 ** H314
H317
H410
015-180-00-6
[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt
415-820-8
137590-32-0
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
015-181-00-1
phosphine
232-260-8
7803-51-2
Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H220
H330
H314
H400
GHS02
GHS04
GHS06
GHS05
GHS09
Dgr
H220
H330
H314
H400
U
015-182-00-7
tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)
430-630-5
10596-22-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
015-183-00-2
(1-hydroxydodecylidene)diphosphonic acid
425-230-2
16610-63-2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
015-184-00-8
salts of glyphosate, with the exception of those specified elsewhere in this Annex
—
—
Aquatic Chronic 2
H411
GHS09
H411
A
015-186-00-9
chlorpyrifos-methyl (ISO) O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
227-011-5
5598-13-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M = 10000
015-187-00-4
reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;
trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide
417-540-1
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
015-189-00-5
phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
423-340-5
162881-26-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
015-190-00-0
bis(2,4-dicumylphenyl)neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
421-920-2
154862-43-8
Aquatic Chronic 4
H413
—
H413
015-191-00-6
dodecyldiphenyl phosphate
431-760-5
27460-02-2
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
015-192-00-1
tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate
432-770-2
139189-30-3
Skin Sens. 1
H317
GHS07
Wng
H317
015-193-00-7
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)
442-960-7
332350-93-3
Acute Tox. 3 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H400
H410
GHS05
GHS06
GHS09
Dgr
H301
H318
H410
015-194-00-2
tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate
444-440-5
220689-12-3
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
015-195-00-8
reaction mass of: potassium o-toluenephosphonate;
potassium m-toluenephosphonate; potassium p-toluenephosphonate
433-860-4
—
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
015-196-00-3
reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
435-960-3
—
Carc. 1B
Muta. 1B
Skin Sens. 1
H350
H340
H317
GHS08
GHS07
Dgr
H350
H340
H317
015-197-00-9
bis(2,4,4-trimethylpentyl)dithiophosphonic acid
420-160-9
107667-02-7
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H226
H331
H302
H314
H411
GHS02
GHS06
GHS05
GHS09
Dgr
H226
H331
H302
H314
H411
015-198-00-4
(4-phenylbutyl)phosphinic acid
420-450-5
86552-32-1
Carc. 2
Eye Dam. 1
H351
H318
GHS05
GHS08
Dgr
H351
H318
015-199-00-X
tris[2-chloro-1-chloromethyl)ethyl] phosphate
237-159-2
13674-87-8
Carc. 2
H351
GSH08
Wng
H351
015-200-00-3
indium phosphide
244-959-5
22398-80-7
Carc. 1B Repr. 2
STOT RE 1
H350
H361f
H372 (lungs)
GHS08
Dgr
H350
H361f
H372 (lungs)
STOT RE 1; H372: C ≥0,1 % Carc 1B;
H350: C
≥0,01 % STOT RE 2;
H373: 0,01 % ≤
C < 0,1 %
015-201-00-9
trixylyl phosphate
246-677-8
25155-23-1
Repr. 1B
H360F
GHS08
Dgr
H360F
015-202-00-4
tris(nonylphenyl) phosphite
247-759-6
26523-78-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
015-203-00-X
diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide
278-355-8
75980-60-8
Repr. 2
H361f (causing atrophy of the testes)
GHS08
Wng
H361f (causing atrophy of the testes)
016-001-00-4
hydrogen sulphide
231-977-3
7783-06-4
Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Aquatic Acute 1
H220
H330
H400
GHS02
GHS04
GHS06
GHS09
Dgr
H220
H330
H400
U
016-002-00-X
barium sulphide
244-214-4
21109-95-5
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H302
H400
GHS07
GHS09
Wng
H332
H302
H400
EUH031
016-003-00-5
barium polysulphides
256-814-3
50864-67-0
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400
EUH031
016-004-00-0
calcium sulphide
243-873-5
20548-54-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400
EUH031
016-005-00-6
calcium polysulphides
215-709-2
1344-81-6
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400
EUH031
016-006-00-1
dipotassium sulphide;
potassium sulphide
215-197-0
1312-73-8
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031
016-007-00-7
potassium polysulphides
253-390-1
37199-66-9
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031
016-008-00-2
ammonium polysulphides
232-989-1
9080-17-5
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031
EUH031: C ≥1 %
016-009-00-8
disodium sulfide;
sodium sulfide
215-211-5
1313-82-2
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H311
H302
H314
H400
GHS06
GHS05
GHS09
Dgr
H311
H302
H314
H400
016-010-00-3
sodium polysulphides
215-686-9
1344-08-7
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H314
H400
EUH031
016-011-00-9
sulphur dioxide
231-195-2
7446-09-5
Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
H331
H314
GHS04
GHS06
GHS05
Dgr
H331
H314
*
U5
016-012-00-4
disulphur dichloride;
sulfur monochloride
233-036-2
10025-67-9
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H301
H332
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H332
H314
H400
EUH014
EUH029
STOT SE 3; H335: C ≥ 1 %
016-013-00-X
sulphur dichloride
234-129-0
10545-99-0
Skin Corr. 1B
STOT SE 3
Aquatic Acute 1
H314
H335
H400
GHS05
GHS07
GHS09
Dgr
H314
H335
H400
EUH014
STOT SE 3; H335: C ≥ 5 %
016-014-00-5
sulphur tetrachloride
—
13451-08-6
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH014
STOT SE 3; H335: C ≥ 5 %
016-015-00-0
thionyl dichloride;
thionyl chloride
231-748-8
7719-09-7
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H332
H302
H314
GHS05
GHS07
Dgr
H332
H302
H314
EUH014
EUH029
STOT SE 3; H335: C ≥ 1 %
016-016-00-6
sulphuryl chloride
232-245-6
7791-25-5
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014
016-017-00-1
chlorosulphonic acid
232-234-6
7790-94-5
Skin Corr. 1A
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014
016-018-00-7
fluorosulphonic acid
232-149-4
7789-21-1
Acute Tox. 4 *
Skin Corr. 1A
H332
H314
GHS05
GHS07
Dgr
H332
H314
016-019-00-2
oleum … % SO3
—
—
Skin Corr. 1A
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014
B
016-020-00-8
sulphuric acid … %
231-639-5
7664-93-9
Skin Corr. 1A
H314
GHS05
Dgr
H314
Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C
< 15 %
Eye Irrit. 2; H319: 5 % ≤ C
< 15 %
B
016-021-00-3
methanethiol;
methyl mercaptan
200-822-1
74-93-1
Flam. Gas. 1
Press. Gas
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H331
H400
H410
GHS02
GHS04
GHS06
GHS09
Dgr
H220
H331
H410
U
016-022-00-9
ethanethiol;
ethyl mercaptan
200-837-3
75-08-1
Flam. Liq. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H225
H332
H400
H410
GHS02
GHS07
GHS09
Dgr
H225
H332
H410
016-023-00-4
dimethyl sulphate
201-058-1
77-78-1
Carc. 1B
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H350
H341
H330
H301
H314
H317
GHS06
GHS08
GHS05
Dgr
H350
H341
H330
H301
H314
H317
Carc. 1B; H350: C ≥ 0,01 % Muta. 2 H341: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5 %
016-024-00-X
dimexano(ISO); bis(methoxythiocarbonyl) disulphide
215-993-8
1468-37-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
016-025-00-5
disul (ISO);
2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;
2,4-DES
205-259-5
149-26-8
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H302
H315
H318
GHS05
GHS07
Dgr
H302
H315
H318
016-026-00-0
sulphamidic acid;
sulphamic acid;
sulfamic acid
226-218-8
5329-14-6
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Wng
H319
H315
H412
016-027-00-6
diethyl sulphate
200-589-6
64-67-5
Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H350
H340
H332
H312
H302
H314
GHS05
GHS08
GHS07
Dgr
H350
H340
H332
H312
H302
H314
016-028-00-1
sodium dithionite;
sodium hydrosulphite
231-890-0
7775-14-6
Self-heat. 1
Acute Tox. 4 *
H251
H302
GHS02
GHS07
Dgr
H251
H302
EUH031
016-029-00-7
p-toluenesulphonic acid, (containing more than 5 % H2SO4)
—
—
Skin Corr. 1B
H314
GHS05
Dgr
H314
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
016-030-00-2
p-toluenesulphonic acid (containing a maximum of 5 % H2SO4)
203-180-0
104-15-4
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
STOT SE 3; H335: C ≥ 20 %
016-031-00-8
tetrahydrothiophene-1,1-dioxide; sulpholane
204-783-1
126-33-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
016-032-00-3
1,3-propanesultone;
1,2-oxathiolane 2,2-dioxide
214-317-9
1120-71-4
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
H350
H312
H302
GHS08
GHS07
Dgr
H350
H312
H302
Carc. 1B; H350: C ≥ 0,01 %
016-033-00-9
dimethylsulfamoylchloride
236-412-4
13360-57-1
Carc. 1B
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H350
H330
H312
H302
H314
GHS06
GHS05
GHS08
Dgr
H350
H330
H312
H302
H314
016-034-00-4
tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)
400-010-9
81898-60-4
Skin Sens. 1
H317
GHS07
Wng
H317
016-035-00-X
pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate
400-120-7
—
Eye Irrit. 2
H319
GHS07
Wng
H319
016-036-00-5
tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate
400-130-1
—
Resp. Sens. 1
Aquatic Chronic 2
H334
H411
GHS08
GHS09
Dgr
H334
H411
016-037-00-0
disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate
400-350-8
85153-93-1
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
016-038-00-6
disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate
400-380-1
86393-35-3
Skin Sens. 1
H317
GHS07
Wng
H317
016-039-00-1
tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate
400-430-2
—
Skin Sens. 1
H317
GHS07
Wng
H317
016-040-00-7
reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate
400-570-4
—
Eye Irrit. 2
H319
GHS07
Wng
H319
016-041-00-2
calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate
400-710-4
—
Acute Tox. 4 *
H332
GHS07
Wng
H332
016-042-00-8
tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate
400-790-0
85665-97-0
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
016-043-00-3
dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl) phenylazo)naphthalene-2-sulphonate
401-010-1
—
Skin Sens. 1
H317
GHS07
Wng
H317
016-044-00-9
disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate
401-320-7
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
016-045-00-4
lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate
401-560-2
108624-00-6
Skin Sens. 1
H317
GHS07
Wng
H317
016-046-00-X
sodium hydrogensulphate
231-665-7
7681-38-1
Eye Dam. 1
H318
GHS05
Dgr
H318
016-047-00-5
hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5-trisulphonate
401-650-1
85665-96-9
Skin Sens. 1
H317
GHS07
Wng
H317
016-048-00-0
sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate
401-870-8
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
016-049-00-6
calcium octadecylxylenesulphonate
402-040-8
—
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
016-050-00-1
potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat
402-150-6
—
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
016-051-00-7
trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulphonate
402-170-5
106359-91-5
Skin Sens. 1
H317
GHS07
Wng
H317
016-052-00-2
benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate
402-240-5
102561-46-6
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411
016-053-00-8
(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate
402-460-1
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
016-054-00-3
sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate
400-030-8
—
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Sens. 1
H331
H372 **
H302
H319
H335
H317
GHS06
GHS08
Dgr
H331
H372 ** H302
H319
H335
H317
016-055-00-9
tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)
400-510-7
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
016-056-00-4
potassium hydrogensulphate
231-594-1
7646-93-7
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
016-057-00-X
styrene-4-sulfonyl chloride
404-770-2
2633-67-2
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317
016-058-00-5
thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol andC 12-14-tert-alkylamine
404-820-3
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H315
H317
H412
GHS07
Wng
H315
H317
H412
016-059-00-0
N, N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride
405-300-9
17339-60-5
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H317
H400
H410
GHS07
GHS09
Wng
H302
H319
H317
H410
016-060-00-6
diammonium peroxodisulphate; ammonium persulphate
231-786-5
7727-54-0
Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H272
H302
H319
H335
H315
H334
H317
GHS03
GHS08
GHS07
Dgr
H272
H302
H319
H335
H315
H334
H317
016-061-00-1
dipotassium peroxodisulphate; potassium persulphate
231-781-8
7727-21-1
Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H272
H302
H319
H335
H315
H334
H317
GHS03
GHS08
GHS07
Dgr
H272
H302
H319
H335
H315
H334
H317
016-062-00-7
bensultap (ISO);
1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane
—
17606-31-4
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
016-063-00-2
sodium metabisulphite
231-673-0
7681-57-4
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
EUH031
016-064-00-8
sodium hydrogensulphite … %;
sodium bisulphite . . . %
231-548-0
7631-90-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
EUH031
B
016-065-00-3
sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate
400-100-8
84057-97-6
Aquatic Chronic 2
H411
GHS09
H411
016-066-00-9
tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2-sulfonatobenzylidenehydrazino)benzoate]copper(II)
404-070-7
116912-62-0
Aquatic Chronic 3
H412
—
H412
016-067-00-4
(4-methylphenyl)mesitylene sulfonate
407-530-5
67811-06-7
Aquatic Chronic 4
H413
—
H413
016-068-00-X
sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate
407-720-8
155160-86-4
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
016-069-00-5
3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid
407-990-7
141915-64-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
016-070-00-0
4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone
408-220-2
—
Aquatic Chronic 4
H413
—
H413
016-071-00-6
trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate
410-130-3
136248-03-8
Skin Sens. 1
H317
GHS07
Wng
H317
016-072-00-1
3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide
411-520-6
112195-27-4
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
016-073-00-7
tetrakis(phenylmethyl)thioperoxydi(carbothioamide)
404-310-0
10591-85-2
Aquatic Chronic 4
H413
—
H413
016-074-00-2
6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene
405-410-7
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H411
016-075-00-8
2,2'-diallyl-4,4'-sulfonyldiphenol
411-570-9
41481-66-7
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
016-076-00-3
2,3-bis((2-mercaptoethyl)thio)-1-propanethiol
411-290-7
131538-00-6
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 ** H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 ** H410
016-077-00-9
2-chloro-p-toluenesulfochloride
412-890-1
42413-03-6
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H314
H317
H412
GHS05
GHS07
Dgr
H314
H317
H412
016-078-00-4
4-methyl-N, N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide
413-300-5
56187-04-3
Aquatic Chronic 4
H413
—
016-079-00-X
N, N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide
412-920-3
16695-22-0
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
016-080-00-5
sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate
412-320-1
31361-99-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
016-081-00-0
hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide
418-350-1
—
Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H302
H319
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H302
H319
H317
H411
016-082-00-6
ethoxysulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea
—
126801-58-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
016-083-00-1
acibenzolar-S-methyl; benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester
420-050-0
135158-54-2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H317
H410
016-084-00-7
prosulfuron (ISO);
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea
—
94125-34-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=100
016-085-00-2
flazasulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
—
104040-78-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
016-086-00-8
tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
402-590-9
109125-56-6
Eye Dam. 1
H318
GHS05
Dgr
H318
016-087-00-3
reaction mass of: thiobis(4,1-phenylene)-S, S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;
propylene carbonate
403-490-8
104558-95-4
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H317
H400
H410
GHS07
GHS09
Wng
H319
H317
H410
016-088-00-9
4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid
407-280-7
71297-11-5
Aquatic Chronic 3
H412
—
H412
016-089-00-4
reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene
413-840-1
—
Self-react. C ****
Aquatic Chronic 4
H242
H413
GHS02
Dgr
H242
H413
016-090-00-X
4-methyl-N-(methylsulfonyl)benzenesulfonamide
415-040-8
14653-91-9
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H302
H335
H318
GHS05
GHS07
Dgr
H302
H335
H318
016-091-00-5
C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate
414-110-5
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
016-092-00-0
reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol
427-050-1
—
Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f
H315
H317
H410
016-093-00-6
reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);
4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)
414-770-4
140698-96-0
Self-react. C ****
Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351
016-094-00-1
sulfur
231-722-6
7704-34-9
Skin Irrit. 2
H315
GHS07
Wng
H315
016-095-00-7
reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);
reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)
417-980-4
—
Self-react. C ****
Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351
016-096-00-2
thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate
—
79277-27-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
016-097-00-8
1-amino-2-methyl-2-propanethiol hydrochloride
434-480-1
32047-53-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H302
H314
H317
H412
GHS05
GHS07
Dgr
H302
H314
H317
H412
017-001-00-7
chlorine
231-959-5
7782-50-5
Ox. Gas 1
Press. Gas
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H270
H331
H319
H335
H315
H400
GHS03
GHS04
GHS06
GHS09
Dgr
H270
H331
H319
H335
H315
H400
M = 100
U
017-002-00-2
hydrogen chloride
231-595-7
7647-01-0
Press. Gas
Acute Tox. 3 *
Skin Corr. 1A
H331
H314
GHS04
GHS06
GHS05
Dgr
H331
H314
U5
017-002-01-X
hydrochloric acid … %
231-595-7
—
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
EyeIrrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 10 %
B
017-003-00-8
barium chlorate
236-760-7
13477-00-4
Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H271
H332
H302
H411
GHS03
GHS07
GHS09
Dgr
H271
H332
H302
H411
017-004-00-3
potassium chlorate
223-289-7
3811-04-9
Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H271
H332
H302
H411
GHS03
GHS07
GHS09
Dgr
H271
H332
H302
H411
017-005-00-9
sodium chlorate
231-887-4
7775-09-9
Ox. Sol. 1
Acute Tox. 4 *
Aquatic Chronic 2
H271
H302
H411
GHS03
GHS07
GHS09
Dgr
H271
H302
H411
017-006-00-4
perchloric acid … %
231-512-4
7601-90-3
Ox. Liq. 1
Skin Corr. 1A
H271
H314
GHS03
GHS05
Dgr
H271
H314
Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 %
Skin Irrit. 2; H315: 1 % ≤ C
< 10 %
Eye Irrit. 2; H319: 1 % ≤ C
< 10 %
Ox. Liq. 1; H271: C > 50 %:
Ox. Liq. 2; H272: C ≤ 50 %:
B
017-007-00-X
barium perchlorate
236-710-4
13465-95-7
Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
H271
H332
H302
GHS03
GHS07
Dgr
H271
H332
H302
017-008-00-5
potassium perchlorate
231-912-9
7778-74-7
Ox. Sol. 1
Acute Tox. 4 *
H271
H302
GHS03
GHS07
Dgr
H271
H302
017-009-00-0
ammonium perchlorate
232-235-1
7790-98-9
Expl. 1.1
Ox. Sol. 1
H201
H271
GHS01
Dgr
H201
H271
T
017-010-00-6
sodium perchlorate
231-511-9
7601-89-0
Ox. Sol. 1
Acute Tox. 4 *
H271
H302
GHS03
GHS07
Dgr
H271
H302
017-011-00-1
sodium hypochlorite, solution… % Cl active
231-668-3
7681-52-9
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031
EUH031: C ≥5 %
B
017-012-00-7
calcium hypochlorite
231-908-7
7778-54-3
Ox. Sol. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H272
H302
H314
H400
GHS03
GHS05
GHS07
GHS09
Dgr
H272
H302
H314
H400
EUH031
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C
< 5 %
Eye Dam.1; H318: 3 % ≤ C
< 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %
M = 10
T
017-013-00-2
calcium chloride
233-140-8
10043-52-4
Eye Irrit. 2
H319
GHS07
Wng
H319
017-014-00-8
ammonium chloride
235-186-4
12125-02-9
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
017-015-00-3
(2-(aminomethyl)phenyl)acetylchloride hydrochloride
417-410-4
61807-67-8
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
017-016-00-9
methyltriphenylphosphonium chloride
418-400-2
1031-15-8
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H315
H318
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H411
017-017-00-4
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride
426-210-6
120086-58-0
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
017-018-00-X
N, N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride
405-660-7
—
Aquatic Chronic 2
H411
GHS09
H411
017-019-00-5
(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride
415-110-8
54417-53-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
017-020-00-0
ethyl propoxy aluminium chloride
421-790-7
13014-29-4
Water-react. 1
Skin Corr. 1A
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014
017-021-00-6
behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride
423-420-1
136920-10-0
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
017-023-00-7
[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N, N-dimethyl-N-(C6-18)-alkyl] trichlorides
425-520-9
197179-61-6
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
017-026-00-3
chlorine dioxide
233-162-8
10049-04-4
Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H270
H330
H314
H400
GHS04
GHS03
GHS06
GHS05
GHS09
Dgr
H270
H330
H314
H400
M = 10
5
017-026-01-0
chlorine dioxide … %
233-162-8
10049-04-4
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H314
H400
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C
< 5 %
Eye Dam.1; H318: 3 % ≤ C
< 5 %
Eye Irrit. 2; H319: 0,3 % ≤ C < 3 %
STOT SE 3; H335: C ≥ 3 % M = 10
B
019-001-00-2
potassium
231-119-8
7440-09-7
Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014
019-002-00-8
potassium hydroxide;
caustic potash
215-181-3
1310-58-3
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C
< 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
020-001-00-X
calcium
231-179-5
7440-70-2
Water-react. 2
H261
GHS02
Dgr
H261
020-002-00-5
calcium cyanide
209-740-0
592-01-8
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H410
EUH032
020-003-00-0
reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]
420-470-4
—
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
022-001-00-5
titanium tetrachloride
231-441-9
7550-45-0
Skin Corr. 1B
H314
GHS05
Dgr
H314
EUH014
022-002-00-0
titanium(4+) oxalate
403-260-7
—
Eye Dam. 1
H318
GHS05
Dgr
H318
022-003-00-6
bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium
412-000-1
125051-32-3
Flam. Sol. 1
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H228
H361f *** H373 **
H411
GHS02
GHS08
GHS09
Dgr
H228
H361f *** H373 ** H411
T
022-004-00-1
Potassium titanium oxide(K 2 Ti 6 O 13 )
432-240-0
12056-51-8
Carc. 2
H351
GHS08
Wng
H351
022-005-00-7
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium
419-840-8
169104-71-6
Flam. Sol. 1****
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H228
H314
H317
H413
GHS02
GHS05
GHS07
Dgr
H228
H314
H317
H413
023-001-00-8
divanadium pentaoxide;
vanadium pentoxide
215-239-8
1314-62-1
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Chronic 2
H341
H361d *** H372 **
H332
H302
H335
H411
GHS08
GHS07
GHS09
Dgr
H341
H361d *** H372 **
H332
H302
H335
H411
024-001-00-0
chromium (VI) trioxide
215-607-8
1333-82-0
Ox. Sol. 1
Carc. 1A
Muta. 1B Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H340
H361f *** H330
H311
H301
H372 **
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H271
H350
H340
H361f *** H330
H311
H301
H372 **
H314
H334
H317
H410
STOT SE 3; H335: C ≥ 1 %
024-002-00-6
potassium dichromate
231-906-6
7778-50-9
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
STOT SE 3; H335: C ≥ 5 %
3
024-003-00-1
ammonium dichromate
232-143-1
7789-09-5
Ox. Sol. 2 ****
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥0,2 %
Skin Sens.; H317:C ≥0,2 %
G3
024-004-00-7
sodium dichromate
234-190-3
10588-01-9
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H400
H410
GHS03
GHS06
GHS05
GHS08
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H410
Resp. Sens. 1; H334: C ≥ 0,2 %
Skin Sens. 1; H317:C ≥0,2 %
STOT SE 3; H335: C ≥ 5 %
3
024-005-00-2
chromyl dichloride;
chromic oxychloride
239-056-8
14977-61-8
Ox. Liq. 1
Carc. 1B
Muta. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350i
H340
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Dgr
H271
H350i
H340
H314
H317
H410
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C
< 10 %
Skin Irrit. 2; H315: 0,5 % ≤
C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤
C < 5 %
STOT SE 3; H335: 0,5 % ≤ C < 5 %
Skin Sens. 1; H317: C ≥ 0,5 %
T3
024-006-00-8
potassium chromate
232-140-5
7789-00-6
Carc. 1B
Muta. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H340
H319
H335
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H340
H319
H335
H315
H317
H410
Skin Sens. 1; H317:C ≥ 0,5 %
3
024-007-00-3
zinc chromates including zinc potassium chromate
—
—
Carc. 1A
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H317
H410
A
024-008-00-9
calcium chromate
237-366-8
13765-19-0
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
024-009-00-4
strontium chromate
232-142-6
7789-06-2
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H400
H410
024-010-00-X
dichromium tris(chromate);
chromium III chromate;
chromic chromate
246-356-2
24613-89-6
Ox. Sol. 1
Carc. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Dgr
H271
H350
H314
H317
H410
T
024-011-00-5
ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)
400-110-2
109125-51-1
Self-react. C ****
Aquatic Acute 1
Aquatic Chronic 1
H242
H400
H410
GHS02
GHS09
Dgr
H242
H410
024-012-00-0
trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)
400-810-8
—
Muta. 2
H341
GHS08
Wng
H341
024-013-00-6
trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)
402-500-8
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
024-014-00-1
trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)
402-870-0
93952-24-0
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
024-015-00-7
disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)
404-930-1
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H332
H318
H411
GHS05
GHS07
GHS09
Dgr
H332
H318
H411
024-016-00-2
tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)
405-110-6
88377-66-6
STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Wng
H373 **
H413
024-017-00-8
chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex
—
—
Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H317
H410
A
024-018-00-3
sodium chromate
231-889-5
7775-11-3
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
Resp. Sens.;
H334: C ≥ 0,2 %
Skin Sens.; H317:C ≥ 0,2 %
3
024-019-00-9
Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfonyl)-3''-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III)
419-230-1
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
024-020-00-4
trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)
418-220-4
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
024-021-00-X
potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)
425-830-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318
025-001-00-3
manganese dioxide
215-202-6
1313-13-9
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
025-002-00-9
potassium permanganate
231-760-3
7722-64-7
Ox. Sol. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H410
025-003-00-4
manganese sulphate
232-089-9
7785-87-7
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 ** H411
025-004-00-X
bis(N, N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate
411-760-1
116633-53-5
Aquatic Chronic 2
H411
GHS09
H411
025-005-00-5
reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C, C,C-trisulfonato (6-)-N29, N30, N31, N32] manganate (3-); tetrasodium [29H, 31H-phthalocyanine-C, C,C, C-tetrasulfonato(6-)-N29, N30, N31, N32], manganate (3-);
pentasodium [29H, 31H-phthalocyanine-C, C,C, C,C-pentasulfonato (6-)-N29, N30, N31, N32] manganate (3-)
417-660-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
026-001-00-6
(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate
407-840-0
100011-37-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
026-002-00-1
(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate
407-880-9
117549-13-0
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
026-003-00-7
iron (II) sulfate
231-753-5
7720-78-7
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
026-003-01-4
iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate
231-753-5
7782-63-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
Skin Irrit.2; H315: C ≥ 25 %
026-004-00-2
potassium ferrite
430-010-4
12160-44-0
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
027-001-00-9
cobalt
231-158-0
7440-48-4
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Dgr
H334
H317
H413
027-002-00-4
cobalt oxide
215-154-6
1307-96-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=10
027-003-00-X
cobalt sulfide
215-273-3
1317-42-6
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10
027-004-00-5
cobalt dichloride
231-589-4
7646-79-9
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F*** H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F*** H302
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 % M=10
1
027-005-00-0
cobalt sulfate
233-334-2
10124-43-3
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F*** H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F*** H302
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 % M=10
1
027-006-00-6
cobalt di(acetate)
200-755-8
71-48-7
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F*** H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F*** H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M = 10
1
027-007-00-1
zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex
425-240-7
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
027-008-00-7
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated(n H2O,2<n<3)
427-390-9
—
Skin Sens. 1
H317
GHS07
Wng
H317
027-009-00-2
cobalt dinitrate
233-402-1
10141-05-6
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F*** H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F*** H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M = 10
1
027-010-00-8
cobalt carbonate
208-169-4
513-79-1
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F*** H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F*** H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 % M=10
1
028-001-00-1
tetracarbonylnickel;
nickel tetracarbonyl
236-669-2
13463-39-3
Flam. Liq. 2
Carc. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H225
H351
H360D *** H330
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H225
H351
H360D *** H330
H410
028-002-00-7
nickel
231-111-4
7440-02-0
Carc. 2
STOT RE 1
Skin Sens. 1
H351
H372**
H317
GHS08
GHS07
Dgr
H351
H372**
H317
S7
028-002-01-4
nickel powder;
[particle diameter < 1mm]
231-111-4
7440-02-0
Carc. 2
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H351
H372**
H317
H412
GHS08
GHS07
Dgr
H351
H372**
H317
H412
028-003-00-2
nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]
215-215-7[1]
234-323-5[2]-[3]
1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413
028-004-00-8
nickel dioxide
234-823-3
12035-36-8
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413
028-005-00-3
dinickel trioxide
215-217-8
1314-06-3
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413
028-006-00-9
nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]
240-841-2[1]
234-349-7[2]-[3]
16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372**
H317
H410
028-007-00-4
trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]
234-829-6[1]
-[2]
12035-72-2 [1]
12035-71-1 [2]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372** H317
H410
028-008-00-X
nickel dihydroxide; [1]
nickel hydroxide [2]
235-008-5 [1]
234-348-1 [2]
12054-48-7 [1]
11113-74-9 [2]
Carc. 1A
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i H360D*** H341
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H360D*** H341
H372**
H332
H302
H315
H334
H317
H410
028-009-00-5
nickel sulfate
232-104-9
7786-81-4
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D*** H372** H332
H302
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥
0,01 %
M = 1
028-010-00-0
nickel carbonate;
basic nickel carbonate;
carbonic acid, nickel (2+) salt; [1]
carbonic acid, nickel salt; [2]
[μ-[carbonato(2-)-O:O']]dihydroxy trinickel; [3]
[carbonato(2-)] tetrahydroxytrinickel [4]
222-068-2 [1]
240-408-8 [2]
265-748-4 [3]
235-715-9 [4]
3333-67-3 [1]
16337-84-1 [2]
65405-96-1 [3]
12607-70-4 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D*** H372**
H332
H302
H315
H334
H317
H410
028-011-00-6
nickel dichloride
231-743-0
7718-54-9
Carc. 1A Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H331
H301
H372**
H315
H334
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H341
H360D*** H331
H301
H372**
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-012-00-1
nickel dinitrate; [1]
nitric acid, nickel salt [2]
236-068-5 [1]
238-076-4 [2]
13138-45-9 [1]
14216-75-2 [2]
Ox. Sol. 2
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350i
H341
H360D*** H372**
H332
H302
H315
H318
H334
H317
H400
H410
GHS03
GHS05
GHS08
GHS07
GHS09
Dgr
H272
H350i
H341
H360D*** H372**
H332
H302
H315
H318
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317 C ≥0,01 %
M = 1
028-013-00-7
nickel matte
273-749-6
69012-50-6
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372**
H317
H410
028-014-00-2
slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate
295-859-3
92129-57-2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D*** H372**
H332
H302
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < %
Skin Sens. 1; H317:C ≥ 0,01 %
M=1
028-015-00-8
slimes and sludges, copper electrolyte refining, decopperised
305-433-1
94551-87-8
Carc. 1A Muta. 2
Repr. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
028-016-00-3
nickel diperchlorate;
perchloric acid, nickel(II) salt
237-124-1
13637-71-3
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H314
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-017-00-9
nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]
237-563-9 [1]
239-793-2 [2]
13842-46-1 [1]
15699-18-0 [2]
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D*** H372**
H332
H302
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C ≥ 0,01 %
M=1
028-018-00-4
nickel bis(sulfamidate);
nickel sulfamate
237-396-1
13770-89-3
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C ≥ 0,01 %
M=1
028-019-00-X
nickel bis(tetrafluoroborate)
238-753-4
14708-14-6
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372** H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥0,01 %
M=1
028-021-00-0
nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]
222-101-0 [1]
239-946-6 [2]
268-755-0 [3]
3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372** H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C ≥0,01 %
M=1
028-022-00-6
nickel di(acetate); [1]
nickel acetate [2]
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D*** H372**
H332
H302
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C≥ 0,01 %
M = 1
028-024-00-7
nickel dibenzoate
209-046-8
553-71-9
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C≥ 0,01 %
M=1
028-025-00-2
nickel bis(4-cyclohexylbutyrate)
223-463-2
3906-55-6
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C ≥0,01 %
M=1
028-026-00-8
nickel(II) stearate;
nickel(II) octadecanoate
218-744-1
2223-95-2
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C;≥0,01 %
M=1
028-027-00-3
nickel dilactate
—
16039-61-5
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-028-00-9
nickel(II) octanoate
225-656-7
4995-91-9
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H314
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
028-029-00-4
nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]
233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
-[4]
10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372** H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥0,01 %
M=1
028-030-00-X
nickel hexafluorosilicate
247-430-7
26043-11-8
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C ≥ 0,01 %
M=1
028-031-00-5
nickel selenate
239-125-2
15060-62-5
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C≥0,01 %
M=1
028-032-00-0
nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt[8]
238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
-[7]
-[8]
14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
028-033-00-6
diammonium nickel hexacyanoferrate
—
74195-78-1
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i H372** H334
H317
H410
028-034-00-1
nickel dicyanide
209-160-8
557-19-7
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
EUH032
028-035-00-7
nickel chromate
238-766-5
14721-18-7
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
028-036-00-2
nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]
21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372** H317
H410
028-037-00-8
dinickel hexacyanoferrate
238-946-3
14874-78-3
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372** H317
H410
028-038-00-3
trinickel bis(arsenate);
nickel(II) arsenate
236-771-7
13477-70-8
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H372** H317
H410
028-039-00-9
nickel oxalate; [1]
oxalic acid, nickel salt [2]
208-933-7 [1]
243-867-2 [2]
547-67-1 [1]
20543-06-0 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372** H317
H410
028-040-00-4
nickel telluride
235-260-6
12142-88-0
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372** H317
H410
028-041-00-X
trinickel tetrasulfide
—
12137-12-1
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372** H317
H410
028-042-00-5
trinickel bis(arsenite)
—
74646-29-0
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372** H317
H410
028-043-00-0
cobalt nickel gray periclase;
C.I. Pigment Black 25; C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]
269-051-6 [1]
261-346-8 [2]
-[3]
68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i H372** H317
028-044-00-6
nickel tin trioxide;
nickel stannate
234-824-9
12035-38-0
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i H372**
H317
028-045-00-1
nickel triuranium decaoxide
239-876-6
15780-33-3
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i H372**
H317
028-046-00-7
nickel dithiocyanate
237-205-1
13689-92-4
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
EUH032
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C≥0,01 %
M=1
028-047-00-2
nickel dichromate
239-646-5
15586-38-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317:C≥0,01 %
M=1
028-048-00-8
nickel(II) selenite
233-263-7
10101-96-9
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i H372**
H334
H317
H410
028-049-00-3
nickel selenide
215-216-2
1314-05-2
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372**
H317
H410
028-050-00-9
silicic acid, lead nickel salt
—
68130-19-8
Carc. 1A
Repr. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360Df H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H360Df H372**
H317
H410
028-051-00-4
nickel diarsenide; [1]
nickel arsenide [2]
235-103-1 [1]
248-169-1 [2]
12068-61-0 [1]
27016-75-7 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372**
H317
H410
028-052-00-X
nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157; C.I. 77900
271-853-6
68610-24-2
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i H372**
H317
028-053-00-5
nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]
267-897-0 [1]
238-596-1 [2]
275-897-7 [3]
67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < %
Skin Sens. 1; H317:C≥0,01%1
M=1
028-054-00-0
nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickelsalt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt;[16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O 1,O 2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids, C6-19-branched, nickel salts; [29]
fatty acids, C 8-18 and C18-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]
240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
294-302-1 [29]
283-972-0 [30]
-[31]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9
[25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]
Carc. 1A Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D*** H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D*** H372**
H334
H317
H410
STOT RE 1;
H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥
0,01 % M=1
028-055-00-6
nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4]
231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]
7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i H372**
H334
H317
H410
028-056-00-1
nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]
234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
-[8]
12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i H372**
H317
H410
028-057-00-7
dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]
234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
-[10]
-[11]
12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i H372**
H317
028-058-00-2
cobalt lithium nickel oxide
442-750-5
—
Carc. 1A
Acute Tox. 2 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H330
H372**
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H330
H372**
H317
H410
029-001-00-4
copper chloride;
copper (I) chloride;
cuprous chloride
231-842-9
7758-89-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H400
H410
029-003-00-5
naphthenic acids, copper salts;
copper naphthenate
215-657-0
1338-02-9
Flam. Liq. 3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H400
H410
GHS02
GHS07
GHS09
Wng
H226
H302
H410
029-004-00-0
copper sulphate
231-847-6
7758-98-7
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410
029-005-00-6
(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid
401-260-1
—
Eye Irrit. 2
H319
GHS07
Wng
H319
029-006-00-1
tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)
403-210-4
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
029-007-00-7
(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide
404-670-9
89797-01-3
Skin Sens. 1
H317
GHS07
Wng
H317
G
029-008-00-2
copper(II) methanesulfonate
405-400-2
54253-62-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
029-009-00-8
phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex
413-650-9
93971-95-0
Aquatic Chronic 3
H412
—
H412
029-010-00-3
reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II)to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)
407-700-9
101408-30-4
Skin Sens. 1
H317
GHS07
Wng
H317
029-011-00-9
sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex
412-730-0
150522-10-4
Skin Corr. 1B
H314
GHS05
Dgr
H314
029-012-00-4
sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)
407-340-2
124719-24-0
Eye Dam. 1
H318
GHS05
Dgr
H318
029-013-00-X
trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)
407-580-8
130201-51-3
Eye Dam. 1
H318
GHS05
Dgr
H318
029-014-00-5
reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N, N',O, O'-copper complex;2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N, N',O, O'-copper complex
419-610-7
171866-24-3
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411
030-001-00-1
zinc powder — zinc dust (pyrophoric)
231-175-3
7440-66-6
Water-react. 1
Pyr. Sol. 1
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H400
H410
GHS02
GHS09
Dgr
H260
H250
H410
T
030-001-01-9
zinc powder — zinc dust (stabilised)
231-175-3
7440-66-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
030-003-00-2
zinc chloride
231-592-0
7646-85-7
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
STOT SE 3; H335: C ≥ 5 %
030-004-00-8
dimethylzinc; [1]
diethylzinc [2]
208-884-1 [1]
209-161-3 [2]
544-97-8 [1]
557-20-0 [2]
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H260
H314
H400
H410
GHS02
GHS05
GHS09
Dgr
H250
H260
H314
H410
EUH014
030-005-00-3
diamminediisocyanatozinc
401-610-3
—
Acute Tox. 4 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
H302
H318
H334
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H318
H334
H317
H400
030-006-00-9
zinc sulphate (hydrous) (mono-, hexa-and hepta hydrate); [1]
zinc sulphate (anhydrous) [2]
231-793-3 [1]
231-793-3 [2]
7446-19-7 [1]
7733-02-0 [2]
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
030-007-00-4
bis(3,5-di-tert-butylsalicylato-O 1,O 2)zinc
403-360-0
42405-40-3
Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H228
H302
H400
H410
GHS02
GHS07
GHS09
Dgr
H228
H302
H410
T
030-008-00-X
hydroxo(2-(benzenesulfonamido)benzoato)zinc(II)
403-750-0
113036-91-2
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411
030-009-00-5
zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate
417-130-2
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
030-010-00-0
2-dodec-1-enylbutanedioic acid,4-methyl ester zinc salt
430-740-3
—
Aquatic Chronic 2
H411
GHS09
H411
030-011-00-6
trizinc bis(orthophosphate)
231-944-3
7779-90-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
030-012-00-1
aluminium-magnesium-zinc-carbonate-hydroxide
423-570-6
169314-88-9
Aquatic Chronic 4
H413
H413
030-013-00-7
zinc oxide
215-222-5
1314-13-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
030-015-00-8
tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate
440-060-9
—
Aquatic Chronic 2
H411
GHS09
H411
033-001-00-X
arsenic
231-148-6
7440-38-2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
033-002-00-5
arsenic compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
*
A1
033-003-00-0
diarsenic trioxide;
arsenic trioxide
215-481-4
1327-53-3
Carc. 1A
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H300
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H300
H314
H410
033-004-00-6
diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide
215-116-9
1303-28-2
Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410
033-005-00-1
arsenic acid and it salts with the exception of those specified elsewhere in this Annex
—
—
Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410
A
033-006-00-7
arsine
232-066-3
7784-42-1
Flam. Gas 1
Press. Gas
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H330
H373 **
H400
H410
GHS02
GHS04
GHS06
GHS08
GHS09
Dgr
H220
H330
H373 ** H410
U
033-007-00-2
tert-butylarsine
423-320-6
4262-43-5
Pyr. Liq. 1
Acute Tox. 2 *
H250
H330
GHS02
GHS06
Dgr
H250
H330
034-001-00-2
selenium
231-957-4
7782-49-2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 4
H331
H301
H373 **
H413
GHS06
GHS08
Dgr
H331
H301
H373 ** H413
034-002-00-8
selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H373**
H410
A
034-003-00-3
sodium selenite
233-267-9
10102-18-8
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 2
H300
H331
H317
H411
GHS06
GHS09
Dgr
H300
H331
H317
H411
EUH031
035-001-00-5
bromine
231-778-1
7726-95-6
Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H330
H314
H400
GHS06
GHS05
GHS09
Dgr
H330
H314
H400
035-002-00-0
hydrogen bromide
233-113-0
10035-10-6
Press. Gas
Skin Corr. 1A
STOT SE 3
H314
H335
GHS04
GHS05
GHS07
Dgr
H314
H335
U
035-002-01-8
hydrobromic acid … %
—
—
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 %
Eye Irrit. 2; H319: 10 % ≤ C < 40 %
STOT SE 3; H335: C ≥ 10 %
B
035-003-00-6
potassium bromate
231-829-8
7758-01-2
Ox. Sol. 1
Carc. 1B
Acute Tox. 3 *
H271
H350
H301
GHS03
GHS06
GHS08
Dgr
H271
H350
H301
035-004-00-1
2-hydroxyethylammonium perbromide
407-440-6
—
Ox. Sol. 2 ****
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H272
H302
H314
H317
H400
GHS03
GHS05
GHS07
GHS09
Dgr
H272
H302
H314
H317
H400
040-001-00-3
zirconium powder (pyrophoric)
231-176-9
7440-67-7
Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Dgr
H260
H250
T
040-002-00-9
zirconium powder, dry (non pyrophoric)
—
—
Self-heat. 1
H251
GHS02
Dgr
H251
T
040-003-00-4
reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS= 1.0:1.0 to 1.0: 1.5
430-610-6
226996-19-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
042-001-00-9
molybdenum trioxide
215-204-7
1313-27-5
Carc. 2
Eye Irrit. 2
STOT SE 3
H351
H319
H335
GHS08
GHS07
Wng
H351
H319
H335
042-002-00-4
tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-)
404-760-8
117342-25-3
Acute Tox. 3 *
Eye Dam. 1
H331
H318
GHS06
GHS05
Dgr
H331
H318
042-003-00-X
tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)
404-860-1
116810-46-9
Flam. Sol. 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H228
H318
H400
H410
GHS02
GHS05
GHS09
Dgr
H228
H318
H410
T
042-004-00-5
reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3)
412-780-3
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
042-005-00-0
reaction mass of: mono-and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine, N-[3-(tridecyloxy)-propyl];
N, N-diorgano dithiocarbamate molybdenum complex
434-240-6
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
046-001-00-X
tetraammine palladium (II)hydrogen carbonate
425-270-0
134620-00-1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373** H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373** H318
H317
H410
047-001-00-2
silver nitrate
231-853-9
7761-88-8
Ox. Sol. 2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H272
H314
H400
H410
GHS03
GHS05
GHS09
Dgr
H272
H314
H410
047-002-00-8
polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt
416-850-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
048-001-00-5
cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
*
A1
048-002-00-0
cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2]
231-152-8 [1]
215-146-2 [2]
7440-43-9 [1]
1306-19-0 [2]
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361fd
H330
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361fd
H330
H372 ** H410
048-003-00-6
cadmium diformate;
cadmiumformate
224-729-0
4464-23-7
Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 ** H410
*
STOT RE 2; H373: C ≥0,25 %
048-004-00-1
cadmium cyanide
208-829-1
542-83-6
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H351
H373 ** H410
EUH032
STOT RE 2; H373: C ≥0,1 %
EUH032:C≥1 %
048-005-00-7
cadmiumhexafluorosilicate(2-);
cadmium fluorosilica
241-084-0
17010-21-8
Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 ** H410
*
STOT RE 2; H373: C ≥0,1 %
048-006-00-2
cadmium fluoride
232-222-0
7790-79-6
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD H330
H301
H372 ** H410
Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 % STOT RE 2:
0,1 % ≤ C <7 %
048-007-00-8
cadmium iodide
232-223-6
7790-80-9
Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 ** H410
*
STOT RE 2; H373: C ≥ 0,1 %
048-008-00-3
cadmium chloride
233-296-7
10108-64-2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD H330
H301
H372 ** H410
Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 %
048-009-00-9
cadmium sulphate
233-331-6
10124-36-4
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD H330
H301
H372 ** H410
Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373 0,1 % ≤ C < 7 %
048-010-00-4
cadmium sulphide
215-147-8
1306-23-6
Carc. 1B
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 4
H350
H341
H361fd
H372 **
H302
H413
GHS08
GHS07
Dgr
H350
H341
H361fd
H372 ** H302
H413
*
STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10 %
1
048-011-00-X
cadmium (pyrophoric)
231-152-8
7440-43-9
Pyr. Sol. 1
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H250
H350
H341
H361fd
H330
H372 **
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H250
H350
H341
H361fd
H330
H372 ** H410
050-001-00-5
tin tetrachloride;
stannic chloride
231-588-9
7646-78-8
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
STOT SE 3; H335:C≥5 %
050-002-00-0
cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide
236-049-1
13121-70-5
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
M=1000
050-003-00-6
fentin acetate (ISO);
triphenyltin acetate
212-984-0
900-95-8
Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d*** H330
H311
H301
H372**
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d*** H330
H311
H301
H372**
H335
H315
H318
H410
M=10
050-004-00-1
fentin hydroxide (ISO);
triphenyltin hydroxide
200-990-6
76-87-9
Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d*** H330
H311
H301
H372**
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d*** H330
H311
H301
H372**
H335
H315
H318
H410
M=10
050-005-00-7
trimethyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
*
A1
050-006-00-2
triethyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
*
A1
050-007-00-8
tripropyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
*
A1
050-009-00-9
fluorotripentylstannane;[1]
hexapentyldistannoxane [2]
243-546-7 [1]
247-143-7 [2]
20153-49-5 [1]
25637-27-8 [2]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
*
1
050-010-00-4
fluorotrihexylstannane
243-547-2
20153-50-8
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
*
1
050-011-00-X
triphenyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
* M=100
A1
050-012-00-5
tetracyclohexylstannane; [1] chlorotricyclohexylstannane; [2] butyltricyclohexylstannane [3]
215-910-5 [1]
221-437-5 [2]
230-358-5 [3]
1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
*
A1
050-013-00-0
trioctyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 4
H319
H335
H315
H413
GHS07
Wng
H319
H335
H315
H413
Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %
A1
050-017-00-2
fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide
236-407-7
13356-08-6
Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H330
H319
H315
H400
H410
GHS06
GHS09
Dgr
H330
H319
H315
H410
050-018-00-8
tin(II) methanesulphonate
401-640-7
53408-94-9
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H411
050-019-00-3
azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H-1,2,4-triazole
255-209-1
41083-11-8
Acute Tox. 2 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H335
H315
H318
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H301
H335
H315
H318
H410
050-020-00-9
trioctylstannane
413-320-4
869-59-0
STOT RE 1
Skin Irrit. 2
Aquatic Chronic 4
H372 **
H315
H413
GHS08
GHS07
Dgr
H372 ** H315
H413
050-021-00-4
dichlorodioctyl stannane
222-583-2
3542-36-7
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
H331
H372**
H412
GHS06
GHS08
Dgr
H331
H372**
H412
050-022-00-X
dibutyltin dichloride;
(DBTC)
211-670-0
683-18-1
Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H360FD
H330
H301
H312
H372**
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H360FD H330
H301
H312
H372**
H314
H410
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 %
Eye Dam.1; H318: 3 % ≤ C
< 5 %
Eye Irrit. 2; H319: 0,01 % ≤ C < 3 %
M=10
050-023-00-5
reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane
422-920-5
—
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
M=10
050-024-00-0
reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane
432-230-6
—
STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H372**
H302
H315
H318
H317
H410
050-025-00-6
trichloromethylstannane
213-608-8
993-16-8
Repr. 2
H361d
GHS08
Wng
H361d
050-026-00-1
2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
260-828-5
57583-34-3
Repr. 2
H361d
GHS08
Wng
H361d
050-027-00-7
2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
239-622-4
15571-58-1
Repr. 1B
H360D
GHS08
Dgr
H360D
050-028-00-2
2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
260-829-0
57583-35-4
Repr. 2
Acute Tox. 4
STOT RE 1
Skin Sens. 1A
H361d
H302
H372
(nervous system, immune system)
H317
GHS08
GHS07
Dgr
H361d
H302
H372 (nervous system, immune system)
H317
050-029-00-8
dimethyltin dichloride
212-039-2
753-73-1
Repr. 2
Acute Tox. 2
Acute Tox. 3
Acute Tox. 3
STOT RE 1
Skin Corr. 1B
H361d
H330
H301
H311
H372
(nervous system, immune system)
H314
GHS08
GHS06
GHS05
Dgr
H361d
H330
H301
H311
H372 (nervous system, immune system)
H314
EUH071
051-001-00-8
antimony trichloride
233-047-2
10025-91-9
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
STOT SE3; H335: C ≥ 5 %
051-002-00-3
antimony pentachloride
231-601-8
7647-18-9
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
STOT SE 3; H335: C ≥ 5 %
051-003-00-9
antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411
*
A1
051-004-00-4
antimony trifluoride
232-009-2
7783-56-4
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H331
H311
H301
H411
GHS06
GHS09
Dgr
H331
H311
H301
H411
051-005-00-X
antimony trioxide
215-175-0
1309-64-4
Carc. 2
H351
GHS08
Wng
H351
051-006-00-5
diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate
403-500-0
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
051-007-00-0
bis(4-dodecylphenyl)iodonium hexafluoroantimonate
404-420-9
71786-70-4
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
053-001-00-3
iodine
231-442-4
7553-56-2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H312
H400
GHS07
GHS09
Wng
H332
H312
H400
053-002-00-9
hydrogen iodide
233-109-9
10034-85-2
Press. Gas
Skin Corr. 1A
H314
GHS04
GHS05
Dgr
H314
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %
Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %
STOT SE 3; H335: C ≥0,02 %
U5
053-002-01-6
hydriodic acid … %
—
—
Skin Corr. 1B
H314
GHS05
Dgr
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
053-003-00-4
iodoxybenzene
—
696-33-3
Expl. ****
****
****
****
053-004-00-X
calcium iodoxybenzoate
—
—
Expl. ****
****
****
****
C
053-005-00-5
(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate(1-)
422-960-3
178233-72-2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373 ** H410
056-001-00-1
barium peroxide
215-128-4
1304-29-6
Ox. Sol. 2
Acute Tox. 4 *
Acute Tox. 4 *
H272
H332
H302
GHS03
GHS07
Dgr
H272
H332
H302
056-002-00-7
barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
*
A1
056-003-00-2
barium carbonate
208-167-3
513-77-9
Acute Tox. 4 *
H302
GHS07
Wng
H302
056-004-00-8
barium chloride
233-788-1
10361-37-2
Acute Tox. 3 *
Acute Tox. 4 *
H301
H332
GHS06
Dgr
H301
H332
064-001-00-8
gadolinium(III)sulfite trihydrate
456-900-2
51285-81-5
Aquatic Chronic 2
H411
GHS09
H411
072-001-00-4
hafnium tetra-n-butoxide
411-740-2
22411-22-9
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
074-001-00-X
hexasodium tungstate hydrate
412-770-9
12141-67-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
074-002-00-5
reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione
408-250-6
—
Flam. Liq. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H225
H332
H314
H317
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H225
H332
H314
H317
H410
076-001-00-5
osmium tetraoxide;
osmic acid
244-058-7
20816-12-0
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B
H330
H310
H300
H314
GHS06
GHS05
Dgr
H330
H310
H300
H314
078-001-00-0
tetrachloroplatinates with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317
A
078-002-00-6
diammonium tetrachloroplatinate
237-499-1
13820-41-2
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H315
H318
H334
H317
078-003-00-1
disodium tetrachloroplatinate
233-051-4
10026-00-3
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H315
H318
H334
H317
078-004-00-7
dipotassium tetrachloroplatinate
233-050-9
10025-99-7
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H315
H318
H334
H317
078-005-00-2
hexachloroplatinates with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317
A
078-006-00-8
disodium hexachloroplatinate
240-983-5
16923-58-3
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317
078-007-00-3
dipotassium hexachloroplatinate
240-979-3
16921-30-5
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317
078-008-00-9
diammonium hexachloroplatinate
240-973-0
16919-58-7
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317
078-009-00-4
hexachloroplatinic acid
241-010-7
16941-12-1
Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H301
H314
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H314
H334
H317
078-010-00-X
tetraammine platinum (II)
hydrogen carbonate
426-730-3
123439-82-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
078-011-00-5
hydroxydisulfito platinum(II)acid
423-310-1
61420-92-6
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373
H314
H334
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373
H314
H334
H317
H412
078-012-00-0
platinum(IV) nitrate/nitric acid solution
432-400-1
—
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
080-001-00-0
mercury
231-106-7
7439-97-6
Repr. 1B
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H360D*** H330
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D*** H330
H372**
H410
080-002-00-6
Inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 ** H410
*
STOT RE 2; H373: C ≥ 0,1 %
A1
080-003-00-1
dimercury dichloride;
mercurous chloride;
calomel
233-307-5
10112-91-1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410
080-004-00-7
organic compounds of mercury with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 ** H410
*
STOT RE 2; H373: C ≥0,1 %
A1
080-005-00-2
mercury difulminate;
mercuric fulminate;
fulminate of mercury
211-057-8
628-86-4
Unst. Expl.
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H331
H311
H301
H373 **
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H200
H331
H311
H301
H373 ** H400
H410
080-005-01-X
mercury difulminate;
mercuric fulminate;
fulminate of mercury [≥ 20 % phlegmatiser]
211-057-8
628-86-4
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H331
H311
H301
H373 **
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H331
H311
H301
H373 ** H400
H410
080-006-00-8
dimercury dicyanide oxide;
mercuric oxycyanide
215-629-8
1335-31-5
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H331
H311
H301
H373**
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H331
H311
H301
H373**
H410
080-007-00-3
dimethylmercury; [1]
diethylmercury [2]
209-805-3 [1]
211-000-7 [2]
593-74-8 [1]
627-44-1 [2]
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 ** H410
*
STOT RE 2; H373: C ≥0,05 %
1
080-008-00-9
phenylmercury nitrate; [1] phenylmercury hydroxide; [2]
basic phenylmercury nitrate [3]
200-242-9 [1]
202-866-7 [2]
-[3]
55-68-5 [1]
100-57-2 [2]
8003-05-2 [3]
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H301
H372 ** H314
H410
080-009-00-4
2-methoxyethylmercury chloride
204-659-7
123-88-6
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H301
H372 ** H314
H410
080-010-00-X
mercury dichloride;
mercuric chloride
231-299-8
7487-94-7
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H361f*** H300
H372**
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H361f*** H300
H372**
H314
H410
080-011-00-5
phenylmercury acetate
200-532-5
62-38-4
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H301
H372 ** H314
H410
081-001-00-3
thallium
231-138-1
7440-28-0
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4
H330
H300
H373 **
H413
GHS06
GHS08
Dgr
H330
H300
H373 ** H413
081-002-00-9
thallium compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H330
H300
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H373 ** H411
A
081-003-00-4
dithallium sulphate;
thallic sulphate
231-201-3
7446-18-6
Acute Tox. 2 *
STOT RE 1
Skin Irrit. 2
Aquatic Chronic 2
H300
H372 **
H315
H411
GHS06
GHS08
GHS09
Dgr
H300
H372 ** H315
H411
082-001-00-6
lead compounds with the exception of those specified elsewhere in this Annex
—
—
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H360Df
H332
H302
H373 ** H410
Repr.2 H361f: C ≥ 2,5 %
*
STOT RE 2; H373: C ≥0,5 %
A1
082-002-00-1
lead alkyls
—
—
Repr. 1A
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H360Df
H330
H310
H300
H373 ** H410
Repr.1A; H360D: C≥ 0,1 %
*
STOT RE 2; H373: C ≥0,05 %
A1
082-003-00-7
lead diazide;
lead azide
236-542-1
13424-46-9
Unst. Expl. Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H200
H360Df
H332
H302
H373 ** H410
1
082-003-01-4
lead diazide;
lead azide [≥ 20 % phlegmatiser]
236-542-1
13424-46-9
Expl. 1.1
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H201
H360Df
H332
H302
H373 ** H410
1
082-004-00-2
lead chromate
231-846-0
7758-97-6
Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df H373**
H410
1
082-005-00-8
lead di(acetate)
206-104-4
301-04-2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 **
H400
H410
GHS08
GHS09
Dgr
H360Df
H373 ** H410
1
082-006-00-3
trilead bis(orthophosphate)
231-205-5
7446-27-7
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 **
H400
H410
GHS08
GHS09
Dgr
H360Df
H373 ** H410
1
082-007-00-9
lead acetate, basic
215-630-3
1335-32-6
Carc. 2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H360Df
H373 **
H400
H410
GHS08
GHS09
Dgr
H351
H360Df
H373 ** H410
1
082-008-00-4
lead(II) methanesulphonate
401-750-5
17570-76-2
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H360Df
H332
H302
H373 **
H315
H318
GHS08
GHS05
GHS07
Dgr
H360Df
H332
H302
H373 ** H315
H318
1
082-009-00-X
lead sulfochromate yellow; C.I. Pigment Yellow 34;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]
215-693-7
1344-37-2
Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df H373**
H410
1
082-010-00-5
lead chromate molybdate sulfate red; C.I. Pigment Red 104;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]
235-759-9
12656-85-8
Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df H373**
H410
1
082-011-00-0
lead hydrogen arsenate
232-064-2
7784-40-9
Carc. 1A
Repr. 1A
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H331
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H360Df
H331
H301
H373 ** H410
1
082-012-00-6
barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped
431-780-4
199876-46-5
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373**
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H411
092-001-00-8
uranium
231-170-6
7440-61-1
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4
H330
H300
H373 **
H413
GHS06
GHS08
Dgr
H330
H300
H373 ** H413
092-002-00-3
uranium compounds with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H330
H300
H373**
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H373**
H411
A
601-001-00-4
methane
200-812-7
74-82-8
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
601-002-00-X
ethane
200-814-8
74-84-0
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
601-003-00-5
propane
200-827-9
74-98-6
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
601-004-00-0
butane; [1] and isobutane [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
C U
601-004-01-8
butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]
isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340
C S U
601-005-00-6
2,2-dimethylpropane;
neopentane
207-343-7
463-82-1
Flam. Gas 1
Press. Gas
Aquatic Chronic 2
H220
H411
GHS02
GHS04
GHS09
Dgr
H220
H411
U
601-006-00-1
pentane
203-692-4
109-66-0
Flam. Liq. 2
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H225
H304
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H336
H411
EUH066
C
601-007-00-7
hexane (containing < 5 % n-hexane (203-777-6));
2-methylpentane;[1]
3-methylpentane; [2]
2,2-dimethylbutane; [3]
2,3-dimethylbutane [4]
203-523-4 [1]
202-481-4 [2]
200-906-8 [3]
201-193-6 [4]
107-83-5 [1]
96-14-0 [2]
75-83-2 [3]
79-29-8 [4]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H411
C
601-008-00-2
heptane; n-heptane; [1]
2,4-dimethylpentane; [2]
2,2,3-trimethylbutane; [3]
3,3-dimethylpentane; [4]
2,3-dimethylpentane; [5]
3-methylhexane; [6]
2,2-dimethylpentane; [7]
2-methylhexane; [8]
3-ethylpentane; [9]
isoheptane; [10]
205-563-8 [1]
203-548-0 [2]
207-346-3 [3]
209-230-8 [4]
209-280-0 [5]
209-643-3 [6]
209-680-5 [7]
209-730-6 [8]
210-529-0 [9]
250-610-8 [10]
142-82-5 [1]
108-08-7 [2]
464-06-2 [3]
562-49-2 [4]
565-59-3 [5]
589-34-4 [6]
590-35-2 [7]
591-76-4 [8]
617-78-7 [9]
31394-54-4 [10]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410
C
601-009-00-8
octane; n-octane; [1]
2,2,4-trimethylpentane; [2]
2,3,3-trimethylpentane; [3]
3,3-dimethylhexane; [4]
2,2,3-trimethylpentane; [5]
2,3,4-trimethylpentane; [6]
3,4-dimethylhexane; [7]
2,3-dimethylhexane; [8]
2,4-dimethylhexane; [9]
4-methylheptane; [10]
3-methylheptane; [11]
2,2-dimethylhexane; [12]
2,5-dimethylhexane; [13]
2-methylheptane; [14]
2,2,3,3-tetramethylbutane; [15]
3-ethyl-2-methylpentane; [16]
3-ethylhexane; [17]
3-ethyl-3-methylpentane; [18]
isooctane; [19]
203-892-1 [1]
208-759-1 [2]
209-207-2 [3]
209-243-9 [4]
209-266-4 [5]
209-292-6 [6]
209-504-7 [7]
209-547-1 [8]
209-649-6 [9]
209-650-1 [10]
209-660-6 [11]
209-689-4 [12]
209-745-8 [13]
209-747-9 [14]
209-855-6 [15]
210-187-2 [16]
210-621-0 [17]
213-923-0 [18]
247-861-0 [19]
111-65-9 [1]
540-84-1 [2]
560-21-4 [3]
563-16-6 [4]
564-02-3 [5]
565-75-3 [6]
583-48-2 [7]
584-94-1 [8]
589-43-5 [9]
589-53-7 [10]
589-81-1 [11]
590-73-8 [12]
592-13-2 [13]
592-27-8 [14]
594-82-1 [15]
609-26-7 [16]
619-99-8 [17]
1067-08-9 [18]
26635-64-3 [19]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410
C
601-010-00-3
ethylene
200-815-3
74-85-1
Flam. Gas 1
Press. Gas
STOT SE 3
H220
H336
GHS02
GHS04
GHS07
Dgr
H220
H336
U
601-011-00-9
propene;
propylene
204-062-1
115-07-1
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
601-012-00-4
but-1-ene; [1]
butene, mixed-1-and-2-isomers; [2]
2-methylpropene; [3]
(Z)-but-2-ene; [4]
(E)-but-2-ene [5]
203-449-2 [1]
203-452-9 [2]
204-066-3 [3]
209-673-7 [4]
210-855-3 [5]
106-98-9 [1]
107-01-7 [2]
115-11-7 [3]
590-18-1 [4]
624-64-6 [5]
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
C U
601-013-00-X
1,3-butadiene;
buta-1,3-diene
203-450-8
106-99-0
Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340
D U
601-014-00-5
isoprene (stabilised)
2-methyl-1,3-butadiene
201-143-3
78-79-5
Flam. Liq. 1
Carc. 1B Muta. 2
Aquatic Chronic 3
H224
H350
H341
H412
GHS02
GHS08
Dgr
H224
H350
H341
H412
D
601-016-00-6
cyclopropane
200-847-8
75-19-4
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
601-017-00-1
cyclohexane
203-806-2
110-82-7
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410
601-018-00-7
methylcyclohexane
203-624-3
108-87-2
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H411
601-019-00-2
1,4-dimethylcyclohexane
209-663-2
589-90-2
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H411
601-020-00-8
benzene
200-753-7
71-43-2
Flam. Liq. 2
Carc. 1a
Muta. 1B
STOT RE 1
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
H225
H350
H340
H372 **
H304
H319
H315
GHS02
GHS08
GHS07
Dgr
H225
H350
H340
H372 ** H304
H319
H315
E
601-021-00-3
toluene
203-625-9
108-88-3
Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
H225
H361d *** H304
H373 **
H315
H336
GHS02
GHS08
GHS07
Dgr
H225
H361d *** H304
H373 ** H315
H336
601-022-00-9
o-xylene; [1]
p-xylene; [2]
m-xylene; [3]
xylene [4]
202-422-2 [1]
203-396-5 [2]
203-576-3 [3]
215-535-7 [4]
95-47-6 [1]
106-42-3 [2]
108-38-3 [3]
1330-20-7 [4]
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
H226
H332
H312
H315
GHS02
GHS07
Wng
H226
H332
H312
H315
*
C
601-023-00-4
ethylbenzene
202-849-4
100-41-4
Flam. Liq. 2
Acute Tox. 4*
STOT RE 2
Asp. Tox. 1
H225
H332
H373
(hearing organs)
H304
GHS02
GHS07
GHS08
Dgr
H225
H332
H373
(hearing organs)
H304
601-024-00-X
cumene; [1]
propylbenzene [2]
202-704-5 [1]
203-132-9 [2]
98-82-8 [1]
103-65-1 [2]
Flam. Liq. 3
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H226
H304
H335
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H304
H335
H411
C
601-025-00-5
mesitylene;
1,3,5-trimethylbenzene
203-604-4
108-67-8
Flam. Liq. 3
STOT SE 3
Aquatic Chronic 2
H226
H335
H411
GHS02
GHS07
GHS09
Wng
H226
H335
H411
STOT SE 3; H335: C ≥ 25 %
601-026-00-0
styrene
202-851-5
100-42-5
Flam. Liq. 3
Repr. 2
Acute Tox. 4*
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2
H226
H361d
H332
H372
(hearing organs)
H315
H319
GHS02
GHS08
GHS07
Dgr
H226
H361d
H332
H372
(hearing organs)
H315
H319
*
D
601-027-00-6
2-phenylpropene;
α-methylstyrene
202-705-0
98-83-9
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 2
H226
H319
H335
H411
GHS02
GHS07
GHS09
Wng
H226
H319
H335
H411
STOT SE 3; H335: C ≥ 25 %
601-028-00-1
2-methylstyrene;
2-vinyltoluene
210-256-7
611-15-4
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411
601-029-00-7
dipentene; limonene;[1]
(R)-p-mentha-1,8-diene;
d-limonene; [2]
(S)-p-mentha-1,8-diene; l-limonene; [3]
trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]
(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5]
205-341-0 [1]
227-813-5 [2]
227-815-6 [3]
229-977-3 [4]
231-732-0 [5]
138-86-3 [1]
5989-27-5 [2]
5989-54-8 [3]
6876-12-6 [4]
7705-14-8 [5]
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H315
H317
H400
H410
GHS02
GHS07
GHS09
Wng
H226
H315
H317
H410
C
601-030-00-2
cyclopentane
206-016-6
287-92-3
Flam. Liq. 2
Aquatic Chronic 3
H225
H412
GHS02
Dgr
H225
H412
601-031-00-8
2,4,4-trimethylpent-1-ene
203-486-4
107-39-1
Flam. Liq. 2
Aquatic Chronic 2
H225
H411
GHS02
GHS09
Dgr
H225
H411
601-032-00-3
benzo[a]pyrene;
benzo[def]chrysene
200-028-5
50-32-8
Carc. 1B
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H360FD H317
H410
Carc. 1B; H350: C ≥ 0,01 %
601-033-00-9
benz[a]anthracene
200-280-6
56-55-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
M=100
601-034-00-4
benz[e]acephenanthrylene
205-911-9
205-99-2
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
601-035-00-X
benzo[j]fluoranthene
205-910-3
205-82-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
601-036-00-5
benzo[k]fluoranthene
205-916-6
207-08-9
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
601-037-00-0
n-hexane
203-777-6
110-54-3
Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H361f *** H304
H373 **
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H361f *** H304
H373 ** H315
H336
H411
STOT RE 2; H373: C ≥ 5 %
601-041-00-2
dibenz[a,h]anthracene
200-181-8
53-70-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
Carc. 1B; H350: C ≥ 0,01 % M=100
601-042-00-8
biphenyl;
diphenyl
202-163-5
92-52-4
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410
601-043-00-3
1,2,4-trimethylbenzene
202-436-9
95-63-6
Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H226
H332
H319
H335
H315
H411
GHS02
GHS07
GHS09
Wng
H226
H332
H319
H335
H315
H411
601-044-00-9
3a,4,7,7a-tetrahydro-4,7-methanoindene
201-052-9
77-73-6
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H225
H332
H302
H319
H335
H315
H411
GHS02
GHS07
GHS09
Dgr
H225
H332
H302
H319
H335
H315
H411
601-045-00-4
1,2,3,4-tetrahydronaphthalene
204-340-2
119-64-2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411
EUH019
601-046-00-X
7-methylocta-1,6-diene
404-210-7
42152-47-6
Flam. Liq. 3
Aquatic Acute 1
Aquatic Chronic 1
H226
H400
H410
GHS02
GHS09
Wng
H226
H410
601-047-00-5
m-mentha-1,3(8)-diene
404-150-1
17092-80-7
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
601-048-00-0
chrysene
205-923-4
218-01-9
Carc. 1B Muta. 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H400
H410
GHS08
GHS09
Dgr
H350
H341
H410
601-049-00-6
benzo[e]pyrene
205-892-7
192-97-2
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
601-051-00-7
4-phenylbut-1-ene
405-980-7
768-56-9
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
601-052-00-2
naphthalene
202-049-5
91-20-3
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS07
GHS08
GHS09
Wng
H351
H302
H410
601-053-00-8
nonylphenol; [1]
4-nonylphenol, branched [2]
246-672-0 [1]
284-325-5 [2]
25154-52-3 [1]
84852-15-3 [2]
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H361fd
H302
H314
H410
601-054-00-3
reaction mass of isomers of: dibenzylbenzene; dibenzyl(methyl)benzene; dibenzyl(dimethyl)benzene; dibenzyl(trimethyl)benzene
405-570-8
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
601-055-00-9
reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes
410-190-0
132983-41-6
Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413
601-056-00-4
reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane
405-470-4
73807-39-3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
601-057-00-X
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate
421-130-8
156679-41-3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
601-058-00-5
di-L-para-menthene
417-870-6
83648-84-4
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
601-059-00-0
methyl 2-benzylidene-3-oxobutyrate
420-940-9
15768-07-7
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411
601-060-00-6
1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane;
x-sodium, y-potassium salts x = 7,755 y =0,245
417-610-1
155522-09-1
Skin Sens. 1
H317
GHS07
Wng
H317
601-061-00-1
(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)
418-960-8
—
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
601-062-00-7
reaction mass of: branched triacontane;
branched dotriacontane;
branched tetratriacontane;
branched hexatriacontane
417-030-9
151006-59-6
Aquatic Chronic 4
H413
—
H413
601-063-00-2
reaction mass of isomers of branched tetracosane
417-060-2
151006-61-0
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
601-064-00-8
branched hexatriacontane
417-070-7
151006-62-1
Aquatic Chronic 4
H413
—
H413
601-065-00-3
reaction mass of: (1'α, 3'α, 6'α)-2,2,3' ,7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
416-930-9
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
601-066-00-9
1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone
426-820-2
78531-60-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
601-067-00-4
triethyl arsenate
427-700-2
15606-95-8
Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410
601-068-00-X
1,2-diacetoxybut-3-ene
421-720-5
18085-02-4
Acute Tox. 4 *
H302
GHS07
Wng
H302
601-069-00-5
2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide
422-680-1
287933-44-2
Aquatic Chronic 3
H412
—
H412
601-070-00-0
reaction mass of: branched icosane; branched docosane; branched tetracosane
417-050-8
151006-58-5
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
601-071-00-6
1-dimethoxymethyl-2-nitro-benzene
423-830-9
20627-73-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
601-072-00-1
reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;
1-(3-isopropylphenyl)-1-phenylethane;
1-(2-isopropylphenyl)-1-phenylethane
430-690-2
52783-21-8
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
601-073-00-7
1-bromo-3,5-difluorobenzene
416-710-2
461-96-1
Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373 ** H315
H317
H400
H410
GHS02
GHS08
GHS07
GHS09
Wng
H226
H302
H373 ** H315
H317
H410
601-074-00-2
reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;
1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]
422-040-1
—
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411
601-075-00-8
4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane
418-770-5
151882-81-4
Carc. 2
H351
GHS08
Wng
H351
601-076-00-3
ethynyl cyclopropane
425-430-1
6746-94-7
Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H225
H315
H318
H412
GHS02
GHS05
Dgr
H225
H315
H318
H412
601-077-00-9
reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;
1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane
426-510-7
196965-91-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
601-078-00-4
reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;
2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane
427-040-5
—
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
601-079-00-X
reaction mass of: trans-trans-cyclohexadeca-1,9-diene;
cis-trans-cyclohexadeca-1,9-diene
429-620-3
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
601-080-00-5
reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers
431-100-6
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
601-081-00-0
cyclohexadeca-1,9-diene
431-730-1
4277-06-9
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
601-082-00-6
reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane
434-420-4
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
601-083-00-1
5-endo-hexyl-bicyclo[2.2.1]hept-2-ene
435-000-3
22094-83-3
Asp. Tox. 1
Skin Irrit. 2
Aquatic Chronic 4
H304
H315
H413
GHS08
GHS07
Dgr
H304
H315
H413
601-084-00-7
reaction mass of:5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)
435-180-3
—
Asp. Tox. 1
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H304
H315
H400
H410
GHS08
GHS07
GHS09
Dgr
H304
H315
H410
601-085-00-2
isopentane;
2-methylbutane
201-142-8
78-78-4
Flam. Liq. 1
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H224
H304
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H224
H304
H336
H411
EUH066
601-087-00-3
2,4,4-trimethylpentene
246-690-9
25167-70-8
Flam. Liq. 2
Asp. Tox. 1
STOT SE 3
H225
H304
H336
GHS02
GHS07
GHS08
Dgr
H225
H304
H336
D
601-088-00-9
4-vinylcyclohexene
202-848-9
100-40-3
Carc. 2
H351
GHS08
Wng
H351
601-089-00-4
muscalure; cis-tricos-9-ene
248-505-7
27519-02-4
Skin Sens. 1B
H317
GHS07
Wng
H317
602-001-00-7
chloromethane;
methyl chloride
200-817-4
74-87-3
Flam. Gas 1
Press. Gas
Carc. 2
STOT RE 2 *
H220
H351
H373 **
GHS02
GHS04
GHS08
Dgr
H220
H351
H373 **
U
602-002-00-2
bromomethane;
methylbromide
200-813-2
74-83-9
Press. Gas
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Ozone 1
H341
H331
H301
H373**
H319
H335
H315
H400
H420
GHS04
GHS06
GHS08
GHS09
Dgr
H341
H331
H301
H373 ** H319
H335
H315
H400
H420
U
602-003-00-8
dibromomethane
200-824-2
74-95-3
Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412
*
602-004-00-3
dichloromethane;
methylene chloride
200-838-9
75-09-2
Carc. 2
H351
GHS08
Wng
H351
602-005-00-9
methyl iodide;
iodomethane
200-819-5
74-88-4
Carc. 2
Acute Tox. 4 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
H351
H312
H331
H301
H335
H315
GHS06
GHS08
Dgr
H351
H312
H331
H301
H335
H315
602-006-00-4
chloroform;
trichloromethane
200-663-8
67-66-3
Carc. 2
Repr. 2
Acute Tox. 3
Acute Tox. 4
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
H351
H361d
H331
H302
H372
H319
H315
GHS06
GHS08
Dgr
H351
H361d
H331
H302
H372
H319
H315
602-007-00-X
bromoform;
tribromomethane
200-854-6
75-25-2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H331
H302
H319
H315
H411
GHS06
GHS09
Dgr
H331
H302
H319
H315
H411
602-008-00-5
carbon tetrachloride;
tetrachloromethane
200-262-8
56-23-5
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic
Chronic 3
Ozone 1
H351
H331
H311
H301
H372**
H412
H420
GHS06
GHS08
Dgr
H351
H331
H311
H301
H372 ** H412
H420
*
STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2 % ≤C
< 1 %
602-009-00-0
chloroethane
200-830-5
75-00-3
Flam. Gas 1
Press. Gas
Carc. 2
Aquatic Chronic 3
H220
H351
H412
GHS02
GHS04
GHS08
Dgr
H220
H351
H412
U
602-010-00-6
1,2-dibromoethane
203-444-5
106-93-4
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H350
H331
H311
H301
H319
H335
H315
H411
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H319
H335
H315
H411
*
602-011-00-1
1,1-dichloroethane
200-863-5
75-34-3
Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3
H225
H302
H319
H335
H412
GHS02
GHS07
Dgr
H225
H302
H319
H335
H412
*
602-012-00-7
1,2-dichloroethane;
ethylene dichloride
203-458-1
107-06-2
Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H350
H302
H319
H335
H315
GHS02
GHS08
GHS07
Dgr
H225
H350
H302
H319
H335
H315
602-013-00-2
1,1,1-trichloroethane;
methyl chloroform
200-756-3
71-55-6
Acute Tox. 4 *
Ozone 1
H332
H420
GHS07
Wng
H332
H420
F
602-014-00-8
1,1,2-trichloroethane
201-166-9
79-00-5
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H351
H332
H312
H302
GHS08
GHS07
Wng
H351
H332
H312
H302
EUH066
*
602-015-00-3
1,1,2,2-tetrachloroethane
201-197-8
79-34-5
Acute Tox. 2 *
Acute Tox. 1
Aquatic Chronic 2
H330
H310
H411
GHS06
GHS09
Dgr
H330
H310
H411
602-016-00-9
1,1,2,2-tetrabromoethane
201-191-5
79-27-6
Acute Tox. 2 *
Eye Irrit. 2
Aquatic Chronic 3
H330
H319
H412
GHS06
Dgr
H330
H319
H412
602-017-00-4
pentachloroethane
200-925-1
76-01-7
Carc. 2
STOT RE 1
Aquatic Chronic 2
H351
H372 **
H411
GHS08
GHS09
Dgr
H351
H372 ** H411
STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 %
602-018-00-X
1-chloropropane; [1]
2-chloropropane [2]
208-749-7 [1]
200-858-8 [2]
540-54-5 [1]
75-29-6 [2]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302
C
602-019-00-5
1-bromopropane;
n-propyl bromide
203-445-0
106-94-5
Flam. Liq. 2
Repr. 1B
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
STOT SE 3
H225
H360FD
H373 **
H319
H335
H315
H336
GHS02
GHS08
GHS07
Dgr
H225
H360FD H373 **
H319
H335
H315
H336
602-021-00-6
1,2-dibromo-3-chloropropane
202-479-3
96-12-8
Carc. 1B
Muta. 1B
Repr. 1A
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H350
H340
H360F *** H301
H373 **
H412
GHS06
GHS08
Dgr
H350
H340
H360F *** H301
H373 ** H412
602-022-00-1
1-chloropentane; [1]
2-chloropentane; [2]
3-chloropentane [3]
208-846-4 [1]
210-885-7 [2]
210-467-4 [3]
543-59-9 [1]
625-29-6 [2]
616-20-6 [3]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302
C
602-023-00-7
vinyl chloride;
chloroethylene
200-831-0
75-01-4
Press. Gas
Flam. Gas 1
Carc. 1A
H220
H350
GHS02
GHS08
Dgr
H220
H350
D U
602-024-00-2
bromoethylene
209-800-6
593-60-2
Press. Gas
Flam. Gas 1
Carc. 1B
H220
H350
GHS02
GHS08
Dgr
H220
H350
U
602-025-00-8
1,1-dichloroethylene;
vinylidene chloride
200-864-0
75-35-4
Flam. Liq. 1
Carc. 2
Acute Tox. 4 *
H224
H351
H332
GHS02
GHS08
GHS07
Dgr
H224
H351
H332
*
D
602-026-00-3
1,2-dichloroethylene; [1]
cis-dichloroethylene; [2]
trans-dichloroethylene [3]
208-750-2 [1]
205-859-7 [2]
205-860-2 [3]
540-59-0 [1]
156-59-2 [2]
156-60-5 [3]
Flam. Liq. 2
Acute Tox. 4 *
Aquatic Chronic 3
H225
H332
H412
GHS02
GHS07
Dgr
H225
H332
H412
*
C
602-027-00-9
trichloroethylene;
trichloroethene
201-167-4
79-01-6
Carc. 1B
Muta. 2
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 3
H350
H341
H319
H315
H336
H412
GHS08
GHS07
Dgr
H350
H341
H319
H315
H336
H412
602-028-00-4
tetrachloroethylene
204-825-9
127-18-4
Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411
602-029-00-X
3-chloropropene;
allyl chloride
203-457-6
107-05-1
Flam. Liq. 2
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H225
H351
H341
H332
H312
H302
H373 ** H319
H335
H315
H400
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H351
H341
H332
H312
H302
H373 ** H319
H335
H315
H400
D
602-030-00-5
1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2]
208-826-5 [1]
233-195-8 [2]
542-75-6 [1]
10061-01-5 [2]
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H311
H301
H332
H304
H319
H335
H315
H317
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H226
H311
H301
H332
H304
H319
H335
H315
H317
H410
C D
602-031-00-0
1,1-dichloropropene
209-253-3
563-58-6
Flam. Liq. 2
Acute Tox. 3 *
Aquatic Chronic 3
H225
H301
H412
GHS02
GHS06
Dgr
H225
H301
H412
602-032-00-6
3-chloro-2-methylpropene
209-251-2
563-47-3
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H225
H332
H302
H314
H317
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H225
H332
H302
H314
H317
H411
602-034-00-7
1,2-dichlorobenzene;
o-dichlorobenzene
202-425-9
95-50-1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410
*
602-035-00-2
1,4-dichlorobenzene;
p-dichlorobenzene
203-400-5
106-46-7
Carc. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H319
H400
H410
GHS08
GHS09
Wng
H351
H319
H410
602-036-00-8
chloroprene (stabilised);
2-chlorobuta-1,3-diene (stabilised)
204-818-0
126-99-8
Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H350
H332
H302
H373 **
H319
H335
H315
GHS02
GHS08
GHS07
Dgr
H225
H350
H332
H302
H373 ** H319
H335
H315
D
602-037-00-3
α-chlorotoluene;
benzyl chloride
202-853-6
100-44-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H350
H331
H302
H373 **
H335
H315
H318
GHS06
GHS08
GHS05
Dgr
H350
H331
H302
H373 ** H335
H315
H318
602-038-00-9
α, α, α-trichlorotoluene;
benzotrichloride
202-634-5
98-07-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H350
H331
H302
H335
H315
H318
GHS06
GHS08
GHS05
Dgr
H350
H331
H302
H335
H315
H318
602-039-00-4
polychlorobiphenyls;
PCB
215-648-1
1336-36-3
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 ** H410
STOT RE 2; H373: C ≥ 0,005 %
C
602-040-00-X
2-chlorotoluene; [1]
3-chlorotoluene; [2]
4-chlorotoluene; [3]
chlorotoluene [4]
202-424-3 [1]
203-580-5 [2]
203-397-0 [3]
246-698-2 [4]
95-49-8 [1]
108-41-8 [2]
106-43-4 [3]
25168-05-2 [4]
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411
C
602-041-00-5
penthachloronaphthalene
215-320-8
1321-64-8
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H312
H302
H319
H315
H410
C
602-042-00-0
1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex
—
—
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H312
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H312
H410
A C
602-043-00-6
lindane (ISO);
γ-HCH or γ-BHC;
γ-1,2,3,4,5,6-hexachlorocyclohexane
200-401-2
58-89-9
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H312
H373 **
H362
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H332
H312
H373 ** H362
H410
M=10
602-044-00-1
camphechlor (ISO);
toxaphene;
232-283-3
8001-35-2
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H312
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H312
H335
H315
H410
602-045-00-7
DDT (ISO);
clofenotane (INN);
dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane
200-024-3
50-29-3
Carc. 2
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H372 ** H410
602-046-00-2
heptachlor (ISO);
1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene
200-962-3
76-44-8
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H311
H301
H373 ** H410
602-047-00-8
chlordane (ISO);
1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan
200-349-0
57-74-9
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H312
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H312
H302
H410
602-048-00-3
aldrin (ISO)
206-215-8
309-00-2
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H311
H301
H372 ** H410
602-049-00-9
dieldrin (ISO)
200-484-5
60-57-1
Carc. 2
Acute Tox. 1
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H310
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H310
H301
H372 ** H410
602-050-00-4
isodrin;
(1α,4α,4aβ, 5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene
207-366-2
465-73-6
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
M=100
602-051-00-X
endrin (ISO);
1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene
200-775-7
72-20-8
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
602-052-00-5
endosulfan (ISO);
1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite;
1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite
204-079-4
115-29-7
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H312
H400
H410
GHS06
GHS09
Dgr
H330
H300
H312
H410
602-053-00-0
isobenzan (ISO);
1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran
206-045-4
297-78-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400
602-054-00-6
3-iodpropene;
allyl iodide
209-130-4
556-56-9
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
602-055-00-1
bromoethane;
ethyl bromide
200-825-8
74-96-4
Flam. Liq. 2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H351
H332
H302
GHS02
GHS08
GHS07
Dgr
H225
H351
H332
H302
602-056-00-7
α, α, α-trifluorotoluene;
benzotrifluoride
202-635-0
98-08-8
Flam. Liq. 2
Aquatic Chronic 2
H225
H411
GHS02
GHS09
Dgr
H225
H411
602-057-00-2
α-bromotoluene;
benzyl bromide
202-847-3
100-39-0
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
602-058-00-8
α, α-dichlorotoluene;
benzylidene chloride;
benzal chloride
202-709-2
98-87-3
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H351
H331
H302
H335
H315
H318
GHS06
GHS08
GHS05
Dgr
H351
H331
H302
H335
H315
H318
602-059-00-3
1-chlorobutane;
butyl chloride
203-696-6
109-69-3
Flam. Liq. 2
H225
GHS02
Dgr
H225
602-060-00-9
bromobenzene
203-623-8
108-86-1
Flam. Liq. 3
Skin Irrit. 2
Aquatic Chronic 2
H226
H315
H411
GHS02
GHS07
GHS09
Wng
H226
H315
H411
602-061-00-4
hexafluoropropene;
hexafluoropropylene
204-127-4
116-15-4
Press. Gas
Acute Tox. 4 *
STOT SE 3
H332
H335
GHS07
Wng
H332
H335
U
602-062-00-X
1,2,3-trichloropropane
202-486-1
96-18-4
Carc. 1B
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H350
H360F *** H332
H312
H302
GHS08
GHS07
Dgr
H350
H360F *** H332
H312
H302
D
602-063-00-5
heptachlor epoxide;
2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane
213-831-0
1024-57-3
Carc. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H373 ** H410
602-064-00-0
1,3-dichloro-2-propanol
202-491-9
96-23-1
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
H350
H301
H312
GHS06
GHS08
Dgr
H350
H301
H312
602-065-00-6
hexachlorobenzene
204-273-9
118-74-1
Carc. 1B
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372 **
H400
H410
GHS08
GHS09
Dgr
H350
H372 ** H410
602-066-00-1
tetrachloro-p-benzoquinone
204-274-4
118-75-2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
602-067-00-7
1,3-dichlorbenzene
208-792-1
541-73-1
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
602-068-00-2
ethylene bis(trichloroacetate)
219-732-9
2514-53-6
Skin Irrit. 2
H315
GHS07
Wng
H315
602-069-00-8
dichloroacetylene
—
7572-29-4
Unst. Expl. Carc. 2
STOT RE 2 *
H200
H351
H373 **
GHS01
GHS08
Wng
H200
H351
H373 **
602-070-00-3
3-chloro-4,5,α, α, α-pentafluorotoluene
401-930-3
77227-99-7
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H226
H332
H302
H400
GHS02
GHS07
GHS09
Wng
H226
H332
H302
H400
602-071-00-9
bromobenzylbromotoluene, reaction mass of isomers
402-210-1
99688-47-8
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373 ** H317
H410
602-072-00-4
dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers; (dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)
278-404-3
76253-60-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
602-073-00-X
1,4-dichlorobut-2-ene
212-121-8
764-41-0
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H330
H311
H301
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H330
H311
H301
H314
H410
Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335:C≥5 %
602-074-00-5
pentachlorobenzene
210-172-0
608-93-5
Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H228
H302
H400
H410
GHS02
GHS07
GHS09
Dgr
H228
H302
H410
T
602-075-00-0
4,4,5,5-tetrachloro-1,3-dioxolan-2-one
404-060-2
22432-68-4
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
H330
H302
H314
GHS06
GHS05
Dgr
H330
H302
H314
602-076-00-6
2,3,4-trichlorobut-1-ene
219-397-9
2431-50-7
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H331
H302
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H331
H302
H319
H335
H315
H410
Carc. 2; H351: C
≥ 0,1 %
602-077-00-1
dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;
mirex
219-196-6
2385-85-5
Carc. 2
Repr. 2
Lact.
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H361fd
H362
H312
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361fd
H362
H312
H302
H410
602-078-00-7
hexachlorocyclopentadiene
201-029-3
77-47-4
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H302
H314
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H311
H302
H314
H410
602-079-00-2
2,3-dichloropropene;
2,3-dichloropropylene
201-153-8
78-88-6
Flam. Liq. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H225
H341
H332
H312
H302
H335
H315
H318
H412
GHS02
GHS08
GHS05
GHS07
Dgr
H225
H341
H332
H312
H302
H335
H315
H318
H412
602-080-00-8
alkanes, C10-13, chloro; chlorinated paraffins, C10-13
287-476-5
85535-84-8
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
EUH066
602-081-00-3
2-chloro-4,5-difluorobenzoic acid
405-380-5
—
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H312
H302
H318
H317
GHS05
GHS07
Dgr
H312
H302
H318
H317
602-082-00-9
2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol
408-020-5
109678-33-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
602-083-00-4
diphenyl ether, pentabromo derivative pentabromodiphenyl ether
251-084-2
32534-81-9
STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H362
H400
H410
GHS08
GHS09
Wng
H373 ** H362
H410
602-084-00-X
1,1-dichloro-1-fluoroethane
404-080-1
1717-00-6
Aquatic
Chronic 3
Ozone 1
H412
H420
GHS07
Wng
H412
H420
602-085-00-5
2-bromopropane
200-855-1
75-26-3
Flam. Liq. 2
Repr. 1a
STOT RE 2 *
H225
H360F *** H373 **
GHS02
GHS08
Dgr
H225
H360F *** H373 **
EUH066
602-086-00-0
trifluoroiodomethane;
trifluoromethyl iodide
219-014-5
2314-97-8
Muta. 2
H341
GHS08
Wng
H341
602-087-00-6
1,2,4-trichlorobenzene
204-428-0
120-82-1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410
602-088-00-1
2,3-dibromopropan-1-ol;
2,3-dibromo-1-propanol
202-480-9
96-13-9
Carc. 1B Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H350
H361f *** H311
H332
H302
H412
GHS08
GHS07
Dgr
H350
H361f *** H311
H332
H302
H412
602-089-00-7
4-bromo-2-chlorofluorobenzene
405-580-2
60811-21-4
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410
602-090-00-2
1-allyl-3-chloro-4-fluorobenzene
406-630-6
121626-73-1
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
602-091-00-8
1,3-dichloro-4-fluorobenzene
406-160-1
1435-48-9
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
H302
H373 **
H315
H411
GHS08
GHS07
Wng
H302
H373 ** H315
H411
602-092-00-3
1-bromo-3,4,5-trifluorobenzene
418-480-9
138526-69-9
Flam. Liq. 3
Carc. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H226
H351
H315
H318
H411
GHS02
GHS08
GHS05
GHS09
Dgr
H226
H351
H315
H318
H411
602-093-00-9
α, α, α,4-tetrachlorotoluene;
p-chlorobenzotrichloride
226-009-1
5216-25-1
Carc. 1B Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H350
H361f *** H372 **
H312
H302
H335
H315
GHS08
GHS07
Dgr
H350
H361f *** H372 ** H312
H302
H335
H315
602-094-00-4
diphenylether;
octabromo derivate
251-087-9
32536-52-0
Repr. 1B
H360Df
GHS08
Dgr
H360Df
602-095-00-X
alkanes, C14-17, chloro;
chlorinated paraffins, C14-17
287-477-0
85535-85-9
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
H410
EUH066
602-096-00-5
malachite green hydrochloride; [1]
malachite green oxalate [2]
209-322-8 [1]
219-441-7 [2]
569-64-2 [1]
2437-29-8 [2]
Repr. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H361d *** H302
H318
H410
602-097-00-0
1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane
422-850-5
148757-89-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
602-098-00-6
2-(3-bromophenoxy)tetrahydro-2H-pyran
429-030-6
57999-49-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
602-099-00-1
3-(4-fluorophenyl)-2-methylpropionylchloride
426-370-7
—
Skin Corr. 1A
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412
EUH014
EUH029
602-100-00-5
reaction mass of: (R, R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;
(S, S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane
420-640-8
—
Aquatic Chronic 3
H412
—
H412
602-101-00-0
2-chloro-4-fluoro-5-nitrophenyl(isobutyl)carbonate
427-020-6
141772-37-4
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373**
H317
H410
602-102-00-6
1,1,1,3,3-pentafluorobutane
430-250-1
406-58-6
Flam. Liq. 2
H225
GHS02
Dgr
H225
602-103-00-1
1-(chlorophenylmethyl)-2-methylbenzene
431-450-1
41870-52-4
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
602-104-00-7
1,1,2,2,3,3,4-heptafluorocyclopentane
430-710-1
15290-77-4
Aquatic Chronic 3
H412
—
H412
602-105-00-2
sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate
422-100-7
102061-82-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
602-106-00-8
2-bromo-4,6-difluoroaniline
429-430-0
444-14-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
602-107-00-3
3,3,4,4-tetrafluoro-4-iodo-1-butene
439-500-2
33831-83-3
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H302
H315
H411
GHS07
GHS09
Wng
H302
H315
H411
602-108-00-9
(2,3,5,6-tetrafluorophenyl)methanol
443-840-7
4084-38-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
602-109-00-4
hexabromocyclododecane [1]
1,2,5,6,9,10-hexabromocyclododecane [2]
247-148-4 [1]
221-695-9[2]
25637-99-4[1]
3194-55-6[2]
Repr. 2
Lact.
H361
H362
GHS08
Wng
H361
H362
603-001-00-X
methanol
200-659-6
67-56-1
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
H225
H331
H311
H301
H370 **
GHS02
GHS06
GHS08
Dgr
H225
H331
H311
H301
H370 **
*
STOT SE 1; H370: C≥10 %
STOT SE 2; H371: 3 % ≤ C<10 %
603-002-00-5
ethanol;
ethyl alcohol
200-578-6
64-17-5
Flam. Liq. 2
H225
GHS02
Dgr
H225
603-003-00-0
propan-1-ol;
n-propanol
200-746-9
71-23-8
Flam. Liq. 2
Eye Dam. 1
STOT SE 3
H225
H318
H336
GHS02
GHS05
GHS07
Dgr
H225
H318
H336
603-004-00-6
butan-1-ol;
n-butanol
200-751-6
71-36-3
Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
H226
H302
H335
H315
H318
H336
GHS02
GHS05
GHS07
Dgr
H226
H302
H335
H315
H318
H336
603-005-00-1
2-methylpropan-2-ol;
tert-butyl alcohol
200-889-7
75-65-0
Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H319
H335
GHS02
GHS07
Dgr
H225
H332
H319
H335
603-006-00-7
pentanol isomers, with the exception of those specified elsewhere in this Annex
250-378-8
Flam. Liq. 3
Acute Tox. 4 * STOT SE 3
H226
H332
H335
GHS02
GHS07
Wng
H226
H332
H335
EUH066
C
603-007-00-2
2-methylbutan-2-ol;
tert-pentanol
200-908-9
75-85-4
Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H225
H332
H335
H315
GHS02
GHS07
Dgr
H225
H332
H335
H315
603-008-00-8
4-methylpentan-2-ol;
methyl isobutyl carbinol
203-551-7
108-11-2
Flam. Liq. 3
STOT SE 3
H226
H335
GHS02
GHS07
Wng
H226
H335
STOT SE 3; H335: C ≥ 25 %
603-009-00-3
cyclohexanol
203-630-6
108-93-0
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H332
H302
H335
H315
GHS07
Wng
H332
H302
H335
H315
603-010-00-9
2-methylcyclohexanol, mixed isomers; [1]
cis-2-methylcyclohexanol; [2]
trans-2-methylcyclohexanol [3]
209-512-0 [1]
231-187-9 [2]
231-186-3 [3]
583-59-5 [1]
7443-70-1 [2]
7443-52-9 [3]
Acute Tox. 4 *
H332
GHS07
Wng
H332
C
603-011-00-4
2-methoxyethanol;
ethylene glycol monomethyl ether
203-713-7
109-86-4
Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H226
H360FD H332
H312
H302
603-012-00-X
2-ethoxyethanol;
ethylene glycol monoethyl ether
203-804-1
110-80-5
Flam. Liq. 3
Repr. 1B
Acute Tox. 3
Acute Tox. 4
H226
H360FD
H331
H302
GHS02
GHS08
GHS06
Dgr
H226
H360FD H331
H302
603-013-00-5
2-isopropoxyethanol;
ethylene glycol monoisopropyl ether
203-685-6
109-59-1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
H332
H312
H319
GHS07
Wng
H332
H312
H319
603-014-00-0
2-butoxyethanol;
ethyleneglycol monobutyl ether;
butyl cellosolve
203-905-0
111-76-2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H332
H312
H302
H319
H315
GHS07
Wng
H332
H312
H302
H319
H315
603-015-00-6
allyl alcohol
203-470-7
107-18-6
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H225
H331
H311
H301
H319
H335
H315
H400
GHS02
GHS06
GHS09
Dgr
H225
H331
H311
H301
H319
H335
H315
H400
603-016-00-1
4-hydroxy-4-methylpentan-2-one; diacetone alcohol
204-626-7
123-42-2
Eye Irrit. 2
H319
GHS07
Wng
H319
Eye Irrit. 2; H319: C≥ 10 %
603-018-00-2
furfuryl alcohol
202-626-1
98-00-0
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
H351
H331
H312
H302
H373**
H319
H335
GHS06
GHS08
Dgr
H351
H331
H312
H302
H373**
H319
H335
603-019-00-8
dimethyl ether
204-065-8
115-10-6
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
603-020-00-3
ethyl methyl ether
—
540-67-0
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
U
603-021-00-9
methyl vinyl ether
203-475-4
107-25-5
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
D U
603-022-00-4
diethyl ether;
ether
200-467-2
60-29-7
Flam. Liq. 1
Acute Tox. 4 *
STOT SE 3
H224
H302
H336
GHS02
GHS07
Dgr
H224
H302
H336
EUH019
EUH066
603-023-00-X
ethylene oxide;
oxirane
200-849-9
75-21-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H220
H350
H340
H331
H319
H335
H315
GHS02
GHS04
GHS06
GHS08
Dgr
H220
H350
H340
H331
H319
H335
H315
U
603-024-00-5
1,4-dioxane
204-661-8
123-91-1
Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3
H225
H351
H319
H335
GHS02
GHS08
GHS07
Dgr
H225
H351
H319
H335
EUH019
EUH066
D
603-025-00-0
tetrahydrofuran
203-726-8
109-99-9
Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3
H225
H351
H319
H335
GHS02
GHS07
GHS08
Dgr
H225
H351
H319
H335
EUH019
STOT SE 3; H335: C≥25 % Eye Irrit.2;
H319: C ≥ 25 %
603-026-00-6
1-chloro-2,3-epoxypropane; epichlorhydrin
203-439-8
106-89-8
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H226
H350
H331
H311
H301
H314
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H350
H331
H311
H301
H314
H317
*
603-027-00-1
ethanediol;
ethylene glycol
203-473-3
107-21-1
Acute Tox. 4 *
H302
GHS07
Wng
H302
603-028-00-7
2-chloroethanol;
ethylene chlorohydrin
203-459-7
107-07-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300
603-029-00-2
bis(2-chloroethyl) ether
203-870-1
111-44-4
Carc. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H351
H330
H310
H300
GHS06
GHS08
Dgr
H351
H330
H310
H300
603-030-00-8
2-aminoethanol;
ethanolamine
205-483-3
141-43-5
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H332
H312
H302
H314
GHS05
GHS07
Dgr
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 5 %
603-031-00-3
1,2-dimethoxyethane;
ethylene glycol dimethyl ether;
EGDME
203-794-9
110-71-4
Flam. Liq. 2
Repr. 1B
Acute Tox. 4 *
H225
H360FD
H332
GHS02
GHS08
GHS07
Dgr
H225
H360FD H332
EUH019
603-032-00-9
ethylene dinitrate;
ethylene glycol dinitrate
211-063-0
628-96-6
Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
H200
H330
H310
H300
H373**
GHS01
GHS06
GHS08
Dgr
H200
H330
H310
H300
H373**
603-033-00-4
oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate
211-745-8
693-21-0
Unst. Expl
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H200
H330
H310
H300
H373 **
H412
GHS01
GHS06
GHS08
Dgr
H200
H330
H310
H300
H373 **
H412
603-033-01-1
oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate;
[>25 % phlegmatiser]
211-745-8
693-21-0
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H201
H330
H310
H300
H373 **
H412
GHS01
GHS06
GHS08
Dgr
H201
H330
H310
H300
H373 ** H412
603-034-00-X
glycerol trinitrate; nitroglycerine
200-240-8
55-63-0
Unst. Expl.
Acute Tox. 2 * Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H200
H330
H310
H300
H373 ** H411
GHS01
GHS06
GHS08
GHS09
Dgr
H200
H330
H310
H300
H373 ** H411
603-034-01-7
glycerol trinitrate; nitroglycerine; [>40 % phlegmatiser]
200-240-8
55-63-0
Expl. 1.1
Acute Tox. 2 * Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H201
H330
H310
H300
H373 ** H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373 ** H411
603-035-00-5
pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.
201-084-3
78-11-5
Unst. Expl.
H200
GHS01
Dgr
H200
603-035-01-2
pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.;[>20 % phlegmatiser]
201-084-3
78-11-5
Expl. 1.1
H201
GHS01
Dgr
H201
T
603-036-00-0
mannitol hexanitrate; nitromannite
239-924-6
15825-70-4
Unst. Expl.
H200
GHS01
Dgr
H200
603-036-01-8
mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]
239-924-6
15825-70-4
Expl. 1.1
H201
GHS01
Dgr
H201
603-037-00-6
cellulose nitrate; nitrocellulose
—
—
Expl. 1.1
H201
GHS01
Dgr
H201
T
603-038-00-1
allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether
203-442-4
106-92-3
Flam. Liq. 3
Carc. 2
Muta. 2
Repr. 2
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H226
H351
H341
H361f *** H332
H302
H335
H315
H318
H317
H412
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H351
H341
H361f *** H332
H302
H335
H315
H318
H317
H412
603-039-00-7
butyl glycidyl ether; butyl 2,3-epoxypropyl ether
219-376-4
2426-08-6
Flam. Liq. 3
Carc. 2
Muta. 2
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
Skin Sens. 1
Aquatic Chronic 3
H226
H351
H341
H332
H302
H335
H317
H412
GHS02
GHS08
GHS07
Wng
H226
H351
H341
H332
H302
H335
H317
H412
603-040-00-2
sodium methanolate; sodium methoxide; [1] potassium methanolate; potassium methoxide; [2] lithium methanolate; lithium methoxide [3]
204-699-5 [1]
212-736-1 [2]
212-737-7 [3]
124-41-4 [1]
865-33-8 [2]
865-34-9 [3]
Self-heat 1
Skin Corr. 1B
H251
H314
GHS02
GHS05
Dgr
H251
H314
EUH014
T
603-041-00-8
potassium ethanolate; potassium ethoxide; [1] sodium ethanolate; sodium ethoxide [2]
213-029-0 [1]
205-487-5 [2]
917-58-8 [1]
141-52-6 [2]
Self-heat 1
Skin Corr. 1B
H251
H314
GHS02
GHS05
Dgr
H251
H314
EUH014
T
603-042-00-3
aluminium-tri-isopropoxide
209-090-8
555-31-7
Flam. Sol. 1
H228
GHS02
Dgr
H228
T
603-043-00-9
triarimol (ISO); 2,4-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol
—
26766-27-8
Acute Tox. 4 *
H302
GHS07
Wng
H302
603-044-00-4
dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol
204-082-0
115-32-2
Acute Tox. 4 * Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H312
H302
H315
H317
H410
603-045-00-X
diisopropyl ether; [1] dipropyl ether [2]
203-560-6 [1]
203-869-6 [2]
108-20-3 [1]
111-43-3 [2]
Flam. Liq. 2
STOT SE 3
H225
H336
GHS02
GHS07
Dgr
H225
H336
EUH019
EUH066
C
603-046-00-5
bis(chloromethyl) ether; oxybis(chloromethane)
208-832-8
542-88-1
Flam. Liq. 2
Carc. 1A
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 *
H225
H350
H330
H311
H302
GHS02
GHS06
GHS08
Dgr
H225
H350
H330
H311
H302
Carc. 1A; H350: C ≥ 0,001 %
603-047-00-0
2-dimethylaminoethanol; N,N-dimethylethanolamine
203-542-8
108-01-0
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H332
H312
H302
H314
STOT SE 3; H335: C≥5 %
603-048-00-6
2-diethylaminoethanol; N,N-diethylethanolamine
202-845-2
100-37-8
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H332
H312
H302
H314
STOT SE 3; H335: C≥5 %
603-049-00-1
chlorfenethol (ISO); 1,1-bis (4-chlorophenyl) ethanol
201-246-3
80-06-8
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
603-050-00-7
1-(2-butoxypropoxy)propan-2-ol
246-011-6
24083-03-2
Acute Tox. 4 * Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
603-051-00-2
2-ethylbutan-1-ol
202-621-4
97-95-0
Acute Tox. 4 * Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
603-052-00-8
3-butoxypropan-2-ol; propylene glycol monobutyl ether
225-878-4
5131-66-8
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315
603-053-00-3
2-methylpentane-2,4-diol
203-489-0
107-41-5
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315
603-054-00-9
di-n-butyl ether; dibutyl ether
205-575-3
142-96-1
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H226
H319
H335
H315
H412
GHS02
GHS07
Wng
H226
H319
H335
H315
H412
STOT SE 3; H335: C≥10 %
603-056-00-X
[(p-tolyloxy)methyl]oxirane; [1] [(m-tolyloxy)methyl]oxirane; [2]2,3-epoxypropyl o-tolyl ether; [3] [(tolyloxy)methyl]oxirane; cresyl glycidyl ether [4]
218-574-8 [1]
218-575-3 [2]
218-645-3 [3]
247-711-4 [4]
2186-24-5 [1]
2186-25-6 [2]
2210-79-9 [3]
26447-14-3 [4]
Muta. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H315
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H315
H317
H411
C
603-057-00-5
benzyl alcohol
202-859-9
100-51-6
Acute Tox. 4 * Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
603-058-00-0
1,3-propylene oxide
207-964-3
503-30-0
Flam. Liq. 2
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302
603-059-00-6
hexan-1-ol
203-852-3
111-27-3
Acute Tox. 4 *
H302
GHS07
Wng
H302
603-060-00-1
2,2'-bioxirane; 1,2:3,4-diepoxybutane
215-979-1
1464-53-5
Carc. 1B Muta. 1B
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
H350
H340
H330
H311
H301
H314
GHS06
GHS08
GHS05
Dgr
H350
H340
H330
H311
H301
H314
603-061-00-7
tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol
202-625-6
97-99-4
Repr. 1B Eye Irrit. 2
H360Df
H319
GHS08
GHS07
Dgr
H360Df
H319
603-062-00-2
tetrahydrofuran-2,5-diyldimethanol
203-239-0
104-80-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
STOT SE 3; H335: C ≥10 %
603-063-00-8
2,3-epoxypropan-1-ol; glycidol; oxiranemethanol
209-128-3
556-52-5
Carc. 1B Muta. 2
Repr. 1B
Acute Tox. 3 * Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H350
H341
H360F *** H331
H312
H302
H319
H335
H315
GHS06
GHS08
Dgr
H350
H341
H360F *** H331
H312
H302
H319
H335
H315
603-064-00-3
1-methoxy-2-propanol; monopropylene glycol methyl ether
203-539-1
107-98-2
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336
603-065-00-9
resorcinol diglycidyl ether;1,3-bis(2,3-epoxypropoxy)benzene
202-987-5
101-90-6
Carc. 2
Muta. 2
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H351
H341
H312
H302
H319
H315
H317
H412
GHS08
GHS07
Wng
H351
H341
H312
H302
H319
H315
H317
H412
603-066-00-4
1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide
203-437-7
106-87-6
Carc. 2
Acute Tox. 3 * Acute Tox. 3 *
Acute Tox. 3 *
H351
H331
H311
H301
GHS06
GHS08
Dgr
H351
H331
H311
H301
*
603-067-00-X
phenyl glycidyl ether; 2,3-epoxypropyl phenyl ether;1,2-epoxy-3-phenoxypropane
204-557-2
122-60-1
Carc. 1B Muta. 2
Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H332
H335
H315
H317
H412
GHS08
GHS07
Dgr
H350
H341
H332
H335
H315
H317
H412
603-068-00-5
2,3-epoxypropyl-2-ethylcyclohexyl ether; ethylcyclohexylglycidyl ether
—
130014-35-6
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
603-069-00-0
2,4,6-tris(dimethylaminomethyl)phenol
202-013-9
90-72-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
603-070-00-6
2-amino-2-methylpropanol
204-709-8
124-68-5
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Wng
H319
H315
H412
603-071-00-1
2,2'-iminodiethanol; diethanolamine
203-868-0
111-42-2
Acute Tox. 4 * STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H302
H373 ** H315
H318
GHS08
GHS05
GHS07
Dgr
H302
H373 ** H315
H318
603-072-00-7
1,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether
219-371-7
2425-79-8
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H332
H312
H319
H315
H317
GHS07
Wng
H332
H312
H319
H315
H317
603-073-00-2
bis-[4-(2,3-epoxipropoxi)phenyl]propane
216-823-5
1675-54-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
Eye Irrit. 2; H319: C≥ 5 % Skin Irrit. 2; H315: C≥5 %
603-074-00-8
reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight ≤ 700)
500-033-5
25068-38-6
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H315
H317
H411
GHS07
GHS09
Wng
H319
H315
H317
H411
Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 %
603-075-00-3
chlormethyl methyl ether; chlorodimethyl ether
203-480-1
107-30-2
Flam. Liq. 2
Carc. 1A
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
H225
H350
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H225
H350
H332
H312
H302
603-076-00-9
but-2-yne-1,4-diol; 2-butyne-1,4-diol
203-788-6
110-65-6
Skin Corr. 1B
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 *
Skin Sens. 1
H314
H331
H301
H312
H373 ** H317
GHS06
GHS05
GHS08
Dgr
H314
H331
H301
H312
H373 ** H317
Skin Corr. 1B; H314: C≥50 % Skin Irrit. 2; H315: 25 %≤ C < 50 %
Eye Irrit. 2; H319: 25 %≤
C<50 %
D
603-077-00-4
1-dimethylaminopropan-2-ol; dimepranol (INN)
203-556-4
108-16-7
Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B
H226
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H302
H314
603-078-00-X
prop-2-yn-1-ol; propargyl alcohol
203-471-2
107-19-7
Flam. Liq. 3
Acute Tox. 3 * Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H226
H331
H311
H301
H314
H411
GHS02
GHS06
GHS05
GHS09
Dgr
H226
H331
H311
H301
H314
H411
603-079-00-5
2,2'-(methylimino)diethanol; N-methyldiethanolamine
203-312-7
105-59-9
Eye Irrit. 2
H319
GHS07
Wng
H319
603-080-00-0
2-methylaminoethanol; N-methylethanolamine; N-methyl-2-ethanolamine; N-methyl-2-amino ethanol; 2-(methylamino)ethanol
203-710-0
109-83-1
Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
STOT SE 3; H335: C≥5 %
603-081-00-6
2,2'-thiodiethanol; thiodiglycol
203-874-3
111-48-8
Eye Irrit. 2
H319
GHS07
Wng
H319
603-082-00-1
1-aminopropan-2-ol; isopropanolamine
201-162-7
78-96-6
Skin Corr. 1B
H314
GHS05
Dgr
H314
603-083-00-7
1,1'-iminodipropan-2-ol; di-isopropanolamine
203-820-9
110-97-4
Eye Irrit. 2
H319
GHS07
Wng
H319
603-084-00-2
styrene oxide;(epoxyethyl)benzene; phenyloxirane
202-476-7
96-09-3
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
H350
H312
H319
GHS08
GHS07
Dgr
H350
H312
H319
603-085-00-8
bronopol (INN); 2-bromo-2-nitropropane-1,3-diol
200-143-0
52-51-7
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H312
H302
H335
H315
H318
H400
GHS05
GHS07
GHS09
Dgr
H312
H302
H335
H315
H318
H400
M=10
603-086-00-3
ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol
245-949-3
23947-60-6
Acute Tox. 4 *
H312
GHS07
Wng
H312
603-087-00-9
2-ethylhexane-1,3-diol; octylene glycol; ethoexadiol
202-377-9
94-96-2
Eye Dam. 1
H318
GHS05
Dgr
H318
603-088-00-4
2-(octylthio)ethanol; 2-hydroxyethyl octyl sulphide
222-598-4
3547-33-9
Eye Dam. 1
H318
GHS05
Dgr
H318
603-089-00-X
7,7-dimethyl-3-oxa-6-azaoctan-1-ol
400-390-6
—
Skin Corr. 1A
Acute Tox. 4 *
H314
H302
GHS05
GHS07
Dgr
H314
H302
603-090-00-5
2-(2-bromoethoxy)anisole
402-010-4
4463-59-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-091-00-0
exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol
402-470-6
87172-89-2
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
603-092-00-6
2-methyl-4-phenylpentanol
402-770-7
92585-24-5
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
603-093-00-1
cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane
402-410-9
87818-31-3
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Dgr
H332
H411
603-094-00-7
1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane
241-536-7
17557-23-2
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
603-095-00-2
2-(propyloxy)ethanol; EGPE
220-548-6
2807-30-9
Acute Tox. 4 *
Eye Irrit. 2
H312
H319
GHS07
Wng
H312
H319
603-096-00-8
2-(2-butoxyethoxy)ethanol; diethylene glycol monobutyl ether
203-961-6
112-34-5
Eye Irrit. 2
H319
GHS07
Wng
H319
603-097-00-3
1,1’,1’-nitrilotripropan-2-ol; triisopropanolamine
204-528-4
122-20-3
Eye Irrit. 2
H319
GHS07
Wng
H319
603-098-00-9
2-phenoxyethanol
204-589-7
122-99-6
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
603-099-00-4
3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride
403-440-5
93633-79-5
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-100-00-8
1,2-dimethoxypropane
404-630-0
7778-85-0
Flam. Liq. 2
H225
GHS02
Dgr
H225
EUH019
603-101-00-3
tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)
405-040-6
—
Eye Irrit. 2
H319
GHS07
Wng
H319
603-103-00-4
oxirane, mono[(C12-14-alkyloxy)methyl] derivs.
271-846-8
68609-97-2
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
603-104-00-X
fenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol
262-095-7
60168-88-9
Repr. 2
Lact.
Aquatic Chronic 2
H361fd
H362
H411
GHS08
GHS09
Wng
H361fd
H362
H411
603-105-00-5
furan
203-727-3
110-00-9
Flam. Liq. 1
Carc. 1B Muta. 2
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 3
H224
H350
H341
H332
H302
H373 ** H315
H412
GHS02
GHS08
GHS07
Dgr
H224
H350
H341
H332
H302
H373 ** H315
H412
EUH019
603-106-00-0
2-methoxypropanol
216-455-5
1589-47-5
Flam. Liq. 3
Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H226
H360D *** H335
H315
H318
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H360D *** H335
H315
H318
603-107-00-6
2-(2-methoxyethoxy)ethanol; diethylene glycol monomethyl ether
203-906-6
111-77-3
Repr. 2
H361d ***
GHS08
Wng
H361d ***
603-108-00-1
2-methylpropan-1-ol; iso-butanol
201-148-0
78-83-1
Flam. Liq. 3
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
H226
H335
H315
H318
H336
GHS02
GHS05
GHS07
Dgr
H226
H335
H315
H318
H336
603-109-00-7
reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane
425-340-0
—
Aquatic Chronic 4
H413
—
H413
603-110-00-2
reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane
426-130-1
166301-21-9
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
603-111-00-8
reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane
426-530-6
—
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
603-112-00-3
cyclopentyl 2-phenylethyl ether
428-340-9
—
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
603-113-00-9
6-glycidyloxynapht-1-yl oxymethyloxirane
429-960-2
27610-48-6
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H341
H312
H315
H317
H412
GHS08
GHS07
Wng
H341
H312
H315
H317
H412
603-114-00-4
9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene
430-830-2
26912-64-1
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-115-00-X
reaction mass of: O, O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-580-0
—
STOT RE 2 *
Aquatic Chronic 4
H373** H413
GHS08
Wng
H373** H413
603-116-00-5
(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride
424-740-2
138271-16-6
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
603-117-00-0
propan-2-ol; isopropyl alcohol; isopropanol
200-661-7
67-63-0
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
603-118-00-6
6-dimethylaminohexan-1-ol
404-680-3
1862-07-3
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Dgr
H302
H314
H412
603-119-00-1
1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)
405-840-5
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
603-120-00-7
2-methyl-5-phenylpentanol
405-890-8
25634-93-9
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315
603-121-00-2
4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone
406-057-1
114565-66-1
Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Wng
H351
H317
H413
603-122-00-8
sodium 2-ethylhexanolate
406-150-7
38411-13-1
Flam. Sol. 1
Skin Corr. 1B
Aquatic Chronic 3
H228
H314
H412
GHS02
GHS05
Dgr
H228
H314
H412
T
603-123-00-3
4-methyl-8-methylenetricyclo[3.3.1.1 3,7]decan-2-ol
406-330-5
122760-84-3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
603-124-00-9
1,4-bis[2-(vinyloxy)ethoxy]benzene
406-900-3
84563-49-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-125-00-4
2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol
407-850-5
89544-40-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
603-126-00-X
2-((4-methyl-2-nitrophenyl)amino)ethanol
408-090-7
100418-33-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
603-127-00-5
butan-2-ol; [1](S)-butan-2-ol; [2] (R)-butan-2-ol; [3](±)-butan-2-ol [4]
201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4]
78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
STOT SE 3
H226
H319
H335
H336
GHS02
GHS07
Wng
H226
H319
H335
H336
C
603-128-00-0
2-(phenylmethoxy)naphthalene
405-490-3
613-62-7
Aquatic Chronic 4
H413
—
H413
603-129-00-6
1-tert-butoxypropan-2-ol
406-180-0
57018-52-7
Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Dgr
H226
H318
603-130-00-1
reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)
406-325-8
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-131-00-7
reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)
407-290-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318
603-132-00-2
2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane
408-200-3
63187-91-7
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
603-133-00-8
reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)
408-240-1
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-134-00-3
reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produce by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6 Linear C12 and C14, 50/50 used.
410-450-3
—
Aquatic Chronic 4
H413
—
H413
603-135-00-9
bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium
410-500-4
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
603-136-00-4
3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol
410-910-3
104226-19-9
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
603-137-00-X
reaction mass of:1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol
411-130-6
—
Eye Dam. 1
H318
GHS05
Dgr
H318
603-138-00-5
3-(2,2-dimethyl-3-hydroxypropyl)toluene;(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol
403-140-4
103694-68-4
Aquatic Chronic 3
H412
—
H412
603-139-00-0
bis(2-methoxyethyl) ether
203-924-4
111-96-6
Flam. Liq. 3
Repr. 1B
H226
H360FD
GHS02
GHS08
Dgr
H226
H360FD
EUH019
603-140-00-6
2,2' -oxybisethanol; diethylene glycol
203-872-2
111-46-6
Acute Tox. 4 *
H302
GHS07
Wng
H302
603-141-00-1
reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane
413-780-6
—
Aquatic Chronic 3
H412
—
H412
603-142-00-7
2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane
407-360-1
116230-20-7
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H312
H302
H373 ** H315
H318
GHS06
GHS08
GHS05
Dgr
H312
H302
H373 ** H315
H318
603-143-00-2
R—2,3-epoxy-1-propanol
404-660-4
57044-25-4
Self-react. C **** Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 * Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H242
H350
H341
H360F *** H331
H312
H302
H314
GHS02
GHS06
GHS08
GHS05
Dgr
H242
H350
H341
H360F *** H331
H312
H302
H314
603-144-00-8
Reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol; 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol
413-530-6
111850-00-1
Aquatic Chronic 2
H411
GHS09
H411
603-145-00-3
2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane
406-970-5
129228-11-1
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-146-00-9
2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol
406-080-7
83016-70-0
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Dgr
H302
H314
H412
603-147-00-4
(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
406-030-4
105812-81-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
603-148-00-X
1,4-bis[(vinyloxy)methyl]cyclohexane
413-370-7
17351-75-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
603-149-00-5
reaction mass of: diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane
407-640-3
63767-86-2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411
603-150-00-0
(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol
411-580-3
107898-54-4
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
603-151-00-6
(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol
413-570-4
—
Aquatic Chronic 3
H412
—
H412
603-152-00-1
2-(4-tert-butylphenyl)ethanol
410-020-5
5406-86-0
Repr. 2
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H361f *** H373 ** H318
H411
GHS08
GHS05
GHS09
Dgr
H361f *** H373 ** H318
H411
603-153-00-7
3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol
410-010-0
104333-00-8
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-154-00-2
1-[(2-tert-butyl)cyclohexyloxy]-2-butanol
412-300-2
139504-68-0
Aquatic Chronic 2
H411
GHS09
H411
603-156-00-3
2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane
411-210-0
89544-48-9
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
603-157-00-9
6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol
411-450-6
143747-72-2
Aquatic Chronic 4
H413
—
H413
603-158-00-4
reaction mass of: 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene
412-460-3
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-159-00-X
2-cyclododecylpropan-1-ol
411-410-8
118562-73-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-160-00-5
1,2-diethoxypropane
412-180-1
10221-57-5
Flam. Liq. 2
H225
GHS02
Dgr
H225
EUH019
603-161-00-0
1,3-diethoxypropane
413-140-6
3459-83-4
Flam. Liq. 3
H226
GHS02
Wng
H226
603-162-00-6
α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]
413-420-8
144736-29-8
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
603-163-00-1
2-phenyl-1,3-propanediol
411-810-2
1570-95-2
Eye Dam. 1
H318
GHS05
Dgr
H318
603-164-00-7
2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole
412-420-5
133909-99-6
Aquatic Chronic 4
H413
—
H413
603-165-00-2
reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol
417-470-1
—
Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Wng
H341
H317
603-166-00-8
R-1-chloro-2,3-epoxypropane
424-280-2
51594-55-9
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H226
H350
H331
H311
H301
H314
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H350
H331
H311
H301
H314
H317
603-167-00-3
3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol
407-920-5
6390-69-8
Aquatic Chronic 4
H413
GHS05
Dgr
H413
603-168-00-9
3-(2-ethylhexyloxy)propane-1,2-diol
408-080-2
70445-33-9
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
603-169-00-4
(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
415-550-0
109887-53-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
603-170-00-X
reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol
415-990-3
67739-11-1
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
603-171-00-5
5-thiazolylmethanol
414-780-9
38585-74-9
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
603-172-00-0
mono-2-[2-(4-dibenzo[b, f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate
415-180-1
773058-82-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
603-173-00-6
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane
421-750-9
57280-22-5
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
603-174-00-1
4-cyclohexyl-2-methyl-2-butanol
420-630-3
83926-73-2
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
603-175-00-7
2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylene glycol monohexyl ether; 3,6-dioxa-1-dodecanol; hexyl carbitol; 3,6-dioxadodecan-1-ol
203-988-3
112-59-4
Acute Tox. 4 *
Eye Dam. 1
H312
H318
GHS05
GHS07
Dgr
H312
H318
603-176-00-2
1,2-bis(2-methoxyethoxy)ethane; TEGDME; triethylene glycol dimethyl ether; triglyme
203-977-3
112-49-2
Repr. 1B
H360Df
GHS08
Dgr
H360Df
EUH019
603-177-00-8
1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether; [1] 2-ethoxy-1-methylethyl acetate; 2PG1EEA [2]
216-374-5 [1]
259-370-9 [2]
1569-02-4 [1]
54839-24-6 [2]
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336
603-178-00-3
2-hexyloxyethanol; ethylene glycol monohexyl ether; n-hexylglycol
203-951-1
112-25-4
Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
603-179-00-9
ergocalciferol (ISO); Vitamin D2
200-014-9
50-14-6
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Dgr
H330
H311
H301
H372 **
603-180-00-4
colecalciferol; Vitamin D3
200-673-2
67-97-0
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Dgr
H330
H311
H301
H372 **
603-181-00-X
tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane
216-653-1
1634-04-4
Flam. Liq. 2
Skin Irrit. 2
H225
H315
GHS02
GHS07
Dgr
H225
H315
603-182-00-5
reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O, O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide
428-630-5
—
Skin Sens. 1
H317
GHS07
Wng
H317
603-183-00-0
2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutylether; butoxytriethylene glycol
205-592-6
143-22-6
Eye Dam. 1
H318
GHS05
Dgr
H318
Eye Dam.1; H318: C≥30 % Eye Irrit. 2; H319: 20 % ≤C< 30 %
603-184-00-6
2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol
416-380-1
146925-83-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-185-00-1
2,4-dichloro-3-ethyl-6-nitrophenol
420-740-1
99817-36-4
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410
603-186-00-7
trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol
419-050-3
79944-37-9
Skin Sens. 1
H317
GHS07
Wng
H317
603-187-00-2
2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride
419-360-9
163661-77-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-188-00-8
reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene
426-970-9
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-189-00-3
reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol
405-250-8
—
Aquatic Chronic 2
H411
GHS09
H411
603-190-00-9
8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane
424-030-2
62406-73-9
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
603-191-00-4
2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol
419-740-4
137658-79-8
Aquatic Chronic 4
H413
—
H413
603-192-00-X
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol
423-240-1
125474-34-2
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
603-193-00-5
disodium 9,10-anthracenedioxide
426-030-8
46492-07-3
Skin Corr. 1A
H314
GHS05
Dgr
H314
603-194-00-0
2-(2-aminoethylamino)ethanol; (AEEA)
203-867-5
111-41-1
Repr. 1B
Skin Corr. 1B
Skin Sens. 1
H360Df
H314
H317
GHS05
GHS08
GHS07
Dgr
H360Df
H314
H317
STOT SE 3; H335: C≥5 %
603-195-00-6
2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol
430-810-3
154825-62-4
Aquatic Chronic 3
H412
—
H412
603-196-00-1
2-(7-ethyl-1H-indol-3-yl)ethanol
431-020-1
41340-36-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 ** H411
GHS08
GHS07
GHS09
Wng
H302
H373 ** H411
603-199-00-8
etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole
—
153233-91-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M = 100
603-200-00-1
1-pentanol; [1] 3-pentanol [2]
200-752-1 [1]
209-526-7 [2]
71-41-0 [1]
584-02-1 [2]
Flam. Liq. 3
Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
H226
H332
H335
H315
GHS02
GHS07
Wng
H226
H332
H335
H315
603-201-00-7
(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol
416-120-5
—
Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413
603-202-00-2
4,4,5,5,5-pentafluoropentan-1-ol
421-360-9
148043-73-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
603-203-00-8
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane
427-580-1
—
Skin Irrit. 2
H315
GHS07
Wng
H315
603-204-00-3
reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane
428-110-8
—
Aquatic Chronic 3
H412
—
H412
603-205-00-9
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride
426-200-1
172015-79-1
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H372** H302
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H372** H302
H318
H317
H412
603-206-00-4
2,2-dichloro-1,3-benzodioxol
426-850-6
2032-75-9
Flam. Liq. 3
Skin Corr. 1A
Acute Tox. 4 *
Skin Sens. 1
H226
H314
H302
H317
GHS02
GHS05
GHS07
Dgr
H226
H314
H302
H317
EUH014
603-207-00-X
2-isobutyl-2-isopropyl-1,3-dimethoxypropane
430-800-9
129228-21-3
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
603-208-00-5
1,2-diethoxyethane
211-076-1
629-14-1
Flam. Liq. 2
Repr. 1A Eye Irrit. 2
H225
H360Df
H319
GHS02
GHS08
GHS07
Dgr
H225
H360Df
H319
EUH019
603-209-00-0
spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S,14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS,5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1] spinosyn A; [2] spinosyn D [3]
-[1]
-[2]
-[3]
-[1]
131929-60-7 [2]
131929-63-0 [3]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=10
603-210-00-6
2,4-diethyl-1,5-pentanediol
429-310-8
57987-55-0
Eye Dam. 1
H318
GHS05
Dgr
H318
603-211-00-1
2,3-epoxypropyltrimethylammonium chloride … %; glycidyl trimethylammonium chloride … %
221-221-0
3033-77-0
Carc. 1B Muta. 2
Repr. 2
Acute Tox. 4 * Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H361f*** H312
H302
H373** H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H350
H341
H361f*** H312
H302
H373** H318
H317
H412
B
603-212-00-7
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide;(HHCB)
214-946-9
1222-05-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
603-213-00-2
2-methoxy-2-methylbutane; tert-amyl methyl ether
213-611-4
994-05-8
Flam. Liq. 2
Acute Tox. 4 * STOT SE 3
H225
H302
H336
GHS02
GHS07
Dgr
H225
H302
H336
603-214-00-8
1,1-diisopropoxycyclohexane
413-740-8
1132-95-2
Skin Corr. 1B
H314
GHS05
Dgr
H314
603-215-00-3
1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
418-330-2
162241-33-0
Expl. 1.1****
Acute Tox. 4 * STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H302
H373** H318
H317
H400
H410
GHS01
GHS05
GHS08
GHS07
GHS09
Dgr
H201
H302
H373** H318
H317
H410
603-216-00-9
cis-1-amino-2,3-dihydro-1H-inden-2-ol
422-660-2
7480-35-5
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
603-217-00-4
2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite
423-560-1
161717-32-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
603-220-00-0
1-{]benzyl[}2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol
432-890-5
72955-94-3
Aquatic Chronic 4
H413
—
H413
603-221-00-6
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Acute Tox. 4 *
Skin Corr. 1B Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
603-221-01-3
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H350
H302
H314
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H350
H302
H314
H411
603-222-00-1
(2R, 3S, 4R, 5R, 7R, 9R, 10R,11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
433-820-6
118058-74-5
Eye Irrit. 2
H319
GHS07
Wng
H319
603-223-00-7
2-cyclopentylidene cyclopentanol 1,1'-bi(cyclopentyliden)-2-ol
434-270-1
6261-30-9
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
603-224-00-2
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane
435-790-1
297730-93-9
Aquatic Chronic 4
H413
—
H413
603-225-00-8
erythromycin A9-oxime (E);(3R, 4S, 5S, 6R, 7R, 9R, 11R,12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
437-070-0
13127-18-9
Aquatic Chronic 2
H411
GHS09
H411
603-226-00-3
4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol
444-500-0
1440-00-2
Aquatic Chronic 3
H412
—
H412
603-227-00-9
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate
445-060-2
203574-04-3
****
Aquatic Acute 1
Aquatic Chronic 1
**** H400
H410
**** GHS09
Wng
**** H410
603-228-00-4
(+/–)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane
419-620-1
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
603-229-00-X
sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate
420-800-7
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
603-230-00-5
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan
440-030-5
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 4
H315
H318
H413
GHS05
Dgr
H315
H318
H413
603-231-00-0
(S)-1,1-diphenyl-1,2-propanediol
443-220-6
—
Aquatic Chronic 3
H412
—
H412
603-232-00-6
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane
444-420-6
—
Aquatic Chronic 4
H413
—
H413
603-233-00-1
reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol
444-430-0
—
Aquatic Chronic 2
H411
GHS09
H411
603-234-00-7
(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene
444-480-3
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
604-001-00-2
phenol; carbolic acid; monohydroxybenzene; phenylalcohol
203-632-7
108-95-2
Muta. 2
Acute Tox. 3 * Acute Tox. 3 *
Acute Tox. 3 * STOT RE 2 *
Skin Corr. 1B
H341
H331
H311
H301
H373 ** H314
GHS06
GHS08
GHS05
Dgr
H341
H331
H311
H301
H373 ** H314
*
Skin Corr. 1B; H314: C ≥ 3 %
Skin Irrit. 2; H315 1 % ≤ C<3 %
Eye Irrit. 2; H319:1 % ≤C<3 %
604-002-00-8
pentachlorophenol
201-778-6
87-86-5
Carc. 2
Acute Tox. 2 * Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H311
H301
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H330
H311
H301
H319
H335
H315
H410
604-003-00-3
sodiumpentachlorophenolate; [1] potassium pentachlorophenolate[2]
205-025-2 [1]
231-911-3 [2]
131-52-2 [1]
7778-73-6 [2]
Carc. 2
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H311
H301
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H330
H311
H301
H319
H335
H315
H410
604-004-00-9
m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4]
203-577-9 [1]
202-423-8 [2]
203-398-6 [3]
215-293-2 [4]
108-39-4 [1]
95-48-7 [2]
106-44-5 [3]
1319-77-3 [4]
Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
H311
H301
H314
GHS06
GHS05
Dgr
H311
H301
H314
*
C
604-005-00-4
1,4-dihydroxybenzene; hydroquinone; quinol
204-617-8
123-31-9
Carc. 2
Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H302
H318
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H341
H302
H318
H317
H400
M=10
604-006-00-X
3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(or 2,5)-xylenol [7]
202-439-5 [1]
202-461-5 [2]
203-321-6 [3]
208-395-3 [4]
209-400-1 [5]
215-089-3 [6]
276-245-4 [7]
95-65-8 [1]
95-87-4 [2]
105-67-9 [3]
526-75-0 [4]
576-26-1 [5]
1300-71-6 [6]
71975-58-1 [7]
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H311
H301
H314
H411
GHS06
GHS05
GHS09
Dgr
H311
H301
H314
H411
C
604-007-00-5
2-naphthol
205-182-7
135-19-3
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
H332
H302
H400
GHS07
GHS09
Wng
H332
H302
H400
604-008-00-0
2-chlorophenol; [1] 4-chlorophenol; [2] 3-chlorophenol; [3] chlorophenol [4]
202-433-2 [1]
203-402-6 [2]
203-582-6 [3]
246-691-4 [4]
95-57-8 [1]
106-48-9 [2]
108-43-0 [3]
25167-80-0 [4]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H312
H302
H411
GHS07
GHS09
Wng
H332
H312
H302
H411
C
604-009-00-6
pyrogallol; 1,2,3-trihydroxybenzene
201-762-9
87-66-1
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H341
H332
H312
H302
H412
GHS08
GHS07
Wng
H341
H332
H312
H302
H412
*
604-010-00-1
resorcinol; 1,3-benzenediol
203-585-2
108-46-3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
H302
H319
H315
H400
GHS07
GHS09
Wng
H302
H319
H315
H400
*
604-011-00-7
2,4-dichlorophenol
204-429-6
120-83-2
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H311
H302
H314
H411
GHS06
GHS05
GHS09
Dgr
H311
H302
H314
H411
604-012-00-2
4-chloro-o-cresol; 4-chloro-2-methylphenol
216-381-3
1570-64-5
Acute Tox. 3 *
Skin Corr. 1A Aquatic Acute 1
H331
H314
H400
GHS06
GHS05
GHS09
Dgr
H331
H314
H400
STOT SE 3; H335: C≥1 %
604-013-00-8
2,3,4,6-tetrachlorophenol
200-402-8
58-90-2
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H315
H400
H410
GHS06
GHS09
Dgr
H301
H319
H315
H410
*
Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2;
H315: C≥5 %
604-014-00-3
chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol
200-431-6
59-50-7
Acute Tox. 4 * Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H312
H302
H318
H317
H400
GHS05
GHS07
GHS09
Dgr
H312
H302
H318
H317
H400
*
604-015-00-9
2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene
200-733-8
70-30-4
Acute Tox. 3 *
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410
*
604-016-00-4
1,2-dihydroxybenzene; pyrocatechol
204-427-5
120-80-9
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H312
H302
H319
H315
GHS07
Wng
H312
H302
H319
H315
604-017-00-X
2,4,5-trichlorophenol
202-467-8
95-95-4
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410
*
Eye Irrit. 2; H319: C≥5 %
Skin Irrit.2; H315: C ≥5 %
604-018-00-5
2,4,6-trichlorophenol
201-795-9
88-06-2
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H319
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H319
H315
H410
604-019-00-0
dichlorophen (ISO)
202-567-1
97-23-4
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
604-020-00-6
2-phenylphenol (ISO)biphenyl-2-ol; 2-hydroxybiphenyl;
201-993-5
90-43-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400
604-021-00-1
sodium 2-biphenylate; 2-phenylphenol, sodium salt
205-055-6
132-27-4
Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H302
H335
H315
H318
H400
GHS05
GHS07
GHS09
Wng
H302
H335
H315
H318
H400
604-022-00-7
2,2-dimethyl-1,3-benzodioxol-4-ol
400-900-7
22961-82-6
Eye Dam. 1
H318
GHS05
Dgr
H318
604-023-00-2
2,4-dichloro-3-ethylphenol
401-060-4
—
Skin Corr. 1B Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
604-024-00-8
4,4-isobutylethylidenediphenol
401-720-1
6807-17-6
Repr. 1B
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360F *** H319
H400
H410
GHS08
GHS09
Dgr
H360F *** H319
H410
604-025-00-3
2,5-bis(1,1-dimethylbutyl)hydroquinone
400-220-0
—
Aquatic Chronic 2
H411
GHS09
H411
604-026-00-9
2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)
400-270-3
—
Aquatic Chronic 2
H411
GHS09
H411
604-027-00-4
2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone
400-530-6
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
604-028-00-X
4-amino-3-fluorophenol
402-230-0
399-95-1
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H350
H302
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H317
H411
604-029-00-5
1-naphtol
201-969-4
90-15-3
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H312
H302
H335
H315
H318
GHS05
GHS07
Dgr
H312
H302
H335
H315
H318
604-031-00-6
guaiacol
201-964-7
90-05-1
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
604-032-00-1
thymol
201-944-8
89-83-8
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
604-033-00-7
isobutyl but-3-enoate
401-170-2
24342-03-8
Flam. Liq. 3
H226
GHS02
Wng
H226
604-034-00-2
4,4'-thiodi-o-cresol
403-330-7
24197-34-0
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
604-035-00-8
4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol
404-160-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
604-036-00-3
4,4'-oxybis(ethylenethio)diphenol
404-590-4
90884-29-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
604-037-00-9
3,5-xylenol; 3,5-dimethylphenol
203-606-5
108-68-9
Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
H311
H301
H314
GHS06
GHS05
Dgr
H311
H301
H314
604-038-00-4
4-chloro-3,5-dimethylphenol; [1] chloroxylenol [2]
201-793-8 [1]
215-316-6 [2]
88-04-0 [1]
1321-23-9 [2]
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H302
H319
H315
H317
GHS07
Wng
H302
H319
H315
H317
604-039-00-X
ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate; fenoxaprop-ethyl
266-362-9
66441-23-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
604-040-00-5
fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide
276-439-9
72178-02-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
604-041-00-0
acifluorfen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1] sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium [2]
256-634-5 [1]
263-560-7 [2]
50594-66-6 [1]
62476-59-9 [2]
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
604-042-00-6
4-nitrosophenol
203-251-6
104-91-6
Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H341
H302
H318
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H341
H302
H318
H411
604-043-00-1
monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether
203-083-3
103-16-2
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
604-044-00-7
mequinol; 4-methoxyphenol; hydroquinone monomethyl ether
205-769-8
150-76-5
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
604-045-00-2
2,3,5-trimethylhydroquinone
211-838-3
700-13-0
Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H335
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H332
H335
H315
H318
H317
H410
604-046-00-8
4-(4-isopropoxyphenylsulfonyl)phenol
405-520-5
95235-30-6
Aquatic Chronic 2
H411
GHS09
H411
604-047-00-3
4-(4-tolyloxy)biphenyl
405-730-7
51601-57-1
STOT RE 2 *
Aquatic Chronic 4
H373 ** H413
GHS08
Wng
H373 ** H413
604-048-00-9
4,4',4''-(ethan-1,1,1-triyl)triphenol
405-800-7
27955-94-8
Aquatic Chronic 2
H411
GHS09
H411
604-049-00-4
4-4'-methylenebis(oxyethylenethio)diphenol
407-480-4
93589-69-6
Aquatic Chronic 2
H411
GHS09
H411
604-051-00-5
3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol
401-110-5
87113-78-8
Aquatic Chronic 3
H412
—
H412
604-052-00-0
2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)
403-800-1
103597-45-1
Aquatic Chronic 4
H413
—
H413
604-053-00-6
2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol
410-760-9
157661-93-3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
604-054-00-1
reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol
412-020-0
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
604-055-00-7
2,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane
413-900-7
85954-11-6
Carc. 2
Skin Sens. 1
H351
H317
GHS08
GHS07
Wng
H351
H317
604-056-00-2
2-(2-hydroxy-3,5-dinitroanilino)ethanol
412-520-9
99610-72-7
Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
H228
H361f *** H302
GHS02
GHS07
GHS08
Dgr
H228
H361f *** H302
604-058-00-3
1,2-bis(3-methylphenoxy)ethane
402-730-9
54914-85-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-059-00-9
2-n-hexadecylhydroquinone
406-400-5
—
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H373 ** H315
H317
H413
GHS08
GHS07
Wng
H373 ** H315
H317
H413
604-060-00-4
9,9-bis(4-hydroxyphenyl)fluorene
406-950-6
3236-71-3
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
604-061-00-X
reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl
407-740-7
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H315
H317
H412
GHS07
Wng
H315
H317
H412
604-062-00-5
2,4-dimethyl-6-(1-methyl-pentadecyl)phenol
411-220-5
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
604-063-00-0
5,6-dihydroxyindole
412-130-9
3131-52-0
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
604-064-00-6
2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol
411-380-6
147315-50-2
Aquatic Chronic 4
H413
—
H413
604-065-00-1
4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)
407-460-5
111850-25-0
Aquatic Chronic 2
H411
GHS09
H411
604-066-00-7
reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]-(C45-compound); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol
414-550-8
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-067-00-2
reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)
414-520-4
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
604-068-00-8
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride
415-170-5
90274-24-1
Acute Tox. 4 * Acute Tox. 4 *
Skin Sens. 1
H332
H302
H317
GHS07
Wng
H332
H302
H317
604-069-00-3
2-(1-methylpropyl)-4-tert-butylphenol
421-740-4
51390-14-8
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
604-070-00-9
triclosan;2,4,4'-trichloro-2'-hydroxy-diphenyl-ether; 5-chloro-2-(2,4-dichlorophenoxy)phenol
222-182-2
3380-34-5
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
M = 100
604-071-00-4
4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol
425-600-3
110726-28-8
Aquatic Chronic 4
H413
—
H413
604-072-00-X
1,2-bis(phenoxymethyl)benzene
428-620-0
10403-74-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-073-00-5
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
428-010-4
82413-20-5
Carc. 2
Repr. 1B Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H360F*** H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H351
H360F*** H317
H410
604-074-00-0
tetrabromobisphenol-A; 2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol
201-236-9
79-94-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-075-00-6
4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol
205-426-2
140-66-9
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
M=10
604-076-00-1
phenolphthalein
201-004-7
77-09-8
Carc. 1B Muta. 2
Repr. 2
H350
H341
H361f***
GHS08
Dgr
H350
H341
H361f***
Carc. 1B; H350: C ≥1 %
604-077-00-7
2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol
419-750-9
98809-58-6
Aquatic Chronic 4
H413
—
H413
604-079-00-8
4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol
428-970-4
13595-25-0
Repr. 2
Skin Sens. 1
Aquatic Chronic 2
H361f*** H317
H411
GHS08
GHS07
GHS09
Wng
H361f*** H317
H411
604-080-00-3
4-fluoro-3-trifluoromethylphenol
432-560-0
61721-07-1
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Chronic 2
H332
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H332
H314
H317
H411
604-081-00-9
1,1-bis(4-hydroxyphenyl)-1-phenylethane
433-130-5
1571-75-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
604-082-00-4
2-chloro-6-fluoro-phenol
433-890-8
2040-90-6
Muta. 1B Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H340
H361f*** H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H340
H361f*** H302
H314
H317
H411
604-083-00-X
4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol
439-270-3
260408-02-4
Aquatic Chronic 4
H413
—
H413
604-084-00-5
1-ethoxy-2,3-difluorobenzene
441-000-4
121219-07-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
604-087-00-1
reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride(or sulfonicacid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol
433-640-8
—
Pyr. Sol. 1
Aquatic Chronic 4
H250
H413
GHS02
Dgr
H250
H413
EUH044
604-089-00-2
2-methyl-5-tert-butylthiophenol
444-970-7
—
Flam. Liq. 3
Repr. 2
STOT RE 2 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H226
H361d*** H373** H304
H319
H315
H317
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H361d*** H373** H304
H319
H315
H317
H336
H410
604-090-00-8
4-tert-butylphenol
202-679-0
98-54-4
Repr. 2
Skin Irrit. 2
Eye Dam. 1
H361f
H315
H318
GHS08
GHS05
Dgr
H361f
H315
H318
604-091-00-3
etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether
407-980-2
80844-07-1
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
H410
M = 100
M = 1 000
605-001-00-5
formaldehyde …%
200-001-8
50-00-0
Carc. 1B Muta. 2
Acute Tox. 3* Acute Tox. 3* Acute Tox. 3*
Skin Corr. 1B
Skin Sens. 1
H350
H341
H301
H311
H331
H314
H317
GHS08
GHS06
GHS05
Dgr
H350
H341
H301
H311
H331
H314
H317
*
Skin Corr. 1B; H314: C ≥25 % Skin Irrit. 2; H315: 5 % ≤C
< 25 %
Eye Irrit. 2; H319: 5 % ≤ C
<25 %
STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2 %
B, D
605-002-00-0
1,3,5-trioxan; trioxymethylene
203-812-5
110-88-3
Flam. Sol. 1
Repr. 2
STOT SE 3
H228
H361d *** H335
GHS02
GHS08
GHS07
Dgr
H228
H361d *** H335
T
605-003-00-6
acetaldehyde; ethanal
200-836-8
75-07-0
Flam. Liq. 1
Carc. 2
Eye Irrit. 2
STOT SE 3
H224
H351
H319
H335
GHS02
GHS08
GHS07
Dgr
H224
H351
H319
H335
605-004-00-1
2,4,6-trimethyl-1,3,5-trioxane; paraldehyde
204-639-8
123-63-7
Flam. Liq. 3
H226
GHS02
Wng
H226
605-005-00-7
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde
203-600-2
108-62-3
Flam. Sol. 2
Acute Tox. 4 *
H228
H302
GHS02
GHS07
Wng
H228
H302
605-006-00-2
butyraldehyde
204-646-6
123-72-8
Flam. Liq. 2
H225
GHS02
Dgr
H225
605-007-00-8
1,1-dimethoxyethane; dimethyl acetal
208-589-8
534-15-6
Flam. Liq. 2
H225
GHS02
Dgr
H225
605-008-00-3
acrolein; prop-2-enal; acrylaldehyde
203-453-4
107-02-8
Flam. Liq. 2
Acute Tox. 1
Acute Tox. 2
Acute Tox. 3
Skin Corr. 1B Aquatic Acute 1
Aquatic Chronic 1
H225
H330
H300
H311
H314
H400
H410
GHS02
GHS06
GHS05
GHS09
Dgr
H225
H330
H300
H311
H314
H410
EUH071
Skin Corr. 1B; H314:C≥ 0,1 %
M = 100
M = 1
D
605-009-00-9
crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2]
224-030-0 [1]
204-647-1 [2]
4170-30-3 [1]
123-73-9 [2]
Flam. Liq. 2
Muta. 2
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H225
H341
H330
H311
H301
H373 ** H335
H315
H318
H400
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H341
H330
H311
H301
H373 ** H335
H315
H318
H400
605-010-00-4
2-furaldehyde
202-627-7
98-01-1
Carc. 2
Acute Tox. 3 * Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H351
H331
H301
H312
H319
H335
H315
GHS06
GHS08
Dgr
H351
H331
H301
H312
H319
H335
H315
605-011-00-X
2-chlorobenzaldehyde; o-chlorobenzaldehyde
201-956-3
89-98-5
Skin Corr. 1B
H314
GHS05
Dgr
H314
605-012-00-5
benzaldehyde
202-860-4
100-52-7
Acute Tox. 4 *
H302
GHS07
Wng
H302
605-014-00-6
chloral hydrate; 2,2,2-trichloroethane-1,1-diol
206-117-5
302-17-0
Acute Tox. 3 * Eye Irrit. 2
Skin Irrit. 2
H301
H319
H315
GHS06
Dgr
H301
H319
H315
605-015-00-1
1,1-diethoxyethane; acetal
203-310-6
105-57-7
Flam. Liq. 2
Eye Irrit. 2
Skin Irrit. 2
H225
H319
H315
GHS02
GHS07
Dgr
H225
H319
H315
605-016-00-7
glyoxal…%; ethandial…%
203-474-9
107-22-2
Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H341
H332
H319
H315
H317
GHS07
GHS08
Wng
H341
H332
H319
H315
H317
*
B
605-017-00-2
1,3-dioxolane
211-463-5
646-06-0
Flam. Liq. 2
H225
GHS02
Dgr
H225
605-018-00-8
propanal; propionaldehyde
204-623-0
123-38-6
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315
605-019-00-3
citral
226-394-6
5392-40-5
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
605-020-00-9
safrole; 5-allyl-1,3-benzodioxole
202-345-4
94-59-7
Carc. 1B Muta. 2
Acute Tox. 4 *
H350
H341
H302
GHS08
GHS07
Dgr
H350
H341
H302
605-021-00-4
formaldehyde, reaction products with butylphenol
294-145-9
91673-30-2
Skin Sens. 1
H317
GHS07
Wng
H317
605-024-00-0
2-bromo-5-hydroxy-4-methoxybenzaldehyde
426-540-0
2973-59-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-025-00-6
chloroacetaldehyde
203-472-8
107-20-0
Carc. 2
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H351
H330
H311
H301
H314
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H330
H311
H301
H314
H400
STOT SE 3; H335: C≥ 5 %
605-026-00-1
2,5,7,7-tetramethyloctanal
405-690-0
114119-97-0
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
605-027-00-7
reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde
410-480-7
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-028-00-2
β-methyl-3-(1-methylethyl)-benzenepropanal
412-050-4
125109-85-5
Aquatic Chronic 2
H411
GHS09
H411
605-029-00-8
2-cyclohexylpropanal
412-270-0
2109-22-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-030-00-3
1-(p-methoxyphenyl)acetaldehyde oxime
411-510-1
3353-51-3
Skin Sens. 1
H317
GHS07
Wng
H317
605-031-00-9
reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate; water (Including free water and water in hydrated 2,2-dimethoxyethanal)]
421-890-0
—
Skin Sens. 1
H317
GHS07
Wng
H317
605-032-00-4
3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal
425-370-4
93957-50-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
605-033-00-X
Reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal; 3,7,11-trimethyl-trans-6,10-dodecadienal
425-910-9
32480-08-3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
605-034-00-5
reaction mass of: (1RS, 2RS,3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde
429-860-9
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
605-035-00-0
(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal
426-330-9
177964-68-0
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H319
H317
H413
GHS07
Wng
H319
H317
H413
605-036-00-6
2-bromomalonaldehyde
430-470-6
2065-75-0
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
605-037-00-1
trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde
421-800-1
120578-03-2
Aquatic Chronic 4
H413
—
H413
605-038-00-7
3-methyl-5-phenylpentan-1-al
433-900-0
55066-49-4
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H315
H317
H411
GHS07
GHS09
Wng
H302
H315
H317
H411
605-039-00-2
3,4-dihydroxy-5-nitrobenzaldehyde
441-810-8
116313-85-0
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
606-001-00-8
acetone; propan-2-one; propanone
200-662-2
67-64-1
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066
606-002-00-3
butanone; ethyl methyl ketone
201-159-0
78-93-3
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066
606-003-00-9
heptan-3-one; butyl ethyl ketone
203-388-1
106-35-4
Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
H226
H332
H319
GHS02
GHS07
Wng
H226
H332
H319
606-004-00-4
4-methylpentan-2-one; isobutyl methyl ketone
203-550-1
108-10-1
Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H319
H335
GHS02
GHS07
Dgr
H225
H332
H319
H335
EUH066
606-005-00-X
2,6-dimethylheptan-4-one; di-isobutyl ketone
203-620-1
108-83-8
Flam. Liq. 3
STOT SE 3
H226
H335
GHS02
GHS07
Wng
H226
H335
STOT SE 3; H335: C ≥ 10 %
606-006-00-5
pentan-3-one; diethyl ketone
202-490-3
96-22-0
Flam. Liq. 2
STOT SE 3
STOT SE 3
H225
H335
H336
GHS02
GHS07
Dgr
H225
H335
H336
EUH066
606-007-00-0
3-methylbutan-2-one; methyl isopropyl ketone
209-264-3
563-80-4
Flam. Liq. 2
H225
GHS02
Dgr
H225
606-009-00-1
4-methylpent-3-en-2-one; mesityl oxide
205-502-5
141-79-7
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Wng
H226
H332
H312
H302
*
606-010-00-7
cyclohexanone
203-631-1
108-94-1
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
606-011-00-2
2-methylcyclohexanone
209-513-6
583-60-8
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
606-012-00-8
3,5,5-trimethylcyclohex-2-enone; isophorone
201-126-0
78-59-1
Carc. 2
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H351
H312
H302
H319
H335
GHS08
GHS07
Wng
H351
H312
H302
H319
H335
STOT SE 3; H335: C ≥10 %
606-013-00-3
p-benzoquinone; quinone
203-405-2
106-51-4
Acute Tox. 3 * Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H331
H301
H319
H335
H315
H400
GHS06
GHS09
Dgr
H331
H301
H319
H335
H315
H400
M=10
606-016-00-X
pindone (ISO); 2-pivaloylindan-1,3-dione
201-462-8
83-26-1
Acute Tox. 3 * STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 ** H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H372 ** H410
606-017-00-5
diketene; diketen
211-617-1
674-82-8
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
D
606-018-00-0
dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone
204-210-5
117-80-6
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410
606-019-00-6
chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,0 4,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one
205-601-3
143-50-0
Carc. 2
Acute Tox. 3 * Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H311
H301
H410
606-020-00-1
5-methylheptan-3-one
208-793-7
541-85-5
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Wng
H226
H319
H335
STOT SE 3; H335: C≥10 %
606-022-00-2
1-phenyl-3-pyrazolidone
202-155-1
92-43-3
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
606-023-00-8
4-methoxy-4-methylpentan-2-one
203-512-4
107-70-0
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
606-024-00-3
heptan-2-one; methyl amyl ketone
203-767-1
110-43-0
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 *
H226
H332
H302
GHS02
GHS07
Wng
H226
H332
H302
606-025-00-9
cyclopentanone
204-435-9
120-92-3
Flam. Liq. 3
Eye Irrit. 2
Skin Irrit. 2
H226
H319
H315
GHS02
GHS07
Wng
H226
H319
H315
606-026-00-4
5-methylhexan-2-one; isoamyl methyl ketone
203-737-8
110-12-3
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
606-027-00-X
heptan-4-one; di-n-propyl ketone
204-608-9
123-19-3
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
606-028-00-5
2,4-dimethylpentan-3-one; di-isopropyl ketone
209-294-7
565-80-0
Flam. Liq. 2
Acute Tox. 4 *
H225
H332
GHS02
GHS07
Dgr
H225
H332
606-029-00-0
pentane-2,4-dione; acetylacetone
204-634-0
123-54-6
Flam. Liq. 3
Acute Tox. 4 *
H226
H302
GHS02
GHS07
Wng
H226
H302
606-030-00-6
hexan-2-one; methyl butyl ketone; butyl methyl ketone; methyl-n-butyl ketone
209-731-1
591-78-6
Flam. Liq. 3
Repr. 2
STOT RE 1
STOT SE 3
H226
H361f *** H372 ** H336
GHS02
GHS08
GHS07
Dgr
H226
H361f *** H372 ** H336
606-031-00-1
3-propanolide;1,3-propiolactone
200-340-1
57-57-8
Carc. 1B
Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
H350
H330
H319
H315
GHS06
GHS08
Dgr
H350
H330
H319
H315
606-032-00-7
hexachloroacetone
204-129-5
116-16-5
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
606-033-00-2
2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione; methazole
243-761-6
20354-26-1
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H312
H302
H319
H315
H411
GHS07
GHS09
Wng
H312
H302
H319
H315
H411
606-034-00-8
metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one
244-209-7
21087-64-9
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=10
606-035-00-3
chloridazon (ISO); 5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one; pyrazon
216-920-2
1698-60-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
606-036-00-9
quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one
219-455-3
2439-01-2
Repr. 2
Acute Tox. 4 * Acute Tox. 4 *
Acute Tox. 4 * STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f *** H332
H312
H302
H373 ** H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f *** H332
H312
H302
H373 ** H319
H317
H410
606-037-00-4
triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone
256-103-8
43121-43-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
606-038-00-X
diphacinone (ISO); 2-diphenylacetylindan-1,3-dione
201-434-5
82-66-6
Acute Tox. 2 * STOT RE 1
H300
H372 **
GHS06
GHS08
Dgr
H300
H372 **
606-039-00-5
5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one
400-680-2
—
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H332
H400
H410
GHS07
GHS09
Wng
H332
H410
606-040-00-0
(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride
401-840-4
55845-90-4
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
606-042-00-1
acetophenone
202-708-7
98-86-2
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
606-043-00-7
2,4-di-tert-butylcyclohexanone
405-340-7
13019-04-0
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
606-044-00-2
2,4,6-trimethylbenzophenone
403-150-9
954-16-5
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
606-045-00-8
oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
243-215-7
19666-30-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-046-00-3
reaction mass of cis-and trans-cyclohexadec-8-en-1-one
401-700-2
3100-36-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-047-00-9
2-benzyl-2-dimethylamino-4-morpholinobutyrophenone
404-360-3
119313-12-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-048-00-4
2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one
406-480-1
—
Aquatic Chronic 4
H413
—
H413
606-049-00-X
4-(trans-4-propylcyclohexyl)acetophenone
406-700-6
78531-61-0
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-050-00-5
6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione
412-480-2
72453-58-8
Aquatic Chronic 2
H411
GHS09
H411
606-051-00-0
4-pentylcyclohexanone
406-670-4
61203-83-6
Aquatic Chronic 2
H411
GHS09
H411
606-052-00-6
4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone
410-410-5
54574-82-2
Aquatic Chronic 3
H412
—
H412
606-053-00-1
flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one
—
96525-23-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-055-00-2
1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone
411-180-9
92836-10-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 ** H411
GHS08
GHS07
GHS09
Wng
H302
H373 ** H411
606-056-00-8
4-chloro-3',4'-dimethoxybenzophenone
404-610-1
116412-83-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-057-00-3
4-propylcyclohexanone
406-810-4
40649-36-3
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
606-058-00-9
4'-fluoro-2,2-dimethoxyacetophenone
407-500-1
21983-80-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-059-00-4
2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride
412-390-3
86386-75-6
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
606-060-00-X
Reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane
412-950-7
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-061-00-5
(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone
423-290-4
66938-41-8
Muta. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H400
H410
GHS08
GHS09
Wng
H341
H410
606-062-00-0
tetrahydrothiopyran-3-carboxaldehyde
407-330-8
61571-06-0
Repr. 1B
Eye Dam. 1
Aquatic Chronic 3
H360D *** H318
H412
GHS08
GHS05
Dgr
H360D *** H318
H412
606-063-00-6
(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal
410-980-5
112704-51-5
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
606-064-00-1
pregn-5-ene-3,20-dione bis(ethylene ketal)
407-450-0
7093-55-2
Aquatic Chronic 4
H413
—
H413
606-065-00-7
1-(4-morpholinophenyl)butan-1-one
413-790-0
—
Aquatic Chronic 2
H411
GHS09
H411
606-066-00-2
(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone
410-440-9
164058-20-2
Aquatic Chronic 2
H411
GHS09
H411
606-067-00-8
reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone
414-870-8
96792-67-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-068-00-3
2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al
415-770-7
1638-05-7
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373 ** H317
H412
GHS08
GHS07
Wng
H373 ** H317
H412
606-069-00-9
spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]
415-460-1
154171-76-3
Aquatic Chronic 2
H411
GHS09
H411
606-070-00-4
butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one
414-790-3
138164-12-2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H361fd
H302
H315
H410
606-071-00-X
17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one
421-050-3
13258-43-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-072-00-5
3-acetyl-1-phenyl-pyrrolidine-2,4-dione
421-600-2
719-86-8
STOT RE 2 *
Aquatic Chronic 2
H373 ** H411
GHS08
GHS09
Wng
H373 ** H411
606-073-00-0
4,4'-bis(dimethylamino)benzophenone; Michler's ketone
202-027-5
90-94-8
Carc. 1B Muta. 2
Eye Dam. 1
H350
H341
H318
GHS08
GHS05
Dgr
H350
H341
H318
606-074-00-6
reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene
425-570-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-075-00-1
1-benzyl-5-ethoxyimidazolidine-2,4-dione
417-340-4
65855-02-9
Acute Tox. 4 *
H302
GHS07
Wng
H302
606-076-00-7
1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione
418-630-3
136465-99-1
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
606-077-00-2
(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone
418-650-2
104872-06-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-078-00-8
1-octylazepin-2-one
420-040-6
59227-88-2
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
606-079-00-3
2-n-butyl-benzo[d]isothiazol-3-one
420-590-7
4299-07-4
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
606-081-00-4
(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one
419-790-7
4229-69-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-082-00-X
reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane
406-930-7
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H372 ** H317
H412
GHS08
GHS07
Dgr
H372 ** H317
H412
606-083-00-5
2-chloro-5-sec-hexadecylhydroquinone
407-750-1
137193-60-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H315
H317
H412
GHS07
Wng
H319
H315
H317
H412
606-084-00-0
1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione
414-540-3
484-33-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-085-00-6
(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one
418-530-1
79200-56-9
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
606-086-00-1
1-(3,3-dimethylcyclohexyl)pent-4-en-1-one
422-330-8
56973-87-6
Aquatic Chronic 2
H411
GHS09
H411
606-087-00-7
6-ethyl-5-fluoro-4(3H)-pyrimidone
422-460-5
137234-87-8
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
606-088-00-2
2,4,4,7-tetramethyl-6-octen-3-one
422-520-0
74338-72-0
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
606-089-00-8
reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone
423-220-2
12223-77-7
Aquatic Chronic 4
H413
—
H413
606-090-00-3
1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone
430-920-1
73096-98-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
606-091-00-9
6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one
421-320-0
118289-55-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-092-00-4
reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
422-320-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-093-00-X
5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one
414-470-3
95885-13-5
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
606-094-00-5
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one
417-460-7
—
Aquatic Chronic 4
H413
—
H413
606-095-00-0
(R, S)-2-azabicyclo[2.2.1]hept-5-en-3-one
421-830-3
49805-30-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
606-096-00-6
3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
424-170-4
130603-71-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
606-097-00-1
2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone
424-210-0
23911-85-5
Aquatic Chronic 4
H413
—
H413
606-098-00-7
1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione
431-220-9
158574-65-3
Aquatic Chronic 4
H413
—
H413
606-099-00-2
5-methoxy-4'-(trifluoromethyl)valerophenone
425-000-1
61718-80-7
Aquatic Chronic 2
H411
GHS09
H411
606-100-00-6
2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one
425-150-8
94723-86-1
Repr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H360F*** H302
H317
H412
GHS08
GHS07
Dgr
H360F*** H302
H317
H412
606-101-00-1
reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione
426-050-7
165038-51-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
606-102-00-7
4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone
431-490-8
79876-59-8
Aquatic Chronic 2
H411
GHS09
H411
606-103-00-2
1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone
426-460-6
—
Skin Sens. 1
H317
GHS07
Wng
H317
606-104-00-8
1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone
426-830-7
78531-59-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-105-00-3
3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione
431-500-0
226065-73-2
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-106-00-9
1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone
427-320-7
83626-30-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-107-00-4
8-azaspiro[4.5]decane-7,9-dione
427-770-4
1075-89-4
Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411
606-108-00-X
1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone
436-710-6
756-13-8
Aquatic Chronic 3
H412
—
H412
606-109-00-5
2-(4-methyl-3-pentenyl)anthraquinone
428-320-1
71308-16-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4
H302
H317
H413
GHS07
Wng
H302
H317
H413
606-110-00-0
5-ethoxy-5H-furan-2-one
428-330-4
2833-30-9
Skin Corr. 1B
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
Skin Sens. 1
H314
H312
H302
H373** H317
GHS05
GHS08
GHS07
Dgr
H314
H312
H302
H373** H317
606-111-00-6
5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one
428-410-9
67014-36-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
606-112-00-1
(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one
428-690-2
1668-86-6
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412
606-113-00-7
1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one
429-040-0
272460-97-6
Eye Dam. 1
Aquatic Chronic 4
H318
H413
GHS05
Dgr
H318
H413
606-114-00-2
4,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone
429-150-9
67887-47-2
Aquatic Chronic 4
H413
—
H413
606-115-00-8
profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
—
139001-49-3
Carc. 2
Repr. 2
Skin Sens. 1
H351
H361d
H317
GHS08
GHS07
Wng
H351
H361d
H317
606-116-00-3
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
—
149979-41-9
Carc. 2
Repr. 2
H351
H361fd
GHS08
Wng
H351
H361fd
606-117-00-9
2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one
429-460-4
7078-98-0
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-118-00-4
N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine
429-640-2
52870-46-9
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
606-119-00-X
(E)-3-methyl-5-cyclopentadecen-1-one
429-900-5
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
606-120-00-5
2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one
430-170-5
114625-74-0
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
606-121-00-0
(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)
430-460-1
133636-82-5
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
606-122-00-6
3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one
430-820-8
114341-88-7
Acute Tox. 4 * STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373** H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373** H315
H318
H317
H410
606-123-00-1
4-hexadecyl-1-phenylpyrazolidin-3-one
430-840-7
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
606-124-00-7
1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione
421-080-7
161462-35-7
STOT RE 2 * Aquatic Acute 1
Aquatic Chronic 1
H373** H400
H410
GHS08
GHS09
Wng
H373** H410
606-125-00-2
1-benzylimidazolidine-2,4-dione
421-340-1
6777-05-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
606-126-00-8
1,4-bis(2,3-dihydroxypropylamino)anthraquinone
421-470-7
99788-75-7
Aquatic Chronic 2
H411
GHS09
H411
606-128-00-9
2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione
422-650-8
148935-94-8
Aquatic Chronic 4
H413
—
H413
606-129-00-4
5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
423-090-7
156732-13-7
Aquatic Chronic 4
H413
—
H413
606-130-00-X
4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone
423-860-2
56309-94-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-131-00-5
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
427-230-8
5571-36-8
Repr. 1B
STOT RE 2 *
Aquatic Chronic 2
H360F*** H373** H411
GHS08
GHS09
Dgr
H360F*** H373** H411
606-132-00-0
(6β)-6,19-epoxyandrost-4-ene-3,17-dione
433-490-3
6563-83-3
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
606-134-00-1
androsta-1,4,9(11)-triene-3,17-dione
433-560-3
15375-21-0
Repr. 2
H361f***
GHS08
Wng
H361f***
606-135-00-7
cyclohexadecanone
438-930-8
2550-52-9
Aquatic Chronic 4
H413
—
H413
606-136-00-2
(3S, 6R, 9S, 12R, 15S, 18R, 21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone
444-350-6
133413-70-4
Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413
606-137-00-8
trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione
444-750-0
211387-26-7
Aquatic Chronic 4
H413
—
H413
606-138-00-3
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone
444-800-1
141645-23-0
Flam. Liq. 3
Acute Tox. 4 * STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373** H315
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H226
H302
H373** H315
H318
H317
H410
M=10
606-139-00-9
(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one
444-830-5
124379-29-9
Aquatic Chronic 4
H413
—
H413
606-140-00-4
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one
444-860-9
474510-57-1
STOT RE 2 * Aquatic Acute 1
Aquatic Chronic 1
H373** H400
H410
GHS08
GHS09
Wn
H373** H410
606-141-00-X
sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate
418-410-7
—
Eye Irrit. 2
H319
GHS07
Wng
H319
606-142-00-5
reaction mass of: (1RS, 2SR,7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one
434-290-9
—
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
606-143-00-0
abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] avermectin B1a (purity ≥ 80 %); [2]
_ [1]
265-610-3 [2]
71751-41-2 [1]
65195-55-3 [2]
Repr. 2
Acute Tox. 2
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H300
H330
H372 (nervous system) H400
H410
GHS06
GHS08
GHS09
Dgr
H361d
H300
H330
H372 (nervous system) H410
STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 %
≤C< 5 %
M = 10 000
606-144-00-6
acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate
—
57960-19-7
Skin Sens. 1
STOT SE 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H317
H370 (lung) (inhalation) H373 (blood system)
H400
H410
GHS07
GHS08
GHS09
Dgr
H317
H370 (lung) (inhalation) H373 (blood system)
H410
M = 1 000
606-145-00-1
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione
99105-77-8
Repr. 2
STOT RE 2
Skin Sens. 1A Aquatic Acute 1
Aquatic Chronic 1
H361d H373 (kidneys) H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d H373 (kidneys) H317
H410
M = 1
M = 10
606-146-00-7
tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one
—
87820-88-0
Carc. 2
Acute Tox. 4
Aquatic Chronic 2
H351
H302
H411
GHS08
GHS07
GHS09
Wng
H351
H302
H411
606-147-00-2
cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one
405-230-9
101205-02-1
Repr. 2
H361d
GHS08
Wng
H361d
607-001-00-0
formic acid … %
200-579-1
64-18-6
Skin Corr. 1A
H314
GHS05
Dgr
H314
Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 %
Skin Irrit. 2; H315: 2 % ≤C
< 10 %
Eye Irrit. 2; H319: 2 %≤
<10 %
B
607-002-00-6
acetic acid … %
200-580-7
64-19-7
Flam. Liq. 3
Skin Corr. 1A
H226
H314
GHS02
GHS05
Dgr
H226
H314
Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25 %≤ C <90 %
Skin Irrit. 2; H315: 10 % ≤C <25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
607-003-00-1
chloroacetic acid
201-178-4
79-11-8
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B Aquatic Acute 1
H331
H311
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H400
STOT SE 3; H335: C≥ 5 %
607-004-00-7
TCA (ISO); trichloroacetic acid
200-927-2
76-03-9
Skin Corr. 1A Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
STOT SE 3; H335: C ≥ 1 %
607-005-00-2
TCA-sodium (ISO); sodium trichloroacetate
211-479-2
650-51-1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H335
H400
H410
GHS07
GHS09
Wng
H335
H410
607-006-00-8
oxalic acid
205-634-3
144-62-7
Acute Tox. 4 * Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
*
607-007-00-3
salts of oxalic acid (with the exception of those specified elsewhere in this Annex)
—
—
Acute Tox. 4 * Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
*
A
607-008-00-9
acetic anhydride
203-564-8
108-24-7
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H332
H302
H314
Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤C
< 25 %
Eye Dam. 1; H318: 5 % ≤ C
< 25 %
Eye Irrit. 2; H319: 1 % ≤C
< 5 %
STOT SE 3; H335: C ≥ 5 %
607-009-00-4
phthalic anhydride
201-607-5
85-44-9
Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H302
H335
H315
H318
H334
H317
GHS08
GHS05
GHS07
Dgr
H302
H335
H315
H318
H334
H317
607-010-00-X
propionic anhydride
204-638-2
123-62-6
Skin Corr. 1B
H314
GHS05
Dgr
H314
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
607-011-00-5
acetyl chloride
200-865-6
75-36-5
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
EUH014
607-012-00-0
benzoyl chloride
202-710-8
98-88-4
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H332
H312
H302
H314
H317
GHS05
GHS07
Dgr
H332
H312
H302
H314
H317
607-013-00-6
dimethyl carbonate
210-478-4
616-38-6
Flam. Liq. 2
H225
GHS02
Dgr
H225
607-014-00-1
methyl formate
203-481-7
107-31-3
Flam. Liq. 1
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H224
H332
H302
H319
H335
GHS02
GHS07
Dgr
H224
H332
H302
H319
H335
607-015-00-7
ethyl formate
203-721-0
109-94-4
Flam. Liq. 2
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H302
H319
H335
GHS02
GHS07
Dgr
H225
H332
H302
H319
H335
607-016-00-2
propyl formate; [1] isopropyl formate [2]
203-798-0 [1]
210-901-2 [2]
110-74-7 [1]
625-55-8 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3
H225
H319
H335
H336
GHS02
GHS07
Dgr
H225
H319
H335
H336
C
607-017-00-8
butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3]
209-772-5 [1]
212-105-0 [2]
208-818-1 [3]
592-84-7 [1]
762-75-4 [2]
542-55-2 [3]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Dgr
H225
H319
H335
C
607-018-00-3
isopentyl formate; [1] 2-methylbutyl formate [2]
203-769-2 [1]
252-343-2 [2]
110-45-2 [1]
35073-27-9 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Dgr
H225
H319
H335
C
607-019-00-9
methyl chloroformate
201-187-3
79-22-1
Flam. Liq. 2
Acute Tox. 2 * Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H330
H312
H302
H314
GHS02
GHS06
GHS05
Dgr
H225
H330
H312
H302
H314
607-020-00-4
ethyl chloroformate
208-778-5
541-41-3
Flam. Liq. 2
Acute Tox. 2 * Acute Tox. 4 *
Skin Corr. 1B
H225
H330
H302
H314
GHS02
GHS06
GHS05
Dgr
H225
H330
H302
H314
607-021-00-X
methyl acetate
201-185-2
79-20-9
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066
607-022-00-5
ethyl acetate
205-500-4
141-78-6
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066
607-023-00-0
vinyl acetate
203-545-4
108-05-4
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
H225
H351
H332
H335
GHS02
GHS08
GHS07
Dgr
H225
H351
H332
H335
D
607-024-00-6
propyl acetate; [1] isopropyl acetate [2]
203-686-1 [1]
203-561-1 [2]
109-60-4 [1]
108-21-4 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066
C
607-025-00-1
n-butyl acetate
204-658-1
123-86-4
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336
EUH066
607-026-00-7
sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3]
203-300-1 [1]
203-745-1 [2]
208-760-7 [3]
105-46-4 [1]
110-19-0 [2]
540-88-5 [3]
Flam. Liq. 2
H225
GHS02
Dgr
H225
EUH066
C
607-027-00-2
methyl propionate
209-060-4
554-12-1
Flam. Liq. 2
Acute Tox. 4 *
H225
H332
GHS02
GHS07
Dgr
H225
H332
607-028-00-8
ethyl propionate
203-291-4
105-37-3
Flam. Liq. 2
H225
GHS02
Dgr
H225
607-029-00-3
n-butyl propionate; [1] sec-butyl propionate; [2] iso-butyl propionate [3]
209-669-5 [1]
-[2]
208-746-0 [3]
590-01-2 [1]
591-34-4 [2]
540-42-1 [3]
Flam. Liq. 3
H226
GHS02
Wng
H226
C
607-030-00-9
propyl propionate
203-389-7
106-36-5
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
607-031-00-4
butyl butyrate
203-656-8
109-21-7
Flam. Liq. 3
H226
GHS02
Wng
H226
C
607-032-00-X
ethyl acrylate
205-438-8
140-88-5
Flam. Liq. 2
Acute Tox. 4 * Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H335
H315
H317
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 %
D
607-033-00-5
n-butyl methacrylate
202-615-1
97-88-1
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Wng
H226
H319
H335
H315
H317
D
607-034-00-0
methyl acrylate; methyl propenoate
202-500-6
96-33-3
Flam. Liq. 2
Acute Tox. 4 * Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H335
H315
H317
D
607-035-00-6
methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate
201-297-1
80-62-6
Flam. Liq. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H335
H315
H317
GHS02
GHS07
Dgr
H225
H335
H315
H317
D
607-036-00-1
2-methoxyethyl acetate; methylglycol acetate
203-772-9
110-49-6
Repr. 1B
Acute Tox. 4 * Acute Tox. 4 *
Acute Tox. 4 *
H360FD H332
H312
H302
GHS08
GHS07
Dgr
H360FD H332
H312
H302
607-037-00-7
2-ethoxyethyl acetate; ethylglycol acetate
203-839-2
111-15-9
Flam. Liq. 3
Repr. 1B
Acute Tox. 4 * Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H226
H360FD H332
H312
H302
607-038-00-2
2-butoxyethyl acetate; butylglycol acetate
203-933-3
112-07-2
Acute Tox. 4 * Acute Tox. 4 *
H332
H312
GHS07
Wng
H332
H312
607-039-00-8
2,4-D (ISO); 2,4-dichlorophenoxyacetic acid
202-361-1
94-75-7
Acute Tox. 4 * STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H335
H318
H317
H412
GHS05
GHS07
Dgr
H302
H335
H318
H317
H412
607-040-00-3
salts of 2,4-D
—
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
A
607-041-00-9
2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid
202-273-3
93-76-5
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410
607-042-00-4
salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid
—
—
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410
A
607-043-00-X
dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid
217-635-6
1918-00-9
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
607-044-00-5
3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate[2]
218-951-7 [1]
233-002-7 [2]
2300-66-5 [1]
10007-85-9 [2]
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
607-045-00-0
dichlorprop (ISO); 2-(2,4-dichlorophenoxy)propionic acid
204-390-5
120-36-5
Acute Tox. 4 * Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H312
H302
H315
H318
GHS05
GHS07
Dgr
H312
H302
H315
H318
607-046-00-6
salts of dichlorprop
—
—
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302
A
607-047-00-1
fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid
202-271-2
93-72-1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410
607-048-00-7
salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
A
607-049-00-2
mecoprop (ISO); 2-(4-chloro-o-tolyloxy)propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1] 2-(4-chloro-2-methylphenoxy)propionic acid [2]
230-386-8 [1]
202-264-4 [2]
7085-19-0 [1]
708519-0 [2]
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
M=100
607-050-00-8
salts of mecoprop
—
—
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
A
607-051-00-3
MCPA (ISO); 4-chloro-o-tolyloxyacetic acid
202-360-6
94-74-6
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
607-052-00-9
salts and esters of MCPA
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
A
607-053-00-4
MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid
202-365-3
94-81-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-054-00-X
salts and esters of MCPB
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302
A
607-055-00-5
endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate
204-959-8
129-67-9
Acute Tox. 3 * Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H301
H312
H319
H335
H315
GHS06
Dgr
H301
H312
H319
H335
H315
607-057-00-6
coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin
201-378-1
81-82-3
STOT RE 2 *
Aquatic Chronic 3
H373 ** H412
GHS08
Wng
H373 ** H412
607-058-00-1
coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]coumarin
204-195-5
117-52-2
Acute Tox. 3 * STOT RE 1
Aquatic Chronic 3
H301
H372 ** H412
GHS06
GHS08
Dgr
H301
H372 ** H412
607-060-00-2
dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)
200-632-9
66-76-2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 2
H372 ** H302
H411
GHS08
GHS07
GHS09
Dgr
H372 ** H302
H411
607-061-00-8
acrylic acid; prop-2-enoic acid
201-177-9
79-10-7
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1A Aquatic Acute 1
H226
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H332
H312
H302
H314
H400
STOT SE 3; H335: C ≥ 1 %
D
607-062-00-3
n-butyl acrylate
205-480-7
141-32-2
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Wng
H226
H319
H335
H315
H317
D
607-063-00-9
isobutyric acid
201-195-7
79-31-2
Acute Tox. 4 * Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
607-064-00-4
benzyl chloroformate
207-925-0
501-53-1
Skin Corr. 1B Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
STOT SE 3; H335: C ≥ 5 %
607-065-00-X
bromoacetic acid
201-175-8
79-08-3
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H331
H311
H301
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H317
H400
607-066-00-5
dichloroacetic acid
201-207-0
79-43-6
Skin Corr. 1A Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
607-067-00-0
dichloroacetyl chloride
201-199-9
79-36-7
Skin Corr. 1A Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
607-068-00-6
iodoacetic acid
200-590-1
64-69-7
Acute Tox. 3 *
Skin Corr. 1A
H301
H314
GHS06
GHS05
Dgr
H301
H314
607-069-00-1
ethyl bromoacetate
203-290-9
105-36-2
Acute Tox. 2 * Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300
607-070-00-7
ethyl chloroacetate
203-294-0
105-39-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * Aquatic Acute 1
H331
H311
H301
H400
GHS06
GHS09
Dgr
H331
H311
H301
H400
607-071-00-2
ethyl methacrylate
202-597-5
97-63-2
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H319
H335
H315
H317
D
607-072-00-8
2-hydroxyethyl acrylate
212-454-9
818-61-1
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
H311
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H311
H314
H317
H400
*
Skin Sens. 1; H317: C ≥ 0,2 %
D
607-073-00-3
4-CPA (ISO); 4-chlorophenoxyacetic acid
204-581-3
122-88-3
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-074-00-9
chlorfenac(ISO); 2,3,6-trichlorophenylacetic acid
201-599-3
85-34-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-075-00-4
chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate
238-413-5
14437-17-3
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
607-076-00-X
dodine(ISO); dodecylguanidinium acetate
219-459-5
2439-10-3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410
607-077-00-5
erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl2,2-dichloropropionate
—
136-25-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-078-00-0
fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate
—
4301-50-2
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300
607-079-00-6
kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate
—
4234-79-1
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2
H311
H302
H411
GHS06
GHS09
Dgr
H311
H302
H411
607-080-00-1
chloroacetyl chloride
201-171-6
79-04-9
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1
Skin Corr. 1A Aquatic Acute 1
H331
H311
H301
H372 ** H314
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H311
H301
H372 ** H314
H400
EUH014
EUH029
607-081-00-7
fluoroacetic acid
205-631-7
144-49-0
Acute Tox. 2 * Aquatic Acute 1
H300
H400
GHS06
GHS09
Dgr
H300
H400
607-082-00-2
fluoroacetates, soluble
—
—
Acute Tox. 2 * Aquatic Acute 1
H300
H400
GHS06
GHS09
Dgr
H300
H400
A
607-083-00-8
2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid
202-366-9
94-82-6
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-084-00-3
salts of 2,4-DB
—
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
A
607-085-00-9
benzyl benzoate
204-402-9
120-51-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-086-00-4
diallyl phthalate
205-016-3
131-17-9
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
607-088-00-5
methacrylic acid; 2-methylpropenoic acid
201-204-4
79-41-4
Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
STOT SE 3; H335: C ≥ 1 %
D
607-089-00-0
propionic acid … %
201-176-3
79-09-4
Skin Corr. 1B
H314
GHS05
Dgr
H314
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤
C < 25 %
STOT SE 3; H335: C ≥ 10 %
B
607-090-00-6
thioglycolic acid
200-677-4
68-11-1
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
H331
H311
H301
H314
GHS06
GHS05
Dgr
H331
H311
H301
H314
*
607-091-00-1
trifluoroacetic acid . . . %
200-929-3
76-05-1
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Chronic 3
H332
H314
H412
GHS05
GHS07
Dgr
H332
H314
H412
*
B
607-092-00-7
methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4]
208-930-0 [1]
218-449-8 [2]
241-420-6 [3]
248-704-9 [4]
547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Wng
H226
H319
H335
C
607-093-00-2
propionyl chloride
201-170-0
79-03-8
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
EUH014
B D
607-094-00-8
peracetic acid . . . %
201-186-8
79-21-0
Flam. Liq. 3
Org. Perox. D **** Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A Aquatic Acute 1
H226
H242
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H242
H332
H312
H302
H314
H400
*
STOT SE 3; H335: C ≥ 1 %
B D
607-095-00-3
maleic acid
203-742-5
110-16-7
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H302
H319
H335
H315
H317
GHS07
Wng
H302
H319
H335
H315
H317
Skin Sens. 1; H317: C ≥0,1 %
607-096-00-9
maleic anhydride
203-571-6
108-31-6
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H302
H314
H334
H317
GHS08
GHS05
GHS07
Dgr
H302
H314
H334
H317
607-097-00-4
benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride
209-008-0
552-30-7
STOT SE 3
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H335
H318
H334
H317
GHS08
GHS05
GHS07
Dgr
H335
H318
H334
H317
607-098-00-X
benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride
201-898-9
89-32-7
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
607-099-00-5
1,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalicanhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4]
201-605-4 [1]
213-308-7 [2]
219-374-3 [3]
247-570-9 [4]
85-43-8 [1]
935-79-5 [2]
2426-02-0 [3]
26266-63-7 [4]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H334
H317
H412
GHS08
GHS05
Dgr
H318
H334
H317
H412
C
607-100-00-9
benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride)
219-348-1
2421-28-5
Eye Irrit. 2
STOT SE 3
H319
H335
GHS07
Wng
H319
H335
Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %
607-101-00-4
1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylicanhydride chlorendic anhydride
204-077-3
115-27-5
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %
607-102-00-X
cyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylicanhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3]
201-604-9 [1]
236-086-3 [2]
238-009-9 [3]
85-42-7 [1]
13149-00-3 [2]
14166-21-3 [3]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
C
607-103-00-5
succinic anhydride
203-570-0
108-30-5
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H302
H319
H335
GHS07
Wng
H302
H319
H335
*
Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %
607-104-00-0
cyclopentane-1,2,3,4-tetracarboxylic dianhydride
227-964-7
6053-68-5
Eye Irrit. 2
STOT SE 3
H319
H335
GHS07
Wng
H319
H335
Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %
607-105-00-6
8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]
204-957-7 [1]
212-557-9 [2]
220-384-5 [3]
129-64-6 [1]
826-62-0 [2]
2746-19-2 [3]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
C
607-106-00-1
8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride
—
123748-85-6
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H302
H319
H335
H315
H334
GHS08
GHS07
Dgr
H302
H319
H335
H315
H334
STOT SE 3; H335: C ≥ 10 %
C
607-107-00-7
2-ethylhexyl acrylate
203-080-7
103-11-7
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H335
H315
H317
GHS07
Wng
H335
H315
H317
D
607-108-00-2
2-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2-diol [3]
220-852-9 [1]
213-663-8 [2]
247-118-0 [3]
2918-23-2 [1]
999-61-1 [2]
25584-83-2 [3]
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H331
H311
H301
H314
H317
GHS06
GHS05
Dgr
H331
H311
H301
H314
H317
*
Skin Sens. 1; H317:C ≥0,2 %
C D
607-109-00-8
hexamethylene diacrylate; hexane-1,6-diol diacrylate
235-921-9
13048-33-4
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
D
607-110-00-3
pentaerythritol triacrylate
222-540-8
3524-68-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
D
607-111-00-9
2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate
239-701-3
15625-89-5
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
D
607-112-00-4
2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate
218-741-5
2223-82-7
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H311
H319
H315
H317
GHS06
Dgr
H311
H319
H315
H317
*
D
607-113-00-X
isobutyl methacrylate
202-613-0
97-86-9
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H226
H319
H335
H315
H317
H400
GHS02
GHS07
GHS09
Wng
H226
H319
H335
H315
H317
H400
D
607-114-00-5
ethylene dimethacrylate
202-617-2
97-90-5
STOT SE 3
Skin Sens. 1
H335
H317
GHS07
Wng
H335
H317
STOT SE 3; H335: C ≥ 10 %
D
607-115-00-0
isobutyl acrylate
203-417-8
106-63-8
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
H226
H332
H312
H315
H317
GHS02
GHS07
Wng
H226
H332
H312
H315
H317
D
607-116-00-6
cyclohexyl acrylate
221-319-3
3066-71-5
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H335
H315
H411
GHS07
GHS09
Wng
H335
H315
H411
STOT SE 3; H335: C ≥ 10 %
D
607-117-00-1
2,3-epoxypropyl acrylate; glycidyl acrylate
203-440-3
106-90-1
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H331
H311
H301
H314
H317
GHS06
GHS05
Dgr
H331
H311
H301
H314
H317
*
Skin Sens. 1; H317:C ≥0,2 %
D
607-118-00-7
1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate
243-105-9
19485-03-1
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H312
H314
H317
GHS05
GHS07
Dgr
H312
H314
H317
D
607-119-00-2
tetramethylene diacrylate; 1,4-butyleneglycol diacrylate
213-979-6
1070-70-8
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H312
H314
H317
GHS05
GHS07
Dgr
H312
H314
H317
D
607-120-00-8
2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate
223-791-6
4074-88-8
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H311
H319
H315
H317
GHS06
Dgr
H311
H319
H315
H317
*
Skin Sens. 1; H317:C≥0,2 %
D
607-121-00-3
8,9,10-trinorborn-2-yl acrylate
—
10027-06-2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
H312
H315
H317
GHS07
Wng
H312
H315
H317
D
607-122-00-9
pentaerythritol tetraacrylate
225-644-1
4986-89-4
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
D
607-124-00-X
2-hydroxyethyl methacrylate
212-782-2
868-77-9
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
D
607-125-00-5
2-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate[2]
213-090-3 [1]
220-426-2 [2]
923-26-2 [1]
2761-09-3 [2]
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
C D
607-126-00-0
2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate
216-853-9
1680-21-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
D
607-127-00-6
2-diethylaminoethyl methacrylate
203-275-7
105-16-8
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H332
H319
H315
H317
GHS07
Wng
H332
H319
H315
H317
D
607-128-00-1
2-tert-butylaminoethyl methacrylate
223-228-4
3775-90-4
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
D
607-129-00-7
ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2]
202-598-0 [1]
211-694-1 [2]
97-64-3 [1]
687-47-8 [2]
Flam. Liq. 3
STOT SE 3
Eye Dam. 1
H226
H335
H318
GHS02
GHS05
GHS07
Dgr
H226
H335
H318
C
607-130-00-2
pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5]
211-047-3 [1]
204-662-3 [2]
210-946-8 [3]
210-843-8 [4]
282-263-3 [5]
628-63-7 [1]
123-92-2 [2]
626-38-0 [3]
624-41-9 [4]
84145-37-9 [5]
Flam. Liq. 3
H226
GHS02
Wng
H226
EUH066
C
607-131-00-8
isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3]
203-322-1 [1]
210-852-7 [2]
219-449-0 [3]
105-68-0 [1]
624-54-4 [2]
2438-20-2 [3]
Flam. Liq. 3
H226
GHS02
Wng
H226
C
607-132-00-3
2-dimethylaminoethyl methacrylate
220-688-8
2867-47-2
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H312
H302
H319
H315
H317
GHS07
Wng
H312
H302
H319
H315
H317
D
607-133-00-9
monoalkylor monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H319
H335
H315
H411
GHS07
GHS09
Wng
H319
H335
H315
H411
STOT SE 3; H335: C ≥ 10 %
A
607-134-00-4
monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
STOTSE 3; H335: C ≥ 10 %
A
607-135-00-X
butyric acid
203-532-3
107-92-6
Skin Corr. 1B
H314
GHS05
Dgr
H314
607-136-00-5
butyryl chloride
205-498-5
141-75-3
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
607-137-00-0
methyl acetoacetate
203-299-8
105-45-3
Eye Irrit. 2
H319
GHS07
Wng
H319
607-138-00-6
butyl chloroformate; chloroformic acid butyl ester
209-750-5
592-34-7
Flam. Liq. 3
Acute Tox. 3 *
Skin Corr. 1B
H226
H331
H314
GHS02
GHS06
GHS05
Dgr
H226
H331
H314
607-139-00-1
2-chloropropionic acid
209-952-3
598-78-7
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314
607-140-00-7
isobutyryl chloride
201-194-1
79-30-1
Flam. Liq. 2
Skin Corr. 1A
H225
H314
GHS02
GHS05
Dgr
H225
H314
607-141-00-2
oxydiethylene bis(chloroformate)
203-430-9
106-75-2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H302
H315
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H411
607-142-00-8
propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate
203-687-7
109-61-5
Flam. Liq. 2
Acute Tox. 3 *
Skin Corr. 1B
H225
H331
H314
GHS02
GHS06
GHS05
Dgr
H225
H331
H314
607-143-00-3
valeric acid
203-677-2
109-52-4
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
607-144-00-9
adipic acid
204-673-3
124-04-9
Eye Irrit. 2
H319
GHS07
Wng
H319
607-145-00-4
methanesulphonic acid
200-898-6
75-75-2
Skin Corr. 1B
H314
GHS05
Dgr
H314
607-146-00-X
fumaric acid
203-743-0
110-17-8
Eye Irrit. 2
H319
GHS07
Wng
H319
607-147-00-5
oxalic acid diethylester; diethyl oxalate
202-464-1
95-92-1
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
607-148-00-0
guanidinium chloride; guanadine hydrochloride
200-002-3
50-01-1
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
607-149-00-6
urethane (INN); ethyl carbamate
200-123-1
51-79-6
Carc. 1B
H350
GHS08
Dgr
H350
607-150-00-1
endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid
205-660-5
145-73-3
Acute Tox. 3 * Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H301
H312
H319
H335
H315
GHS06
Dgr
H301
H312
H319
H335
H315
607-151-00-7
propargite (ISO); 2-(4-tert-butylphenoxy)cyclohexyl prop-2-ynyl sulphite
219-006-1
2312-35-8
Carc. 2
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H331
H315
H318
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H331
H315
H318
H410
M = 10
607-152-00-2
2,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid
200-026-4
50-31-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-153-00-8
benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid
223-297-0
3813-05-6
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Wng
H319
H315
H412
607-154-00-3
ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate; benzoylprop-ethyl (ISO)
244-845-5
22212-55-1
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
607-155-00-9
3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s
—
2079-00-7
Acute Tox. 2 *
H300
GHS06
Dgr
H300
607-156-00-4
chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate
201-270-4
80-33-1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410
607-158-00-5
sodium salt of chloroacetic acid; sodium chloroacetate
223-498-3
3926-62-3
Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
H301
H315
H400
GHS06
GHS09
Dgr
H301
H315
H400
607-159-00-0
chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate
208-110-2
510-15-6
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
607-160-00-6
isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO)
—
51337-71-4
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-161-00-1
diethanolamine salt of 4-CPA
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-162-00-7
dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate[2]
200-923-0 [1]
204-828-5 [2]
75-99-0 [1]
127-20-8 [2]
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
607-163-00-2
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid
208-293-9
520-45-6
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-164-00-8
sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate
224-580-1
4418-26-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-165-00-3
diclofop-methyl (ISO)methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;
257-141-8
51338-27-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
607-166-00-9
medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate
219-634-6
2487-01-6
Acute Tox. 3 * Acute Tox. 4 *
H301
H312
GHS06
Dgr
H301
H312
607-167-00-4
sodium 3-chloroacrylate
—
4312-97-4
Acute Tox. 4 * Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
607-168-00-X
dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome
—
83-59-0
Acute Tox. 3 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H311
H302
H400
H410
GHS06
GHS09
Dgr
H311
H302
H410
607-169-00-5
sodium fluoroacetate
200-548-2
62-74-8
Acute Tox. 2 * Acute Tox. 1
Acute Tox. 2 * Aquatic Acute 1
H330
H310
H300
H400
GHS06
GHS09
Dgr
H330
H310
H300
H400
607-170-00-0
bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate
250-859-2
31895-22-4
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
607-173-00-7
dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate
400-460-6
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-174-00-2
reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate
400-580-9
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-175-00-8
methyl 2-(2-nitrobenzylidene)acetoacetate
400-650-9
39562-27-1
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-176-00-3
reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)
400-830-7
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-177-00-9
tribenuron-methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester; methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3methylureidosulfonyl)benzoate
401-190-1
101200-48-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M = 100
607-178-00-4
methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate
401-340-6
83055-99-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-179-00-X
(benzothiazol-2-ylthio)succinic acid
401-450-4
95154-01-1
Skin Sens. 1
H317
GHS07
Wng
H317
607-180-00-5
potassium 2-hydroxycarbazole-1-carboxylate
401-630-2
96566-70-0
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3
H302
H319
H335
H412
GHS07
Wng
H302
H319
H335
H412
607-181-00-0
3,5-dichloro-2,4-difluorobenzoyl fluoride
401-800-6
101513-70-6
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H331
H314
H302
H317
H412
GHS06
GHS05
Dgr
H331
H314
H302
H317
H412
EUH029
607-182-00-6
methyl 3-sulphamoyl-2-thenoate
402-050-2
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-183-00-1
zinc 2-hydroxy-5-C13-18 alkylbenzoate
402-280-3
—
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411
607-184-00-7
S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate
402-290-8
85702-90-5
Flam. Liq. 3
Resp. Sens. 1
Skin Sens. 1
H226
H334
H317
GHS02
GHS08
Dgr
H226
H334
H317
607-185-00-2
ethyl trans-3-dimethylaminoacrylate
402-650-4
1117-37-9
Skin Sens. 1
H317
GHS07
Wng
H317
607-186-00-8
quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid
402-780-1
84087-01-4
Skin Sens. 1
H317
GHS07
Wng
H317
607-187-00-3
bis(2,2,6,6-tetramethyl-4-piperidyl) succinate
402-940-0
62782-03-0
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
607-188-00-9
hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate
402-970-4
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-189-00-4
trimethylenediaminetetraacetic acid
400-400-9
1939-36-2
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
607-190-00-X
methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)
401-890-7
77402-03-0
Carc. 1B Muta. 1B
Acute Tox. 4 *
Eye Irrit. 2
H350
H340
H302
H319
GHS08
GHS07
Dgr
H350
H340
H302
H319
607-191-00-5
isobutyl 3,4-epoxybutyrate
401-920-9
100181-71-3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
607-192-00-0
disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate
402-360-8
92511-22-3
Eye Dam. 1
H318
GHS05
Dgr
H318
607-194-00-1
propylene carbonate
203-572-1
108-32-7
Eye Irrit. 2
H319
GHS07
Wng
H319
607-195-00-7
2-methoxy-1-methylethyl acetate
203-603-9
108-65-6
Flam. Liq. 3
H226
GHS02
Wng
H226
607-196-00-2
heptanoic acid
203-838-7
111-14-8
Skin Corr. 1B
H314
GHS05
Dgr
H314
607-198-00-3
propyl 3,4,5-trihydroxybenzoate
204-498-2
121-79-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
607-199-00-9
octyl 3,4,5-trihydroxybenzoate
213-853-0
1034-01-1
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
607-200-00-2
dodecyl 3,4,5-trihydroxybenzoate
214-620-6
1166-52-5
Skin Sens. 1
H317
GHS07
Wng
H317
607-201-00-8
thiocarbonyl chloride
207-341-6
463-71-8
Acute Tox. 3 * Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H331
H302
H319
H335
H315
GHS06
Dgr
H331
H302
H319
H335
H315
607-203-00-9
2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate
279-452-8
80387-97-9
Repr. 1B
Skin Sens. 1
Aquatic Chronic 3
H360D *** H317
H412
GHS08
GHS07
Dgr
H360D *** H317
H412
607-204-00-4
(chlorophenyl)(chlorotolyl)methane, mixed isomers
400-140-6
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-205-00-X
methyl chloroacetate
202-501-1
96-34-4
Flam. Liq. 3
Acute Tox. 3 * Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H226
H331
H301
H335
H315
H318
GHS02
GHS06
GHS05
Dgr
H226
H331
H301
H335
H315
H318
607-206-00-5
isopropyl chloroacetate
203-301-7
105-48-6
Flam. Liq. 3
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H226
H301
H319
H335
H315
GHS02
GHS06
Dgr
H226
H301
H319
H335
H315
607-207-00-0
haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl)
402-560-5
87237-48-7
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
607-208-00-6
4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers
403-000-2
91853-67-7
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
607-209-00-1
reaction mass of O, O'-diisopropyl (pentathio)dithioformate and O, O'-diisopropyl (trithio)dithioformate and O, O'-diisopropyl (tetrathio)dithioformate
403-030-6
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
607-210-00-7
methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)
403-230-3
77402-05-2
Carc. 1B Muta. 1B
Skin Corr. 1B
Skin Sens. 1
H350
H340
H314
H317
GHS08
GHS05
GHS07
Dgr
H350
H340
H314
H317
607-211-00-2
methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate
403-270-1
6386-39-6
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-212-00-8
poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate
403-300-3
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-213-00-3
ethyl 3,3-bis(tert-pentylperoxy)butyrate
403-320-2
67567-23-1
Org. Perox. D**** Flam. Liq. 3
Aquatic Chronic 2
H242
H226
H411
GHS02
GHS09
Dgr
H242
H226
H411
607-214-00-9
N, N-hydrazinodiacetic acid
403-510-5
19247-05-3
Acute Tox. 3 * STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H301
H373 ** H317
H412
GHS06
GHS08
Dgr
H301
H373 ** H317
H412
607-215-00-4
3-(3-tert-butyl-4-hydroxyphenyl)propionic acid
403-920-4
107551-67-7
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
607-216-00-X
glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine
403-950-8
—
Acute Tox. 2 * Acute Tox. 4 *
Skin Corr. 1B Aquatic Acute 1
H330
H302
H314
H400
GHS06
GHS05
GHS09
Dgr
H330
H302
H314
H400
607-217-00-5
2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate
403-960-2
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-218-00-0
dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid
403-980-1
15165-67-0
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
607-219-00-6
bis(2-ethylhexyl) dithiodiacetate
404-510-8
62268-47-7
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
607-221-00-7
6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid
404-550-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-222-00-2
6-(2,3-dimethylmaleimido)hexyl methacrylate
404-870-6
63740-41-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-223-00-8
transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate
405-060-5
118712-89-3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
607-224-00-3
methyl 2-(3-nitrobenzylidene)acetoacetate
405-270-7
39562-17-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-225-00-9
3-azidosulfonylbenzoic acid
405-310-3
15980-11-7
Self-React. C **** STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H241
H373 ** H318
H317
GHS02
GHS08
GHS05
GHS07
Dgr
H241
H373 ** H318
H317
607-226-00-4
reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate
405-360-6
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H315
H318
H317
H412
GHS05
GHS07
Dgr
H315
H318
H317
H412
607-227-00-X
potassium 2-amino-2-methylpropionate octahydrate
405-560-3
120447-91-8
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314
607-228-00-5
bis(2-methoxyethyl) phthalate
204-212-6
117-82-8
Repr. 1B
H360Df
GHS08
Dgr
H360Df
607-229-00-0
diethylcarbamoyl chloride
201-798-5
88-10-8
Carc. 2
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H351
H332
H302
H319
H335
H315
GHS08
GHS07
Wng
H351
H332
H302
H319
H335
H315
607-230-00-6
2-ethylhexanoic acid
205-743-6
149-57-5
Repr. 2
H361d ***
GHS08
Wng
H361d ***
607-231-00-1
clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid
216-935-4
1702-17-6
Eye Dam. 1
H318
GHS05
Dgr
H318
607-232-00-7
pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate
259-686-7
55512-33-9
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
607-233-00-2
hexyl acrylate
219-698-5
2499-95-8
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H335
H315
H317
H411
GHS07
GHS09
Wng
H319
H335
H315
H317
H411
607-234-00-8
flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid
207-397-1
467-69-6
Aquatic Chronic 2
H411
GHS09
H411
607-235-00-3
mecrilate; methyl 2-cyanoacrylate
205-275-2
137-05-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
STOT SE 3; H335: C ≥ 10 %
607-236-00-9
ethyl 2-cyanoacrylate
230-391-5
7085-85-0
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
STOT SE 3; H335: C ≥ 10 %
607-237-00-4
benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole
276-942-3
72850-64-7
Aquatic Chronic 2
H411
GHS09
H411
607-238-00-X
tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate
—
102851-06-9
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410
607-239-00-5
fenpropathrin (ISO); α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate
254-485-0
39515-41-8
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H312
H400
H410
GHS06
GHS09
Dgr
H330
H301
H312
H410
607-240-00-0
cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalicanhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetrahydro-4-methylphthalicanhydride; [6] 2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]
216-906-6 [1]
222-323-8 [2]
226-247-6 [3]
234-290-7 [4]
247-830-1 [5]
251-823-9 [6]
255-853-3 [7]
1694-82-2 [1]
3425-89-6 [2]
5333-84-6 [3]
11070-44-3 [4]
26590-20-5 [5]
34090-76-1 [6]
42498-58-8 [7]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
C
607-241-00-6
hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalicanhydride [4]
243-072-0 [1]
247-094-1 [2]
256-356-4 [3]
260-566-1 [4]
19438-60-9 [1]
25550-51-0 [2]
48122-14-1 [3]
57110-29-9 [4]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
C
607-242-00-1
tetrachlorophthalic anhydride
204-171-4
117-08-8
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H334
H317
H400
H410
GHS08
GHS05
GHS09
Dgr
H318
H334
H317
H410
607-243-00-7
sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]
217-846-3 [1]
246-590-5 [2]
258-527-9 [3]
1982-69-0 [1]
25059-78-3 [2]
53404-28-7 [3]
Aquatic Chronic 3
H412
—
H412
607-244-00-2
isooctyl acrylate
249-707-8
29590-42-9
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410
STOT SE 3; H335: C ≥ 10 %
607-245-00-8
tert-butyl acrylate
216-768-7
1663-39-4
Flam. Liq. 2
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H332
H312
H302
H335
H315
H317
H411
GHS02
GHS07
GHS09
Dgr
H225
H332
H312
H302
H335
H315
H317
H411
D
607-246-00-3
allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester
202-473-0
96-05-9
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
H226
H331
H312
H302
H400
GHS02
GHS06
GHS09
Dgr
H226
H331
H312
H302
H400
607-247-00-9
dodecyl methacrylate
205-570-6
142-90-5
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410
STOT SE 3; H335: C ≥ 10 %
607-248-00-4
naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate
205-073-4
132-67-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-249-00-X
(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate
256-032-2
42978-66-5
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H335
H315
H317
H411
GHS07
GHS09
Wng
H319
H335
H315
H317
H411
STOT SE 3; H335: C ≥ 10 %
607-250-00-5
4H-3,1-benzoxazine-2,4(1H)-dione
204-255-0
118-48-9
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
607-251-00-0
2-methoxypropyl acetate
274-724-2
70657-70-4
Flam. Liq. 3
Repr. 1B
STOT SE 3
H226
H360D *** H335
GHS02
GHS08
GHS07
Dgr
H226
H360D *** H335
607-252-00-6
lambda-cyhalothrin (ISO); reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)
415-130-7
91465-08-6
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H312
H400
H410
GHS06
GHS09
Dgr
H330
H301
H312
H410
M=10000
607-253-00-1
cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
269-855-7
68359-37-5
Acute Tox. 2 *
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H300
H331
H400
H410
GHS06
GHS09
Dgr
H300
H331
H410
M=1000
607-254-00-7
α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin
269-855-7
68359-37-5
Acute Tox. 2 *
Acute Tox. 2 * Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410
607-255-00-2
fluroxypyr (ISO);4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid
—
69377-81-7
Aquatic Chronic 3
H412
—
H412
607-256-00-8
azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
—
131860-33-8
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H331
H400
H410
GHS06
GHS09
Dgr
H331
H410
607-257-00-3
isopropyl propionate
211-300-8
637-78-5
Flam. Liq. 2
H225
GHS02
Dgr
H225
607-258-00-9
dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate
403-990-6
70950-45-7
Aquatic Chronic 4
H413
—
H413
607-259-00-4
methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate
404-130-2
105560-93-8
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-260-00-X
ethyl 2-(3-nitrobenzylidene)acetoacetate
404-490-0
39562-16-8
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-261-00-5
iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate
404-800-4
118832-72-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-262-00-0
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
405-050-0
86393-33-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
607-263-00-6
potassium iron(III) 1,3-propanediamine-N, N,N',N'-tetraacetate hemihydrate
405-680-6
—
Self-heat. 2 **** Aquatic Chronic 2
H252
H411
GHS02
GHS09
Wng
H252
H411
607-264-00-1
2-chloro-4-(methylsulfonyl)benzoic acid
406-520-8
53250-83-2
Eye Dam. 1
H318
GHS05
Dgr
H318
607-265-00-7
ethyl-2-chloro-2,2-diphenylacetate
406-580-5
52460-86-3
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
607-266-00-2
reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid
406-890-0
130296-87-6
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
607-267-00-8
tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate
407-620-4
33610-13-8
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H334
H317
H412
GHS08
Dgr
H334
H317
H412
607-268-00-3
2-methylpropyl (R)-2-hydroxypropanoate
407-770-0
61597-96-4
Eye Irrit. 2
H319
GHS07
Wng
H319
607-269-00-9
(R)-2-(4-hydroxyphenoxy)propanoic acid
407-960-3
94050-90-5
Eye Dam. 1
H318
GHS05
Dgr
H318
607-270-00-4
3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane
410-730-5
90498-90-1
Acute Tox. 4 *
H312
GHS07
Wng
H312
607-271-00-X
2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane
417-420-9
156324-82-2
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
607-272-00-5
fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]
279-752-9 [1]
-[2]
81406-37-3 [1]
154486-27-8 [2]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-273-00-0
ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate
404-520-2
—
Aquatic Chronic 3
H412
—
H412
607-274-00-6
2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate
405-350-1
54527-73-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-275-00-1
sodium benzoyloxybenzene-4-sulfonate
405-450-5
66531-87-1
Skin Sens. 1
H317
GHS07
Wng
H317
607-276-00-7
bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex
405-635-0
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
607-277-00-2
reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate
405-720-2
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
607-278-00-8
reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate
405-760-0
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-279-00-3
reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate
405-960-8
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-280-00-9
sodium 4-chloro-1-hydroxybutane-1-sulfonate
406-190-5
54322-20-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
607-281-00-4
reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates
407-000-3
127519-17-9
Aquatic Chronic 2
H411
GHS09
H411
607-282-00-X
2-acetoxymethyl-4-benzyloxybut-1-yl acetate
407-140-5
131266-10-9
Aquatic Chronic 3
H412
—
H412
607-283-00-5
E-ethyl-4-oxo-4-phenylcrotonate
408-040-4
15121-89-8
Acute Tox. 4 * Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H317
H410
607-284-00-0
reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)
410-040-4
136213-76-8
Aquatic Chronic 2
H411
GHS09
H411
607-285-00-6
reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate
410-065-0
—
Skin Sens. 1
H317
GHS07
Wng
607-286-00-1
reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate
410-070-8
141880-36-6
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-287-00-7
O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate
410-140-8
—
Aquatic Chronic 3
H412
—
H412
607-288-00-2
tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a, b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively
410-160-7
148732-74-5
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
607-289-00-8
3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid
410-370-9
105488-33-3
Aquatic Chronic 4
H413
—
H413
607-290-00-3
reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate
410-540-2
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
607-291-00-9
dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate
410-630-1
104051-92-5
Aquatic Chronic 4
H413
—
H413
607-292-00-4
reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid
410-640-6
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
607-293-00-X
reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate
410-650-0
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
607-294-00-5
sodium 2-benzoyloxy-1-hydroxyethane-sulfonate
410-680-4
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-295-00-0
reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate
410-800-5
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-296-00-6
reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid
410-830-9
—
Aquatic Chronic 4
H413
—
H413
607-297-00-1
(E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)
410-960-6
92761-26-7
Eye Dam. 1
H318
GHS05
Dgr
H318
607-298-00-7
2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate
411-010-3
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-299-00-2
methyl 3-(acetylthio)-2-methyl-propanoate
411-040-7
97101-46-7
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
607-300-00-6
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4, N29, N30, N31, N32-sulfonylamino)benzoato(5-)]cuprate(II) where a =1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25
411-430-7
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-301-00-1
reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid
411-860-5
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-302-00-7
reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid
411-910-6
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H411
607-303-00-2
1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
413-760-7
93107-30-3
Repr. 2
Aquatic Chronic 3
H361f *** H412
GHS08
Wng
H361f *** H412
607-304-00-8
fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
274-125-6
69806-50-4
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D *** H400
H410
GHS08
GHS09
Dgr
H360D *** H410
607-305-00-3
fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
—
79241-46-6
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H400
H410
GHS08
GHS09
Wng
H361d *** H410
607-306-00-9
chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate
282-714-4
84332-86-5
Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411
607-307-00-4
vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione
256-599-6
50471-44-8
Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Chronic 2
H351
H360FD H317
H411
GHS08
GHS07
GHS09
Dgr
H351
H360FD H317
H411
607-308-00-X
esters of 2,4-D
—
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
A
607-309-00-5
carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate
—
128639-02-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-310-00-0
kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate
—
143390-89-0
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
607-311-00-6
benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate
246-591-0
25059-80-7
Aquatic Chronic 2
H411
GHS09
H411
607-312-00-1
methoxyacetic acid
210-894-6
625-45-6
Repr. 1B
Acute Tox. 4 *
Skin Corr. 1B
H360FD H302
H314
GHS08
GHS05
GHS07
Dgr
H360FD H302
H314
STOT SE 3; H335: C ≥ 5 %
607-313-00-7
neodecanoyl chloride
254-875-0
40292-82-8
Acute Tox. 2 * Acute Tox. 4 *
Skin Corr. 1B
H330
H302
H314
GHS06
GHS06
Dgr
H330
H302
H314
STOT SE 3; H335: C ≥ 5 %
607-314-00-2
ethofumesate (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-ylmethanesulfonate
247-525-3
26225-79-6
Aquatic Chronic 2
H411
GHS09
H411
607-315-00-8
glyphosate (ISO); N-(phosphonomethyl)glycine
213-997-4
1071-83-6
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
607-316-00-3
glyphosate-trimesium; glyphosate-trimethylsulfonium
—
81591-81-3
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-317-00-9
bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP
204-211-0
117-81-7
Repr. 1B
H360FD
GHS08
Dgr
H360FD
607-318-00-4
dibutyl phthalate; DBP
201-557-4
84-74-2
Repr. 1B
Aquatic Acute 1
H360Df
H400
GHS08
GHS09
Dgr
H360Df
H400
607-319-00-X
deltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate
258-256-6
52918-63-5
Acute Tox. 3 *
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
M=1000000
607-320-00-5
bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate
413-930-0
130066-57-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-321-00-0
(S)-methyl-2-chloropropionate
412-470-8
73246-45-4
Flam. Liq. 3
STOT RE 2 *
Eye Irrit. 2
H226
H373 ** H319
GHS02
GHS08
Wng
H226
H373 ** H319
607-322-00-6
4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid
413-120-7
107144-30-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-323-00-1
2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate
413-850-6
123968-25-2
Aquatic Chronic 4
H413
—
H413
607-324-00-7
reaction mass of: N, N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine
413-800-3
—
Aquatic Chronic 4
H413
—
H413
607-325-00-2
(S)-2-chloropropionic acid
411-150-5
29617-66-1
Acute Tox. 4 * Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
607-326-00-8
reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate
410-720-0
141847-13-4
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
607-327-00-3
2-(2-iodoethyl)-1,3-propanediol diacetate
411-780-0
127047-77-2
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-328-00-9
methyl 4-bromomethyl-3-methoxybenzoate
410-310-1
70264-94-7
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
607-329-00-4
reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate
411-250-9
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-330-00-X
(S)-2,3-dihydro-1H-indole-2-carboxylic acid
410-860-2
79815-20-6
Repr. 2
STOT RE 2 *
Skin Sens. 1
H361f *** H373 ** H317
GHS08
GHS07
Wng
H361f *** H373 ** H317
607-331-00-5
reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane
406-750-9
—
Aquatic Chronic 4
H413
—
H413
607-332-00-0
cyclopentyl chloroformate
411-460-0
50715-28-1
Flam. Liq. 3
Acute Tox. 3 * Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H226
H331
H302
H373 ** H318
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H331
H302
H373 ** H318
H317
607-333-00-6
reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate
405-670-1
—
Acute Tox. 4 * STOT RE 2 *
Skin Corr. 1B Aquatic Acute 1
Aquatic Chronic 1
H302
H373 ** H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 ** H314
H410
607-334-00-1
ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate
405-880-3
100501-62-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-335-00-7
methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate
406-250-0
72619-32-0
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
607-336-00-2
4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate
406-560-6
122760-85-4
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
607-337-00-8
di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate
406-052-4
125078-60-6
Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H226
H302
H315
H318
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H302
H315
H318
H411
607-338-00-3
2-methylpropyl 2-hydroxy-2-methylbut-3-enoate
406-235-9
72531-53-4
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315
607-339-00-9
2,3,4,5-tetrachlorobenzoylchloride
406-760-3
42221-52-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
607-340-00-4
1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate
406-990-4
—
Aquatic Chronic 2
H411
GHS09
H411
607-341-00-X
(9S)-9-amino-9-deoxyerythromycin
406-790-7
26116-56-3
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
607-342-00-5
4-chlorobutyl veratrate
410-950-1
69788-75-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-343-00-0
4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)
407-410-2
—
Aquatic Chronic 4
H413
—
H413
607-344-00-6
reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate
407-810-7
—
STOT RE 2 *
H373 **
GHS08
Wng
H373 **
607-345-00-1
potassium 2-(2,4-dichlorophenoxy)-(R)-propionate
413-580-9
113963-87-4
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
607-346-00-7
3-icosyl-4-henicosylidene-2-oxetanone
401-210-9
83708-14-9
Aquatic Chronic 4
H413
—
H413
607-347-00-2
sodium (R)-2-(2,4-dichlorophenoxy)propionate
413-340-3
119299-10-4
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
607-348-00-8
magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)
413-360-2
—
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
607-349-00-3
mono-(tetrapropylammonium)hydrogen 2,2'-dithiobisbenzoate
411-270-8
—
Aquatic Chronic 3
H412
H412
607-350-00-9
bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane
412-060-9
136210-32-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-351-00-4
methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate
407-550-4
69184-17-4
Aquatic Chronic 2
H411
GHS09
H411
607-352-00-X
4,4'-oxydiphthalic anhydride
412-830-4
1823-59-2
Aquatic Chronic 3
H412
—
H412
607-353-00-5
reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate
407-520-0
80657-64-3
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-354-00-0
ethyl 2-cyclohexylpropionate
412-280-5
2511-00-4
Aquatic Chronic 2
H411
GHS09
H411
607-355-00-6
p-tolyl 4-chlorobenzoate
411-530-0
15024-10-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-356-00-1
ethyl trans-2,2,6-trimethylcyclohexanecarboxylate
412-540-8
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-357-00-7
reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran
412-450-9
131766-73-9
Skin Sens. 1
H317
GHS07
Wng
H317
607-358-00-2
(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate
412-670-5
54275-93-3
Resp. Sens. 1
H334
GHS08
Dgr
H334
607-359-00-8
(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate
412-800-0
76109-32-5
Resp. Sens. 1
H334
GHS08
Dgr
H334
607-360-00-3
sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate
411-680-7
133167-77-8
Skin Sens. 1
H317
GHS07
Wng
H317
607-361-00-9
methyl (R)-2-(4-hydroxyphenoxy)propionate
411-950-4
96562-58-2
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-362-00-4
reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate
413-500-2
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H315
H318
H411
GHS05
GHS09
Dgr
H315
H318
H411
607-363-00-X
methyl-3-methoxyacrylate
412-900-4
5788-17-0
Skin Sens. 1
H317
GHS07
Wng
H317
607-364-00-5
3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione
413-330-9
134724-55-3
Aquatic Chronic 4
H413
H413
607-365-00-0
2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride
410-620-7
119154-86-8
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
607-366-00-6
3,5-dimethylbenzoyl chloride
413-010-9
6613-44-1
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
607-367-00-1
potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N, O,O, N)-ferrate-(1-)monohydrate
411-640-9
153352-59-1
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-368-00-7
1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole
411-650-3
110895-43-7
Acute Tox. 3 *
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410
607-369-00-2
reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid
411-660-8
147027-04-1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
607-370-00-8
2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol
412-210-3
41620-33-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-371-00-3
3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate
413-410-3
88150-62-3
Aquatic Chronic 4
H413
—
H413
607-372-00-9
ethoxylated bisphenol A di-(norbornene carboxylate)
412-410-0
—
Aquatic Chronic 3
H412
—
H412
607-373-00-4
(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate
414-200-4
119738-06-6
Muta. 2
Repr. 1B
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1
Aquatic Chronic 1
H341
H360Df
H302
H373 ** H400
H410
GHS08
GHS07
GHS09
Dgr
H341
H360Df
H302
H373 ** H410
607-374-00-X
5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride
417-220-1
37441-29-5
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-376-00-0
benzyl 2,4-dibromobutanoate
420-710-8
23085-60-1
Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f *** H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f *** H315
H317
H410
607-377-00-6
trans-4-cyclohexyl-L-proline monohydrochloride
419-160-1
90657-55-9
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H361f *** H302
H315
H318
H317
GHS08
GHS05
GHS07
Dgr
H361f *** H302
H315
H318
H317
607-378-00-1
ammonium (Z)-α-methoxyimino-2-furylacetate
405-990-1
97148-39-5
Flam. Sol. 2
H228
GHS02
Dgr
H228
T
607-379-00-7
reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N, N-bis(2-hydroxyethyl)stearamide
401-230-8
Aquatic Chronic 3
H412
—
H412
607-380-00-2
reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate
407-320-3
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412
607-381-00-8
reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid
413-710-4
—
Aquatic Chronic 4
H413
—
H413
607-382-00-3
2-((4-amino-2-nitrophenyl)amino)benzoic acid
411-260-3
117907-43-4
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-383-00-9
reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate
415-430-8
86403-32-9
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
607-384-00-4
reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate
413-750-2
171090-93-0
Aquatic Chronic 4
H413
—
H413
607-385-00-X
copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate
414-590-6
125229-74-5
Aquatic Chronic 2
H411
GHS09
H411
607-386-00-5
reaction mass of: tetradecanoic acid (42,5-47,5 %); poly(1-7)lactate esters of tetradecanoic acid (52,5-57,5 %)
412-580-6
174591-51-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
607-387-00-0
reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %)
412-590-0
58856-63-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
607-388-00-6
4-ethylamino-3-nitrobenzoic acid
412-090-2
2788-74-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
607-389-00-1
trisodium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionate
414-130-4
119710-96-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-390-00-7
1,2,3,4-tetrahydro-6-nitro-quinoxaline
414-270-6
41959-35-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-391-00-2
dimethylcyclopropane-1,1-dicarboxylate
414-240-2
6914-71-2
Aquatic Chronic 3
H412
—
H412
607-392-00-8
2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate
414-260-1
88938-37-8
Aquatic Chronic 4
H413
—
H413
607-393-00-3
3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
415-750-8
106447-44-3
Skin Sens. 1
H317
GHS07
Wng
H317
607-394-00-9
5-methylpyrazine-2-carboxylic acid
413-260-9
5521-55-1
Eye Dam. 1
H318
GHS05
Dgr
H318
607-395-00-4
reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate
410-230-7
—
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
607-396-00-X
bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate
414-840-4
147783-69-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-397-00-5
reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates(branched C10-14 and C18-30 alkylated)
415-930-6
—
Repr. 2
Skin Sens. 1
H361f*** H317
GHS08
GHS07
Wng
H361f*** H317
607-398-00-0
ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate
414-820-5
125630-94-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-399-00-6
2,2-dimethyl 3-methyl-3-butenyl propanoate
415-610-6
104468-21-5
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
607-400-00-X
methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate
414-400-1
32750-89-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-401-00-5
ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate
414-450-4
88805-65-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317
607-402-00-0
methyl N-(phenoxycarbonyl)-L-valinate
414-500-5
153441-77-1
Aquatic Chronic 3
H412
—
H412
607-403-00-6
reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol
414-810-0
—
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 ** H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H373 ** H318
H410
607-404-00-1
reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid
415-190-4
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-405-00-7
2-hexyldecyl-p-hydroxybenzoate
415-380-7
148348-12-3
Aquatic Chronic 2
H411
GHS09
H411
607-406-00-2
potassium 2,5-dichlorobenzoate
415-700-5
184637-62-5
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
607-407-00-8
ethyl 2-carboxy-3-(2-thienyl)propionate
415-680-8
143468-96-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317
607-408-00-3
potassium N-(4-fluorophenyl)glycinate
415-710-1
184637-63-6
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H373 ** H318
H317
H412
GHS08
GHS05
GHS07
Dgr
H373 ** H318
H317
H412
607-409-00-9
reaction mass of: (3R)-[1S-(1α,2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus
415-840-7
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-410-00-4
mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate
415-880-5
779343-34-9
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
607-411-00-X
oxiranemethanol, 4-methylbenzene-sulfonate, (S)-
417-210-7
70987-78-9
Carc. 1B Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H350
H341
H318
H317
H411
607-412-00-5
ethyl 2-(1-cyanocyclohexyl)acetate
415-970-4
133481-10-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373 ** H412
GHS08
GHS07
Wng
H302
H373 ** H412
607-413-00-0
trans-4-phenyl-L-proline
416-020-1
96314-26-0
Repr. 2
Skin Sens. 1
H361f *** H317
GHS08
GHS07
Wng
H361f *** H317
607-414-00-6
tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate
402-070-1
88122-99-0
Aquatic Chronic 4
H413
—
H413
607-415-00-1
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride)
419-590-1
—
Flam. Sol. 1
Skin Sens. 1
H228
H317
GHS02
GHS07
Dgr
H228
H317
T
607-416-00-7
4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide
420-730-7
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-417-00-2
3-chloropropyl chloroformiate
425-770-9
628-11-5
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H331
H302
H373** H315
H318
H317
GHS06
GHS05
GHS08
Dgr
H331
H302
H373** H315
H318
H317
607-418-00-8
2-ethylhexyl 4-aminobenzoate
420-170-3
26218-04-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-419-00-3
(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid
422-240-9
166596-68-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-420-00-9
2,2-bis(hydroxymethyl)butanoic acid
424-090-1
10097-02-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-421-00-4
cypermethrin cis/trans +/-40/60; (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H335
H400
H410
GHS07
GHS09
Wng
H332
H302
H335
H410
607-422-00-X
α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
67375-30-8
Acute Tox. 3 * STOT RE 2 * STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H301
H373** H335
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H373** H335
H410
M=1000
607-423-00-5
esters of mecoprop and of mecoprop-P
—
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
A
607-424-00-0
trifloxystrobin (ISO); (E, E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester
—
141517-21-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-425-00-6
metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate
260-979-7
57837-19-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
607-426-00-1
1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4]
284-032-2 [1]
-[2]
205-017-9 [3]
210-088-4 [4]
84777-06-0 [1]
-[2]
131-18-0 [3]
605-50-5 [4]
Repr. 1B
Aquatic Acute 1
H360FD H400
GHS08
GHS09
Dgr
H360FD H400
607-427-00-7
bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate
260-300-4
56634-95-8
Repr. 2
Acute Tox. 4 * Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H332
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d *** H332
H302
H317
H410
607-428-00-2
tetrasodium ethylene diamine tetraacetate
200-573-9
64-02-8
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
607-429-00-8
edetic acid; (EDTA)
200-449-4
60-00-4
Eye Irrit. 2
H319
GHS07
Wng
H319
607-430-00-3
BBP; benzyl butyl phthalate e
201-622-7
85-68-7
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H400
H410
GHS08
GHS09
Dgr
H360Df
H410
607-431-00-9
prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
245-387-9
23031-36-9
Acute Tox. 3 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H400
H410
GHS06
GHS09
Dgr
H331
H302
H410
607-432-00-4
S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]
-[1]
-[2]
87392-12-9 [1]
178961-20-1 [2]
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-433-00-X
cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Acute Tox. 4 * STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H302
H335
H315
H317
H410
607-434-00-5
mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid
240-539-0
16484-77-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
607-435-00-0
2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate
416-810-6
111969-64-3
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H373 ** H318
H411
GHS08
GHS05
GHS09
Dgr
H373 ** H318
H411
607-436-00-6
2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate
417-350-9
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
607-437-00-1
3-(4-aminophenyl)-2-cyano-2-propenoic acid
417-480-6
252977-62-1
Skin Sens. 1
H317
GHS07
Wng
H317
607-438-00-7
methyl-2-[(aminosulfonyl)methyl]benzoate
419-010-5
112941-26-1
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
607-439-00-2
methyl tetrahydro-2-furancarboxylate
420-670-1
37443-42-8
Eye Dam. 1
H318
GHS05
Dgr
H318
607-440-00-8
methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate
421-220-7
144740-59-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-441-00-3
3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid
421-490-6
167684-63-1
Aquatic Chronic 4
H413
—
H413
607-442-00-9
benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate
416-050-5
87460-09-1
Eye Dam. 1
H318
GHS05
Dgr
H318
607-444-00-X
reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate
416-230-3
35541-81-2
Aquatic Chronic 4
H413
—
H413
607-445-00-5
Iron (III) tris(4-methylbenzenesulfonate)
420-960-8
77214-82-5
Eye Dam. 1
H318
GHS05
Dgr
H318
607-446-00-0
methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate
416-240-8
155522-12-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-447-00-6
sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate
416-370-5
156738-27-1
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-448-00-1
2,3,5,6-tetrafluorobenzoic acid
416-800-1
652-18-6
Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318
607-449-00-7
reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]
417-080-1
—
Self-react. D ****
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H317
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H317
H410
607-450-00-2
2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate
419-040-9
89604-92-2
Aquatic Chronic 4
H413
—
H413
607-451-00-8
4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt
417-640-5
161935-19-9
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-453-00-9
4-benzyl-2,6-dihydroxy-4-aza-heptylene bis (2,2-dimethyloctanoate)
418-100-1
172964-15-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-454-00-4
reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid
418-170-3
116193-72-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-455-00-X
1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt
419-520-8
172890-93-6
Skin Sens. 1
H317
GHS07
Wng
H317
607-456-00-5
3-amino-4-chlorobenzoic acid, hexadecyl ester
419-700-6
143269-74-3
Aquatic Chronic 2
H411
GHS09
H411
607-457-00-0
tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)
420-350-1
172277-97-3
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
607-458-00-6
reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]
420-850-1
—
Aquatic Chronic 2
H411
GHS09
H411
607-459-00-1
isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate
418-930-4
—
Aquatic Chronic 4
H413
—
H413
607-460-00-7
3-tridecyloxy-propyl-ammonium 9-octadecenoate
418-990-1
778577-53-0
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H373 ** H319
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H373 ** H319
H315
H410
607-461-00-2
reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate; pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate
421-160-1
—
Aquatic Chronic 3
H412
—
H412
607-462-00-8
reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates
421-230-1
88230-35-7
Aquatic Chronic 2
H411
GHS09
H411
607-463-00-3
3-(phenothiazin-10-yl)propionic acid
421-260-5
362-03-8
Aquatic Chronic 2
H411
GHS09
H411
607-464-00-9
reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
421-280-4
Aquatic Chronic 3
H412
—
H412
607-465-00-4
tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate
421-440-3
778583-04-3
Aquatic Chronic 3
H412
—
H412
607-466-00-X
reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate
421-480-1
—
Aquatic Chronic 2
H411
GHS09
H411
607-467-00-5
1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate
419-430-9
56533-00-7
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
Skin Corr. 1B Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 ** H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 ** H314
H410
607-468-00-0
reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate
419-450-8
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-469-00-6
disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate
419-460-2
120029-06-3
Aquatic Chronic 3
H412
—
H412
607-470-00-1
potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
414-100-0
154336-20-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-471-00-7
1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane
429-280-6
151900-44-6
Aquatic Chronic 4
H413
—
H413
607-473-00-8
pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid
426-590-3
187412-41-5
Skin Sens. 1
H317
GHS07
Wng
H317
607-474-00-3
(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid
410-430-4
117573-89-4
Aquatic Chronic 4
H413
—
H413
607-475-00-9
reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)
412-940-2
148878-18-6
Skin Sens. 1
H317
GHS07
Wng
H317
607-476-00-4
trisodium N, N-bis(carboxymethyl)-β-alanine
414-070-9
129050-62-0
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
607-477-00-X
(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt
426-740-8
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
607-478-00-5
tetramethylammonium hydrogen phthalate
416-900-5
79723-02-7
Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1
H301
H373 ** H400
GHS06
GHS08
GHS09
Dgr
H301
H373 ** H400
607-479-00-0
hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate
418-550-9
168689-49-4
Aquatic Chronic 4
H413
—
H413
607-480-00-6
1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters
271-084-6
68515-42-4
Repr. 1B
H360Df
GHS08
Dgr
H360Df
607-481-00-1
reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate
430-290-8
—
Aquatic Chronic 4
H413
—
H413
607-482-00-7
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride
430-360-8
84793-24-8
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-483-00-2
1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich
276-158-1
71888-89-6
Repr. 1B
H360D***
GHS08
Dgr
H360D***
607-484-00-8
ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate
430-480-0
221452-67-1
Aquatic Chronic 4
H413
—
H413
607-485-00-3
(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate
430-510-2
—
Aquatic Chronic 4
H413
—
H413
607-486-00-9
potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate
402-110-8
110081-40-8
Aquatic Chronic 3
H412
—
H412
607-487-00-4
reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate
402-660-9
—
Repr. 1B
Aquatic Chronic 3
H360D *** H412
GHS08
Dgr
H360D *** H412
607-488-00-X
ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate
414-210-9
147379-38-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-489-00-5
reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate
414-890-7
71302-79-9
Skin Sens. 1
H317
GHS07
Wng
H317
607-490-00-0
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate
415-060-7
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-491-00-6
reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)
427-140-9
—
Carc. 2
H351
GHS08
Wng
H351
607-492-00-1
2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate
415-490-5
141773-73-1
Aquatic Chronic 2
H411
GHS09
H411
607-493-00-7
methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate
415-670-3
78850-37-0
Eye Dam. 1
H318
GHS05
Dgr
H318
607-494-00-2
bis(2-ethylhexyl)octylphosphonate
417-170-0
52894-02-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-495-00-8
sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate
417-550-6
168151-92-6
Skin Sens. 1
H317
GHS07
Wng
H317
607-496-00-3
2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite
418-310-3
126050-54-2
Aquatic Chronic 4
H413
—
H413
607-497-00-9
cerium oxide isostearate
419-760-3
—
Aquatic Chronic 4
H413
—
H413
607-498-00-4
(E)-3,7-dimethyl-2,6-octadienylhexadecanoate
421-370-3
3681-73-0
Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413
607-499-00-X
bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)
421-660-1
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
607-500-00-3
calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate
421-670-4
—
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
607-501-00-9
reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives
421-820-9
192268-65-8
Aquatic Chronic 4
H413
—
H413
607-502-00-4
(N-benzyl-N, N,N-tributyl)ammonium 4-dodecylbenzenesulfonate
422-200-0
178277-55-9
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H314
H302
H411
GHS05
GHS07
GHS09
Dgr
H314
H302
H411
607-503-00-X
2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane
422-210-5
68957-94-8
Skin Corr. 1B
H314
GHS05
Dgr
H314
607-504-00-5
diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate
422-670-7
—
Repr. 2
Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1
Aquatic Chronic 1
H361f
H301
H373** H400
H410
GHS06
GHS08
GHS09
Dgr
H361f
H301
H373** H410
607-505-00-0
pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate
422-930-1
Aquatic Chronic 3
H412
—
H412
607-506-00-6
reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate
422-970-8
Aquatic Chronic 2
H411
GHS09
H411
607-507-00-1
potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate
422-980-2
187026-95-5
Eye Dam. 1
H318
GHS05
Dgr
H318
607-508-00-7
disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]
423-110-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318
607-509-00-2
2-phenoxyethyl 4-aminobenzoate
430-880-5
88938-23-2
Aquatic Chronic 2
H411
GHS09
H411
607-510-00-8
(2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
427-200-4
76646-91-8
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
607-511-00-3
reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid
423-750-4
—
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
607-512-00-9
trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate
423-970-0
182926-43-8
Aquatic Chronic 3
H412
—
H412
607-513-00-4
reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid
423-200-3
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-514-00-X
potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate
427-240-2
134841-35-3
Skin Sens. 1
H317
GHS07
Wng
H317
607-515-00-5
reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate
429-650-7
147732-60-3
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
607-516-00-0
N, N'-bis(trifluoroacetyl)-S, S'-bis-L-homocysteine
429-670-6
105996-54-1
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-517-00-6
(S)-α-(acetylthio)benzenepropanoic acid
430-300-0
76932-17-7
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
607-518-00-1
3-oxoandrost-4-ene-17-β-carboxylic acid
414-990-0
302-97-6
Repr. 2
Aquatic Chronic 4
H361f
H413
GHS08
Wng
H361f
H413
607-519-00-7
poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-280-0
176429-27-9
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410
607-520-00-2
reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate
427-740-0
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-521-00-8
tetraethyl N, N'-(methylenedicyclohexane-4,1-diyl)bis-DL-aspartate
429-270-1
136210-30-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-522-00-3
sodium salt of the polymer of:sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate
429-720-7
184246-86-4
Aquatic Chronic 3
H412
—
H412
607-523-00-9
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate
430-200-7
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-524-00-4
tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters
430-310-5
—
Aquatic Chronic 4
H413
H413
607-525-00-X
(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid
431-520-1
64485-90-1
Flam. Sol. 1**** Carc. 2
Aquatic Chronic 3
H228
H351
H412
GHS02
GHS08
Dgr
H228
H351
H412
607-526-00-5
cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane
—
15263-53-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-527-00-0
Reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate
423-180-6
—
STOT RE 2 *
H373 **
GHS08
Wng
H373 **
607-528-00-6
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid
430-900-2
192725-50-1
Eye Dam. 1
H318
GHS05
Dgr
H318
607-529-00-1
benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate
426-070-6
67299-45-0
Aquatic Chronic 3
H412
—
H412
607-530-00-7
reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate
406-040-9
125643-61-0
Aquatic Chronic 4
H413
—
H413
607-531-00-2
methyl 3-amino-4,6-dibromo-2-methyl-benzoate
425-190-6
119916-05-1
STOT RE 2 *
Aquatic Chronic 2
H373** H411
GHS08
GHS09
Wng
H373** H411
607-532-00-8
(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt
425-510-4
167944-94-7
Aquatic Chronic 3
H412
—
H412
607-533-00-3
pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
414-910-4
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-534-00-9
ethyl 2-(3-benzoylphenyl)propanoate
414-920-9
60658-04-0
Acute Tox. 3 * STOT RE 1
Skin Sens. 1
Aquatic Chronic 2
H301
H372** H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H372** H317
H411
607-535-00-4
potassium 4-iodo-2-sulfonato-benzoic acid
426-620-5
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-536-00-X
(2,6-xylyloxy) acetic acid
430-910-7
13335-71-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
607-537-00-5
isopropylammonium 2-(3-benzoylphenyl)propionate
417-970-1
—
Acute Tox. 3 * Acute Tox. 4 * STOT RE 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H372** H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H312
H372** H318
H410
607-539-00-6
propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate
431-000-2
198705-81-6
Aquatic Chronic 4
H413
—
H413
607-540-00-1
1-(mercaptomethyl)cyclopropylacetic acid
420-240-3
162515-68-6
Skin Corr. 1B
Acute Tox. 4 * Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H312
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H317
H411
607-541-00-7
[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)
421-940-1
28698-31-9
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
607-542-00-2
methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate
422-110-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-543-00-8
poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-480-8
176429-22-4
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410
607-544-00-3
ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate
427-490-2
158585-86-5
Aquatic Chronic 3
H412
—
H412
607-545-00-9
1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate
424-070-0
94346-09-5
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-546-00-4
reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate
424-290-7
188070-47-5
Skin Sens. 1
H317
GHS07
Wng
H317
607-547-00-X
18-methylnonadecyl 2,2-dimethylpropanoate
424-370-1
125496-22-2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
607-548-00-5
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate
431-010-7
154486-26-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
607-549-00-0
methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate
424-430-7
125778-19-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-550-00-6
2-amino-4-bromo-5-chlorobenzoic acid
424-700-4
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-551-00-1
tetrabutylammonium 2-amino-6-iodopurinate
424-710-9
156126-48-6
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H373** H315
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373** H315
H318
H317
H411
607-552-00-7
hexadecyl -amino-4-isopropoxybenzoate
424-830-1
—
Aquatic Chronic 4
H413
—
H413
607-553-00-2
7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt
424-850-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318
607-554-00-8
2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid
424-870-1
27624-67-5
Expl. 1.1
Eye Dam. 1
Aquatic Chronic 3
H201
H318
H412
GHS01
GHS05
Dgr
H201
H318
H412
607-555-00-3
1,1,3,3-tetramethylbutylperoxypivalate
424-980-8
22288-41-1
Flam. Liq. 2
Org. Perox. D
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H242
H315
H317
H411
GHS02
GHS07
GHS09
Dgr
H225
H242
H315
H317
H411
607-556-00-9
2-acetoxymethylene-4-acetylphenylacetate
425-160-2
24085-06-1
Acute Tox. 4 * STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373** H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09 Dgr
H302
H373** H318
H317
H410
607-557-00-4
salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid
425-210-3
169939-84-8
Skin Sens. 1
H317
GHS07
Wng
H317
607-558-00-X
2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate
425-250-1
147027-10-9
Aquatic Chronic 2
H411
GHS09
H411
607-559-00-5
coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid
425-400-6
179986-09-5
Aquatic Chronic 4
H413
—
H413
607-560-00-0
(R, S)-2-butyloctanedioic acid
431-210-4
50905-10-7
Eye Dam. 1
H318
GHS05
Dgr
H318
607-561-00-6
sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate
425-460-3
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-562-00-1
reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate
425-530-3
98769-75-6
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
607-563-00-7
5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid
431-250-2
171850-30-9
Aquatic Chronic 2
H411
GHS09
H411
607-564-00-2
1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate
425-730-0
51178-75-7
Skin Sens. 1
H317
GHS07
Wng
H317
607-565-00-8
3-ethyl 5 methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
425-820-1
88150-42-9
Acute Tox. 3 * STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373** H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H373** H318
H410
607-566-00-3
reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate
426-140-6
—
Aquatic Chronic 4
H413
—
H413
607-567-00-9
potassium 3-iodo-6-methylbenzenesulfonate
426-300-5
—
Eye Dam. 1
H318
GHS05
Dgr
H318
607-568-00-4
potassium 2-chloro-3-(benzyloxy)propionate
426-350-8
138666-92-9
Acute Tox. 4 * STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373** H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373** H318
H317
607-569-00-X
reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate
426-470-0
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-570-00-5
sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate
426-520-1
71420-85-4
Skin Sens. 1
H317
GHS07
Wng
H317
607-571-00-0
2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate
431-400-7
57374-49-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-572-00-6
diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate
426-790-0
162208-27-7
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373** H317
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373** H317
H410
607-573-00-1
reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium; 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate
426-840-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318
607-574-00-7
[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate
426-890-4
77341-67-4
Eye Dam. 1
H318
GHS05
Dgr
H318
607-575-00-2
4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt
426-900-7
—
STOT SE 3
Aquatic Chronic 3
H335
H412
GHS07
Wng
H335
H412
607-576-00-8
branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate
427-030-0
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-577-00-3
(2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate
427-100-0
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
607-578-00-9
ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate
427-110-5
—
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 4
H302
H373** H413
GHS08
GHS07
Wng
H302
H373** H413
607-579-00-4
diethyl[(p-ethoxyanilino)methylene]malonate
431-430-0
103976-28-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
607-580-00-X
ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate
422-360-1
100491-29-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-581-00-5
ethyl 2-ethoxy-4-carboxymethylbenzoate
427-630-2
99469-99-5
Eye Dam. 1
H318
GHS05
Dgr
H318
607-582-00-0
reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
427-650-1
—
Aquatic Chronic 3
H412
—
H412
607-583-00-6
4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid
427-680-5
188907-52-0
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-584-00-1
trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate
427-710-7
215612-56-9
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
607-585-00-7
strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate
427-930-3
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-586-00-2
dodecyl 3-amino-4-chlorobenzoate
428-020-9
6195-20-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-587-00-8
ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate
428-030-3
67914-69-6
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1
Aquatic Chronic 1
H302
H373** H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373** H410
607-588-00-3
reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate
428-050-2
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-589-00-9
tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate
428-070-1
91788-83-9
STOT RE 1
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H372** H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H372** H302
H410
607-590-00-4
hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate
428-140-1
210706-50-6
Aquatic Chronic 4
H413
—
H413
607-591-00-X
reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate
428-400-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318
607-592-00-5
di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate
428-870-0
—
Aquatic Chronic 4
H413
—
H413
607-593-00-0
4-(2-methylacryloyloxy)phenyl4-allyloxybenzoate
429-000-2
159235-16-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-594-00-6
ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
429-020-1
204254-96-6
STOT RE 2 *
Skin Sens. 1
H373** H317
GHS08
GHS07
Wng
H373** H317
607-595-00-1
N-amidino-N-methylglycine-2-oxopropionate
429-120-5
208535-04-0
Eye Dam. 1
H318
GHS05
Dgr
H318
607-596-00-7
ethyl 2-(4-phenoxyphenyl)lactate
429-220-9
132584-17-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-597-00-2
tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate
429-230-3
—
Eye Dam. 1
H318
GHS05
Dgr
H318
607-598-00-8
trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate
429-240-8
212652-59-0
Eye Dam. 1
H318
GHS05
Dgr
H318
607-599-00-3
1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate
431-610-9
68860-54-8
Org. Perox. D
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H317
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H317
H410
607-600-00-7
(1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate
431-700-8
—
Aquatic Chronic 2
H411
GHS09
H411
607-601-00-2
1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate
429-370-5
220410-74-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-602-00-8
ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate
429-680-0
122665-86-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-603-00-3
lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate
429-730-1
193562-37-7
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-604-00-9
guanidinium benzoate
429-820-0
26739-54-8
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-605-00-4
methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate
429-890-2
144550-06-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-606-00-X
(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid
430-100-3
86978-24-7
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-607-00-5
reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol
430-180-1
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-608-00-0
pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate
430-210-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-609-00-6
ethyl (3R)-4-cyano-3-hydroxybutanoate
430-220-6
141942-85-0
Eye Irrit. 2
H319
GHS07
Wng
H319
607-610-00-1
trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate
430-280-3
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-611-00-7
methyl 3-amino-2,2,3-trimethylbutyrate
431-720-7
90886-53-6
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412
607-612-00-2
Reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate
432-190-1
182176-52-9
Acute Tox. 4 * STOT RE 2 *
Eye Dam. 1
H302
H373** H318
GHS05
GHS08
GHS07
Dgr
H302
H373** H318
607-613-00-8
reaction mass of: succinic acid; monopersuccinic acid; dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic aciddimethyl adipate hydrogen peroxide methanolwater
432-790-1
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4*
Skin Corr. 1B STOT SE 2
H332
H312
H302
H314
H371 (eyes)
GHS07
GHS05
GHS08
Dgr
H332
H312
H302
H314
H371 (eyes)
607-614-00-3
2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid
426-480-5
63562-33-4
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
607-615-00-9
reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance
431-120-5
—
Acute Tox. 3 * Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H331
H302
H319
H317
GHS06
Dgr
H331
H302
H319
H317
607-616-00-4
2,4-dichloro-5-fluorobenzoylchloride
428-390-1
86393-34-2
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H335
H315
H318
H317
H412
GHS05
GHS07
Dgr
H335
H315
H318
H317
H412
607-617-00-X
bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate
430-700-5
10138-36-0
Skin Sens. 1
H317
GHS07
Wng
H317
607-618-00-5
menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt
204-987-0
130-37-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
607-619-00-0
menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonicacid, compound with nicotin-3-amide (1:1)
277-543-7
73581-79-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
607-620-00-6
trisodium nitrilotriacetate
225-768-6
5064-31-3
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
H351
H302
H319
GHS08
GHS07
Wng
H351
H302
H319
Carc. 2; H351: C
≥ 5 %
607-621-00-1
milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]
—
—
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410
M=100
607-622-00-7
2-ethylhexyl-2-ethylhexanoate
231-057-1
7425-14-1
Repr. 2
H361d***
GHS08
Wng
H361d***
607-624-00-8
perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctanesulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5]
217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]
1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]
Carc. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 * Acute Tox. 4 *
Lact.
Aquatic Chronic 2
H351
H360D*** H372**
H332
H302
H362
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D*** H372**
H332
H302
H362
H411
607-625-00-3
clodinafop-propargyl (ISO)
—
105512-06-9
Acute Tox. 4 * STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373** H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373** H317
H410
Skin Sens. 1; H317: C ≥ 0,001 %
M=1
607-626-00-9
ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate
401-290-5
103112-35-2
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
607-627-00-4
[(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate
416-360-0
162221-28-5
Skin Sens. 1
H317
GHS07
Wng
H317
607-628-00-X
4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine
419-240-6
171054-89-0
Eye Dam. 1
H318
GHS05
Dgr
H318
607-629-00-5
[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid
419-270-1
123599-82-6
Eye Irrit. 2
H319
GHS07
Wng
H319
607-630-00-0
acrylic acid, 3-(trimethoxysilyl)propyl ester
419-560-6
4369-14-6
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H332
H314
H317
H412
GHS05
GHS07
Dgr
H332
H314
H317
H412
607-631-00-6
reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl)oxo(phenyl)acetate
442-300-8
—
Skin Sens. 1
H317
GHS07
Wng
H317
607-632-00-1
N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide
420-210-1
111244-14-5
Aquatic Chronic 4
H413
—
H413
607-633-00-7
trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate
440-480-2
341026-59-3
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-634-00-2
(S)-(–)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate
420-610-4
36394-75-9
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
607-635-00-8
trisodium N-(3-propionato)-l-aspartate
422-090-4
172737-80-3
Eye Dam. 1
H318
GHS05
Dgr
H318
607-636-00-3
1-bromo-2-methylpropyl propionate
422-900-6
158894-67-8
Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Skin Sens. 1
H226
H351
H314
H317
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H351
H314
H317
607-637-00-9
disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate
423-730-5
250688-43-8
Eye Dam. 1
H318
GHS05
Dgr
H318
607-638-00-4
2-hydroxybenzoic acid 2-butyloctyl ester
431-090-3
190085-41-7
Aquatic Chronic 4
H413
—
H413
607-639-00-X
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate
431-770-1
216698-07-6
Aquatic Chronic 4
H413
—
H413
607-641-00-0
2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid
431-930-9
43028-69-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
607-642-00-6
3,6,9-trithiaundecamethylene-1,11-dimethacrylate
432-210-7
141631-22-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
607-643-00-1
dimethyl (2S)-2-hydroxysuccinate
432-310-0
617-55-0
Flam. Liq. 3
Eye Dam. 1
Skin Sens. 1
H226
H318
H317
GHS02
GHS05
GHS07
Dgr
H226
H318
H317
607-644-00-7
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate
432-350-9
81752-87-6
Skin Irrit. 2
H315
GHS07
Wng
H315
607-645-00-2
tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate
432-550-6
243858-01-7
Eye Dam. 1
H318
GHS05
Dgr
H318
607-646-00-8
D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
432-960-5
124655-09-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-647-00-3
5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane
433-530-1
143446-73-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
H302
H317
H400
GHS07
GHS09
Wng
H302
H317
H400
607-649-00-4
[3-(chlorocarbonyl)-2-methylphenyl]acetate
433-690-0
167678-46-8
Skin Corr. 1A
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
607-650-00-X
2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate
433-910-5
145153-52-2
Skin Sens. 1
H317
GHS07
Wng
H317
607-651-00-5
sodium 2-(nonanoyloxy)benzenesulfonate
434-360-9
91125-43-8
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-652-00-0
ethyl N2-dodecanoyl-l-argininate hydrochloride
434-630-6
60372-77-2
Eye Dam. 1
Aquatic Acute 1
H318
H400
GHS05
GHS09
Dgr
H318
H400
607-653-00-6
tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate
434-840-8
225786-91-4
Aquatic Chronic 2
H411
GHS09
H411
607-654-00-1
(S)-3-hydroxy-γ-butyrolactone
434-990-4
7331-52-4
Skin Sens. 1
H317
GHS07
Wng
H317
607-655-00-7
ethyl 6,8-dichlorooctanoate
435-080-1
1070-64-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-656-00-2
sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid
435-350-7
141250-43-3
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-657-00-8
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
436-920-8
172399-10-9
Eye Dam. 1
H318
GHS05
Dgr
H318
607-658-00-3
3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt
440-770-9
371921-63-0
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-659-00-9
pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid
442-030-0
321912-47-4
Eye Dam. 1
H318
GHS05
Dgr
H318
607-660-00-4
2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazophenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt
442-230-8
321679-52-1
Eye Dam. 1
H318
GHS05
Dgr
H318
607-661-00-X
1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate
442-850-9
114772-40-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-662-00-5
methyl 2-(acetylamino)-3-chloropropionate
442-860-3
87333-22-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
607-663-00-0
bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate
442-980-6
127474-91-3
Aquatic Chronic 4
H413
—
H413
607-664-00-6
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate
443-120-2
393509-79-0
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
607-665-00-1
trans-methyl-2-ethyl-but-2-enoate
443-150-6
101226-85-1
Flam. Liq. 3
H226
GHS02
Wng
H226
607-666-00-7
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid
443-560-5
88784-33-2
Eye Irrit. 2
H319
GHS07
Wng
H319
607-667-00-2
chloro-1-ethylcyclohexyl carbonate
444-950-8
99464-83-2
Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Wng
H341
H317
607-668-00-8
trans-2-isopropyl-5-carboxy-1,3-dioxane
445-770-2
42031-28-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-669-00-3
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate
445-990-9
376588-17-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
607-670-00-9
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate
448-700-9
500791-70-8
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373** H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H373** H318
H317
H410
M=10
607-671-00-4
diethyl 1,4-cyclohexanedicarboxylate
417-310-0
72903-27-6
Aquatic Chronic 2
H411
GHS09
H411
607-672-00-X
reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate
419-000-0
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-673-00-5
1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate
419-570-0
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
607-675-00-6
reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid
422-260-8
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
607-676-00-1
reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid
423-670-1
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
607-677-00-7
2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazoly]methyl]amino]carbonyl}-L-Valinate
424-660-8
—
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H373** H318
H317
GHS05
GHS08
GHS07
Dgr
H373** H318
H317
607-678-00-2
reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate
427-090-8
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-679-00-8
reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo[}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetate)
431-440-5
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
607-680-00-3
tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-ylvinyl}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
432-810-9
—
Aquatic Chronic 4
H413
—
H413
607-681-00-9
reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate
432-910-2
—
Aquatic Chronic 4
H413
—
H413
607-682-00-4
complex reaction mass of Chinese gum rosin post reacted with acrylic acid
434-230-1
144413-22-9
Aquatic Chronic 4
H413
—
H413
607-683-00-X
reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)
435-450-0
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
607-684-00-5
alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts
435-660-2
243662-67-1
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
607-685-00-0
ammonium 2-cocoyloxyethanesulfonate
441-050-7
—
Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318
607-686-00-6
6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)
441-550-5
—
Self-react. C **** Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351
607-687-00-1
reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)
442-800-6
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
607-688-00-7
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride
444-320-2
—
Acute Tox. 4 *
H302
GHS07
Wng
H302
607-689-00-2
reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis-and trans-isomers); methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’including cis-and trans-isomers)
444-920-4
—
Aquatic Chronic 3
H412
—
H412
607-690-00-8
dimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N, N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate
432-860-1
255387-46-3
Skin Sens. 1
H317
GHS07
Wng
H317
607-691-00-3
magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
448-690-6
—
Aquatic Chronic 4
H413
—
H413
607-692-00-9
zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
446-470-4
—
Aquatic Chronic 4
H413
—
H413
607-693-00-4
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate
443-860-6
302776-68-7
Aquatic Chronic 4
H413
—
H413
607-694-00-X
ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate
443-870-0
163520-33-0
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
607-696-00-0
pentyl formate
211-340-6
638-49-3
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Dgr
H226
H319
H335
C
607-697-00-6
tert-butyl propionate
—
20487-40-5
Flam. Liq. 2
H225
GHS02
Dgr
H225
C
607-698-00-1
4-tert-butylbenzoic acid
202-696-3
98-73-7
Repr. 1B
STOT RE 1
Acute Tox. 4
H360F H372
H302
GHS07
GHS08
Dgr
H360F H372
H302
607-699-00-7
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
82657-04-3
Carc. 2
Acute Tox. 3
Acute Tox. 2
STOT RE 1
Skin Sens. 1B Aquatic Acute 1
Aquatic Chronic 1
H351
H331
H300
H372 (nervous
system) H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H331
H300
H372 (nervous
system) H317
H410
M = 10 000
M = 100 000
607-700-00-0
indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] reaction mass of (S)-Indoxacarb and (R)-Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]
173584-44-6 [1]
144171-61-9 [2]
Acute Tox. 3
Acute Tox. 4
STOT RE 1
Skin Sens. 1B Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H372 (blood, nervous system, heart)
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H332
H372 (blood, nervous system, heart)
H317
H410
M = 1
M = 1
607-702-00-1
dihexyl phthalate
201-559-5
84-75-3
Repr. 1B
H360FD
GHS08
Dgr
H360FD
607-703-00-7
ammoniumpentadeca-fluorooctanoate
223-320-4
3825-26-1
Carc. 2
Repr. 1B Lact.
Acute Tox. 4
Acute Tox. 4
STOT RE 1
Eye Dam.1
H351
H360D H362
H332
H302
H372 (liver) H318
GHS08
GHS07
GHS05
Dgr
H351
H360D H362
H332
H302
H372 (liver) H318
607-704-00-2
perfluorooctanoic acid
206-397-9
335-67-1
Carc. 2
Repr. 1B Lact.
Acute Tox. 4
Acute Tox. 4
STOT RE 1
Eye Dam. 1
H351
H360D H362
H332
H302
H372 (liver) H318
GHS08
GHS07
GHS05
Dgr
H351
H360D H362
H332
H302
H372 (liver) H318
607-705-00-8
benzoic acid
200-618-2
65-85-0
STOT RE 1
Skin Irrit. 2
Eye Dam. 1
H372 (lungs) (inhalation) H315
H318
GHS08
GHS05
Dgr
H372 (lungs) (inhalation) H315
H318
607-706-00-3
methyl 2,5-dichlorobenzoate
220-815-7
2905-69-3
Acute Tox. 4
STOT SE 3
Aquatic Chronic 2
H302
H336
H411
GHS07
GHS09
Wng
H302
H336
H411
608-001-00-3
acetonitrile; cyanomethane
200-835-2
75-05-8
Flam. Liq. 2
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
H225
H332
H312
H302
H319
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
608-002-00-9
trichloroacetonitrile
208-885-7
545-06-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H331
H311
H301
H411
GHS06
GHS09
Dgr
H331
H311
H301
H411
608-003-00-4
acrylonitrile
203-466-5
107-13-1
Flam. Liq. 2
Carc. 1B
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H225
H350
H331
H311
H301
H335
H315
H318
H317
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H331
H311
H301
H335
H315
H318
H317
H411
*
D
608-004-00-X
2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin
200-909-4
75-86-5
Acute Tox. 2 * Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
608-005-00-5
n-butyronitrile
203-700-6
109-74-0
Flam. Liq. 2
Acute Tox. 3 * Acute Tox. 3 *
Acute Tox. 3 *
H225
H331
H311
H301
GHS02
GHS06
Dgr
H225
H331
H311
H301
608-006-00-0
bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol
216-882-7
1689-84-5
Repr. 2
Acute Tox. 2 * Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H330
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d *** H330
H301
H317
H410
M = 10
608-007-00-6
ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile
216-881-1
1689-83-4
Repr. 2
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H331
H301
H312
H373 ** H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d *** H331
H301
H312
H373 ** H319
H410
M = 10
608-008-00-1
chloroacetonitrile
203-467-0
107-14-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H331
H311
H301
H411
GHS06
GHS09
Dgr
H331
H311
H301
H411
608-009-00-7
malononitrile
203-703-2
109-77-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
608-010-00-2
methacrylonitrile; 2-methyl-2-propene nitrile
204-817-5
126-98-7
Flam. Liq. 2
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
Skin Sens. 1
H225
H331
H311
H301
H317
GHS02
GHS06
Dgr
H225
H331
H311
H301
H317
*
Skin Sens. 1; H317: C ≥0,2 %
D
608-011-00-8
oxalonitrile; cyanogen
207-306-5
460-19-5
Press. Gas
Flam. Gas 1
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H220
H331
H400
H410
GHS02
GHS04
GHS06
GHS09
Dgr
H220
H331
H410
U
608-012-00-3
benzonitrile
202-855-7
100-47-0
Acute Tox. 4 * Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302
608-013-00-9
2-chlorobenzonitrile
212-836-5
873-32-5
Acute Tox. 4 * Acute Tox. 4 *
Eye Irrit. 2
H312
H302
H319
GHS07
Wng
H312
H302
H319
608-014-00-4
chlorothalonil (ISO); tetrachloroisophthalonitrile
217-588-1
1897-45-6
Carc. 2
Acute Tox. 2 * STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H335
H318
H317
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H330
H335
H318
H317
H410
M=10
608-015-00-X
dichlobenil (ISO); 2,6-dichlorobenzonitrile
214-787-5
1194-65-6
Acute Tox. 4 *
Aquatic Chronic 2
H312
H411
GHS07
GHS09
Wng
H312
H411
608-016-00-5
1,4-Dicyano-2,3,5,6-tetra-chloro-benzene
401-550-8
1897-41-2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
608-017-00-0
bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate
216-885-3
1689-99-2
Repr. 2
Acute Tox. 3 * Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H331
H302
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d *** H331
H302
H317
H410
M = 10
608-018-00-6
ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate
223-375-4
3861-47-0
Repr. 2
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d *** H301
H319
H317
H410
M = 10
608-019-00-1
2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN
201-132-3
78-67-1
Self-react. C
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Chronic 3
H242
H332
H302
H412
GHS02
GHS07
Dgr
H242
H332
H302
H412
T
608-020-00-7
diphenoxymethylenecyanamide
427-300-8
79463-77-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
608-021-00-2
3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile
403-710-2
76823-93-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
608-022-00-8
3,7-dimethyloctanenitrile
403-620-3
40188-41-8
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411
608-023-00-3
fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
406-140-2
114369-43-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
608-024-00-9
2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile
407-650-8
97460-76-9
Aquatic Chronic 4
H413
—
H413
608-025-00-4
2-nitro-4,5-bis(benzyloxy)phenylacetonitrile
410-970-0
117568-27-1
Aquatic Chronic 4
H413
—
H413
608-026-00-X
3-cyano-3,5,5-trimethylcyclohexanone
411-490-4
7027-11-4
Acute Tox. 4 * STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H302
H373 ** H317
H412
GHS08
GHS07
Wng
H302
H373 ** H317
H412
608-027-00-5
reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile
412-660-0
—
Aquatic Chronic 2
H411
GHS09
H411
608-028-00-0
4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate
413-510-7
147374-67-2
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H373 ** H317
H411
GHS08
GHS09
Wng
H373 ** H317
H411
608-029-00-6
1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile
411-990-2
68612-94-2
Skin Sens. 1
H317
GHS07
Wng
H317
608-030-00-1
N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide
412-340-0
147741-93-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
608-031-00-7
2-benzyl-2-methyl-3-butenitrile
407-870-4
97384-48-0
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
608-032-00-2
acetamiprid (ISO);
(E)-N 1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
—
135410-20-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
608-033-00-8
N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide
407-970-8
75511-91-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
608-034-00-3
chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile
—
122453-73-0
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H400
H410
GHS06
GHS09
Dgr
H331
H302
H410
M=100
608-035-00-9
(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile
419-290-9
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
608-036-00-4
3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile
419-060-8
79026-02-1
Aquatic Chronic 4
H413
—
H413
608-037-00-X
reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile
422-190-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
608-038-00-5
2,2,4-trimethyl-4-phenyl-butane-nitrile
422-580-8
75490-39-0
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
608-039-00-0
2-phenylhexanenitrile
423-460-8
3508-98-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
608-040-00-6
4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)
423-490-1
130755-46-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
608-041-00-1
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile
423-500-4
138401-24-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
608-042-00-7
(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide
421-810-4
194602-27-2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
608-043-00-2
3-(cis-3-hexenyloxy)propanenitril
415-220-6
142653-61-0
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H400
H410
GHS06
GHS09
Dgr
H331
H302
H410
608-044-00-8
2-cyclohexylidene-2-phenylacetonitrile
423-740-1
10461-98-0
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
608-046-00-9
5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile
425-310-7
77889-90-8
Aquatic Chronic 4
H413
—
H413
608-047-00-4
2-piperidin-1-yl-benzonitrile
427-330-1
72752-52-4
Aquatic Chronic 2
H411
GHS09
H411
608-048-00-X
1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile
427-450-4
152630-47-2
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H302
H373**
H317
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H411
608-049-00-5
2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile
429-180-2
157362-53-3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
608-050-00-0
reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;
5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile
429-760-5
—
Aquatic Chronic 4
H413
—
H413
608-051-00-6
(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-760-2
219861-18-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
608-052-00-1
(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-770-7
128173-52-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
608-053-00-7
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-780-1
103146-25-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
608-054-00-2
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)3-(hydroxymethyl)benzonitrile hemisulfate
430-790-6
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
608-056-00-3
N-methyl-N-cyanomethylmorpholiniummethylsulfate
429-340-1
—
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
608-057-00-9
4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate
431-200-1
208538-34-5
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
608-058-00-4
esfenvalerate (ISO);
(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate
—
66230-04-4
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H317
H400
H410
GHS06
GHS09
Dgr
H331
H301
H317
H410
M = 10000
608-059-00-X
5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile
421-240-6
120068-79-3
Aquatic Chronic 2
H411
GHS09
H411
608-060-00-5
5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile
421-300-1
138564-59-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
608-062-00-6
2-fluoro-4-hydroxybenzonitrile
422-810-7
82380-18-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
608-063-00-1
(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile
441-070-6
61826-76-4
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410
608-064-00-7
cyanomethyltrimethylammoniummethylsulfate
433-720-2
—
Aquatic Chronic 3
H412
—
H412
608-065-00-2
salts of bromoxynil with the exception of those specified elsewhere in this Annex
—
—
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H330
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d *** H330
H301
H317
H410
M = 10
A
608-066-00-8
salts of ioxynil with the exception of those specified elsewhere in this Annex
—
—
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d *** H331
H301
H312
H373 **
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d *** H331
H301
H312
H373 **
H319
H410
M = 10
A
609-001-00-6
1-nitropropane
203-544-9
108-03-2
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Wng
H
226
H332
H312
H302
*
609-002-00-1
2-nitropropane
201-209-1
79-46-9
Flam. Liq. 3
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
H226
H350
H332
H302
GHS02
GHS08
GHS07
Dgr
H226
H350
H332
H302
609-003-00-7
nitrobenzene
202-716-0
98-95-3
Carc. 2. Repr. 1B
Acute Tox. 3
Acute Tox. 3
Acute Tox. 3
STOT RE 1
Aquatic Chronic 3
H351
H360F
H301
H331
H311
H372 (blood) H412
GHS06
GHS08
Dgr
H351
H360F
H301
H331
H311
H372 (blood) H412
609-004-00-2
dinitrobenzene; [1]
1,4-dinitrobenzene; [2]
1,3-dinitrobenzene; [3]
1,2-dinitrobenzene [4]
246-673-6 [1]
202-833-7 [2]
202-776-8 [3]
208-431-8 [4]
25154-54-5 [1]
100-25-4 [2]
99-65-0 [3]
528-29-0 [4]
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H410
609-005-00-8
1,3,5-trinitrobenzene
202-752-7
99-35-4
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H330
H310
H300
H373**
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373**
H410
609-006-00-3
4-nitrotoluene
202-808-0
99-99-0
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411
609-007-00-9
2,4-dinitrotoluene; [1]
dinitrotoluene [2]
204-450-0 [1]
246-836-1 [2]
121-14-2 [1]
25321-14-6 [2]
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361f***
H331
H311
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f***
H331
H311
H301
H373**
H410
609-008-00-4
2,4,6-trinitrotoluene; TNT
204-289-6
118-96-7
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H201
H331
H311
H301
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H331
H311
H301
H373 **
H411
609-009-00-X
2,4,6-trinitrophenol;
picric acid
201-865-9
88-89-1
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H201
H331
H311
H301
GHS01
GHS06
Dgr
H201
H331
H311
H301
609-010-00-5
salts of picric acid
—
—
Unst. Expl
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H201
H331
H311
H301
GHS01
GHS06
Dgr
H201
H331
H311
H301
T
609-011-00-0
2,4,6-trinitroanisole
—
606-35-9
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H201
H332
H312
H302
H411
GHS01
GHS07
GHS09
Wng
H201
H332
H312
H302
H411
609-012-00-6
2,4,6-trinitro-m-cresol
210-027-1
602-99-3
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H201
H332
H312
H302
GHS01
GHS07
Wng
H201
H332
H312
H302
609-013-00-1
2,4,6-trinitro-m-xylene
211-187-5
632-92-8
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
H201
H332
H312
H302
H373 **
GHS01
GHS08
GHS07
Wng
H201
H332
H312
H302
H373 **
609-015-00-2
4-nitrophenol;
p-nitrophenol
202-811-7
100-02-7
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
H332
H312
H302
H373 **
GHS08
GHS07
Wng
H332
H312
H302
H373 **
609-016-00-8
dinitrophenol (reaction mass of isomers); [1]
2,4(or 2,6)-dinitrophenol [2]
247-096-2 [1]
275-732-9 [2]
25550-58-7 [1]
71629-74-8 [2]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410
609-018-00-9
2,4,6-trinitroresorcinol;
styphnic acid
201-436-6
82-71-3
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H201
H332
H312
H302
GHS01
GHS07
Dgr
H201
H332
H312
H302
609-019-00-4
lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide;
lead styphnate
239-290-0
15245-44-0
Unst. Expl
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H200
H360Df
H332
H302
H373 **
H410
1
609-019-01-1
lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate (≥ 20 % phlegmatiser)
239-290-0
15245-44-0
Expl. 1.1
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H201
H360Df
H332
H302
H373 **
H410
1
609-020-00-X
DNOC (ISO);
4,6-dinitro-o-cresol
208-601-1
534-52-1
Muta. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H330
H310
H300
H315
H318
H317
H400
H410
GHS06
GHS08
GHS05
GHS07
GHS09
Dgr
H341
H330
H310
H300
H315
H318
H317
H410
EUH044
609-021-00-5
sodium salt of DNOC;
sodium 4,6-dinitro-o-cresolate; [1]
potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2]
219-007-7 [1]
-[2]
2312-76-7 [1]
5787-96-2 [2]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410
609-022-00-0
ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide
221-037-0
2980-64-5
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H410
609-023-00-6
dinocap (ISO);
(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which "octyl" is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups
254-408-0
39300-45-3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360D***
H332
H302
H373**
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D***
H332
H302
H373**
H315
H317
H410
M=100
609-024-00-1
binapacryl (ISO);
2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate
207-612-9
485-31-4
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H360D *** H312
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D *** H312
H302
H410
609-025-00-7
dinoseb (ISO);
6-sec-butyl-2,4-dinitrophenol
201-861-7
88-85-7
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H311
H301
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H360Df
H311
H301
H319
H410
EUH044
609-026-00-2
salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex
—
—
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H311
H301
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H360Df
H311
H301
H319
H410
EUH044
A
609-027-00-8
dinocton;
reaction mass of isomers:
methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate
—
63919-26-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
609-028-00-3
dinex (ISO);
2-cyclohexyl-4,6-dinitrophenol
205-042-5
131-89-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
609-029-00-9
salts and esters of dinex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
A
609-030-00-4
dinoterb (ISO);
2-tert-butyl-4,6-dinitrophenol
215-813-8
1420-07-1
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H360D *** H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D *** H300
H311
H410
EUH044
609-031-00-X
salts and esters of dinoterb
—
—
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H360D *** H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D *** H300
H311
H410
A
609-032-00-5
bromofenoxim (ISO);
3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime
236-129-6
13181-17-4
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
609-033-00-0
dinosam (ISO);
2-(1-methylbutyl)-4,6-dinitrophenol
—
4097-36-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
609-034-00-6
salts and esters of dinosam
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
A
609-035-00-1
nitroethane
201-188-9
79-24-3
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H302
GHS02
GHS07
Wng
H226
H332
H302
*
609-036-00-7
nitromethane
200-876-6
75-52-5
Flam. Liq. 3
Acute Tox. 4 *
H226
H302
GHS02
GHS07
Wng
H226
H302
*
609-037-00-2
5-nitroacenaphthene
210-025-0
602-87-9
Carc. 1B
H350
GHS08
Dgr
H350
609-038-00-8
2-nitronaphthalene
209-474-5
581-89-5
Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411
609-039-00-3
4-nitrobiphenyl
202-204-7
92-93-3
Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411
609-040-00-9
nitrofen (ISO);
2,4-dichlorophenyl 4-nitrophenyl ether
217-406-0
1836-75-5
Carc. 1B
Repr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H360D *** H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H360D *** H302
H410
609-041-00-4
2,4-dinitrophenol
200-087-7
51-28-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H331
H311
H301
H373 **
H400
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H400
609-042-00-X
pendimethalin (ISO);
N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine
254-938-2
40487-42-1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
609-043-00-5
quintozene (ISO);
pentachloronitrobenzene
201-435-0
82-68-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
609-044-00-0
tecnazene (ISO);
1,2,4,5-tetrachloro-3-nitrobenzene
204-178-2
117-18-0
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
609-045-00-6
reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6
—
8069-76-9
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
609-046-00-1
trifluralin (ISO) (containing <0.5 ppm NPDA);
α, α, α-trifluoro-2,6-dinitro-N, N-dipropyl-p-toluidine (containing
< 0,5 ppm NPDA);
2,6-dinitro-N, N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA);
N, N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)
216-428-8
1582-09-8
Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410
M=10
609-047-00-7
2-nitroanisole
202-052-1
91-23-6
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302
609-048-00-2
sodium 3-nitrobenzenesulphonate
204-857-3
127-68-4
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
609-049-00-8
2,6-dinitrotoluene
210-106-0
606-20-2
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H350
H341
H361f ***
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H412
609-050-00-3
2,3-dinitrotoluene
210-013-5
602-01-7
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361f ***
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H410
609-051-00-9
3,4-dinitrotoluene
210-222-1
610-39-9
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H350
H341
H361f ***
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H411
609-052-00-4
3,5-dinitrotoluene
210-566-2
618-85-9
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H350
H341
H361f ***
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H412
609-053-00-X
hydrazine-trinitromethane
414-850-9
—
Expl. 1.1 ****
Self-react. A
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
H201
H240
H350
H331
H301
H317
GHS01
GHS06
GHS08
Dgr
H201
H240
H350
H331
H301
H317
609-054-00-5
2,3-dinitrophenol; [1]
2,5-dinitrophenol; [2]
2,6-dinitrophenol; [3]
3,4-dinitrophenol; [4]
salts of dinitrophenol [5]
200-628-7 [1]
206-348-1 [2]
209-357-9 [3]
209-415-3 [4]-[5]
66-56-8 [1]
329-71-5 [2]
573-56-8 [3]
577-71-9 [4]-[5]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411
609-055-00-0
2,5-dinitrotoluene
210-581-4
619-15-8
Carc. 1B Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H350
H341
H361f ***
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H411
609-056-00-6
2,2-dibromo-2-nitroethanol
412-380-9
69094-18-4
Expl. 1.1
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H351
H302
H373 **
H314
H317
H400
H410
GHS01
GHS08
GHS05
GHS07
GHS09
Dgr
H201
H351
H302
H373 **
H314
H317
H410
*
STOT SE 3; H335: C ≥ 1 %
T
609-057-00-1
3-chloro-2,4-difluoronitrobenzene
411-980-8
3847-58-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
609-058-00-7
2-nitro-2-phenyl-1,3-propanediol
410-360-4
5428-02-4
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H372 ** H312
H302
H317
H411
GHS08
GHS07
GHS09
Dgr
H372 **
H312
H302
H317
H411
EUH070
609-059-00-2
2-chloro-6-(ethylamino)-4-nitrophenol
411-440-1
131657-78-8
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
609-060-00-8
4-[(3-hydroxypropyl)amino]-3-nitrophenol
406-305-9
92952-81-3
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
609-061-00-3
(E, Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime
406-100-4
94097-88-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
609-062-00-9
2-bromo-2-nitropropanol
407-030-7
24403-04-1
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H311
H302
H373 **
H314
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H311
H302
H373 **
H314
H317
H410
609-063-00-4
2-[(4-chloro-2-nitrophenyl)amino]ethanol
413-280-8
59320-13-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
609-064-00-X
mesotrione(ISO);
2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione
—
104206-82-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
609-065-00-5
2-nitrotoluene
201-853-3
88-72-2
Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H350
H340
H361f *** H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H340
H361f *** H302
H411
609-066-00-0
lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
418-870-9
154212-58-5
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2 **
H332
H312
H302
H371 **
GHS08
GHS07
Dgr
H332
H312
H302
H371 **
609-067-00-6
sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3(4-methoxy-2-sulfophenylazo)4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine
416-280-6
156769-97-0
Skin Sens. 1
H317
GHS07
Wng
H317
609-068-00-1
musk xylene;
5-tert-butyl-2,4,6-trinitro-m-xylene
201-329-4
81-15-2
Expl. 1.1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H351
H400
H410
GHS01
GHS08
GHS09
Wng
H201
H351
H410
T
609-069-00-7
musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
4'-tert-butyl-2', 6'-dimethyl-3',
5'-dinitroacetophenone
201-328-9
81-14-1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
609-070-00-2
1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene
415-580-4
130841-23-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
609-071-00-8
reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;
2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol
423-520-3
156137-33-6
Skin Sens. 1
H317
GHS07
Wng
H317
609-072-00-3
4-mesyl-2-nitrotoluene
430-550-0
1671-49-4
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H361f***
H302
H317
H412
GHS08
GHS07
Wng
H361f***
H302
H317
H412
609-073-00-9
lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato}-N'-(2-aminoethyl)piperazine
427-850-9
—
Skin Sens. 1
H317
GHS07
Wng
H317
610-001-00-3
trichloronitromethane;
chloropicrin
200-930-9
76-06-2
Acute Tox. 2 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H330
H302
H319
H335
H315
GHS06
Dgr
H330
H302
H319
H335
H315
610-002-00-9
1,1-dichloro-1-nitroethane
209-854-0
594-72-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
610-003-00-4
chlorodinitrobenzene
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410
C
610-004-00-X
2-chloro-1,3,5-trinitrobenzene
201-864-3
88-88-0
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H330
H310
H300
H400
H410
GHS01
GHS06
GHS09
Dgr
H201
H330
H310
H300
H410
610-005-00-5
1-chloro-4-nitrobenzene
202-809-6
100-00-5
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H351
H341
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H351
H341
H331
H311
H301
H373 **
H411
610-006-00-0
chloronitroanilines with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H330
H310
H300
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H411
A C
610-007-00-6
1-chloro-1-nitropropane
209-990-0
600-25-9
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
*
610-008-00-1
2,6-dichloro-4-nitroanisole
403-350-6
17742-69-7
Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411
610-009-00-7
2-chloro-4-nitroaniline
204-502-2
121-87-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
610-010-00-2
2-bromo-1-(2-furyl)-2-nitroethylene
406-110-9
35950-52-8
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H314
H317
H410
611-001-00-6
azobenzene
203-102-5
103-33-3
Carc. 1B Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H341
H332
H302
H373 **
H410
611-002-00-1
azoxybenzene
207-802-1
495-48-7
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
611-003-00-7
fenaminosulf (ISO);
sodium 4-dimethylaminobenzenediazosulphonate
205-419-4
140-56-7
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 3
H301
H312
H412
GHS06
Dgr
H301
H312
H412
611-004-00-2
methyl-ONN-azoxymethyl acetate;
methyl azoxy methyl acetate
209-765-7
592-62-1
Carc. 1B Repr. 1B
H350
H360D ***
GHS08
Dgr
H350
H360D ***
611-005-00-8
disodium {5-[(4'-((2,6-hydroxy3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato (4-)}cuprate(2-);
CI Direct Brown 95
240-221-1
16071-86-6
Carc. 1B
H350
GHS08
Dgr
H350
611-006-00-3
4-o-tolylazo-o-toluidine;
4-amino-2',3-dimethylazobenzene;
fast garnet GBC base; AAT;
o-aminoazotoluene
202-591-2
97-56-3
Carc. 1B
Skin Sens. 1
H350
H317
GHS08
Dgr
H350
H317
611-007-00-9
tricyclazole (ISO);
5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole;
255-559-5
41814-78-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
611-008-00-4
4-aminoazobenzene;
4-phenylazoaniline
200-453-6
60-09-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
611-009-00-X
sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)
401-220-3
—
Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412
611-010-00-5
2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N, N-dipropylamino)propionanilide
403-010-7
106359-94-8
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
611-011-00-0
N, N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate
403-340-1
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dg
H318
H411
611-012-00-6
reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N, N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate
403-410-1
114565-65-0
Skin Sens. 1
H317
GHS07
Wng
H317
611-013-00-1
trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate
403-650-7
117409-78-6
Expl. 1.3 ****
Aquatic Chronic 2
H203
H411
GHS01
GHS09
Dgr
H203
H411
611-014-00-7
(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide
404-250-5
115099-55-3
Skin Sens. 1
H317
GHS07
Wng
H317
611-015-00-2
tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
404-320-5
116889-78-2
Skin Sens. 1
H317
GHS07
Wng
H317
611-016-00-8
reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or 2,6 or 3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride
404-540-1
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-017-00-3
2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide
404-910-2
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-018-00-9
tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate
405-130-5
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-019-00-4
tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate
405-150-4
106028-58-4
Skin Sens. 1
H317
GHS07
Wng
H317
611-020-00-X
tetrakis(tetramethylammonium)
6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate
405-170-3
116340-05-7
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 3
H301
H317
H412
GHS06
Dgr
H301
H317
H412
611-021-00-5
2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate
405-480-9
—
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 4
H302
H373 ** H315
H413
GHS08
GHS07
Wng
H302
H373 **
H315
H413
611-022-00-0
4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate
404-980-4
—
Self-react. C
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H331
H301
H312
H373 **
H318
H317
H400
H410
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H242
H331
H301
H312
H373 **
H318
H317
H410
T
611-023-00-6
disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate
404-600-7
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-024-00-1
benzidine based azo dyes;
4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex
—
—
Carc. 1B
H350
GHS08
Dgr
H350
A
611-025-00-7
disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;
C.I. Direct Black 38
217-710-3
1937-37-7
Carc. 1B Repr. 2
H350
H361d ***
GHS08
Dgr
H350
H361d ***
611-026-00-2
tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];
C.I. Direct Blue 6
220-012-1
2602-46-2
Carc. 1B Repr. 2
H350
H361d ***
GHS08
Dgr
H350
H361d ***
611-027-00-8
disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28
209-358-4
573-58-0
Carc. 1B Repr. 2
H350
H361d ***
GHS08
Dgr
H350
H361d ***
611-028-00-3
C,C'-azodi(formamide)
204-650-8
123-77-3
Resp. Sens. 1
H334
GHS08
Dgr
H334
G
611-029-00-9
o-dianisidine based azo dyes;
4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex
—
—
Carc. 1B
H350
GHS08
Dgr
H350
A
611-030-00-4
o-tolidine based dyes;
4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex
—
—
Carc. 1B
H350
GHS08
Dgr
H350
A
611-031-00-X
4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;
C.I. Basic Red 9
209-321-2
569-61-9
Carc. 1B
H350
GHS08
Dgr
H350
611-032-00-5
1,4,5,8-tetraaminoanthra
quinone;
C.I. Disperse Blue 1
219-603-7
2475-45-8
Carc. 1B
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H350
H315
H318
H317
GHS08
GHS05
GHS07
Dgr
H350
H315
H318
H317
611-033-00-0
hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'diylazo)]-bis[5'-sulfonatobenzene-2,2'-diolato-O(2), O(2), N(1)]-copper(II)
400-020-3
82027-60-9
Aquatic Chronic 2
H411
GHS09
H411
611-034-00-6
N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide
402-430-8
105076-77-5
Aquatic Chronic 4
H413
—
H413
611-035-00-1
tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate
403-660-1
107246-80-0
Aquatic Chronic 2
H411
GHS09
H411
611-036-00-7
2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate
405-440-0
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-037-00-2
3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)1,4-dimethyl-1,2,4-triazolium methylsulphate
406-055-0
124584-00-5
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
611-038-00-8
trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate
406-820-9
—
Eye Irrit. 2
H319
GHS07
Wng
H319
611-039-00-3
7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid
407-050-6
117715-57-8
Skin Sens. 1
H317
GHS07
Wng
H317
611-040-00-9
3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid
407-670-7
115099-58-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
611-041-00-4
2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide
407-680-1
98809-11-1
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
611-042-00-X
trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate
411-770-6
136213-71-3
Aquatic Chronic 3
H412
—
H412
611-043-00-5
reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1), O(2'))-chromate;
trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''disulfamoyl-3,3''-disulfonato
bis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)
402-850-1
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-044-00-0
reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium
((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)
403-720-7
117527-94-3
Aquatic Chronic 2
H411
GHS09
H411
611-045-00-6
2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene
404-830-8
—
Aquatic Chronic 4
H413
—
H413
611-046-00-1
4,4'-diamino-2-methylazobenzene
407-590-2
43151-99-1
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H317
H410
611-047-00-7
reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-890-3
111381-11-4
Aquatic Chronic 4
H413
—
H413
611-048-00-2
reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-900-6
111381-12-5
Aquatic Chronic 4
H413
—
H413
611-049-00-8
reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)
408-000-6
118658-98-3
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373 **
H317
H412
GHS08
Wng
H373 **
H317
H412
611-050-00-3
reaction mass of: pentasodium
7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl]azo]-7-sulfonato-1naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonatophenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate
415-350-3
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-051-00-9
2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride
411-110-7
136213-74-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
611-052-00-4
monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex
400-720-9
—
Aquatic Chronic 3
H412
—
H412
611-053-00-X
2,2'-azobis[2-methylpropionamidine] dihydrochloride
221-070-0
2997-92-4
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
611-055-00-0
C.I. Disperse Yellow 3;
N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide
220-600-8
2832-40-8
Carc. 2
Skin Sens. 1
H351
H317
GHS08
GHS07
Wng
H351
H317
611-056-00-6
C.I. Solvent Yellow 14;
1-phenylazo-2-naphthol
212-668-2
842-07-9
Carc. 2
Muta. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H341
H317
H413
GHS08
GHS07
Wng
H351
H341
H317
H413
611-057-00-1
6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile
400-340-3
85136-74-9
Carc. 1B
Aquatic Chronic 4
H350
H413
GHS08
Wng
H350
H413
611-058-00-7
(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate
402-060-7
108225-03-2
Carc. 1B
Eye Dam. 1
Aquatic Chronic 2
H350
H318
H411
GHS08
GHS05
GHS09
Dgr
H350
H318
H411
611-059-00-2
octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate
412-960-1
148878-21-1
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
611-060-00-8
reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy 3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
413-180-4
187285-15-0
Eye Dam. 1
H318
GHS05
Dgr
H318
611-061-00-3
disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate
412-530-3
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-062-00-9
octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate
413-550-5
—
Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318
611-063-00-4
trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato2-naphthylazo)-biphenyl 1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)
413-590-3
164058-22-4
Carc. 1B
H350
GHS08
Dgr
H350
611-064-00-X
4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol
410-600-8
124719-26-2
STOT RE 2 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H373 **
H315
H410
611-065-00-5
4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol
410-610-2
111850-24-9
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H319
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373 **
H319
H315
H317
H410
611-066-00-0
tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
411-540-5
130201-57-9
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
611-067-00-6
reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate
406-910-8
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
611-068-00-1
tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate
400-690-7
85665-98-1
Aquatic Chronic 2
H411
GHS09
H411
611-069-00-7
N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline
413-380-1
—
Aquatic Chronic 2
H411
GHS09
H411
611-070-00-2
reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);
trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)
405-665-4
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
611-071-00-8
tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate
406-073-9
131013-81-5
Acute Tox. 3 *
Aquatic Chronic 3
H301
H412
GHS06
Dgr
H301
H412
611-072-00-3
2,4-bis[2,2'-[2-(N, N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride
407-010-8
118208-02-9
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
611-073-00-9
dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate
407-310-9
122630-55-1
Aquatic Chronic 4
H413
—
H413
611-074-00-4
reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);
sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)
407-100-7
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-075-00-X
reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;
tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)
406-000-0
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
611-076-00-5
3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole
406-280-4
117584-16-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
611-077-00-0
dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3, N4-η:N3', N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)
407-230-4
126637-70-5
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
611-078-00-6
(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(-3-(diethylammonio)propylamino)1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate
407-240-9
159604-94-1
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-079-00-1
disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)2-naphthalenesulfonate
410-390-8
147703-64-8
Eye Dam. 1
H318
GHS05
Dgr
H318
611-080-00-7
sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate
410-150-2
147703-65-9
Skin Sens. 1
H317
GHS07
Wng
H317
611-081-00-2
tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6)]cuprate(II)
411-470-5
141048-13-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
611-082-00-8
reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)
407-570-3
—
Aquatic Chronic 2
H411
GHS09
H411
611-083-00-3
reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;
2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)
411-560-4
—
STOT RE 1
Skin Sens. 1
Aquatic Chronic 2
H372 ** H317
H411
GHS08
GHS07
GHS09
Dgr
H372 ** H317
H411
611-085-00-4
reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine
411-880-4
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-086-00-X
monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex,
monohydrate
411-360-7
—
Aquatic Chronic 3
H412
—
H412
611-087-00-5
reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;
3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)
411-710-9
—
Aquatic Chronic 4
H413
—
H413
611-088-00-0
reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;
trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate
411-890-9
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
611-089-00-6
2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate
411-100-2
136213-73-5
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 ** H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373 ** H317
H410
611-090-00-1
2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate
413-290-2
93672-52-7
Self-react. C
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H242
H302
H318
H317
H412
GHS02
GHS05
GHS07
Dgr
H242
H302
H318
H317
H412
T
611-091-00-7
sodium (1,0-1,95)/lithium (0,051) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate
413-470-0
134595-59-8
Skin Sens. 1
H317
GHS07
Wng
H317
611-092-00-2
tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)-pyrazol-1-yl)benzenesulfonamidato)chromate
413-210-6
—
Aquatic Chronic 2
H411
GHS09
H411
611-093-00-8
sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate
410-770-3
146177-84-6
Skin Sens. 1
H317
GHS07
Wng
H317
611-094-00-3
reaction mass of: 2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;
2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)
411-600-0
143145-93-1
Aquatic Chronic 4
H413
—
H413
611-095-00-9
hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide
412-240-7
89797-03-5
Aquatic Chronic 2
H411
GHS09
H411
611-096-00-4
methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate
413-040-2
149850-30-6
Skin Sens. 1
H317
GHS07
Wng
H317
611-097-00-X
reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene
and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)
414-150-3
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-098-00-5
tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate
405-950-3
131013-83-7
Acute Tox. 3 * Aquatic Chronic 3
H301
H412
GHS06
Dgr
H301
H412
611-099-00-0
(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'dipyridinium dichloride dihydrochloride
401-500-5
118658-99-4
Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411
611-100-00-4
potassium sodium 3,3'-(3(or 4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate
403-810-6
140876-13-7
Eye Dam. 1
H318
GHS05
Dgr
H318
611-101-00-X
2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide
405-200-5
104366-25-8
Skin Sens. 1
H317
GHS07
Wng
H317
611-102-00-5
reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid; disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid
424-500-7
—
Aquatic Chronic 3
H412
—
H412
611-103-00-0
trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)
407-110-1
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
611-104-00-6
reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)5-hydroxy-4(or 2 or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-); trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);
disodium 3,3'-(2,4-dihydroxy1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate
406-870-1
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-105-00-1
sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate
407-800-2
136213-75-7
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-106-00-7
hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate
410-180-6
157627-99-1
Eye Dam. 1
H318
GHS05
Dgr
H318
611-107-00-2
potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate
412-490-7
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-108-00-8
disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate
413-600-6
6527-62-4
Aquatic Chronic 3
H412
—
H412
611-109-00-3
reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)
407-710-3
—
Aquatic Chronic 2
H411
GHS09
H411
611-110-00-9
tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene
408-210-8
124605-82-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-111-00-4
disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)
414-230-8
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-112-00-X
tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate
413-070-6
—
Skin Sens. 1
H317
GHS07
Wng
H317
611-113-00-5
lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)
414-280-0
149626-00-6
Aquatic Chronic 2
H411
GHS09
H411
611-114-00-0
lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)
414-250-7
149564-66-9
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
611-115-00-6
trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)
414-290-5
149564-65-8
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
611-116-00-1
reaction mass of: trisodium 5{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
414-620-8
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-117-00-7
1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt
415-100-3
149850-29-3
Skin Sens. 1
H317
GHS07
Wng
H317
611-118-00-2
sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt
413-990-8
Skin Sens. 1
H317
GHS07
Wng
H317
611-119-00-8
tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate
415-400-4
148878-22-2
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-120-00-3
5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt
418-340-7
157707-94-3
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-121-00-9
main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;
main component 8 (isomer):
asym. 1:2 Cr-complex of: A:
3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol
417-280-9
30785-74-1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
611-122-00-4
hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel
417-250-5
151436-99-6
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-123-00-X
3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate
424-310-4
178452-66-9
Eye Dam. 1
H318
GHS05
Dgr
H318
611-124-00-5
reaction mass of: pentasodium
5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;
pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;
tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate
424-320-9
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
611-125-00-0
reaction mass of: disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;
disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex
423-940-7
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
611-126-00-6
2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride
424-120-1
174514-06-8
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
611-127-00-1
pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate
423-790-2
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
G
611-128-00-7
N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt
419-500-9
171599-85-2
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-129-00-2
reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;
5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid
418-230-9
163879-69-4
Expl. 1.3 ****
Repr. 2
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H203
H361f ***
H373 **
H317
H411
GHS01
GHS08
GHS07
GHS09
Dgr
H203
H361f ***
H373 **
H317
H411
611-130-00-8
tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate
418-520-5
183130-96-3
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
611-131-00-3
2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one
420-580-2
151798-26-4
Repr. 1B
Aquatic Chronic 4
H360D *** H413
GHS08
Dgr
H360D *** H413
611-132-00-9
pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-210-2
178452-71-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-133-00-4
product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt
419-260-5
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
611-134-00-X
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex
423-770-3
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
611-135-00-5
reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt
424-250-9
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-136-00-0
2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate
424-260-3
—
Repr. 2
Eye Dam. 1
Aquatic Chronic 2
H361f ***
H318
H411
GHS05
GHS08
GHS09
Dgr
H361f ***
H318
H411
611-137-00-6
6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole
419-870-1
159038-16-1
Aquatic Chronic 4
H413
—
H413
611-138-00-1
2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole
415-910-7
152828-25-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
611-139-00-7
reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride
424-510-1
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
611-140-00-2
azafenidin (ISO);
2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one
—
68049-83-2
Repr. 1B
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 ** H400
H410
GHS08
GHS09
Dgr
H360Df
H373 **
H410
M = 1 000
611-141-00-8
5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt
414-410-6
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-142-00-3
product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino] benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;
sodium chloride
425-740-5
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-143-00-9
reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)
428-260-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318
611-144-00-4
reaction mas of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
429-070-4
214362-06-8
Eye Dam. 1
H318
GHS05
Dgr
H318
611-145-00-X
reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate;
3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino{-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt
429-440-5
—
Eye Dam. 1
H318
GHS05
Dgr
H318
611-146-00-5
reaction mass of: pentasodium
3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate
430-070-1
—
Aquatic Chronic 2
H411
GHS09
H411
611-147-00-0
sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate
430-090-0
205764-96-1
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-148-00-6
reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;
2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)ethoxy)ethanol;
3-(2,6-dichloro-4-nitrophenylazo)carbazol
429-590-1
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
611-149-00-1
2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate
427-570-7
193486-83-8
Aquatic Chronic 2
H411
GHS09
H411
611-150-00-7
tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate
440-460-3
—
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
611-151-00-2
chrysoidine;
4-(phenylazo)benzene-1,3-diamine
207-803-7
495-54-5
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H315
H410
611-152-00-8
chrysoidine monohydrochloride;
4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate;
4-(phenylazo)benzene-1,3-diamine monoacetate; [2]
chrysoidine acetate;
4-(phenylazo)benzene-1,3-diamine acetate; [3]
chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]
chrysoidine dihydrochloride;
4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]
chrysoidine sulfate;
bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]
208-545-8 [1]
278-290-5 [2]
279-116-0 [3]
264-409-8 [4]
281-549-5 [5]
282-432-1 [6]
532-82-1 [1]
75660-25-2 [2]
79234-33-6 [3]
63681-54-9 [4]
83968-67-6 [5]
84196-22-5 [6]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H341
H302
H315
H318
H410
611-153-00-3
chrysoidine C10-14-alkyl derivatives;
benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds
with 4-(phenylazo)-1,3-benzenediamine; [1]
chrysoidine compound with dibutylnaphthalene sulfonic acid;
dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]
286-946-7 [1]
304-236-8 [2]
85407-90-5 [1]
94247-67-3 [2]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H341
H302
H315
H318
GHS05
GHS08
GHS07
Dgr
H341
H302
H315
H318
611-154-00-9
trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate
403-670-6
92408-46-3
Aquatic Chronic 3
H412
—
H412
611-155-00-4
4,4'-oxybis(benzenesulfonylazide)
431-850-4
7456-68-0
Expl. 1.1****
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H373**
H400
H410
GHS01
GHS08
GHS09
Dgr
H201
H373**
H410
611-156-00-X
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate
432-270-4
221354-37-6
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H361f*** H373**
H411
GHS08
GHS09
Wng
H361f*** H373**
H411
611-157-00-5
benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo)) bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6{3,4-dihydroxy-2-}(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate
432-590-4
243869-48-9
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
611-158-00-0
reaction product of: 2,3,4,2', 3',
4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride
421-520-8
—
****
Aquatic Chronic 4
**** H413
****
**** H413
611-159-00-6
disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate
421-880-6
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-160-00-1
reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane; 1,1,1-tris(phenyl-4'-(6''-diazo-5'',
6''-dihydro-5''-oxo-naphthalene1''-sulfonato)ethane;
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)
422-760-6
—
****
Aquatic Chronic 4
**** H413
****
**** H413
611-161-00-7
trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O, O,N]chromate(III)
423-100-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318
611-162-00-2
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)
429-600-4
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
611-163-00-8
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate
429-610-9
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
611-164-00-3
reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile;
2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile);
2,2’-dimethyl-2,2’-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile)
429-710-2
—
Self-react. D
Acute Tox. 4 *
Aquatic Chronic 2
H242
H302
H411
GHS02
GHS07
GHS09
Dgr
H242
H302
H411
611-165-00-9
reaction mass of: tetrasodium - 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
431-830-5
—
Aquatic Chronic 3
H412
—
H412
611-166-00-4
reaction mass of: pentasodium
4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium - 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-}2-(sulfonatooxy)ethylsulfonyl{phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
432-100-9
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-167-00-X
sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)
435-240-9
—
Aquatic Chronic 3
H412
—
H412
611-168-00-5
reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid
435-440-6
—
Eye Dam. 1
H318
GHS05
Dgr
H318
611-169-00-0
sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate
435-800-2
—
Aquatic Chronic 3
H412
—
H412
611-170-00-6
reaction mas of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)4-sulfonatobenzoate(5-)-κ-O)cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5))cuprate(II)
435-880-9
—
Aquatic Chronic 3
H412
—
H412
611-171-00-1
reaction mass of trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate
436-890-6
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-172-00-7
reaction mass of: triammonium
6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate
438-310-7
—
Self-react. C****
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H242
H361f***
H302
H373**
H412
GHS02
GHS08
GHS07
Dgr
H242
H361f***
H302
H373**
H412
611-173-00-2
reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2oxo-1-pyridyl]propanoicacid, disodium salt
440-510-4
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-174-00-8
reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino[-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt
442-290-5
457624-86-1
Eye Dam. 1
H318
GHS05
Dgr
H318
611-175-00-3
reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)aniline]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{naphthalene-2,7-disulfonate; trisodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
disodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 5-4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate
444-050-5
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
611-176-00-9
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate
444-250-2
—
Self-react. C**** Aquatic Chronic 2
H242
H411
GHS02
GHS09
Dgr
H242
H411
611-177-00-4
reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)
444-290-0
508202-43-5
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
611-178-00-X
reaction mass of: pentasodium
4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
445-280-9
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
611-179-00-5
reaction mass of: pentasodium
2-[[8-[[4-chloro-6-[[4-(2-sulfonatethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate
450-010-8
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
611-180-00-0
iron, complexes with diazotised
4-aminobenzenesulfonamide, diazotized 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts
417-850-7
—
Aquatic Chronic 2
H411
GHS09
H411
612-001-00-9
mono-methylamine; [1]
di-methylamine; [2]
tri-methylamine [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
Flam. Gas 1
Press. Gas
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H220
H332
H335
H315
H318
GHS02
GHS04
GHS05
GHS07
Dgr
H220
H332
H335
H315
H318
*
Skin Irrit. 2;
H315: C ≥ 5 %
Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2;
H319: 0,5 % ≤
C < 5 %
STOT SE 3; H335: C ≥ 5 %
U5
612-001-01-6
mono-methylamine … %; [1]
di-methylamine … %; [2]
tri-methylamine … % [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
Flam. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H224
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H224
H332
H302
H314
*
STOT SE 3; H335: C ≥ 5 %
B
612-002-00-4
ethylamine
200-834-7
75-04-7
Flam. Gas 1
Press. Gas
Eye Irrit. 2
STOT SE 3
H220
H319
H335
GHS02
GHS04
GHS07
Dgr
H220
H319
H335
U
612-003-00-X
diethylamine
203-716-3
109-89-7
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 1 %
612-004-00-5
triethylamine
204-469-4
121-44-8
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 1 %
612-005-00-0
butylamine
203-699-2
109-73-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 1 %
612-006-00-6
ethylenediamine;
1,2-diaminoethane
203-468-6
107-15-3
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H226
H312
H302
H314
H334
H317
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H312
H302
H314
H334
H317
612-007-00-1
2-aminopropane;
isopropylamine
200-860-9
75-31-0
Flam. Liq. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H224
H319
H335
H315
GHS02
GHS07
Dgr
H224
H319
H335
H315
612-008-00-7
niline
200-539-3
62-53-3
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H331
H311
H301
H372 **
H318
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H341
H331
H311
H301
H372 **
H318
H317
H400
*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %
612-009-00-2
salts of aniline
—
—
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H331
H311
H301
H372 **
H318
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H341
H331
H311
H301
H372 **
H318
H317
H400
*
STOT RE 1; H372: C ≥ 1 % STOT RE 2;
H373: 0,2 % ≤
C < 1 %
A
612-010-00-8
chloroanilines (with exception of those specified elsewhere in this Annex)
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410
C
612-011-00-3
4-nitrosoaniline
211-535-6
659-49-4
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302
612-012-00-9
o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3]
201-855-4 [1]
202-729-1 [2]
202-810-1 [3]
88-74-4 [1]
99-09-2 [2]
100-01-6 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
H412
C
612-013-00-4
3-aminobenzene sulphonic acid;
metanilic acid
204-473-6
121-47-1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302
612-014-00-X
sulphanilic acid;
4-aminobenzenesulphonic acid
204-482-5
121-57-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
612-015-00-5
N-methylaniline
202-870-9
100-61-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410
612-016-00-0
N,N-dimethylaniline
204-493-5
121-69-7
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H351
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H351
H331
H311
H301
H411
612-017-00-6
N-methyl-N-2,4,6-tetranitroaniline; tetryl
207-531-9
479-45-8
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
H201
H331
H311
H301
H373**
GHS01
GHS06
GHS08
Dgr
H201
H331
H311
H301
H373**
612-018-00-1
bis(2,4,6-trinitrophenyl)amine;
hexyl
205-037-8
131-73-7
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H201
H330
H310
H300
H373**
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373**
H411
612-019-00-7
dipicrylamine, ammonium salt
220-639-0
2844-92-0
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H201
H330
H310
H300
H373**
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373**
H411
612-020-00-2
1-naphthylamine
205-138-7
134-32-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
612-022-00-3
2-naphthylamine
202-080-4
91-59-8
Carc. 1A
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
Carc. 1A; H350: C ≥ 0,01 %
612-023-00-9
phenylhydrazine; [1] phenylhydrazinium chloride; [2] phenylhydrazine hydrochloride; [3]
phenylhydrazinium sulphate
(2:1) [4]
202-873-5 [1]
200-444-7 [2]
248-259-0 [3]
257-622-2 [4]
100-63-0 [1]
59-88-1 [2]
27140-08-5 [3]
52033-74-6 [4]
Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H350
H341
H331
H311
H301
H372 **
H319
H315
H317
H400
GHS06
GHS08
GHS09
Dgr
H350
H341
H331
H311
H301
H372 **
H319
H315
H317
H400
612-024-00-4
m-toluidine;
3-aminotoluene
203-583-1
108-44-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H331
H311
H301
H373 **
H400
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H400
612-025-00-X
nitrotoluidines, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411
C
612-026-00-5
diphenylamine
204-539-4
122-39-4
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410
612-027-00-0
xylidines with the exception of those specified elsewhere in this Annex;
dimethyl anilines with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411
C
612-028-00-6
p-phenylenediamine
203-404-7
106-50-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H319
H317
H410
612-029-00-1
benzene-1,4-diamine dihydrochloride;
p-phenylenediamine dihydrochloride
210-834-9
624-18-0
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H319
H317
H410
612-030-00-7
2-methyl-p-phenylenediamine sulphate [1]
210-431-8 [1]
228-871-4 [2]
615-50-9 [1]
6369-59-1 [2]
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H301
H332
H312
H317
H411
GHS06
GHS09
Dgr
H301
H332
H312
H317
H411
612-031-00-2
N,N-dimethylbenzene-1,3-diamine; [1]
4-amino-N,N-dimethylaniline;
3-amino-N,N'-dimethylaniline [2]
220-623-3 [1]
202-807-5 [2]
2836-04-6 [1]
99-98-9 [2]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301
C
612-032-00-8
N, N,N',N'-tetramethyl-p-phenylenediamine
202-831-6
100-22-1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302
612-033-00-3
2-aminophenol
202-431-1
95-55-6
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
H341
H332
H302
GHS08
GHS07
Wng
H341
H332
H302
612-034-00-9
2-amino-4,6-dinitrophenol;
picramic acid
202-544-6
96-91-3
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H201
H332
H312
H302
H412
GHS01
GHS07
Dgr
H201
H332
H312
H302
H412
612-034-01-6
2-amino-4,6-dinitrophenol;
picramic acid; [≥ 20 % water]
202-544-6
96-91-3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
G
612-035-00-4
2-methoxyaniline;
o-anisidine
201-963-1
90-04-0
Carc. 1B Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H350
H341
H331
H311
H301
GHS06
GHS08
Dgr
H350
H341
H331
H311
H301
612-036-00-X
3,3'-dimethoxybenzidine;
o-dianisidine
204-355-4
119-90-4
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302
612-037-00-5
salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine
—
—
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302
A
612-038-00-0
2-nitro-p-anisidine;
4-methoxy-2-nitroaniline
202-547-2
96-96-8
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H330
H310
H300
H373 **
H412
GHS06
GHS08
Dgr
H330
H310
H300
H373 **
H412
612-039-00-6
2-ethoxyaniline;
o-phenetidine
202-356-4
94-70-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H311
H301
H373 **
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
612-040-00-1
2,4-dinitroaniline
202-553-5
97-02-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H330
H310
H300
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H411
612-041-00-7
4,4'-bi-o-toluidine
204-358-0
119-93-7
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
612-042-00-2
benzidine;
1,1'-biphenyl-4,4'-diamine;
4,4'-diaminobiphenyl;
biphenyl-4,4'-ylenediamine
202-199-1
92-87-5
Carc. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
Carc. 1A; H350: C ≥ 0,01 %
612-043-00-8
N,N'-dimethylbenzidine
—
2810-74-4
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302
612-044-00-3
N,N'-diacetylbenzidine
210-338-2
613-35-4
Carc. 1B Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H350
H341
H332
H312
H302
GHS08
GHS07
Dgr
H350
H341
H332
H312
H302
612-046-00-4
allylamine
203-463-9
107-11-9
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H225
H331
H311
H301
H411
GHS02
GHS06
GHS09
Dgr
H225
H331
H311
H301
H411
612-047-00-X
benzylamine
202-854-1
100-46-9
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
612-048-00-5
dipropylamine
205-565-9
142-84-7
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
STOT SE 3; H335: C ≥ 1 %
612-049-00-0
di-n-butylamine; [1]
di-sec-butylamine [2]
203-921-8 [1]
210-937-9 [2]
111-92-2 [1]
626-23-3 [2]
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Wng
H226
H332
H312
H302
612-050-00-6
cyclohexylamine
203-629-0
108-91-8
Flam. Liq. 3
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H361f***
H312
H302
H314
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H361f***
H312
H302
H314
612-051-00-1
4,4'-diaminodiphenylmethane;
4,4'-methylenedianiline
202-974-4
101-77-9
Carc. 1B
Muta. 2
STOT SE 1
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H370 **
H373 **
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H370 **
H373 **
H317
H411
612-052-00-7
(S)-sec-butylamine;
(S)-2-aminobutane; [1] (R)-sec-butylamine;
(R)-2-aminobutane; [2]
sec-butylamine;
2-aminobutane [3]
208-164-7 [1]
236-232-6 [2]
237-732-7 [3]
513-49-5 [1]
13250-12-9 [2]
13952-84-6 [3]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H225
H332
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H225
H332
H302
H314
H400
C
612-053-00-2
N-ethylaniline
203-135-5
103-69-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H311
H301
H373 **
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
612-054-00-8
N,N-diethylaniline
202-088-8
91-66-7
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411
*
612-055-00-3
N-methyl-o-toluidine; [1] N-methyl-m-toluidine; [2] N-methyl-p-toluidine [3]
210-260-9 [1]
211-795-0 [2]
210-769-6 [3]
611-21-2 [1]
696-44-6 [2]
623-08-5 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
H412
C
612-056-00-9
N,N-dimethyl-p-toluidine; [1] N,N-dimethyl-m-toluidine; [2] N,N-dimethyl-o-toluidine [3]
202-805-4 [1]
204-495-6 [2]
210-199-8 [3]
99-97-8 [1]
121-72-2 [2]
609-72-3 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
H412
*
C
612-057-00-4
piperazine; [solid]
203-808-3
110-85-0
Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H361fd
H314
H334
H317
GHS05
GHS08
Dgr
H361fd
H314
H334
H317
612-057-01-1
piperazine; [liquid]
203-808-3
110-85-0
Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H361fd
H314
H334
H317
GHS05
GHS08
Dgr
H361fd
H314
H334
H317
612-058-00-X
2,2'-iminodiethylamine;
diethylenetriamine
203-865-4
111-40-0
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H312
H302
H314
H317
GHS05
GHS07
Dgr
H312
H302
H314
H317
612-059-00-5
3,6-diazaoctanethylenediamin;
triethylenetetramine
203-950-6
112-24-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H314
H317
H412
GHS05
GHS07
Dgr
H312
H314
H317
H412
612-060-00-0
3,6,9-triazaundecamethylenediamine; tetraethylenepentamine
203-986-2
112-57-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H411
612-061-00-6
3-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane
203-680-9
109-55-7
Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H226
H302
H314
H317
GHS02
GHS05
GHS07
Dgr
H226
H302
H314
H317
612-062-00-1
3-aminopropyldiethylamine;
N,N-diethyl-1,3-diaminopropane
203-236-4
104-78-9
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H226
H312
H302
H314
H317
GHS02
GHS05
GHS07
Dgr
H226
H312
H302
H314
H317
612-063-00-7
3,3'-iminodi(propylamine);
dipropylenetriamine
200-261-2
56-18-8
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
H330
H311
H302
H314
H317
GHS06
GHS05
Dgr
H330
H311
H302
H314
H317
612-064-00-2
3,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine
223-775-9
4067-16-7
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
612-065-00-8
polyethlyenepolyamines with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H410
612-066-00-3
dicyclohexylamine
202-980-7
101-83-7
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
612-067-00-9
3-aminomethyl-3,5,5-trimethylcyclohexylamine
220-666-8
2855-13-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H302
H314
H317
H412
GHS05
GHS07
Dgr
H312
H302
H314
H317
H412
612-068-00-4
3,3'-dichlorobenzidine;
3,3'-dichlorobiphenyl-4,4'-ylenediamine
202-109-0
91-94-1
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H312
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H312
H317
H410
612-069-00-X
salts of 3,3'-dichlorobenzidine;
salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine
—
—
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H312
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H312
H317
H410
A
612-070-00-5
salts of benzidine
208-519-6
208-520-1
244-236-4
252-984-8
531-85-1
531-86-2
21136-70-9
36341-27-2
Carc. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
A
612-071-00-0
salts of 2-naphthylamine
209-030-0
210-313-6
553-00-4
612-52-2
Carc. 1A
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
A
612-072-00-6
biphenyl-4-ylamine;
xenylamine;
4-aminobiphenyl
202-177-1
92-67-1
Carc. 1A
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302
612-073-00-1
salts of biphenyl-4-ylamine;
salts of xenylamine;
salts of 4-aminobiphenyl
—
—
Carc. 1A
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302
A
612-074-00-7
benzyldimethylamine
203-149-1
103-83-3
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H226
H332
H312
H302
H314
H412
GHS02
GHS05
GHS07
Dgr
H226
H332
H312
H302
H314
H412
612-075-00-2
2-aminoethyldimethylamine;
2-dimethylaminoethylamine
203-541-2
108-00-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H312
H302
H314
612-076-00-8
ethyldimethylamine
209-940-8
598-56-1
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H302
H314
612-077-00-3
dimethylnitrosoamine;
N-nitrosodimethylamine
200-549-8
62-75-9
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 2
H350
H330
H301
H372 **
H411
GHS06
GHS08
GHS09
Dgr
H350
H330
H301
H372 **
H411
Carc. 1B; H350: C ≥ 0,001 %
612-078-00-9
2,2'-dichloro-4,4'-methylenedianiline;
4,4'-methylene bis(2-chloroaniline)
202-918-9
101-14-4
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
612-079-00-4
salts of 2,2'-dichloro-4,4'-methylenedianiline;
salts of 4,4'-methylenebis(2-chloroaniline)
—
—
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
A
612-080-00-X
4-amino-N,N-diethylaniline;
N,N-diethyl-p-phenylendiamine
202-214-1
93-05-0
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314
612-081-00-5
salts of 4,4'-bi-o-toluidine;
salts of 3,3'-dimethylbenzidine;
salts of o-tolidine
210-322-5
265-294-7
277-985-0
612-82-8
64969-36-4
74753-18-7
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
A
612-082-00-0
thiourea;
thiocarbamide
200-543-5
62-56-6
Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H351
H361d *** H302
H411
GHS08
GHS07
GHS09
Wng
H351
H361d *** H302
H411
612-083-00-6
1-methyl-3-nitro-1-nitrosoguanidine
200-730-1
70-25-7
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H350
H332
H319
H315
H411
GHS08
GHS07
GHS09
Dgr
H350
H332
H319
H315
H411
Carc. 1B; H350: C ≥ 0,01 %
612-084-00-1
dapsone;
4,4'-diamino diphenyl sulfone
201-248-4
80-08-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
612-085-00-7
4,4'-methylenedi-o-toluidine
212-658-8
838-88-0
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H317
H410
612-086-00-2
amitraz (ISO);
N,N-bis(2,4-xylyliminomethyl)
methylamine
251-375-4
33089-61-1
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 ** H317
H410
M = 10
612-087-00-8
guazatine (ISO)
108173-90-6
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H312
H302
H335
H315
H318
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H312
H302
H335
H315
H318
H410
612-088-00-3
simazine (ISO);
6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine
204-535-2
122-34-9
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
612-089-00-9
1,5-naphthylenediamine
218-817-8
2243-62-1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
612-090-00-4
2,2'-(nitrosoimino)bisethanol
214-237-4
1116-54-7
Carc. 1B
H350
GHS08
Dgr
H350
612-091-00-X
o-toluidine;
2-aminotoluene
202-429-0
95-53-4
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
H350
H331
H301
H319
H400
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H319
H400
612-092-00-5
N, N'-(2,2-dimethylpropylidene)hexamethylenediamine
401-660-6
1000-78-8
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
612-093-00-0
3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline
401-790-3
104147-32-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
612-094-00-6
4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride
402-190-4
113674-95-6
STOT RE 1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H373**
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H372**
H302
H373**
H318
H317
H410
612-095-00-1
benzyl-2-hydroxydodecyldi
methylammonium benzoate
402-610-6
113694-52-3
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H410
612-096-00-7
4,4'-carbonimidoylbis[N, N-dimethylaniline]
207-762-5
492-80-8
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H351
H302
H319
H411
GHS08
GHS07
GHS09
Wng
H351
H302
H319
H411
612-097-00-2
salts of 4,4'-carbonimidoylbis[N, N-dimethylaniline]
—
—
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H351
H302
H319
H411
GHS08
GHS07
GHS09
Wng
H351
H302
H319
H411
A
612-098-00-8
nitrosodipropylamine
210-698-0
621-64-7
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
Carc. 1B; H350: C ≥ 0,001 %
612-099-00-3
4-methyl-m-phenylenediamine;
2,4-toluenediamine
202-453-1
95-80-7
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H361f***
H301
H312
H373**
H317
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f***
H301
H312
H373**
H317
H411
612-100-00-7
propylenediamine
201-155-9
78-90-0
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H226
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H312
H302
H314
612-101-00-2
methenamine;
hexamethylenetetramine
202-905-8
100-97-0
Flam. Sol. 2
Skin Sens. 1
H228
H317
GHS02
GHS07
Wng
H228
H317
612-102-00-8
N, N-bis(3-aminopropyl)methylamine
203-336-8
105-83-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
H331
H311
H302
H314
GHS06
GHS05
Dgr
H331
H311
H302
H314
612-103-00-3
N, N,N',N'-tetramethylethylenediamine
203-744-6
110-18-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H302
H314
612-104-00-9
hexamethylenediamine
204-679-6
124-09-4
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Corr. 1B
H312
H302
H335
H314
GHS05
GHS07
Dgr
H312
H302
H335
H314
612-105-00-4
2-piperazin-1-ylethylamine
205-411-0
140-31-8
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H302
H314
H317
H412
GHS05
GHS07
Dgr
H312
H302
H314
H317
H412
612-106-00-X
2,6-diethylaniline
209-445-7
579-66-8
Acute Tox. 4 *
H302
—
H302
612-107-00-5
1-phenylethylamine; [1]
DL-α-methylbenzylamine [2]
202-706-6 [1]
210-545-8 [2]
98-84-0 [1]
618-36-0 [2]
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
612-108-00-0
3-aminopropyltriethoxysilane
213-048-4
919-30-2
Acute Tox. 4 *
Skin Corr. 1B
H302
H314
GHS05
GHS07
Dgr
H302
H314
612-109-00-6
bis(2-dimethylaminoethyl)(methyl)amine
221-201-1
3030-47-5
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
H311
H302
H314
GHS06
GHS05
Dgr
H311
H302
H314
612-110-00-1
2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)
229-962-1
6864-37-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Chronic 2
H331
H311
H302
H314
H411
GHS06
GHS05
GHS09
Dgr
H331
H311
H302
H314
H411
612-111-00-7
2-methyl-m-phenylenediamine;
2,6-toluenediamine
212-513-9
823-40-5
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H341
H312
H302
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H312
H302
H317
H411
612-112-00-2
p-anisidine;
4-methoxyaniline
203-254-2
104-94-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
H330
H310
H300
H373 **
H400
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H400
612-113-00-8
6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine
403-240-8
106264-79-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
612-114-00-3
R, R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate
404-390-7
—
Flam. Sol. 1
Skin Sens. 1
Aquatic Chronic 3
H228
H317
H412
GHS02
GHS07
Wng
H228
H317
H412
612-115-00-9
dimethyldioctadecylammonium hydrogen sulfate
404-050-8
123312-54-9
Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413
612-116-00-4
C8-18 alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate
404-690-8
68132-19-4
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H314
H317
H410
612-117-00-X
C12-14-tert-alkylamine, methylphosphonic acid salt
404-750-3
119415-07-5
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
612-118-00-5
A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide
405-080-4
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
612-119-00-0
benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate
405-330-2
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
612-120-00-6
aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline
277-704-1
74070-46-5
Carc. 2
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GH09
Wng
H351
H317
H410
M = 100
M = 10
612-121-00-1
amines, polyethylenepoly-; HEPA
268-626-9
68131-73-7
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H410
612-122-00-7
hydroxylamine … %
[> 55 % in aqueous solution]
232-259-2
7803-49-8
Unst. Expl. Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H200
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
GHS01
GHS05
GHS08
GHS07
GHS09
Dgr
H200
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
B
612-122-01-4
hydroxylamine …% [≤ 55 % in aqueous solution]
232-259-2
7803-49-8
Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
B
612-123-00-2
hydroxylammonium chloride; hydroxylamine hydrochloride; [1] bis(hydroxylammonium) sulfate;
hydroxylamine sulfate (2:1) [2]
226-798-2 [1]
233-118-8 [2]
5470-11-1 [1]
10039-54-0 [2]
Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H290
H351
H312
H302
H373**
H319
H315
H317
H400
GHS05
GHS08
GHS07
GHS09
Wng
H290
H351
H312
H302
H373**
H319
H315
H317
H400
612-124-00-8
N,N,N-trimethylanilinium chloride
205-319-0
138-24-9
Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Dgr
H311
H301
612-125-00-3
2-methyl-p-phenylenediamine;
2,5-toluenediamine
202-442-1
95-70-5
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H301
H332
H312
H317
H411
GHS06
GHS09
Dgr
H301
H332
H312
H317
H411
612-126-00-9
toluene-2,4-diammonium sulphate;
4-methyl-m-phenylenediamine sulfate
265-697-8
65321-67-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350
H301
H312
H319
H317
H411
GHS06
GHS08
GHS09
Dgr
H350
H301
H312
H319
H317
H411
612-127-00-4
3-aminophenol
209-711-2
591-27-5
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411
612-128-00-X
4-aminophenol
204-616-2
123-30-8
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H332
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H332
H302
H410
612-129-00-5
diisopropylamine
203-558-5
108-18-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H302
H314
STOT SE 3; H335: C ≥ 5 %
612-130-00-0
2,6-diamino-3,5-diethyltoluene;
4,6-diethyl-2-methyl-1,3-benzenediamine; [1]
2,4-diamino-3,5-diethyltoluene;
2,4-diethyl-6-methyl-1,3-benzenediamine; [2] diethylmethylbenzenediamine [3]
218-255-3 [1]
218-256-9 [2]
270-877-4 [3]
2095-01-4 [1]
2095-02-5 [2]
68479-98-1 [3]
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H319
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373 **
H319
H410
C
612-131-00-6
didecyldimethylammonium chloride
230-525-2
7173-51-5
Acute Tox. 4 *
Skin Corr. 1B
H302
H314
GHS05
GHS07
Dgr
H302
H314
612-132-00-1
N, N'-diphenyl-p-phenylenediamine;
N, N'-diphenyl-1,4-benzenediamine
200-806-4
74-31-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
612-133-00-7
(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;
4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate
247-162-0
25646-77-9
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H317
H410
612-134-00-2
N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;
4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate
247-161-5
25646-71-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
612-135-00-8
N-2-naphthylaniline;
N-phenyl-2-naphthylamine
205-223-9
135-88-6
Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H351
H319
H315
H317
H411
GHS08
GHS07
GHS09
Wng
H351
H319
H315
H317
H411
612-136-00-3
N-isopropyl-N'-phenyl-p-phenylenediamine
202-969-7
101-72-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
Skin Sens. 1; H317:C ≥0,1 %
612-137-00-9
4-chloroaniline
203-401-0
106-47-8
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H311
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H317
H410
612-138-00-4
furalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate
260-875-1
57646-30-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
612-139-00-X
mefenacet (ISO);
2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide
277-328-8
73250-68-7
Aquatic Chronic 2
H411
GHS09
H411
612-140-00-5
quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides
264-151-6
63449-41-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H312
H302
H314
H400
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H400
612-141-00-0
4,4'-methylenebis(2-ethylaniline);
4,4'-methylenebis(2-ethylbenzeneamine)
243-420-1
19900-65-3
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410
612-142-00-6
biphenyl-2-ylamine
201-990-9
90-41-5
Carc. 2
Acute Tox. 4 * Aquatic Chronic 3
H351
H302
H412
GHS08
GHS07
Wng
H351
H302
H412
612-143-00-1
N5,N5-diethyltoluene-2,5-diamine monohydrochloride;
4-diethylamino-2-methylaniline monohydrochloride
218-130-3
2051-79-8
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H301
H319
H317
H410
612-144-00-7
flumetralin (ISO);
N-(2-chloro-6-fluorobenzyl)-N-ethyl-α, α,α-trifluoro-2,6-dinitro-p-toluidine
—
62924-70-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H317
H400
H410
GHS07
GHS09
Wng
H319
H315
H317
H410
612-145-00-2
o-phenylenediamine
202-430-6
95-54-5
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H341
H301
H332
H312
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H341
H301
H332
H312
H319
H317
H410
612-146-00-8
o-phenylenediamine dihydrochloride
210-418-7
615-28-1
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H341
H301
H332
H312
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H341
H301
H332
H312
H319
H317
H410
612-147-00-3
m-phenylenediamine
203-584-7
108-45-2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H311
H301
H319
H317
H410
612-148-00-9
m-phenylenediamine dihydrochloride
208-790-0
541-69-5
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H311
H301
H319
H317
H410
612-149-00-4
1,3-diphenylguanidine
203-002-1
102-06-7
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H361f ***
H302
H319
H335
H315
H411
GHS08
GHS07
GHS09
Wng
H361f ***
H302
H319
H335
H315
H411
612-151-00-5
methyl-phenylene diamine;
diaminotoluene;
[technical product — reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]
—
—
Carc. 1B Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H361f***
H301
H312
H373**
H319
H317
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f***
H301
H312
H373**
H319
H317
H411
612-152-00-0
N, N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine
406-610-7
62478-82-4
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Chronic 3
H226
H332
H302
H373 **
H314
H412
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H332
H302
H373 **
H314
H412
612-153-00-6
4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride
407-020-2
132885-85-9
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
612-154-00-1
6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]
410-890-6
95235-29-3
Aquatic Chronic 4
H413
—
H413
612-155-00-7
2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene
411-730-8
93071-94-4
Aquatic Chronic 4
H413
—
H413
612-156-00-2
reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride
405-620-9
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
612-157-00-8
(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride
410-780-8
—
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H373 **
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H318
H317
H411
612-158-00-3
reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;
4-dodecylsalicylaldoxime
410-820-4
—
Aquatic Chronic 4
H413
—
H413
612-159-00-9
reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid
410-880-1
—
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
612-160-00-4
p-toluidine;
4-aminotoluene; [1]
toluidinium chloride; [2]
toluidine sulphate (1:1) [3]
203-403-1 [1]
208-740-8 [2]
208-741-3 [3]
106-49-0 [1]
540-23-8 [2]
540-25-0 [3]
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H351
H331
H311
H301
H319
H317
H400
GHS06
GHS08
GHS09
Dgr
H351
H331
H311
H301
H319
H317
H400
612-161-00-X
2,6-xylidine;
2,6-dimethylaniline
201-758-7
87-62-7
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H351
H332
H312
H302
H335
H315
H411
GHS08
GHS07
GHS09
Wng
H351
H332
H312
H302
H335
H315
H411
612-162-00-5
dimethyldioctadecylammonium chloride;
DODMAC
203-508-2
107-64-2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
612-163-00-0
metalaxyl-M (ISO);
mefenoxam;
(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester
—
70630-17-0
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
612-164-00-6
2-butyl-2-ethyl-1,5-diaminopentane
412-700-7
137605-95-9
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H302
H373 **
H314
H317
H412
GHS08
GHS05
GHS07
Dgr
H312
H302
H373 **
H314
H317
H412
612-165-00-1
N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine
413-810-8
65181-78-4
Aquatic Chronic 2
H411
GHS09
H411
612-166-00-7
reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);
trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)
411-830-1
114765-88-7
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
612-167-00-2
5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b, f]azepine-hydrochloride
410-490-1
—
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H373 **
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H318
H317
H411
612-168-00-8
3,5-dichloro-2,6-difluoropyrdine-4-amine
220-630-1
2840-00-8
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Chronic 2
H312
H302
H411
GHS07
GHS09
Wng
H312
H302
H411
612-169-00-3
bis(N-methyl-N-phenylhydrazine)sulfate
423-170-1
618-26-8
Flam. Liq. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H225
H372**
H302
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H225
H372**
H302
H318
H317
H410
612-170-00-9
4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime
405-260-2
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
612-171-00-4
N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane
410-060-3
130728-76-6
Muta. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H317
H411
GHS08
GHS09
Wng
H341
H317
H411
612-172-00-X
4,4'-methylenebis(N,N'-dimethylcyclohexanamine
412-840-9
13474-64-1
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Chronic 3
H302
H373 **
H314
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H314
H412
612-173-00-5
lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate
411-140-0
125328-86-1
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
612-174-00-0
4,4-dimethoxybutylamine
407-690-6
19060-15-2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H302
H314
H317
H412
GHS05
GHS07
Dgr
H302
H314
H317
H412
612-175-00-6
2-(O-aminooxy)ethylamine dihydrochloride
412-310-7
37866-45-8
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
612-176-00-1
polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine
410-570-6
143747-73-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
612-177-00-7
2-naphthylamino-6-sulfomethylamide
412-120-4
104295-55-8
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H373 **
H317
H411
GHS08
GHS09
Wng
H373 **
H317
H411
612-178-00-2
1,4,7,10-tetraazacyclododecane disulfate
412-080-8
112193-77-8
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
Aquatic Chronic 3
H302
H335
H318
H412
GHS05
GHS07
Dgr
H302
H335
H318
H412
612-179-00-8
1-(2-propenyl)pyridinium chloride
412-740-5
25965-81-5
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
612-180-00-3
3-aminobenzylamine
412-230-2
4403-70-7
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
612-181-00-9
2-phenylthioaniline
413-030-8
1134-94-7
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
612-182-00-4
1-ethyl-1-methylmorpholinium bromide
418-210-1
65756-41-4
Muta. 2
H341
GHS08
Wng
H341
612-183-00-X
1-ethyl-1-methylpyrrolidinium bromide
418-200-5
69227-51-6
Muta. 2
H341
GHS08
Wng
H341
612-184-00-5
6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one
403-830-5
89331-94-2
Aquatic Chronic 3
H412
—
H412
612-185-00-0
1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N, N,N-trimethylammonium iodide
407-400-8
59493-72-0
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
612-186-00-6
bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate
406-770-8
149057-64-7
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H318
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H373 **
H318
H317
H410
612-187-00-1
2,3,4-trifluoroaniline
407-170-9
3862-73-5
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H373 **
H315
H318
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 **
H315
H318
H411
612-188-00-7
4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)
407-560-9
107934-68-9
Aquatic Chronic 2
H411
GHS09
H411
612-189-00-2
4-amino-2-(aminomethyl)phenol dihydrochloride
412-510-4
135043-64-0
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
612-190-00-8
4,4'-methylenebis(2-isopropyl-6-methylaniline)
415-150-6
16298-38-7
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411
612-191-00-3
polymer of allylamine hydrochloride
415-050-2
71550-12-4
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
612-192-00-9
2-isopropyl-4-(N-methyl)aminomethylthiazole
414-800-6
154212-60-9
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H315
H318
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H411
612-193-00-4
3-methylaminomethylphenylamine
414-570-7
18759-96-1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H410
612-194-00-X
2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride
414-670-0
141890-30-4
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
612-195-00-5
bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate
415-210-1
160236-81-7
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H332
H302
H318
H410
612-196-00-0
4-chloro-o-toluidine; [1]
4-chloro-o-toluidine hydrochloride [2]
202-441-6[1]
221-627-8[2]
95-69-2[1]
3165-93-3[2]
Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H331
H311
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H331
H311
H301
H410
612-197-00-6
2,4,5-trimethylaniline; [1]
2,4,5-trimethylaniline hydrochloride [2]
205-282-0[1]-[2]
137-17-7 [1]
21436-97-5[2]
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H350
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H411
612-198-00-1
4,4'-thiodianiline and its salts
205-370-9
139-65-1
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
612-199-00-7
4,4'-oxydianiline and its salts;
p-aminophenyl ether
202-977-0
101-80-4
Carc. 1B Muta.
1B Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H350
H340
H361f ***
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H340
H361f ***
H331
H311
H301
H411
612-200-00-0
2,4-diaminoanisole;
4-methoxy-m-phenylenediamine; [1]
2,4-diaminoanisole sulphate [2]
210-406-1 [1]
254-323-9 [2]
615-05-4 [1]
39156-41-7 [2]
Carc. 1B Muta. 2
Acute Tox. 4 *
Aquatic Chronic 2
H350
H341
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H302
H411
612-201-00-6
N,N,N',N'-tetramethyl-4,4'-methylendianiline
202-959-2
101-61-1
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
612-202-00-1
3,4-dichloroaniline
202-448-4
95-76-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H318
H317
H410
612-203-00-7
C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %- 85 %, chain > C10: <3 %)
417-360-3
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
H312
H302
H315
GHS07
Wng
H312
H302
H315
612-204-00-2
C.I. Basic Violet 3;
4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride
208-953-6
548-62-9
Carc. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H351
H302
H318
H410
612-205-00-8
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5)
208-953-6
548-62-9
Carc. 1B
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H350
H302
H318
H410
612-206-00-3
famoxadone (ISO);
3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione
—
131807-57-3
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
612-207-00-9
4-ethoxyaniline;
p-phenetidine
205-855-5
156-43-4
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H341
H332
H312
H302
H319
H317
GHS08
GHS07
Wng
H341
H332
H312
H302
H319
H317
612-208-00-4
N-methylbenzene-1,2-diammonium hydrogen phosphate
424-460-0
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
612-209-00-X
6-methoxy-m-toluidine;
p-cresidine
204-419-1
120-71-8
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302
612-210-00-5
5-nitro-o-toluidine; [1]
5-nitro-o-toluidine hydrochloride [2]
202-765-8 [1]
256-960-8 [2]
99-55-8 [1]
51085-52-0 [2]
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 3
H351
H331
H311
H301
H412
GHS06
GHS08
Dgr
H351
H331
H311
H301
H412
612-211-00-0
N-[(benzotriazole-1-yl)methyl)]4-carboxy-benzenesulfonamide
416-470-9
170292-97-4
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
612-212-00-6
2,6-dichloro-4-trifluoromethylaniline
416-430-0
24279-39-8
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H332
H302
H315
H317
H410
612-213-00-1
isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine
419-850-2
148348-13-4
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
612-214-00-7
4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine
421-390-2
89114-90-9
Aquatic Chronic 4
H413
—
H413
612-215-00-2
3-chloro-2-(isopropylthio)aniline
421-700-6
179104-32-6
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
612-216-00-8
1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt
425-870-2
19450-38-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
612-217-00-3
1-methoxy-2-propylamine
422-550-4
37143-54-7
Flam. Liq. 2
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3
H225
H314
H302
H412
GHS02
GHS05
GHS07
Dgr
H225
H314
H302
H412
612-219-00-4
(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride
402-200-7
—
Aquatic Chronic 3
H412
—
H412
612-220-00-X
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine
431-060-1
153719-38-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
612-221-00-5
2-amino-4-(trifluoromethyl)benzenethiol hydrochloride
429-560-8
4274-38-8
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H314
H332
H312
H302
H373**
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H312
H302
H373**
H317
H400
612-222-00-0
cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine
425-080-8
104860-26-6
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373**
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373**
H318
H410
612-223-00-6
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine
425-300-2
186450-73-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
612-224-00-1
N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine
426-150-0
121246-28-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
612-225-00-7
1,4,7,10-tetraazacyclododecane
425-450-9
294-90-6
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H312
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H410
612-226-00-2
3-(2'-phenoxyethoxy)propylamine
427-870-8
6903-18-0
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H315
H318
H412
GHS05
GHS07
Dgr
H302
H315
H318
H412
612-227-00-8
benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride
428-290-8
120606-08-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
612-228-00-3
reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N, N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N, N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine
414-340-6
—
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H226
H332
H312
H302
H371
H318
H317
H412
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H332
H312
H302
H371
H318
H317
H412
612-229-00-9
mepanipyrim;
4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine
—
110235-47-7
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
612-230-00-4
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide
431-530-4
—
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
612-231-00-X
3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride
427-370-1
164288-56-6
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
612-232-00-5
reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid
430-410-9
186148-38-9
Aquatic Chronic 3
H412
—
H412
612-237-00-2
hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphos
phate; [3] hydroxylamine 4-methylben
zenesulfonate [4]
233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]
10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]
Expl. 1.1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H312
H302
H373**
H319
H315
H317
H400
GHS01
GHS08
GHS07
GHS09
Dgr
H201
H351
H312
H302
H373**
H319
H315
H317
H400
T
612-238-00-8
(3-chloro-2-hydroxypropyl)
trimethylammonium chloride …%
222-048-3
3327-22-8
Carc. 2
Aquatic Chronic 3
H351
H412
GHS08
Wng
H351
H412
B
612-239-00-3
biphenyl-3,3', 4,4'-tetrayltetraamine;
diaminobenzidine
202-110-6
91-95-2
Carc. 1B Muta. 2
H350
H341
GHS08
Dgr
H350
H341
612-240-00-9
pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl)aniline
—
53112-28-0
Aquatic Chronic 2
H411
GHS09
H411
612-241-00-4
piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3]
228-042-7 [1]
205-551-2 [2]
217-775-8 [3]
6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]
Repr. 2
Eye Irrit. 2
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H361fd
H319
H315
H334
H317
H412
GHS08
Dgr
H361fd
H319
H315
H334
H317
H412
612-242-00-X
cyprodinil (ISO);
4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine
—
121552-61-2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10
612-243-00-5
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate
420-560-3
79617-97-3
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
M=10
612-244-00-0
3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride
421-310-6
87691-88-1
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H302
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f***
H302
H319
H317
H410
612-245-00-6
2-ethylphenylhydrazine hydrochloride
421-460-2
19398-06-2
Carc. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H372**
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H372**
H302
H318
H317
H410
M=10
612-246-00-1
(2-chloroethyl)(3-hydroxypropyl)ammonium chloride
429-740-6
40722-80-3
Carc. 1B
Muta. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H350
H340
H373**
H317
H412
GHS08
GHS07
Dgr
H350
H340
H373**
H317
H412
612-247-00-7
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide
423-530-8
152828-23-4
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 3
H372** H302
H412
GHS08
GHS07
Dgr
H372**
H302
H412
612-248-00-2
reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)
439-540-0
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
612-249-00-8
4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride
425-030-5
159939-85-2
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H361f***
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H361f***
H302
H314
H317
H411
612-250-00-3
chloro-N, N-dimethylformiminium chloride
425-970-6
3724-43-4
Repr. 1B
Acute Tox. 4 *
Skin Corr. 1A
H360D***
H302
H314
GHS05
GHS08
GHS07
Dgr
H360D***
H302
H314
EUH014
612-251-00-9
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
426-020-3
51229-78-8
Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H228
H361d***
H302
H315
H317
H411
GHS02
GHS08
GHS07
GHS09
Wng
H228
H361d***
H302
H315
H317
H411
612-252-00-4
imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine
428-040-8
138261-41-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
612-253-00-X
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Aquatic Chronic 3
H412
—
H412
612-253-01-7
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Repr. 1B
Aquatic Chronic 3
H360D***
H412
GHS08
Dgr
H360D***
H412
612-254-00-5
reaction products of diisopropanolamine with formaldehyde (1:4)
432-440-8
220444-73-5
Carc. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H351
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H302
H314
H317
H411
612-255-00-0
1-(3-methoxypropyl)-4-piperidinamine
431-950-8
179474-79-4
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H312
H302
H314
H412
GHS05
GHS07
Dgr
H312
H302
H314
H412
612-256-00-6
benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate
427-470-3
137864-22-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
612-257-00-1
tripropylammonium dihydrogenphosphate
433-700-3
35687-90-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
612-259-00-2
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine
437-720-3
227085-51-0
Eye Dam. 1
H318
GHS05
Dgr
H318
612-261-00-3
3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline
441-190-9
121451-05-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=10
612-265-00-5
bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate
444-360-0
191617-13-7
Aquatic Chronic 3
H412
—
H412
612-266-00-0
3-chloro-4-(3-fluorobenzyloxy)aniline
445-590-4
202197-26-0
Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H373**
H410
612-267-00-6
bis(hydrogenated tallow C16-18-alkyl)hydroxylamine
418-370-0
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
612-269-00-7
reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1yl)methyl]-4-octyl-N-(4-octylphenyl)aniline
420-720-2
—
Aquatic Chronic 4
H413
—
H413
612-270-00-2
(S)-azetidine-2-carboxylic acid
4-cyanobenzylamide hydrochloride
433-010-2
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
612-271-00-8
reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate
434-970-5
160987-57-5
Aquatic Chronic 4
H413
—
H413
612-272-00-3
ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4))iron(3+) monohydrate
435-210-5
—
Aquatic Chronic 2
H411
GHS09
H411
612-273-00-9
alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride
435-650-8
—
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
612-274-00-4
(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate
445-750-3
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
612-275-00-X
fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil
447-880-6
206565-89-1
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
M=10
612-276-00-5
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts
451-430-4
500717-36-2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
612-277-00-0
reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium
451-440-9
586372-44-3
Eye Dam. 1
H318
GHS05
Dgr
H318
612-278-00-6
ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide
214-984-6
1239-45-8
Muta. 2
Acute Tox. 2 *
Acute Tox. 4 *
H341
H330
H302
GHS06
GHS08
Dgr
H341
H330
H302
612-279-00-1
(R, S)-2-amino-3,3-dimethylbutane amide
447-860-7
144177-62-8
Repr. 2
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H361f*** H373** H319
H315
H317
GHS08
GHS07
Wng
H361f*** H373**
H319
H315
H317
612-280-00-7
3-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine
205-057-7
132-32-1
Carc. 1B
H350
GHS08
Dgr
H350
612-281-00-2
leucomalachite green; N, N,N',N'-tetramethyl-4,4'-benzylidenedianiline
204-961-9
129-73-7
Carc. 2
Muta. 2
H351
H341
GHS08
Wng
H351
H341
612-282-00-8
octadecylamine
204-695-3
124-30-1
Asp. Tox. 1
STOT RE 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H304
H373 (gastrointestinal tract, liver, immune
system)
H315
H318
H400
H410
GHS05
GHS08
GHS09
Dgr
H304
H373 (gastrointestinal tract, liver, immune
system)
H315
H318
H410
M = 10
M = 10
612-283-00-3
(Z)-octadec-9-enylamine
204-015-5
112-90-3
Acute Tox. 4
Asp Tox. 1
STOT SE 3
STOT RE 2
Skin Corr. 1B Aquatic Acute 1
Aquatic Chronic 1
H302
H304
H335
H373 (gastro-intestinal tract, liver, immune system)
H314
H400
H410
GHS05
GHS07
GHS08
GHS09
Dgr
H302
H304
H335
H373 (gastro-intestinal tract, liver, immune system)
H314
H410
M = 10
M = 10
612-284-00-9
amines, hydrogenated tallow alkyl
262-976-6
61788-45-2
Asp Tox. 1
STOT RE 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H304
H373 (gastro-intestinal tract, liver, immune system)
H315
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H304
H373 (gastro-intestinal tract, liver, immune system)
H315
H318
H410
M = 10
M = 10
612-285-00-4
amines, coco alkyl
262-977-1
61788-46-3
Acute Tox. 4
Asp. Tox. 1
STOT SE 3
STOT RE 2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H304
H335
H373 (gastro-intestinal tract, liver, immune system)
H314
H400
H410
GHS05
GHS07
GHS08
GHS09
Dgr
H302
H304
H335
H373 (gastro-intestinal tract, liver, immune system)
H314
H410
M = 10
M = 10
612-286-00-X
amines, tallow alkyl
263-125-1
61790-33-8
Acute Tox. 4
Asp. Tox. 1
STOT RE 2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H304
H373 (gastro-intestinal tract, liver, immune system)
H314
H400
H410
GHS05
GHS07
GHS08
GHS09
Dgr
H302
H304
H373 (gastro-intestinal tract, liver, immune system)
H314
H410
M = 10
M = 10
612-287-00-5
fluazinam (ISO); 3-chloro-N-[3- chloro-2,6-dinitro-4-(trifluor omethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine
—
79622-59-6
Repr. 2
Acute Tox. 4
Eye Dam. 1
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1
H361d
H332
H318
H317
H400
H410
GHS08
GHS07
GHS05
GHS09
Dgr
H361d
H332
H318
H317
H410
M = 10
M = 10
613-001-00-1
ethyleneimine; aziridine
205-793-9
151-56-4
Flam. Liq. 2
Carc. 1B
Muta. 1B
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Chronic 2
H225
H350
H340
H330
H310
H300
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H340
H330
H310
H300
H314
H411
D
613-002-00-7
pyridine
203-809-9
110-86-1
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302
*
613-003-00-2
1,2,3,4-tetranitrocarbazole
—
6202-15-9
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H201
H332
H312
H302
GHS01
GHS07
Dgr
H201
H332
H312
H302
613-004-00-8
crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine
208-622-6
535-89-7
Acute Tox. 2 *
H300
GHS06
Dgr
H300
613-007-00-4
desmetryne (ISO);6-isopropylamino-2-methylamino-4-methylthio-1,3,5- triazine
213-800-1
1014-69-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
613-008-00-X
dazomet (ISO);tetrahydro-3,5-dimethyl-1,3,5- thiadiazine-2-thione
208-576-7
533-74-4
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
613-009-00-5
2,4,6-trichloro-1,3,5-triazine; cyanuric chloride
203-614-9
108-77-0
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H330
H302
H314
H317
GHS06
GHS05
Dgr
H330
H302
H314
H317
EUH014
STOT SE 3; H335: C ≥ 5 %
613-010-00-0
ametryn (ISO);N-ethyl-N'-isopropyl-6-(methyl-thio)-1,3,5-triazine-2,4-diamine
212-634-7
834-12-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M = 100
613-011-00-6
amitrole (ISO);1,2,4-triazol-3-ylamine
200-521-5
61-82-5
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H361d *** H373 **
H411
GHS08
GHS09
Wng
H361d *** H373 **
H411
613-012-00-1
bentazone (ISO);3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide
246-585-8
25057-89-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H302
H319
H317
H412
GHS07
Wng
H302
H319
H317
H412
613-013-00-7
cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitrile
244-544-9
21725-46-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-014-00-2
ethoxyquin (ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline
202-075-7
91-53-2
Acute Tox. 4*
H302
GHS07
Wng
H302
613-015-00-8
fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluor-omethylbenzimidazole-1-carboxylate
238-134-9
14255-88-0
Acute Tox. 4*
Acute Tox. 4*
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
613-016-00-3
fuberidazole (ISO);2-(2-furyl-)-1H-benzimidazole
223-404-0
3878-19-1
Carc. 2
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373 (heart)
H317
H400
H410
GHS07
GHS08
GHS09
Wng
H351
H302
H373 (heart)
H317
H410
M = 1
613-017-00-9
bis(8-hydroxyquinolinium) sulphate
205-137-1
134-31-6
Acute Tox. 4*
H302
GHS07
Wng
H302
613-018-00-4
morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion
7411-47-4
Acute Tox. 4*
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H335
H315
H412
GHS07
Wng
H302
H319
H335
H315
H412
613-019-00-X
thioquinox(ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline
202-272-8
93-75-4
Acute Tox. 4 *
H302
GHS07
Wng
H302
613-020-00-5
tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine
246-347-3
24602-86-6
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360D *** H332
H302
H315
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D *** H332
H302
H315
H410
613-021-00-0
dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3- dicarbonitrile
222-098-6
3347-22-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-022-00-6
pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
A
613-023-00-1
2-methyl-4-oxo-3-(penta-2,4- dienyl)cyclopent-2-enyl [1R- [1α[S*(Z)],3β]]-chrysanthemate; pyrethrin I
204-455-8
121-21-1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
613-024-00-7
2-methyl-4-oxo-3-(penta-2,4- dienyl)cyclopent-2-enyl[1R- [1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2- dimethylcyclopropanecar boxylate; pyrethrin II
204-462-6
121-29-9
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
613-025-00-2
cinerin I; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
246-948-0
25402-06-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-026-00-8
cinerin II; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate
204-454-2
121-20-0
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-027-00-3
piperidine
203-813-0
110-89-4
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H225
H331
H311
H314
GHS02
GHS06
GHS05
Dgr
H225
H331
H311
H314
*
613-028-00-9
morpholine
203-815-1
110-91-8
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dg
H226
H332
H312
H302
H314
613-029-00-4
dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid
220-487-5
2782-57-2
Ox. Sol. 2
Acute Tox. 4 * Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031
T
613-030-00-X
troclosene potassium; [1] troclosene sodium [2]
218-828-8 [1]
220-767-7 [2]
2244-21-5 [1]
2893-78-9 [2]
Ox. Sol. 2
Acute Tox. 4 * Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031
*
STOT SE 3;
H335: C ≥ 10 % EUH031: C ≥10 %
G
613-030-01-7
troclosene sodium, dihydrate
220-767-7
51580-86-0
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H410
EUH031
613-031-00-5
symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion
201-782-8
87-90-1
Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031
613-032-00-0
methyl-2,3,5,6-tetrachloro-4- pyridylsulphone;2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine
236-035-5
13108-52-6
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H312
H302
H319
H317
GHS07
Wng
H312
H302
H319
H317
613-033-00-6
2-methylaziridine; propyleneimine
200-878-7
75-55-8
Flam. Liq. 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Eye Dam. 1
Aquatic Chronic 2
H225
H350
H330
H310
H300
H318
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H330
H310
H300
H318
H411
Carc. 1B;
H350: C ≥ 0,01 %
613-034-00-1
1,2-dimethylimidazole
217-101-2
1739-84-0
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H302
H315
H318
GHS05
GHS07
Dgr
H302
H315
H318
613-035-00-7
1-methylimidazole
210-484-7
616-47-7
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
613-036-00-2
2-methylpyridine; 2-picoline
203-643-7
109-06-8
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H226
H332
H312
H302
H319
H335
GHS02
GHS07
Wng
H226
H332
H312
H302
H319
H335
613-037-00-8
4-methylpyridine; 4-picoline
203-626-4
108-89-4
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H226
H311
H332
H302
H319
H335
H315
GHS02
GHS06
Dgr
H226
H311
H332
H302
H319
H335
H315
613-038-00-3
6-phenyl-1,3,5-triazine-2,4- diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine
202-095-6
91-76-9
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
613-039-00-9
ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol
202-506-9
96-45-7
Repr. 1B
Acute Tox. 4 *
H360D *** H302
GHS08
GHS07
Dgr
H360D *** H302
613-040-00-4
azaconazole (ISO);1-{[2-(2,4-dichlorophenyl)-1,3- dioxolan-2-yl]methyl}-1H-1,2.4- triazole
262-102-3
60207-31-0
Acute Tox. 4 *
H302
GHS07
Wng
H302
613-041-00-X
morpholine-4-carbonyl chloride
239-213-0
15159-40-7
Carc. 2
Eye Irrit. 2
Skin Irrit. 2
H351
H319
H315
GHS08
Wng
H351
H319
H315
EUH014
613-043-00-0
imazalil sulphate (ISO) powder; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate; [1](±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
613-043-01-8
imazalil sulphate (ISO), aqueous solution; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Wng
H302
H314
H317
H410
Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 %
Eye Dam. 1; H318: 15 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 %
613-044-00-6
captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide
205-087-0
133-06-2
Carc. 2
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H331
H318
H317
H400
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H331
H318
H317
H400
M=10
613-045-00-1
folpet (ISO);N-(trichloromethylthio)phthalimide
205-088-6
133-07-3
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H351
H332
H319
H317
H400
GHS08
GHS07
GHS09
Wng
H351
H332
H319
H317
H400
M=10
613-046-00-7
captafol (ISO);1,2,3,6-tetrahydro-N-(1,1,2,2- tetrachloroethylthio)phthalimide
219-363-3
2425-06-1
Carc. 1B Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H317
H400
H410
GHS08
GHS09
Dgr
H350
H317
H410
613-047-00-2
1-dimethylcarbamoyl-5-methyl pyrazol-3-yl dimethylcarbamate; dimetilan (ISO)
211-420-0
644-64-4
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
613-048-00-8
carbendazim (ISO);methyl benzimidazol-2-ylcarbamate
234-232-0
10605-21-7
Muta. 1B Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H340
H360FD H400
H410
GHS08
GHS09
Dgr
H340
H360FD H410
613-049-00-3
benomyl (ISO);methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate
241-775-7
17804-35-2
Muta. 1B Repr. 1B STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H340
H360FD H335
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H340
H360FD H335
H315
H317
H410
M = 10
613-050-00-9
carbadox (INN);methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl) quinoxaline 1,4-dioxide
229-879-0
6804-07-5
Flam. Sol. 1
Carc. 1B
Acute Tox. 4 *
H228
H350
H302
GHS02
GHS08
GHS07
Dgr
H228
H350
H302
T
613-051-00-4
molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate
218-661-0
2212-67-1
Carc. 2
Repr. 2
Acute Tox. 4 * Acute Tox. 4 *
STOT RE 2 * Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361f *** H332
H302
H373 ** H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361f *** H332
H302
H373 ** H317
H410
M = 100
613-052-00-X
trifenmorph (ISO);4-tritylmorpholine
215-812-2
1420-06-0
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-053-00-5
anilazine (ISO);2-chloro-N-(4,6-dichloro-1,3,5- triazin-2-yl)aniline
202-910-5
101-05-3
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
613-054-00-0
thiabendazol (ISO);2-(thiazole-4-yl)benzimidazole
205-725-8
148-79-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-056-00-1
1,2-dimethyl-3,5-diphenylpyra zolium methylsulphate; difenzoquat methyl sulfate
256-152-5
43222-48-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS09
Wng
H302
H410
613-058-00-2
permethrin (ISO);m-phenoxybenzyl 3-(2,2-dichorovinyl)-2,2-dimethylcyclopro panecarboxylate
258-067-9
52645-53-1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H317
H400
H410
GHS07
GHS09
Wng
H332
H302
H317
H410
M = 1 000
613-059-00-8
profluralin (ISO);N-(cyclopropylmethyl)-α, α,α- trifluoro-2,6-dinitro-N-propyl-p-toluidine
247-656-6
26399-36-0
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
613-060-00-3
resmethrin (ISO);5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate
233-940-7
10453-86-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=1000
613-061-00-9
6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania
239-732-2
15662-33-6
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
613-062-00-4
sabadilla (ISO);veratrine
—
8051-02-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
613-063-00-X
secbumeton (ISO);2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
247-554-1
26259-45-0
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
613-064-00-5
5-(3,6,9-trioxa-2-undecy loxy)benzo(d)-1,3-dioxolane; sesamex
—
51-14-9
Acute Tox. 4 *
H302
GHS07
Wng
H302
613-065-00-0
simetryn (ISO);2,4-bis(ethylamino)-6- methylthio-1,3,5-triazine
213-801-7
1014-70-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-066-00-6
terbumeton (ISO);2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
251-637-8
33693-04-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-067-00-1
propazine (ISO);2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine
205-359-9
139-40-2
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
613-068-00-7
atrazine (ISO);2-chloro-4-ethylamine-6- isopropylamine-1,3,5-triazine
217-617-8
1912-24-9
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 ** H317
H400
H410
GHS08
GHS09
Wng
H373 ** H317
H410
613-069-00-2
ε-caprolactam
203-313-2
105-60-2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H332
H302
H319
H335
H315
GHS07
Wng
H332
H302
H319
H335
H315
613-070-00-8
propylenethiourea
—
2122-19-2
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 3
H361d *** H302
H412
GHS08
GHS07
Wng
H361d *** H302
H412
613-071-00-3
2-fluoro-5-trifluoromethylpyridine
400-290-2
69045-82-5
Flam. Liq. 3
Skin Sens. 1
Aquatic Chronic 3
H226
H317
H412
GHS02
GHS07
Wng
H226
H317
H412
613-072-00-9
N, N-bis(2-ethylhexyl)-((1,2,4- triazol-1-yl)methyl)amine
401-280-0
91273-04-0
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
613-073-00-4
N, N-dimethyl-2-(3-(4-chloro phenyl)-4,5-dihydropyrazol-1- ylphenylsulphonyl)ethylamine
401-410-6
10357-99-0
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H373 ** H317
H411
GHS08
GHS09
Wng
H373 ** H317
H411
613-074-00-X
3-(3-methylpent-3-yl)isoxazol-5- ylamine
401-460-9
82560-06-3
Acute Tox. 3 *
Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 3
H331
H301
H318
H412
GHS06
GHS05
Dgr
H331
H301
H318
H412
613-075-00-5
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione
401-570-7
89415-87-2
Ox. Sol. 1 ****
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
H271
H331
H314
H302
H317
H400
GHS03
GHS06
GHS05
GHS09
Dgr
H271
H331
H314
H302
H317
H400
613-076-00-0
3-chloro-5-trifluoromethyl-2- pyridylamine
401-670-0
79456-26-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
613-077-00-6
reaction mass of 5-heptyl-1,2,4- triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine
401-940-8
—
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H302
H319
H411
GHS07
GHS09
Wng
H302
H319
H411
613-078-00-1
N,N,N,N-tetrakis(4,6-bis(butyl- (N-methyl-2,2,6,6-tetramethyl piperidin-4-yl)amino)triazin-2- yl)-4,7-diazadecane-1,10- diamine
401-990-0
106990-43-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
613-079-00-7
4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2- yl)pyridine, reaction mass of isomers
402-520-7
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H312
H302
H315
H317
H410
613-080-00-2
3-(bis(2-ethylhexyl)amino methyl)benzothiazole-2(3H)- thione
402-540-6
105254-85-1
Skin Corr. 1B Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
613-081-00-8
1-butyl-2-methylpyridinium bromide
402-680-8
26576-84-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
613-082-00-3
2-methyl-1-pentylpyridinium bromide
402-690-2
—
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H312
H302
H412
GHS07
Wng
H312
H302
H412
613-083-00-9
2-(4-(3-(4-chlorophenyl)-2-pyra zolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate
402-120-2
—
Skin Corr. 1B STOT RE 2 * Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H373 ** H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H314
H373 ** H317
H410
613-084-00-4
2-(4-(3-(4-chlorophenyl)-4,5- dihydropyrazolyl)phenylsulphonyl) ethyldimethylammonium hydrogen phosphonate
402-490-5
106359-93-7
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
613-085-00-X
reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5- oxo-2H-2-furylide namino)benzyl)phenyl)pyrrole-2,5-dione
401-970-1
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
613-086-00-5
caffeine
200-362-1
58-08-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
613-087-00-0
tetrahydrothiophene
203-728-9
110-01-0
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H225
H332
H312
H302
H319
H315
H412
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H315
H412
613-088-00-6
1,2-benzisothiazol-3(2H)-one;1,2-benzisothiazolin-3-one
220-120-9
2634-33-5
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H302
H315
H318
H317
H400
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H317
H400
Skin Sens. 1; H317: C≥0,05 %
613-089-00-1
diquat dibromide; [1]diquat dichloride; [2]6,7-dihydrodipyrido[1,2-α:2',1'- c]pyrazinediylium dihydroxide [3]
201-579-4 [1]
223-714-6 [2]
301-467-6 [3]
85-00-7 [1]
4032-26-2 [2]
94021-76-8 [3]
Acute Tox. 2 * STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H372 ** H302
H319
H335
H315
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H372 ** H302
H319
H335
H315
H317
H410
613-090-00-7
paraquat dichloride;1,1-dimethyl-4,4'-bipyridinium dichloride; [1]paraquat dimethylsulfate;1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]
217-615-7 [1]
218-196-3 [2]
1910-42-5 [1]
2074-50-2 [2]
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H301
H372 ** H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H311
H301
H372 ** H319
H335
H315
H410
613-091-00-2
morfamquat dichloride; [1]morfamquat sulfate [2]
225-062-8 [1] [2]
4636-83-3 [1]
29873-36-7 [2]
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H335
H315
H412
GHS07
Wng
H302
H319
H335
H315
H412
613-092-00-8
1,10-phenanthroline
200-629-2
66-71-7
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
613-093-00-3
hexasodium 6,13-dichloro-3,10- bis((4-(2,5-disulfonatoanilino)-6- fluoro-1,3,5-triazin-2- ylamino)prop-3-ylamino)-5,12- dioxa-7,14-diazapentacene-4,11- disulfonate
400-050-7
85153-92-0
Resp. Sens. 1
Skin Sens. 1
H334
H317
GHS08
Dgr
H334
H317
613-094-00-9
4-methoxy-N,6-dimethyl-1,3,5- triazin-2-ylamine
401-360-5
5248-39-5
Acute Tox. 4 * STOT RE 2 *
H302
H373 **
GHS08
GHS07
Wng
H302
H373 **
613-095-00-4
sodium 3-(2H-benzotriazol-2- yl)-5-sec-butyl-4-hydroxyben zenesulfonate
403-080-9
92484-48-5
Eye Dam. 1
H318
GHS05
Dgr
H318
613-096-00-X
2-amino-6-ethoxy-4-methylamino-1,3,5-triazine
403-580-7
62096-63-3
Acute Tox. 4 *
H302
GHS07
Wng
H302
613-097-00-5
7-amino-3-((5-carboxymethyl-4- methyl-1,3-thiazol-2- ylthio)methyl)-8-oxo-5-thia-1- azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid
403-690-5
111298-82-9
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H334
H317
H412
GHS08
Dgr
H334
H317
H412
613-098-00-0
N-(n-octyl)-2-pyrrolidone
403-700-8
2687-94-7
Skin Corr. 1B Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411
613-099-00-6
1-dodecyl-2-pyrrolidone
403-730-1
2687-96-9
Skin Corr. 1B Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
613-100-00-X
2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione
404-230-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
613-101-00-5
N—tert-pentyl-2-benzothiazolesulfenamide
404-380-2
110799-28-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-102-00-0
dimethomorph (ISO);4-(3-(4-chlorophenyl)-3-(3,4- dimethoxyphenyl)acryloyl)morpholine
404-200-2
110488-70-5
Aquatic Chronic 2
H411
GHS09
H411
613-103-00-6
sodium 5-n-butylbenzotriazole
404-450-2
118685-34-0
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1
Aquatic Chronic 2
H302
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H411
613-104-00-1
5-tert-butyl-3-isoxazolylamine hydrochloride
404-840-2
—
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1
Aquatic Chronic 3
H302
H373 ** H318
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 ** H318
H412
613-105-00-7
hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6- morpholino-1,3,5-triazine-4,2- diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7- disulfonate)
405-160-9
124537-30-0
Acute Tox. 3 * Skin Sens. 1
Aquatic Chronic 3
H301
H317
H412
GHS06
Dgr
H301
H317
H412
613-106-00-2
tetrapotassium 2-(4-(5-(1-(2,5- disulfonatophenyl)-3-ethoxycar bonyl-5-hydroxypyrazol-4- yl)penta-2,4-dienylidene)-3- ethoxycarbonyl-5-oxo-2-pyra zolin-1-yl)benzene-1,4- disulfonate
405-240-3
—
Skin Sens. 1
H317
GHS07
Wng
H317
613-107-00-8
hexasodium 2,2'-vinylenebis((3- sulfonato-4,1-pheny lene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate
405-280-1
76508-02-6
Eye Irrit. 2
H319
GHS07
Wng
H319
613-108-00-3
benzothiazole-2-thiol
205-736-8
149-30-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
613-109-00-9
bis(piperidinothiocarbonyl) disulphide
202-328-1
94-37-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H319
H335
H315
H317
GHS07
Wng
H319
H335
H315
H317
613-110-00-4
dimepiperate (ISO);S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate
262-784-2
61432-55-1
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
613-111-00-X
1,2,4-triazole
206-022-9
288-88-0
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
H361d *** H302
H319
GHS08
GHS07
Wng
H361d *** H302
H319
613-112-00-5
octhilinone (ISO);2-octyl-2H-isothiazol-3-one
247-761-7
26530-20-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H302
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H302
H314
H317
H410
Skin Sens. 1; H317: C≥0,05 %
613-113-00-0
2-(morpholinothio)benzothiazole
203-052-4
102-77-2
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H315
H317
H411
GHS07
GHS09
Wng
H319
H315
H317
H411
613-114-00-6
2,2',2''-(hexahydro-1,3,5- triazine-1,3,5-triyl)triethanol;1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine
225-208-0
4719-04-4
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
Skin Sens. 1; H317: C ≥
0,1 %
613-115-00-1
hymexazol (ISO);3-hydroxy-5-methylisoxazole
233-000-6
10004-44-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
613-116-00-7
tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing ≥0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
Acute Tox. 2 * STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H330
H372** H319
H335
H315
H317
H400
GHS06
GHS08
GHS09
Dgr
H330
H372** H319
H335
H315
H317
H400
M=10
613-116-01-4
tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H319
H335
H315
H317
H400
GHS07
GHS09
Wng
H319
H335
H315
H317
H400
M=10
613-117-00-2
diniconazole (ISO);(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1- ethanol;(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4- triazol-1-yl)pent-1-en-3-ol
—
76714-88-0
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-118-00-8
flubenzimine (ISO);N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2- ylidene]aniline
253-703-1
37893-02-0
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
613-119-00-3
(benzothiazol-2-ylthio)methyl thiocyanate; TCMTB
244-445-0
21564-17-0
Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H319
H315
H317
H400
H410
GHS06
GHS09
Dgr
H330
H302
H319
H315
H317
H410
613-120-00-9
bioresmethrin (ISO);(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1- en-1-yl)cyclopropanecarboxylate
249-014-0
28434-01-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M = 1000
613-122-00-X
diclobutrazole (ISO);(R*, R*)-(±)-β-[(2,4-dichlorop henyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2- (1H—1,2,4-triazol-1yl)pentan-3-ol
—
75736-33-3
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
613-123-00-5
5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem
251-684-4
33813-20-6
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-124-00-0
fenpropimorph (ISO);cis-4-[3-(p-tert-butylphenyl)-2- methylpropyl]-2,6-dimethylmorpholine
266-719-9
67564-91-4
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H361d *** H302
H315
H411
GHS08
GHS07
GHS09
Wng
H361d *** H302
H315
H411
613-125-00-6
hexythiazox(ISO);trans-5-(4-chlorophenyl)-N- cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide
—
78587-05-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-126-00-1
imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1- methylethyl)-5-oxo-1H- imidazol-2-yl]-3-pyridine carboxylate
—
81334-34-1
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
613-127-00-7
1,1-dimethylpiperidinium chloride; mepiquat chloride
246-147-6
24307-26-4
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
613-128-00-2
prochloraz (ISO);N-propyl-N-[2-(2,4,6-trichlorop henoxy)ethyl]-1H-imidazole-1- carboxamide
266-994-5
67747-09-5
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-129-00-8
metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one
255-349-3
41394-05-2
Acute Tox. 4 *
Aquatic Acute 1
H302
H400
GHS07
GHS09
Wng
H302
H400
613-131-00-9
pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1- ij]quinolin-4-one
—
57369-32-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
613-132-00-4
hexazinone (ISO);3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione
257-074-4
51235-04-2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
613-134-00-5
myclobutanil(ISO);2-(4-chlorophenyl)-2-(1H-1,2,4- triazol-1-ylmethyl)hexanenitrile
—
88671-89-0
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H361d *** H302
H319
H411
GHS08
GHS07
GHS09
Wng
H361d *** H302
H319
H411
613-135-00-0
di(benzothiazol-2-yl) disulphide
204-424-9
120-78-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
EUH031
613-136-00-6
N-cyclohexylbenzothiazole-2- sulphenamide
202-411-2
95-33-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
613-137-00-1
methabenzthiazuron (ISO);1-(1,3-benzothiazol-2-yl)1,3- dimethylurea
242-505-0
18691-97-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-138-00-7
quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline
—
124495-18-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
613-139-00-2
metsulfuron-methyl (ISO); methyl-2-{[(4-methoxy-6- methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate
—
74223-64-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M = 1000
613-140-00-8
cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5- dimethyl-2-oxocyclohexyl]-2- hydroxyethyl}piperidine-2,6- dione
200-636-0
66-81-9
Muta. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Chronic 2
H341
H360D *** H300
H411
GHS06
GHS08
GHS09
Dgr
H341
H360D *** H300
H411
613-141-00-3
1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone
401-470-3
93686-63-6
Aquatic Chronic 4
H413
—
H413
613-142-00-9
trans—N-methyl-2-styryl-[4'- aminomethine-(1-acetyl-1-(2- methoxyphenyl)acetamido)]py ridinium acetate
405-860-4
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
613-143-00-4
1-(3-phenylpropyl)-2-methylpyridinium bromide
405-930-4
10551-42-5
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412
613-144-00-X
reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4- dimethylthiazoliummethylsulfate
406-460-2
125139-08-4
Aquatic Chronic 3
H412
—
H412
613-145-00-5
(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate
406-960-0
77497-97-3
Aquatic Chronic 2
H411
GHS09
H411
613-146-00-0
N-ethyl-N-methylpiperidinium iodide
407-780-5
4186-71-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
613-147-00-6
4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine
407-940-4
111681-72-2
Eye Dam. 1
H318
GHS05
Dgr
H318
613-148-00-1
tetrasodium 1,2-bis(4-fluoro-6- [5-(1-amino-2-sulfonatoanthra chinon-4-ylamino)-2,4,6- trimethyl-3-sulfonatopheny lamino]-1,3,5-triazin-2- ylamino)ethane
411-240-4
143683-23-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-150-00-2
2,2'-[3,3'-(piperazine-1,4-diyl)di propyl]bis(1H-benzimidazo[2,1—b]benzo[l, m,n][3,8]phenanthroline-1,3,6-trione
406-295-6
—
Aquatic Chronic 4
H413
—
H413
613-151-00-8
1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine
406-360-9
104218-44-2
Aquatic Chronic 4
H413
—
H413
613-152-00-3
phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate
406-600-2
89392-03-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
613-153-00-9
2,3,5-trichloropyridine
407-270-2
16063-70-0
Aquatic Chronic 3
H412
—
H412
613-154-00-4
2-amino-4-chloro-6-methoxypyrimidine
410-050-9
5734-64-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
613-155-00-X
5-chloro-2,3-difluoropyridine
410-090-7
89402-43-7
Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 3
H226
H302
H412
GHS02
GHS07
Wng
H226
H302
H412
613-156-00-5
2-butyl-4-chloro-5-formylimidazole
410-260-0
83857-96-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
613-157-00-0
2,4-diamino-5-methoxymethylpyrimidine
410-330-0
54236-98-5
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
H302
H373 ** H319
GHS08
GHS07
Wng
H302
H373 ** H319
613-158-00-6
2,3-dichloro-5-trifluoromethyl- pyridine
410-340-5
69045-84-7
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H332
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H332
H302
H318
H317
H411
613-159-00-1
fenazaquin (ISO);4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline
410-580-0
120928-09-8
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H400
H410
GHS06
GHS09
Dgr
H301
H332
H410
613-160-00-7
(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptanes dihydrobromide
411-000-9
125224-62-6
Skin Sens. 1
H317
GHS07
Wng
H317
613-161-00-2
(2,4-diaminopteridin-6-yl)methanol hydrobromide
430-620-0
76145-91-0
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373** H317
H412
GHS08
GHS07
Wng
H373** H317
H412
613-162-00-8
(6R-trans)-1-((7-ammonio-2- carboxylato-8-oxo-5-thia-1- azabicyclo-[4.2.0]oct-2-en-3- yl)methyl)pyridinium iodide
423-260-0
100988-63-4
Muta. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H317
H411
613-163-00-3
azimsulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H- tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea
—
120162-55-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=1000
613-164-00-9
flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide
—
142459-58-3
Acute Tox. 4 * STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373** H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373** H317
H410
M=100
613-165-00-4
flupyrsulfuron-methyl-sodium(ISO);methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt
—
144740-54-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=100
613-167-00-5
reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H -isothiazol-3- one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3- one [EC no. 220-239-6] (3:1)
—
55965-84-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H317
H410
Skin Corr. 1B; H314: C ≥0,6 %
Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %
Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %
Skin Sens. 1; H317: C ≥ 0,0015 %
613-168-00-0
1-vinyl-2-pyrrolidone
201-800-4
88-12-0
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * STOT RE 2 *
STOT SE 3
Eye Dam. 1
H351
H332
H312
H302
H373 ** H335
H318
GHS06
GHS05
GHS09
Dgr
H351
H332
H312
H302
H373 ** H335
H318
D
613-169-00-6
9-vinylcarbazole
216-055-0
1484-13-5
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H312
H302
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H312
H302
H315
H317
H410
M=100
613-170-00-1
2,2-ethylmethylthiazolidine
404-500-3
694-64-4
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
613-171-00-7
hexaconazole (ISO);(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2- ol
413-050-7
79983-71-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
613-172-00-2
5-chloro-1,3-dihydro-2H-indol-2-one
412-200-9
17630-75-0
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H361f *** H302
H317
H412
GHS08
GHS07
Wng
H361f *** H302
H317
H412
613-173-00-8
fluquinconazole (ISO);3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one
411-960-9
136426-54-5
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H372 ** H312
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H372 ** H312
H315
H410
613-174-00-3
tetraconazole (ISO);
(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether
407-760-6
112281-77-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411
613-175-00-9
epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
406-850-2
133855-98-8
Carc. 2
Repr. 1B
Aquatic Chronic 2
H351
H360Df
H411
GHS08
GHS09
Dgr
H351
H360Df
H411
613-176-00-4
2-methyl-2-azabicyclo[2.2.1]heptane
404-810-9
4524-95-2
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
H226
H312
H302
H373 **
H314
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H312
H302
H373 **
H314
613-177-00-X
8-amino-7-methylquinoline
412-760-4
5470-82-6
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H317
H411
GHS07
GHS09
Wng
H312
H302
H317
H411
613-178-00-5
4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine
410-470-2
137796-06-6
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
STOT SE 3; H335: C ≥ 5 %
613-179-00-0
lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide
411-690-1
111337-53-2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H302
H314
H317
H411
GHS05
GHS07
Dgr
H302
H314
H317
H411
613-180-00-6
N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide
407-430-1
3741-80-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-181-00-1
5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone
405-090-9
67485-29-4
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H372 **
H302
H319
H400
H410
GHS08
GHS07
GHS09
Dgr
H372 **
H302
H319
H410
613-182-00-7
1-(1-naphthylmethyl)quinolinium chloride
406-220-7
65322-65-8
Carc. 2
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H351
H341
H302
H315
H318
H412
GHS08
GHS05
GHS07
Dgr
H351
H341
H302
H315
H318
H412
613-183-00-2
reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one
413-640-4
—
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
613-184-00-8
nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate
413-670-8
—
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
613-185-00-3
2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one
407-630-9
82633-79-2
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410
613-186-00-9
(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate
408-050-9
76855-69-1
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H317
H411
GHS07
GHS09
Wng
H319
H317
H411
613-187-00-4
5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene
410-530-8
—
Skin Sens. 1
H317
GHS07
Wng
H317
613-188-00-X
1-(3-(4-fluorophenoxy)propyl)3-methoxy-4-piperidinone
411-500-7
116256-11-2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
613-189-00-5
1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane
414-030-0
52667-88-6
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
613-190-00-0
disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate
414-040-5
149530-93-8
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
613-191-00-6
3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine
421-150-7
143860-04-2
Repr. 1B
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F *** H314
H400
H410
GHS08
GHS05
GHS09
Dgr
H360F *** H314
H410
613-192-00-1
3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane
426-750-2
151860-15-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-193-00-7
pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate
414-930-3
—
Aquatic Chronic 2
H411
GHS09
H411
613-194-00-2
6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt
418-000-8
163062-28-0
Eye Dam. 1
H318
GHS05
Dgr
H318
613-195-00-8
2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one)
418-280-1
18600-59-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
613-196-00-3
5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt
418-380-5
168113-78-8
Eye Dam. 1
H318
GHS05
Dgr
H318
613-197-00-9
reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;
2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;
[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;
[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine
420-390-1
187547-46-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
613-198-00-4
2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine
415-500-8
145963-84-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
613-199-00-X
reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6 trione;
reaction mass of oligomers of
3,5-bis(3-aminomethylphenyl)1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5(1H,3H,5H)-triazine-2,4,6-trione
421-550-1
—
Carc. 1B
Repr. 1B
Skin Sens. 1
Aquatic Chronic 3
H350
H360D *** H317
H412
GHS08
Dgr
H350
H360D *** H317
H412
613-200-00-3
reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts
420-980-7
—
Eye Dam. 1
H318
GHS05
Dgr
H318
613-201-00-9
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole
422-390-5
143322-57-0
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f *** H372 **
H332
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H361f *** H372 **
H332
H302
H317
H410
EUH070
613-202-00-4
pymetrozine (ISO);
(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one
—
123312-89-0
Carc. 2
Aquatic Chronic 3
H351
H412
GHS08
Wng
H351
H412
613-203-00-X
pyraflufen-ethyl (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1] pyraflufen (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]
-[1]
-[2]
129630-19-9 [1]
129630-17-7 [2]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=1000
613-204-00-5
oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
254-637-6
39807-15-3
Repr. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H361d*** H373**
H400
H410
GHS08
GHS09
Wng
H361d*** H373**
H410
M = 1000
613-205-00-0
propiconazole(ISO);
(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole
262-104-4
60207-90-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
613-206-00-6
fenamidone (ISO);
(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one
—
161326-34-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-208-00-7
imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
—
114311-32-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-209-00-2
cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride
417-430-3
63645-17-0
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H301
H373 **
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H317
H411
613-210-00-8
2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane
417-650-1
88128-57-8
STOT RE 2 *
Aquatic Chronic 3
H373 **
H412
GHS08
Wng
H373 **
H412
613-211-00-3
N-methyl-4-(p-formylstyryl)pyridinium methylsulfate
418-240-3
74401-04-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-212-00-9
4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)
418-320-8
133467-41-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-213-00-4
cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline
416-040-0
120807-02-5
Aquatic Chronic 3
H412
—
H412
613-214-00-X
N, N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide
416-260-7
147613-95-4
Aquatic Chronic 4
H413
—
H413
613-215-00-5
2-chloromethyl-3,4-dimethoxypyridinium chloride
416-440-5
72830-09-2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H373 **
H315
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 **
H315
H318
H317
H411
613-216-00-0
6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole
416-490-8
162208-01-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-217-00-6
4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine
416-770-1
73754-27-5
Aquatic Chronic 4
H413
—
H413
613-218-00-1
6-hydroxyindole
417-020-4
2380-86-1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
613-219-00-7
7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole
417-140-7
79185-77-6
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
613-220-00-2
trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide
417-290-3
147086-81-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
613-221-00-8
2-chloro-5-methyl-pyridine
418-050-0
18368-64-4
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 3
H312
H302
H315
H412
GHS07
Wng
H312
H302
H315
H412
613-222-00-3
4-(1-oxo-2-propenyl)-morpholine
418-140-1
5117-12-4
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373 **
H318
H317
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H318
H317
613-223-00-9
N-isopropyl-3-(4-fluorophenyl)-1H-indole
418-790-4
93957-49-4
Aquatic Chronic 4
H413
—
H413
613-224-00-4
2,5-dimercaptomethyl-1,4-dithiane
419-770-8
136122-15-1
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
613-225-00-X
reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;
2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.
421-290-9
—
STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Wng
H373 **
H413
613-226-00-5
1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride
420-950-3
163831-67-2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
613-227-00-0
(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
419-600-2
99199-90-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
613-228-00-6
(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
419-630-6
793669-26-8
Aquatic Chronic 2
H411
GHS09
H411
613-229-00-1
1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine
411-930-5
106917-31-1
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
613-230-00-7
florasulam (ISO);
2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];
pyrimidine-2-sulfonanilide
—
145701-23-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-231-00-2
2,6-diamino-3-((pyridine-3-yl)azo)pyridine
421-430-9
28365-08-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373**
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H411
613-232-00-8
3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide
431-030-6
163269-30-5
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H373**
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H331
H373**
H318
H410
613-233-00-3
4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane
423-230-7
56552-15-9
Eye Dam. 1
H318
GHS05
Dgr
H318
613-234-00-9
imidazo[1,2-b]pyridazin hydrochloride
431-510-5
18087-70-2
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
613-235-00-4
2,3-dihydro-2,2-dimethyl-1H-perimidine
424-060-6
6364-17-6
Acute Tox. 4*
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H410
613-236-00-X
2-chloro-3-trifluoromethylpyridine
424-520-6
65753-47-1
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Chronic 3
H311
H301
H372**
H314
H412
GHS06
GHS05
GHS08
Dgr
H311
H301
H372**
H314
H412
613-237-00-5
6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine
424-950-4
133949-92-5
Aquatic Chronic 4
H413
—
H413
613-238-00-0
sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate
430-890-1
81992-66-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
613-239-00-6
2-[3-(methylamino)propyl]-1H-benzimidazole
425-760-4
64137-52-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
613-241-00-7
3-(2H-tetrazol-5-yl)pyridine
426-810-8
3250-74-6
Eye Dam. 1
H318
GHS05
Dgr
H318
613-242-00-2
reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts
426-860-0
191877-09-5
Eye Dam. 1
H318
GHS05
Dgr
H318
613-243-00-8
4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)
427-350-0
182235-14-9
Aquatic Chronic 2
H411
GHS09
H411
613-244-00-3
5,7-dichloro-4-hydroxyquinoline
427-420-0
21873-52-9
Aquatic Chronic 2
H411
GHS09
H411
613-245-00-9
2-fluoro-6-trifluoromethylpyridine
428-100-3
94239-04-0
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H226
H332
H302
H412
GHS02
GHS07
Wng
H226
H332
H302
H412
613-246-00-4
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
428-200-7
103577-66-8
Aquatic Chronic 3
H412
—
H412
613-247-00-X
3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole
428-910-7
107786-36-7
Aquatic Chronic 4
H413
—
H413
613-248-00-5
3,4-dimethyl-1H-pyrazole
429-130-1
2820-37-3
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
613-249-00-0
1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate
429-300-3
155601-30-2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
613-250-00-6
reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;
methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;
2-isopropyl-N-hydroxyethyl 1,3-oxazolidine
429-990-6
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
613-251-00-1
(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole
430-560-5
180637-89-2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
613-253-00-2
2,2-dialkyl-4-hydroxymethyl1,3-dioxolane;
reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)
430-580-4
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
EUH019
613-254-00-8
forchlorfenuron (ISO);
1-(2-chloro-4-pyridyl)-3-phenylurea
—
68157-60-8
Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411
613-255-00-3
reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)
424-270-8
—
Eye Dam. 1
H318
GHS05
Dgr
H318
613-256-00-9
3'5'-anhydro thymidine
425-810-5
38313-48-3
Aquatic Chronic 3
H412
—
H412
613-257-00-4
2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate
426-400-9
170222-39-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
613-258-00-X
reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;
4-chloro-5-methylbenzotriazole sodium salt;
5-chloro-4-methylbenzotriazole sodium salt
427-730-6
202420-04-0
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
613-259-00-5
reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;
[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate
428-790-6
72963-72-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
613-260-00-0
(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin
430-730-9
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
613-261-00-6
pyrazole-1-carboxamidine monohydrochloride
429-520-1
4023-02-3
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373** H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
H412
613-262-00-1
disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene
427-310-2
180850-95-7
Eye Dam. 1
H318
GHS05
Dgr
H318
613-263-00-7
monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate
429-570-2
—
Skin Sens. 1
H317
GHS07
Wng
H317
613-266-00-3
2-chloro-5-chloromethylthiazole
429-830-5
105827-91-6
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H311
H314
H302
H317
H411
GHS06
GHS05
GHS09
Dgr
H311
H314
H302
H317
H411
613-267-00-9
thiamethoxam (ISO);
3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine
428-650-4
153719-23-4
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=10
613-268-00-4
(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine
425-930-8
151213-39-7
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H314
H332
H302
H373**
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H302
H373**
H411
613-269-00-X
2-thiazolidinylidenecyanamide
427-720-1
26364-65-8
Acute Tox. 4*
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
613-270-00-5
5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide
428-150-6
113171-13-4
Aquatic Chronic 3
H412
—
H412
613-271-00-0
tritosulfuron (ISO) (containing ≤0,02 % AMTT);
1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)
—
142469-14-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10
613-272-00-6
pyraclostrobin (ISO);
methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate
—
—
Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H315
H400
H410
GHS06
GHS09
Dgr
H331
H315
H410
M=100
613-273-00-1
tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine
427-600-9
192439-46-6
Aquatic Chronic 2
H411
GHS09
H411
613-274-00-7
2,6-dichloro-1-fluoropyridiniumtetrafluoroborate
427-400-1
140623-89-8
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H410
613-275-00-2
3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride
424-530-0
93076-03-0
Acute Tox. 3 *
STOT SE 2
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H301
H371**
H373**
H318
H317
H411
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H371**
H373**
H318
H317
H411
613-276-00-8
1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one
426-110-2
98377-35-6
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-277-00-3
(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one
427-070-9
—
Aquatic Chronic 4
H413
—
H413
613-278-00-9
(3-aminophenyl)pyridin-3-ylmethanone
428-230-0
79568-06-2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
613-279-00-4
2-ethyl-2,3-dihydro-2-methyl-1H-perimidine
424-380-6
43057-68-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410
613-280-00-X
tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
dimethyl propyleneurea
230-625-6
7226-23-5
Repr. 2
Acute Tox. 4 *
Eye Dam. 1
H361f***
H302
H318
GHS05
GHS08
GHS07
Dgr
H361f***
H302
H318
613-281-00-5
quinoline
202-051-6
91-22-5
Carc. 1B Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H350
H341
H312
H302
H319
H315
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H312
H302
H319
H315
H411
613-282-00-0
triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol
—
131983-72-7
Aquatic Chronic 2
H411
GHS09
H411
613-283-00-6
ketoconazole;
1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
265-667-4
65277-42-1
Repr. 1B
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360F***
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H360F***
H301
H373**
H410
613-284-00-1
metconazole (ISO);
(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
—
125116-23-6
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H361d***
H302
H411
GHS08
GHS07
GHS09
Wng
H361d***
H302
H411
613-285-00-7
1-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]
219-989-7 [1]
219-989-7 [2]
2592-95-2 [1]
123333-53-9 [2]
Expl. 1.3
H203
GHS01
Dgr
H203
613-286-00-2
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N, N-dimethylformamide (EC no
200-679-5)]
418-260-2
183196-57-8
Skin Sens. 1
H317
GHS07
Wng
H317
613-286-01-X
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N, N-dimethylformamide (EC No 200-679-5)]
418-260-2
183196-57-8
Repr. 1B
Skin Sens. 1
H360D*** H317
GHS08
GHS07
Dgr
H360D*** H317
613-287-00-8
1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole
419-540-7
160194-26-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
613-288-00-3
1,3-bis(dimethylcarbamoyl)-imidazolium chloride
420-930-4
135756-61-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
613-289-00-9
3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole
432-020-4
142623-48-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-290-00-4
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride
432-470-1
189012-93-9
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
613-291-00-X
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
434-820-9
106461-41-0
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410
613-292-00-5
N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine
435-010-8
26157-73-3
Muta. 2
Aquatic Chronic 3
H341
H412
GHS08
Wng
H341
H412
613-293-00-0
2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonyl
methyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester
448-050-6
444065-11-6
Aquatic Chronic 4
H413
—
H413
613-294-00-6
2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester
448-260-8
379268-96-9
Aquatic Chronic 4
H413
—
H413
613-295-00-1
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride
448-720-8
363138-44-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
613-296-00-7
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1yl)benzene-1,4-disulfonate
418-270-7
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
613-297-00-2
5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole
420-820-6
—
Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2
H226
H302
H411
GHS02
GHS07
GHS09
Wng
H226
H302
H411
613-298-00-8
bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate
421-560-6
—
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H373**
H318
H411
GHS05
GHS08
GHS09
Dgr
H373**
H318
H411
613-299-00-3
main component 1 (isomer 1):
2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 1 (isomer 2):
2-{6-fluoro-4-[3-(2,5-disulfophenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt
422-610-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318
613-300-00-7
1-imidazol-1-yl-octadecan-2-ol
434-120-3
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
613-301-00-2
dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate
443-910-7
—
Aquatic Chronic 4
H413
—
H413
613-302-00-8
disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate
432-980-4
243858-60-8
Eye Dam. 1
H318
GHS05
Dgr
H318
613-303-00-3
2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine
429-800-1
95737-68-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-304-00-9
5,6-dihydroxy-2,3-dihydro-1H-indolium bromide
421-170-6
138937-28-7
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
613-305-00-4
2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole
448-630-9
3147-77-1
Aquatic Chronic 4
H413
—
H413
613-306-00-X
(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate
433-520-5
82911-69-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
613-307-00-5
clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine
—
210880-92-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M=10
613-308-00-0
2-amino-5-methylthiazole
423-800-5
7305-71-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410
613-309-00-6
1-methyl-3-phenyl-1-piperazine
431-180-2
5271-27-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H312
H302
H315
H318
H412
GHS05
GHS07
Dgr
H312
H302
H315
H318
H412
613-310-00-1
(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride
432-360-3
105813-13-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
613-311-00-7
methyl-5-nitrophenyl-guanidine
435-500-1
152460-07-6
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H302
H319
H317
H412
GHS07
Wng
H302
H319
H317
H412
613-312-00-2
2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride
420-200-5
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
613-313-00-8
2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione
442-780-9
173838-67-0
Aquatic Chronic 3
H412
—
H412
613-314-00-3
4-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one
443-770-7
7693-82-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
613-315-00-9
tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate
430-390-1
—
Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412
613-316-00-4
trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)
257-765-0
52234-82-9
Muta. 2
Eye Dam. 1
Skin Sens. 1
H341
H318
H317
GHS05
GHS08
GHS07
Dgr
H341
H318
H317
613-317-00-X
penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole
266-275-6
66246-88-6
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
H361d
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H361d
H302
H410
M = 1
M = 1
614-002-00-X
salts of nicotine
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H330
H310
H300
H411
GHS06
GHS09
Dgr
H330
H310
H300
H411
A
614-003-00-5
strychnine
200-319-7
57-24-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
614-004-00-0
salts of strychnine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410
A
614-005-00-6
colchicine
200-598-5
64-86-8
Muta. 1B
Acute Tox. 2 *
H340
H300
GHS06
GHS08
Dgr
H340
H300
614-006-00-1
brucine;
2,3-dimethoxystrychnine
206-614-7
357-57-3
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Chronic 3
H330
H300
H412
GHS06
Dgr
H330
H300
H412
614-007-00-7
brucine sulphate; [1]
brucine nitrate; [2]
strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]
strychnidin-10-one, 2,3-dimethoxy-, compd.with (S) mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]
225-432-9 [1]
227-317-9 [2]
269-439-5 [3]
269-710-8 [4]
4845-99-2 [1]
5786-97-0 [2]
68239-26-9 [3]
68310-42-9 [4]
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Chronic 3
H330
H300
H412
GHS06
Dgr
H330
H300
H412
A
614-008-00-2
aconitine
206-121-7
302-27-2
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
614-009-00-8
salts of aconitine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
A
614-010-00-3
atropine
200-104-8
51-55-8
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
614-011-00-9
salts of atropine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
A
614-012-00-4
hyoscyamine
202-933-0
101-31-5
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
614-013-00-X
salts of hyoscyamine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
A
614-014-00-5
hyoscine
200-090-3
51-34-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300
614-015-00-0
salts of hyoscine
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300
A
614-016-00-6
pilocarpine
202-128-4
92-13-7
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
614-017-00-1
salts of pilocarpine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
A
614-018-00-7
papaverine
200-397-2
58-74-2
Acute Tox. 4 *
H302
GHS07
Wng
H302
614-019-00-2
salts of papaverine
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302
A
614-020-00-8
physostigmine
200-332-8
57-47-6
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
614-021-00-3
salts of physostigmine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300
A
614-022-00-9
digitoxin
200-760-5
71-63-6
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H301
H373 **
GHS06
GHS08
Dgr
H331
H301
H373 **
614-023-00-4
ephedrine
206-080-5
299-42-3
Acute Tox. 4 *
H302
GHS07
Wng
H302
614-024-00-X
salts of ephedrine
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302
A
614-025-00-5
ouabain
211-139-3
630-60-4
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H301
H373 **
GHS06
GHS08
Dgr
H331
H301
H373 **
614-026-00-0
strophantin-K
234-239-9
11005-63-3
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H301
H373 **
GHS06
GHS08
Dgr
H331
H301
H373 **
614-027-00-6
bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;
red squill;
scilliroside
208-077-4
507-60-8
Acute Tox. 2 *
H300
GHS06
Dgr
H300
614-028-00-1
reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;
2-ethylhexyl di-D-glucopyranoside
414-420-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318
614-029-00-7
constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside
419-640-0
68784-14-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
615-001-00-7
methyl isocyanate
210-866-3
624-83-9
Flam. Liq. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Resp. Sens. 1
Skin Sens. 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H225
H361d*** H330
H311
H301
H334
H317
H335
H315
H318
GHS02
GHS06
GHS05
GHS08
Dgr
H225
H361d*** H330
H311
H301
H334
H317
H335
H315
H318
615-002-00-2
methyl isothiocyanate
209-132-5
556-61-6
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H301
H314
H317
H410
615-003-00-8
thiocyanic acid
207-337-4
463-56-9
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
EUH032
615-004-00-3
salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
EUH032
A
615-005-00-9
4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate; [1]
2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate; [2]
o-(p-isocyanatobenzyl)phenyl isocyanate;
diphenylmethane-2,4'-diisocyanate; [3]
methylenediphenyl diisocyanate [4]
202-966-0 [1]
219-799-4 [2]
227-534-9 [3]
247-714-0 [4]
101-68-8 [1]
2536-05-2 [2]
5873-54-1 [3]
26447-40-5 [4]
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H351
H332
H373**
H319
H335
H315
H334
H317
GHS08
GHS07
Dgr
H351
H332
H373**
H319
H335
H315
H334
H317
Eye Irrit. 2; H319:
C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1 %
STOT SE 3; H335: C ≥ 5 %
C2
615-006-00-4
2-methyl-m-phenylene diisocyanate;
toluene-2,4-di-isocyanate; [1]
4-methyl-m-phenylene diisocyanate;
toluene-2,6-di-isocyanate; [2]
m-tolylidene diisocyanate;
toluene-diisocyanate [3]
202-039-0 [1]
209-544-5 [2]
247-722-4 [3]
91-08-7 [1]
584-84-9 [2]
26471-62-5 [3]
Carc. 2
Acute Tox. 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H351
H330
H319
H335
H315
H334
H317
H412
GHS06
GHS08
Dgr
H351
H330
H319
H335
H315
H334
H317
H412
Resp. Sens. 1; H334: C ≥
0,1 %
C
615-007-00-X
1,5-naphthylene diisocyanate
221-641-4
3173-72-6
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Aquatic Chronic 3
H332
H319
H335
H315
H334
H412
GHS08
GHS07
Dgr
H332
H319
H335
H315
H334
H412
615-008-00-5
3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate
223-861-6
4098-71-9
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2
H331
H319
H335
H315
H334
H317
H411
GHS06
GHS08
GHS09
Dgr
H331
H319
H335
H315
H334
H317
H411
*
Resp. Sens. 1; H334: C ≥0,5 %
Skin Sens.1; H317: C ≥0,5 %
2
615-009-00-0
4,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate
225-863-2
5124-30-1
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H331
H319
H335
H315
H334
H317
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
H317
*
Resp. Sens. 1; H334: C ≥0,5 %
Skin Sens. 1; H317: C ≥0,5 %
2
615-010-00-6
2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]
2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]
241-001-8 [1]
239-714-4 [2]
16938-22-0 [1]
15646-96-5 [2]
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H331
H319
H335
H315
H334
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
*
Resp. Sens. 1; H334: C ≥0,5 %
Skin Sens. 1; H317: C ≥0,5 %
C2
615-011-00-1
hexamethylene-di-isocyanate
212-485-8
822-06-0
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H331
H319
H335
H315
H334
H317
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
H317
*
Resp. Sens. 1; H334: C ≥
0,5 %
Skin Sens. 1; H317: C ≥0,5 %
2
615-012-00-7
4-isocyanatosulphonyltoluene;
tosyl isocyanate
223-810-8
4083-64-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
EUH014
Eye Irrit.;
H319: C ≥ 5 %
STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 %
615-014-00-8
tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate
—
7276-58-6
Acute Tox. 4 *
H302
GHS07
Wng
H302
615-015-00-3
1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;
isobornyl thiocyanoacetate
204-081-5
115-31-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
615-016-00-9
potassium cyanate
209-676-3
590-28-3
Acute Tox. 4 *
H302
GHS07
Wng
H302
615-017-00-4
calcium cyanamide
205-861-8
156-62-7
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H302
H335
H318
GHS05
GHS07
Dgr
H302
H335
H318
615-018-00-X
2-(2-butoxyethoxy)ethyl thiocyanate
203-985-7
112-56-1
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
H226
H311
H301
GHS02
GHS06
Dgr
H226
H311
H301
615-019-00-5
dicyclohexylcarbodiimide
208-704-1
538-75-0
Acute Tox. 3 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H311
H302
H318
H317
GHS06
GHS05
Dgr
H311
H302
H38
H317
615-020-00-0
methylene dithiocyanate
228-652-3
6317-18-6
Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
H330
H301
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H330
H301
H314
H317
H400
615-021-00-6
1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;
TGIC
219-514-3
2451-62-9
Muta. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H340
H331
H301
H373 **
H318
H317
H412
GHS06
GHS08
GHS05
Dgr
H340
H331
H301
H373 **
H318
H317
H412
615-022-00-1
methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate
410-550-7
79277-18-2
STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
H373**
H334
H317
GHS08
Dgr
H373**
H334
H317
EUH014
615-023-00-7
2-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate
410-900-9
83056-32-0
Flam. Liq. 3
Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1
H226
H341
H332
H373 **
H318
H334
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H341
H332
H373 **
H318
H334
EUH014
615-024-00-2
2-phenylethylisocyanate
413-080-0
1943-82-4
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2
H331
H302
H314
H334
H317
H411
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H314
H334
H317
H411
615-025-00-8
4,4'-ethylidenediphenyl dicyanate
405-740-1
47073-92-7
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H373 **
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H332
H302
H373 **
H318
H410
615-026-00-3
4,4'-methylenebis(2,6-dimethylphenyl cyanate)
405-790-4
101657-77-6
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
615-028-00-4
ethyl 2-(isocyanatosulfonyl)benzoate
410-220-2
77375-79-2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H302
H373**
H318
H334
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H334
H317
EUH014
615-029-00-X
2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane
411-280-2
—
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H330
H302
H314
H334
H317
H412
GHS06
GHS08
GHS05
Dgr
H330
H302
H314
H334
H317
H412
615-030-00-5
alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
A
615-031-00-0
thallium thiocyanate
222-571-7
3535-84-0
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2
Aquatic Chronic 2
H330
H300
H312
H373**
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H312
H373**
H411
615-032-00-6
metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
A
615-033-00-1
reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)
430-980-9
—
Aquatic Chronic 4
H413
—
H413
615-034-00-7
reaction product of diphenylmethanediisocyanate, octylamine,
4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)
430-750-8
—
Aquatic Chronic 4
H413
—
H413
615-035-00-2
reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio
1:1.86:0.14)
430-930-6
122886-55-9
Aquatic Chronic 4
H413
—
H413
615-036-00-8
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers:
65 % 2,4-and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)
430-940-0
—
Aquatic Chronic 4
H413
—
H413
615-037-00-3
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)
430-950-5
—
Aquatic Chronic 4
H413
—
H413
615-038-00-9
reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline
(molarratio 1:2)
430-960-1
—
Aquatic Chronic 4
H413
—
H413
615-039-00-4
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)
430-970-4
—
Aquatic Chronic 4
H413
—
H413
615-044-00-1
4-chlorophenylisocyanate
203-176-9
104-12-1
Acute Tox. 2 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H335
H315
H318
H334
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H330
H302
H335
H315
H318
H334
H410
615-045-00-7
4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)
420-530-1
—
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Dgr
H334
H317
H413
616-001-00-X
N, N-dimethylformamide;
dimethyl formamide
200-679-5
68-12-2
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
H360D *** H332
H312
H319
GHS08
GHS07
Dgr
H360D *** H332
H312
H319
616-002-00-5
2-fluoroacetamide
211-363-1
640-19-7
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311
616-003-00-0
acrylamide;
prop-2-enamide
201-173-7
79-06-1
Carc. 1B
Muta. 1B Repr. 2
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H350
H340
H361f *** H301
H372 **
H332
H312
H319
H315
H317
GHS06
GHS08
Dgr
H350
H340
H361f *** H301
H372 **
H332
H312
H319
H315
H317
D
616-004-00-6
allidochlor (ISO);
N,N-diallylchloroacetamide
202-270-7
93-71-0
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H312
H302
H319
H315
H411
GHS07
GHS09
Wng
H312
H302
H319
H315
H411
616-005-00-1
chlorthiamid (ISO);
2,6-dichloro (thiobenzamide)
217-637-7
1918-13-4
Acute Tox. 4 *
H302
GHS07
Wng
H302
616-007-00-2
diphenamid (ISO);
N, N-dimethyl-2,2-diphenylacetamide
213-482-4
957-51-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-008-00-8
propachlor (ISO);
2-chloro-N-isopropylacetanilide;
α-chloro-N-isopropylacetanilide
217-638-2
1918-16-7
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H317
H400
H410
GHS07
GHS09
Wng
H302
H319
H317
H410
616-009-00-3
propanil (ISO);
3',4'-dichloropropionanilide
211-914-6
709-98-8
Acute Tox. 4 *
Aquatic Acute 1
H302
H400
GHS07
GHS09
Wng
H302
H400
M=10
616-010-00-9
tosylchloramide sodium
204-854-7
127-65-1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
H302
H314
H334
GHS08
GHS05
GHS07
Dg
H302
H314
H334
EUH031
616-012-00-X
N-(dichlorofluoromethylthio)phthalimide;
N-(fluorodichloromethylthio)phthalimide
211-952-3
719-96-0
Skin Irrit. 2
H315
GHS07
Wng
H315
616-013-00-5
butyraldehyde oxime
203-792-8
110-69-0
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
H311
H302
H319
GHS06
Dgr
H311
H302
H319
616-014-00-0
2-butanone oxime;
ethyl methyl ketoxime;
ethyl methyl ketone oxime
202-496-6
96-29-7
Carc. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H351
H312
H318
H317
GHS08
GHS05
GHS07
Dgr
H351
H312
H318
H317
616-015-00-6
alachlor (ISO);
2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide
240-110-8
15972-60-8
Carc. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H317
H410
M=10
616-016-00-1
1-(3,4-dichlorophenylimino)
thiosemicarbazide
—
5836-73-7
Acute Tox. 2 *
H300
GHS06
Dgr
H300
616-017-00-7
cartap hydrochloride
239-309-2
15263-52-2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
616-018-00-2
N,N-diethyl-m-toluamide;
deet
205-149-7
134-62-3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H315
H412
GHS07
Wng
H302
H319
H315
H412
616-019-00-8
perfluidone (ISO);
1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide;
253-718-3
37924-13-3
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
616-020-00-3
tebuthiuron (ISO);
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
251-793-7
34014-18-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
616-021-00-9
thiazafluron (ISO);
1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea
246-901-4
25366-23-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
616-022-00-4
acetamide
200-473-5
60-35-5
Carc. 2
H351
GHS08
Wng
H351
616-023-00-X
N-hexadecyl(or octadecyl)-N-hexadecyl (or octadecyl)benzamide
401-980-6
—
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
616-024-00-5
2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide
402-260-4
54942-74-4
Aquatic Chronic 4
H413
—
H413
616-025-00-0
valinamide
402-840-7
20108-78-5
Repr. 2
Eye Irrit. 2
Skin Sens. 1
H361f *** H319
H317
GHS08
Wng
H361f *** H319
H317
616-026-00-6
thioacetamide
200-541-4
62-55-5
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H350
H302
H319
H315
H412
GHS08
GHS07
Dgr
H350
H302
H319
H315
H412
616-027-00-1
tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate
403-760-5
—
Skin Sens. 1
H317
GHS07
Wng
H317
616-028-00-7
N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide
403-790-9
108673-51-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-029-00-2
N, N'-ethylenebis(vinylsulfonylacetamide)
404-790-1
66710-66-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
616-030-00-8
ethidimuron (ISO);
1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
250-010-6
30043-49-3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
616-031-00-3
dimethachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide;
256-625-6
50563-36-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
616-032-00-9
diflufenican (ISO);
N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide
—
83164-33-4
Aquatic Chronic 3
H412
—
H412
616-033-00-4
cyprofuram (ISO);
N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide
274-050-9
69581-33-5
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
616-034-00-X
pyracarbolid; (ISO);
3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide
246-419-4
24691-76-7
Aquatic Chronic 3
H412
—
H412
616-035-00-5
cymoxanil (ISO);
2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
261-043-0
57966-95-7
Repr. 2
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H373 (blood, thymus)
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361fd
H302
H373 (blood, thymus)
H317
H410
M = 1
M = 1
616-036-00-0
2-chloracetamide
201-174-2
79-07-2
Repr. 2
Acute Tox. 3 *
Skin Sens. 1
H361f *** H301
H317
GHS06
GHS08
Dgr
H361f *** H301
H317
Skin Sens. 1; H317: C ≥ 0,1 %
616-038-00-1
(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride
406-010-5
88918-84-7
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
616-039-00-7
3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide
406-200-8
117827-06-2
Skin Sens. 1
H317
GHS07
Wng
H317
616-040-00-2
potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide
406-650-5
97888-41-0
Eye Dam. 1
H318
GHS05
Dgr
H318
616-041-00-8
3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide
406-840-8
101664-25-9
Aquatic Chronic 4
H413
—
H413
616-042-00-3
N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide
407-070-5
142859-67-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-043-00-9
isoxaben (ISO);
N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide
407-190-8
82558-50-7
Aquatic Chronic 4
H413
—
H413
616-044-00-4
N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide
402-510-2
—
Aquatic Chronic 2
H411
GHS09
H411
616-045-00-X
2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide
405-190-2
122371-93-1
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-046-00-5
N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide
406-390-2
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-047-00-0
reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N, N-di(C16)alkylacetamide;
2,2',2'',2'''-(ethylenedinitrilotetrakis-N, N-di(C18)alkylacetamide
406-640-0
—
Skin Sens. 1
H317
GHS07
Wng
H317
616-048-00-6
3'-trifluoromethylisobutyranilide
406-740-4
1939-27-1
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411
616-049-00-1
2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide
408-150-2
99141-89-6
Aquatic Chronic 4
H413
—
H413
616-050-00-7
lufenuron (ISO);
N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
410-690-9
103055-07-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
616-051-00-2
reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;
2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene
411-070-0
—
Aquatic Chronic 4
H413
—
H413
616-052-00-8
formamide
200-842-0
75-12-7
Repr. 1B
H360D ***
GHS08
Dgr
H360D ***
616-053-00-3
N-methylacetamide
201-182-6
79-16-3
Repr. 1B
H360D ***
GHS08
Dgr
H360D ***
616-054-00-9
iprodione (ISO);
3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide
253-178-9
36734-19-7
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
616-055-00-4
propyzamide (ISO);
3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide
245-951-4
23950-58-5
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
616-056-00-X
N-methylformamide
204-624-6
123-39-7
Repr. 1B
Acute Tox. 4 *
H360D *** H312
GHS08
GHS07
Dg
H360D *** H312
616-057-00-5
reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide;
2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;
N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide
412-790-8
—
Carc. 1B
Muta. 2
STOT RE 2 *
H350
H341
H373 **
GHS08
Dgr
H350
H341
H373 **
616-058-00-0
1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene
412-570-1
119462-56-5
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H318
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H373 **
H318
H317
H410
616-059-00-6
4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide
412-650-6
121487-83-0
Aquatic Chronic 4
H413
—
H413
616-060-00-1
condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily
amino-ethyl-piperazine and triethylenetetramine)
413-770-1
—
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
616-061-00-7
N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide
413-610-0
124172-53-8
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
616-062-00-2
N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide
411-590-8
70693-57-1
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
616-063-00-8
3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione
411-920-0
106917-30-0
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H373 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H373 **
H314
H410
616-064-00-3
N—tert-butyl-3-methylpicolinamide
406-720-5
32998-95-1
Aquatic Chronic 3
H412
—
H412
616-065-00-9
3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea
411-970-3
79881-89-3
Acute Tox. 4 *
STOT RE 2 *
H302
H373 **
GHS08
GHS07
Wng
H302
H373 **
616-066-00-4
5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone
405-100-1
115662-06-1
Repr. 2
H361f ***
GHS08
Wng
H361f ***
616-067-00-X
dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate
407-300-4
92683-20-0
Aquatic Chronic 4
H413
—
H413
616-068-00-5
potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate
406-500-9
174393-75-0
Skin Sens. 1
H317
GHS07
Wng
H317
616-069-00-0
1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide
406-210-2
110560-22-0
Aquatic Chronic 4
H413
—
H413
616-070-00-6
reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;
3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
406-530-2
—
Aquatic Chronic 4
H413
—
H413
616-071-00-1
reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;
bis(N-octadecyl-N'-phenyleneureido)methylene;
bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)
406-550-1
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-072-00-7
1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine
407-120-6
55612-11-8
Aquatic Chronic 4
H413
—
H413
616-073-00-2
4'-ethoxy-2-benzimidazoleanilide
407-600-5
120187-29-3
Muta. 2
Aquatic Chronic 4
H341
H413
GHS08
Wng
H341
H413
616-074-00-8
N-butyl-2-(4-morpholinylcarbonyl)benzamide
407-730-2
104958-67-0
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412
616-075-00-3
D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)
408-120-9
65197-96-8
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
616-076-00-9
tebufenozide (ISO);
N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide
412-850-3
112410-23-8
Aquatic Chronic 2
H411
GHS09
H411
616-077-00-4
reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;
potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate
411-310-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318
616-078-00-X
2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide
411-330-3
104541-33-5
Aquatic Chronic 4
H413
—
H413
616-079-00-5
1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate
411-700-4
140921-24-0
Skin Sens. 1
H317
GHS07
Wng
H317
616-080-00-0
4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)
411-850-0
119018-29-0
Aquatic Chronic 3
H412
—
H412
616-081-00-6
5-bromo-8-naphtholactam
413-480-5
24856-00-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
616-082-00-1
N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide
413-200-1
129604-78-0
Skin Sens. 1
H317
GHS07
Wng
H317
616-083-00-7
[2-[(4-nitrophenyl)amino]ethyl]urea
410-700-1
27080-42-8
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
616-084-00-2
2,4-bis[N'-(4-methylphenyl)ureido]toluene
411-790-5
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-085-00-8
3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione
412-190-6
168900-02-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-086-00-3
2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene
412-250-1
102387-48-4
Aquatic Chronic 4
H413
—
H413
616-087-00-9
reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;
7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate
412-260-6
52658-19-2
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H317
H411
GHS07
GHS09
Wng
H319
H317
H411
616-088-00-4
2-aminosulfonyl-N, N-dimethylnicotinamide
413-440-7
112006-75-4
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
616-089-00-X
5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran
415-360-8
41107-56-6
Muta. 2
H341
GHS08
Wng
H341
616-090-00-5
1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride
415-660-9
70918-74-0
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411
616-091-00-0
1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione
423-400-0
59653-74-6
Muta. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H340
H331
H302
H373 **
H318
H317
GHS06
GHS08
GHS05
Dgr
H340
H331
H302
H373 **
H318
H317
616-092-00-6
polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N, N-di-2-propenylformamide
404-035-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-093-00-1
reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride
406-620-1
129217-90-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-095-00-2
3,3'-dioctadecyl-1,1'-methylene
bis(4,1-phenylene)diurea
406-690-3
43136-14-7
Aquatic Chronic 4
H413
—
H413
616-096-00-8
N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide
408-110-4
110483-07-3
Aquatic Chronic 4
H413
—
H413
616-097-00-3
N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide
411-840-6
83372-55-8
Aquatic Chronic 4
H413
—
H413
616-098-00-9
1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide
411-750-7
119126-15-7
Aquatic Chronic 2
H411
GHS09
H411
616-099-00-4
2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide
414-170-2
135937-20-1
Aquatic Chronic 4
H413
—
H413
616-100-00-8
1,3-dimethyl-1,3-bis(trimethylsilyl)urea
414-180-7
10218-17-4
Acute Tox. 4 *
Skin Irrit. 2
H302
H315
GHS07
Wng
H302
H315
616-101-00-3
(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide
414-600-9
149182-72-9
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-102-00-9
reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);
1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;
1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]
415-870-0
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-103-00-4
(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide
415-030-3
120298-38-6
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
616-104-00-X
benalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate
275-728-7
71626-11-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-105-00-5
chlorotoluron (ISO);
3-(3-chloro-p-tolyl)-1,1-dimethylurea
239-592-2
15545-48-9
Carc. 2
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d *** H400
H410
GHS08
GHS09
Wng
H351
H361d *** H410
616-106-00-0
phenmedipham (ISO);
methyl 3-(3-methylcarbaniloyloxy)carbanilate
237-199-0
13684-63-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-107-00-6
cinidon ethyl (ISO);
ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate
—
142891-20-1
Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410
616-108-00-1
iodosulfuron-methyl-sodium; sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide
—
144550-36-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-109-00-7
sulfosulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea
—
141776-32-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-110-00-2
cyclanilide (ISO);
1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid
419-150-7
113136-77-9
Acute Tox. 4 * Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
616-111-00-8
fenhexamid (ISO);
N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid
422-530-5
126833-17-8
Aquatic Chronic 2
H411
GHS09
H411
616-112-00-3
oxasulfuron (ISO);
oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate
—
144651-06-9
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410
616-113-00-9
desmedipham (ISO);
ethyl 3-phenylcarbamoyloxyphenylcarbamate
237-198-5
13684-56-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=10
616-114-00-4
dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-
418-010-2
136897-58-0
Aquatic Chronic 4
H413
—
H413
616-115-00-X
N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide
416-150-9
136450-06-1
Aquatic Chronic 4
H413
—
H413
616-116-00-5
N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate
416-790-9
143052-96-4
Aquatic Chronic 4
H413
—
H413
616-117-00-0
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide
416-860-9
777891-21-1
Repr. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f *** H317
H400
H410
GHS08
GHS09
Wng
H361f *** H317
H410
616-118-00-6
N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride
417-950-0
65797-42-4
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-119-00-1
2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide
418-060-5
118020-93-2
Aquatic Chronic 4
H413
—
H413
616-120-00-7
reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;
N-(3-dimethylamino-2-methyl-phenyl)-benzamide;
N-(3-dimethylamino-3-methyl-phenyl)-benzamide
420-600-1
—
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411
616-121-00-2
2,4-dihydroxy-N-(2-methoxyphenyl)benzamide
419-090-1
129205-19-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-122-00-8
methyl neodecanamide
414-460-9
105726-67-8
Acute Tox. 4 *
H302
GHS07
Wng
H302
616-123-00-3
N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide
414-740-0
96141-86-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-124-00-9
lithium bis(trifluoromethylsulfonyl)imide
415-300-0
90076-65-6
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Chronic 3
H311
H301
H373**
H314
H412
GHS06
GHS05
GHS08
Dgr
H311
H301
H373**
H314
H412
616-125-00-4
3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide
415-730-9
151338-11-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
410
616-126-00-X
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide
423-960-6
139756-01-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412
616-127-00-5
reaction mass of: N, N'-Ethane-1,2-diylbis(decanamide);
12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;
N, N'-Ethane-1,2-diylbis(12hydroxyoctadecanamide)
430-050-2
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-128-00-0
N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide
417-530-7
123590-00-1
Aquatic Chronic 4
H413
—
H413
616-129-00-6
N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide
419-710-0
42774-15-2
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
616-130-00-1
N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide
421-780-2
150919-56-5
Aquatic Chronic 4
H413
—
H413
616-131-00-7
1-aminocyclopentanecarboxamide
422-950-9
17193-28-1
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
H372**
H302
H318
GHS05
GHS08
GHS07
Dgr
H372**
H302
H318
616-132-00-2
N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide
423-250-6
130016-98-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-133-00-8
N-cyclohexyl-S, S-dioxo
benzo[b]tiophene-2-carboxamide
423-990-1
149118-66-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
616-134-00-3
3,3'-bis(dioctyloxyphosphinothioylthio)-N, N'-oxybis(methylene)dipropionamide
401-820-5
793710-14-2
Aquatic Chronic 3
H412
—
H412
616-135-00-9
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide
430-230-0
136522-17-3
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-136-00-4
reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)
430-380-7
—
Aquatic Chronic 2
H411
GHS09
H411
616-137-00-X
4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane
401-130-4
71526-07-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-138-00-5
benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide
431-600-4
112226-61-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-139-00-0
(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide
420-380-5
136465-81-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
616-140-00-6
N, N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]
429-380-1
133336-92-2
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-141-00-1
zoxamide (ISO);
(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide
—
156052-68-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M=10
616-142-00-7
1,3-bis(vinylsulfonylacetamido)propane
428-350-3
93629-90-4
Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H341
H318
H317
H412
GHS08
GHS05
GHS07
Dgr
H341
H318
H317
H412
616-143-00-2
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide
422-560-9
149591-38-8
Repr. 2
Eye Irrit. 2
Aquatic Chronic 4
H361f *** H319
H413
GHS08
Wng
H361f *** H319
H413
616-144-00-8
3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-130-1
—
Aquatic Chronic 4
H413
—
H413
616-145-00-3
pethoxamide (ISO);
2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1enyl)acetamide
—
106700-29-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
M=100
616-146-00-9
N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide
431-330-7
142776-95-2
Aquatic Chronic 4
H413
—
H413
616-147-00-4
1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide
424-160-1
139481-22-4
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-148-00-X
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide
424-550-1
84245-12-5
Carc. 1B
Muta. 1B
Repr. 1B
H350
H340
H360FD
GHS08
Dgr
H350
H340
H360FD
616-150-00-0
(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride
425-260-6
—
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H373**
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H373**
H318
H317
H411
616-151-00-6
N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide
425-650-6
171887-03-9
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
616-152-00-1
4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide
425-850-3
125971-96-2
Aquatic Chronic 4
H413
—
H413
616-153-00-7
4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide
425-860-8
125971-57-5
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-154-00-2
3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-110-0
—
Aquatic Chronic 4
H413
—
H413
616-155-00-8
N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide
431-040-0
104560-40-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-156-00-3
6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide
430-500-8
204277-61-2
Aquatic Chronic 4
H413
—
H413
616-157-00-9
3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride
427-780-9
114565-70-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
616-158-00-4
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide
427-880-2
90357-53-2
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411
616-160-00-5
2,2'-azobis[N-(2-hydroxyethyl)2-methylpropionamide]
429-090-3
61551-69-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
616-161-00-0
2,4-dichloro-5-hydroxyacetanilide
429-110-0
67669-19-6
Aquatic Chronic 3
H412
—
H412
616-162-00-6
isostearic acid monoisopropanolamide
431-540-9
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
616-163-00-1
4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]
430-350-3
192463-88-0
Aquatic Chronic 4
H413
—
H413
616-164-00-7
dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide
—
149961-52-4
Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d***
H332
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361d***
H332
H410
M=10
616-165-00-2
beflubutamid (ISO);
(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide
—
113614-08-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=100
616-166-00-8
cyazofamid (ISO);
4-chloro-2-cyano-N, N-dimethyl-5-p-tolylimidazole-1-sulfonamide
—
120116-88-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M=10
616-167-00-3
N, N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide
418-290-6
168612-06-4
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
616-168-00-9
1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium
418-440-0
136997-71-2
Skin Sens. 1
H317
GHS07
Wng
H317
616-169-00-4
4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one
420-220-4
92771-56-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-170-00-X
(2R)-2-amino-2-phenylacetamide
420-370-0
6485-67-2
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
616-171-00-5
2-(para-chlorophenyl)glycineamide
420-830-0
102333-75-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
616-172-00-0
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetra
methyl-1-piperidinyl)oxidanyl
423-840-3
14691-89-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
616-174-00-1
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride
424-560-4
151257-01-1
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
616-175-00-7
2-(2-hexyldecyloxy)benzamide
431-230-3
202483-62-3
Aquatic Chronic 4
H413
—
H413
616-176-00-2
3-N, N-bis(methoxyethyl)aminoacetanilide
432-530-7
24294-01-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
616-177-00-8
(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
N-[3-({4-[(2-{]butyl[}(4methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3yl[}amino)-4-chlorophenyl]tetradecanamide
432-970-1
217324-98-6
Aquatic Chronic 4
H413
—
H413
616-178-00-3
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide
434-500-9
52583-35-4
Aquatic Chronic 4
H413
—
H413
616-179-00-9
2-chloro-N-(4-methylphenyl)acetamide
435-170-9
16634-82-5
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
616-180-00-4
N, N-(dimethylamino)thioacetamide hydrochloride
435-470-1
27366-72-9
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D*** H400
H410
GHS08
GHS09
Dgr
H360D*** H410
616-181-00-X
4'-methyldodecane-1-sulfonanilide
435-490-9
17417-32-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-182-00-5
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide
435-860-1
214417-91-1
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
616-183-00-0
N-dodecyl-4-methoxybenzamide
442-340-6
1854-15-5
Aquatic Chronic 4
H413
—
H413
616-184-00-6
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide
442-560-2
105043-55-8
Aquatic Chronic 4
H413
—
H413
616-186-00-7
N, N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)
443-010-4
53641-10-4
Aquatic Chronic 3
H412
—
H412
616-188-00-8
2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide
443-980-9
221215-20-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-189-00-3
N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide
444-780-4
452962-97-9
Aquatic Chronic 4
H413
—
H413
616-190-00-9
N-decyl-4-nitrobenzamide
445-880-0
64026-19-3
Aquatic Chronic 4
H413
—
H413
616-191-00-4
2-ethyl-N-methyl-N-(3-methylphenyl)butanamide
446-190-2
406488-30-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H319
H315
H317
H411
GHS07
GHS09
Wng
H302
H319
H315
H317
H411
616-192-00-X
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide
448-060-0
727678-39-9
Aquatic Chronic 4
H413
—
H413
616-193-00-5
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide
449-940-7
368450-39-9
Aquatic Chronic 4
H413
—
H413
616-194-00-0
2,2-diethoxy-N, N-dimethylacetamide
449-950-1
34640-92-1
Eye Irrit. 2
H319
GHS07
Wng
H319
616-196-00-1
disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide
419-990-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
616-197-00-7
reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane
sulfonamide
422-500-1
—
STOT RE 2 *
H373**
GHS08
Wng
H373**
616-198-00-2
1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene
423-300-7
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
616-200-00-1
reaction mass of N, N’-ethane1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N, N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide)
432-430-3
Aquatic Chronic 4
H413
H413
616-201-00-7
12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine
432-840-2
220926-97-6
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413
616-202-00-2
reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide
434-330-5
—
Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Wng
H351
H317
H413
616-203-00-8
reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol5-ylazo)5-diethylaminophenyl]acetamide
442-280-0
—
Aquatic Chronic 4
H413
—
H413
616-204-00-3
N, N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]
451-060-3
122886-55-9
Aquatic Chronic 4
H413
—
H413
616-205-00-9
metazachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)-acetamide
266-583-0
67129-08-2
Skin Sens. 1B
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H317
H351
H400
H410
GHS07
GHS08
GHS09
Wng
H317
H351
H410
M = 100
M = 100
616-206-00-4
flufenoxuron (ISO);
1-(4-(2-cloro-α, α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea
417-680-3
101463-69-8
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
H410
M = 10 000
M = 10 000
616-208-00-5
N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one
220-250-6
2687-91-4
Repr. 1B
H360D
GHS08
Dgr
H360D
616-209-00-0
amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea
407-380-0
120923-37-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
M = 100
M = 100
616-210-00-6
tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide
119168-77-3
Acute Tox. 3
Acute Tox. 4
STOT RE 2
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H373 (gastro-intestinal tract) (Oral)
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H332
H373 (gastro-intestinal tract) (Oral)
H317
H410
M = 10
M = 10
616-211-00-1
proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one
189278-12-4
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
M = 1
M = 10
616-212-00-7
3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate
259-627-5
55406-53-6
Acute Tox. 3
Acute Tox. 4
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H372 (larynx) H318
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H372 (larynx) H318
H317
H410
M = 10
M = 1
617-001-00-2
di-tert-butyl peroxide
203-733-6
110-05-4
Org. Perox. E Flam. Liq. 2 Muta. 2
H242
H225
H341
GHS02
GHS08
Dgr
H242
H225
H341
617-002-00-8
α, α-dimethylbenzyl hydroperoxide;
cumene hydroperoxide
201-254-7
80-15-9
Org. Perox. E
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Chronic 2
H242
H331
H312
H302
H373 **
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H242
H331
H312
H302
H373 **
H314
H411
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C
< 10 %
Eye Dam. 1; H318: 3 % ≤ C
< 10 %
Eye Irrit. 2; H319: 1 % ≤ C
< 3 %
STOT SE 3; H335: C < 10 %
617-003-00-3
dilauroyl peroxide
203-326-3
105-74-8
Org. Perox. D
H242
GHS02
Dgr
H242
617-004-00-9
1,2,3,4-tetrahydro-1-naphthyl hydroperoxide
212-230-0
771-29-9
Org. Perox. D
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H242
H302
H314
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H302
H314
H410
STOT SE 3; H335: C ≥ 5 %
617-006-00-X
bis(α, α-dimethylbenzyl)
peroxide
201-279-3
80-43-3
Org. Perox. F
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H242
H319
H315
H411
GHS02
GHS07
GHS09
Wng
H242
H319
H315
H411
617-007-00-5
tert-butyl α, α-dimethylbenzyl peroxide
222-389-8
3457-61-2
Org. Perox. E
Skin Irrit. 2
Aquatic Chronic 2
H242
H315
H411
GHS02
GHS07
GHS09
Wng
H242
H315
H411
617-008-00-0
dibenzoyl peroxide;
benzoyl peroxide
202-327-6
94-36-0
Org. Perox. B
Eye Irrit. 2
Skin Sens. 1
H241
H319
H317
GHS01
GHS02
GHS07
Dgr
H241
H319
H317
617-010-00-1
1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1’-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]
78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]
Org. Perox. A
Skin Corr. 1B
Acute Tox. 4 *
H240
H314
H302
GHS01
GHS05
GHS07
Dgr
H240
H314
H302
STOT SE 3; H335: C ≥ 5 %
C
617-010-01-9
1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide;
[3] cyclohexanone, peroxide [4] [≤ 91 % solution]
201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]
78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]
Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B
H242
H302
H314
GHS02
GHS05
GHS07
Dgr
H242
H302
H314
STOT SE 3; H335: C ≥ 5 %
C T
617-012-00-2
8-p-menthyl hydroperoxide;
p-menthane hydroperoxide
201-281-4
80-47-7
Org. Perox. D
Skin Corr. 1B
Acute Tox. 4 *
H242
H314
H332
GHS02
GHS05
GHS07
Dgr
H242
H314
H332
STOT SE 3; H335: C ≥ 5 %
617-013-00-8
O, O-tert-butyl O-docosyl monoperoxyoxalate
404-300-6
116753-76-5
Org. Perox. C **** Aquatic Acute 1
Aquatic Chronic 1
H242
H400
H410
GHS02
GHS09
Dgr
H242
H410
617-014-00-3
6-(nonylamino)-6-oxo-peroxyhexanoic acid
406-680-9
104788-63-8
Org. Perox. C **** Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H242
H318
H317
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H318
H317
H400
617-015-00-9
bis(4-methylbenzoyl)peroxide
407-950-9
895-85-2
Org. Perox. B **** Aquatic Acute 1
Aquatic Chronic 1
H241
H400
H410
GHS01
GHS02
GHS09
Dgr
H241
H410
617-016-00-4
3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate
413-910-1
—
Org. Perox. C **** Flam. Liq. 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H242
H226
H315
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H226
H315
H410
617-017-00-X
reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;
2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene
412-140-3
32144-25-5
Org. Perox. D
Aquatic Chronic 4
H242
H413
GHS02
Dgr
H242
H413
T
617-018-00-5
reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide,
63 % by weight;
1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight
410-840-3
71566-50-2
Org. Perox. C **** Aquatic Chronic 2
H242
H411
GHS02
GHS09
Dgr
H242
H411
T
617-019-00-0
6-(phthalimido)peroxyhexanoic acid
410-850-8
128275-31-0
Org. Perox. D
Eye Dam. 1
Aquatic Acute 1
H242
H318
H400
GHS02
GHS05
GHS09
DgDgr
H242
H318
H400
T
617-020-00-6
1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)
420-060-5
117663-11-3
Flam. Liq. 3
Org. Perox. D **** Aquatic Chronic 2
H226
H242
H411
GHS02
GHS09
Dgr
H226
H242
H411
617-021-00-1
methylethylketone peroxide trimer
429-320-2
—
Org. Perox. B****
Asp. Tox. 1
Skin Irrit. 2
Skin Sens. 1
H241
H304
H315
H317
GHS01
GHS02
GHS08
GHS07
Dgr
H241
H304
H315
H317
617-022-00-7
reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate
442-480-8
—
Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H242
H302
H314
H317
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H302
H314
H317
H411
647-001-00-8
glucosidase, β-
232-589-7
9001-22-3
Resp. Sens. 1
H334
GHS08
Dgr
H334
647-002-00-3
cellulase
232-734-4
9012-54-8
Resp. Sens. 1
H334
GHS08
Dgr
H334
647-003-00-9
cellobiohydrolase, exo-
253-465-9
37329-65-0
Resp. Sens. 1
H334
GHS08
Dgr
H334
647-004-00-4
cellulases with the exception of those specified elsewhere in this Annex
—
—
Resp. Sens. 1
H334
GHS08
Dgr
H334
A
647-005-00-X
bromelain, juice
232-572-4
9001-00-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-006-00-5
ficin
232-599-1
9001-33-6
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-007-00-0
papain
232-627-2
9001-73-4
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-008-00-6
pepsin A
232-629-3
9001-75-6
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-009-00-1
rennin
232-645-0
9001-98-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-010-00-7
trypsin
232-650-8
9002-07-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-011-00-2
chymotrypsin
232-671-2
9004-07-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-012-00-8
subtilisin
232-752-2
9014-01-1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
H335
H315
H318
H334
GHS08
GHS05
GHS07
Dgr
H335
H315
H318
H334
647-013-00-3
proteinase, microbial neutral
232-966-6
9068-59-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-014-00-9
proteases with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
647-015-00-4
amylase, α-
232-565-6
9000-90-2
Resp. Sens. 1
H334
GHS08
Dgr
H334
647-016-00-X
amylases with the exception of those specified elsewhere in this Annex
—
—
Resp. Sens. 1
H334
GHS08
Dgr
H334
647-017-00-5
laccase
420-150-4
80498-15-3
Resp. Sens. 1
H334
GHS08
Dgr
H334
648-001-00-0
Distillates (coal tar), benzole fraction;
Light Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80oC to 160 oC (175oF to 320oF).]
283-482-7
84650-02-2
Carc. 1B
H350
GHS08
Dgr
H350
648-002-00-6
Tar oils, brown-coal; Light Oil;
[The distillate from lignite tar boiling in the range of approximately 80 o C to 250 o C (176oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]
302-674-4
94114-40-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-003-00-1
Benzol forerunnings (coal); Light Oil Redistillate, low boiling;
[The distillate from coke oven light oil having an approximate distillation range below 100 o C (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.]
266-023-5
65996-88-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-004-00-7
Distillates (coal tar), benzole fraction, BTX-rich;
Light Oil Redistillate, low boiling;
[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).]
309-984-9
101896-26-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-005-00-2
Aromatic hydrocarbons, C6-10, C8-rich; Light Oil Redistillate, low boiling
292-697-5
90989-41-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-006-00-8
Solvent naphtha (coal), light; Light Oil Redistillate, low boiling
287-498-5
85536-17-0
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-007-00-3
Solvent naphtha (coal), xylene-styrene cut; Light Oil Redistillate, intermediate boiling
287-502-5
85536-20-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-008-00-9
Solvent naphtha (coal), coumarone-styrene contg.; Light Oil Redistillate, intermediate boiling
287-500-4
85536-19-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-009-00-4
Naphtha (coal), distn. residues;
Light Oil Redistillate, high boiling;
[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]
292-636-2
90641-12-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-010-00-X
Aromatic hydrocarbons, C8; Light Oil Redistillate, high boiling
292-694-9
90989-38-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-012-00-0
Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;
Light Oil Redistillate, high boiling;
[A complex combination of hydrocarbons obtained from the evaporation of solven under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 o C to 215 o C (248 oF to 419 oF).]
295-281-1
91995-20-9
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-013-00-6
Aromatic hydrocarbons, C9-12, benzene distn.;
Light Oil Redistillate, high boiling
295-551-9
92062-36-7
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-014-00-1
Extract residues (coal), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90o C to 160 o C (194oF to 320 oF). It consists predomi nantly of benzene, toluene and xylenes.]
295-323-9
91995-61-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-015-00-7
Extract residues (coal tar), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling;
[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC to 195o C (185oF to 383oF).]
309-868-8
101316-63-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-016-00-2
Extract residues (coal), benzole fraction acid;
Light Oil Extract Residues, low boiling;
[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]
298-725-2
93821-38-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-017-00-8
Extract residues (coal), light oil alk., distn. overheads;
Light Oil Extract Residues, low boiling;
[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145o C (293 oF).
Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]
292-625-2
90641-02-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-018-00-3
Extract residues (coal), light oil alk., acid ext., indene fraction;
Light Oil Extract Residues, intermediate boiling
309-867-2
101316-62-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-019-00-9
Extract residues (coal), light oil alk., indene naphtha fraction; Light Oil Extract Residues, high boiling;
[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed Carbolic oils, having an approximate boiling range of 155o C to 180o C (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.]
292-626-8
90641-03-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-020-00-4
Solvent naphtha (coal);
Light Oil Extract Residues, high boiling;
[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130o C to 210o C (266oF to 410oF). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]
266-013-0
65996-79-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-021-00-X
Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135o C to 210o C (275oF to 410oF). May also include unsaturated hydrocarbons such as indene and coumarone.]
309-971-8
101794-90-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-022-00-5
Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;
[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m-and p-cresol and boiling in the range of 140o C to 215o C (284 oF to 419 oF).]
292-609-5
90640-87-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-023-00-0
Distillates (coal tar), light oils; Carbolic Oil;
[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 o C to 210 o C (302 oF to 410 oF).]
283-483-2
84650-03-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-024-00-6
Tar oils, coal; Carbolic Oil;
[The distillate from high temperature coal tar having an approximate distillation range of 130 o C to 250 o C (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]
266-016-7
65996-82-9
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-026-00-7
Extract residues (coal), light oil alk., acid ext.;
Carbolic Oil Extract Residue; [The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases).
Composed primarily of indene, indan and alkylbenzenes.]
292-624-7
90641-01-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-027-00-2
Extract residues (coal), tar oil alk.;
Carbolic Oil Extract Residue; [The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]
266-021-4
65996-87-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-028-00-8
Extract oils (coal), light oil; Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-622-6
90640-99-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-029-00-3
Pyridine, alkyl derivs.; Crude Tar Bases;
[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approxi mately above 150o C (302oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]
269-929-9
68391-11-7
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-030-00-9
Tar bases, coal, picoline fraction;
Distillate Bases;
[Pyridine bases boiling in the range of approximately 125o C to 160o C (257oF 320oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]
295-548-2
92062-33-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-031-00-4
Tar bases, coal, lutidine fraction;
Distillate Bases
293-766-2
91082-52-9
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-032-00-X
Extract oils (coal), tar base, collidine fraction;
Distillate Bases;
[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]
273-077-3
68937-63-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-033-00-5
Tar bases, coal, collidine fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 181 o C to 186 o C (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]
295-543-5
92062-28-7
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-034-00-0
Tar bases, coal, aniline fraction; Distillate Bases;
[The distillation fraction boiling in the range of approximately 180o C to 200o C (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar.
It contains chiefly aniline, collidines, lutidines and toluidines.]
295-541-4
92062-27-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-035-00-6
Tar bases, coal, toluidine fraction;
Distillate Bases
293-767-8
91082-53-0
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-036-00-1
Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;
Redistillates;
[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately160 o C to 190 o C (320 oF to 374 oF).]
295-292-1
91995-31-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-037-00-7
Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190o C to 270o C (374oF to 518oF). Composed primarily of substituted dinuclear aromatics.]
295-295-8
91995-35-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-038-00-2
Extract oils (coal), coal tar-residual pyrolysis oils, naph thalene oil, redistillate; Redistillates;
[The redistillate from the fractional distillation of dephe nolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220o C to 230o C (428oF to 446oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]
295-329-1
91995-66-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-039-00-8
Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225o C to 255o C (437oF to 491oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.]
310-170-0
122070-79-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-040-00-3
Extract oils (coal), coal tar residual pyrolysis oils, naph thalene oil, distn. residues; Redistillates;
[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 o C to 260o C (464oF to 500oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]
310-171-6
122070-80-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-041-00-9
Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500oF to 554oF).]
309-851-5
101316-45-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-042-00-4
Distillates (coal tar), upper, fluorene-rich;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]
284-900-0
84989-11-7
Carc. 1B
H350
GHS08
Dgr
H350
M
648-043-00-X
Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate;
[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]
292-606-9
90640-85-0
Carc. 1B
H350
GHS08
Dgr
H350
M
648-044-00-5
Distillates (coal tar), heavy oils; Heavy Anthracene Oil; [Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240oC to 400oC (464oF to 752 oF). Composed primarily of tri-and polynuclear hydrocarbons and heterocyclic compounds.]
292-607-4
90640-86-1
Carc. 1B
H350
GHS08
Dgr
H350
648-045-00-0
Distillates (coal tar), upper; Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 220oC to 450oC (428oF to 842oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]
266-026-1
65996-91-0
Carc. 1B
H350
GHS08
Dgr
H350
M
648-046-00-6
Anthracene oil, acid ext.; Anthracene Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approxi mately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]
295-274-3
91995-14-1
Carc. 1B
H350
GHS08
Dgr
H350
M
648-047-00-1
Distillates (coal tar); Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distil lationrange of 100oC to 450oC (212oF to 842oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]
266-027-7
65996-92-1
Carc. 1B
H350
GHS08
Dgr
H350
M
648-048-00-7
Distillates (coal tar), pitch, heavy oils;
Heavy Anthracene Oil;
[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri-and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]
295-312-9
91995-51-6
Carc. 1B
H350
GHS08
Dgr
H350
M
648-049-00-2
Distillates (coal tar), pitch; Heavy Anthracene Oil;
[The oil obtained from condensation of the vapors from the heat treatment of pitch.
Composed primarily of two-to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]
309-855-7
101316-49-8
Carc. 1B
H350
GHS08
Dgr
H350
M
648-050-00-8
Distillates (coal tar), heavy oils, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri-and polynuclear aromatics and heterocyclic hydrocarbons.]
295-304-5
91995-42-5
Carc. 1B
H350
GHS08
Dgr
H350
M
648-051-00-3
Distillates (coal tar), pitch, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri-and polynuclear aromatic hydrocarbons and heterocyclic compounds.]
295-313-4
91995-52-7
Carc. 1B
H350
GHS08
Dgr
H350
M
648-052-00-9
Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;
Coal Tar Extract; [A complet combination of hydrocarbons obtained by the treatment of lignite carbon ization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-296-6
97926-76-6
Carc. 1B
H350
GHS08
Dgr
H350
M
648-053-00-4
Paraffin waxes (coal), brown-coal high-temp tar, clay-treated; Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-297-1
97926-77-7
Carc. 1B
H350
GHS08
Dgr
H350
M
648-054-00-X
Pitch; Pitch
263-072-4
61789-60-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-055-00-5
Pitch, coal tar, high-temp.; Pitch; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86oF to 356oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
266-028-2
65996-93-2
Carc. 1B
H350
GHS08
Dgr
H350
648-056-00-0
Pitch, coal tar, high-temp., heat-treated; Pitch; [The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80oC to180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
310-162-7
121575-60-8
Carc. 1B
H350
GHS08
Dgr
H350
M
648-057-00-6
Pitch, coal tar, high-temp., secondary;
Pitch Redistillate; [The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri-and polynuclear aromatic compounds which also contain heteroatoms.]
302-650-3
94114-13-3
Carc. 1B
H350
GHS08
Dgr
H350
M
648-058-00-1
Residues (coal tar), pitch distn.; Pitch Redistillate;
[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400oC to 470oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]
295-507-9
92061-94-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-059-00-7
Tar, coal, high-temp., distn. and storage residues;
Coal Tar Solids Residue;
[Coke-and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]
295-535-1
92062-20-9
Carc. 1B
H350
GHS08
Dgr
H350
M
648-060-00-2
Tar, coal, storage residues; Coal Tar Solids Residue;
[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]
293-764-1
91082-50-7
Carc. 1B
H350
GHS08
Dgr
H350
M
648-061-00-8
Tar, coal, high-temp., residues; Coal Tar Solids Residue;
[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]
309-726-5
100684-51-3
Carc. 1B
H350
GHS08
Dgr
H350
M
648-062-00-3
Tar, coal, high-temp., high-solids;
Coal Tar Solids Residue;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]
273-615-7
68990-61-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-063-00-9
Waste solids, coal-tar pitch coking;
Coal Tar Solids Residue;
[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]
295-549-8
92062-34-5
Carc. 1B
H350
GHS08
Dgr
H350
M
648-064-00-4
Extract residues (coal), brown; Coal Tar Extract;
[The residue from extraction of dried coal.]
294-285-0
91697-23-3
Carc. 1B
H350
GHS08
Dgr
H350
M
648-065-00-X
Paraffin waxes (coal), brown-coal-high-temp. tar;
Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-454-1
92045-71-1
Carc. 1B
H350
GHS08
Dgr
H350
M
648-066-00-5
Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;
Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predomi nantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-455-7
92045-72-2
Carc. 1B
H350
GHS08
Dgr
H350
M
648-067-00-0
Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-298-7
97926-78-8
Carc. 1B
H350
GHS08
Dgr
H350
M
648-068-00-6
Tar, coal, low-temp, distn. residues;
Tar Oil, intermediate boiling; [Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]
309-887-1
101316-85-2
Carc. 1B
H350
GHS08
Dgr
H350
M
648-069-00-1
Pitch, coal tar, low-temp; Pitch Residue;
[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-651-4
90669-57-1
Carc. 1B
H350
GHS08
Dgr
H350
M
648-070-00-7
Pitch, coal tar, low-temp., oxidized;
Pitch Residue, oxidised;
[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-654-0
90669-59-3
Carc. 1B
H350
GHS08
Dgr
H350
M
648-071-00-2
Pitch, coal tar, low-temp., heat-treated;
Pitch Residue, oxidised; Pitch Residue, heat-treated;
[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122oF to 284oF). Composed primarily of a complex mixture of aromatic compounds.]
292-653-5
90669-58-2
Carc. 1B
H350
GHS08
Dgr
H350
M
648-072-00-8
Distillates (coal-petroleum), condensed-ring arom;
Distillates;
[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428oF to 842oF). Composed primarily of 3-to 4-membered condensed ring aromatic hydrocarbons.]
269-159-3
68188-48-7
Carc. 1B
H350
GHS08
Dgr
H350
M
648-073-00-3
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived; Pyrolysis Products;
[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212oF to 428oF) according to DIN 52025.];
309-956-6
101794-74-5
Carc. 1B
H350
GHS08
Dgr
H350
M
648-074-00-9
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbonsobtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numberspredominantly in the range of C20 through C28 and having a softening pointof 100oC to 220oC (212oF to 428oF) according to DIN 52025.]
309-957-1
101794-75-6
Carc. 1B
H350
GHS08
Dgr
H350
M
648-075-00-4
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100oC to 220oC (212oF to 428oF) according to DIN 52025.]
309-958-7
101794-76-7
Carc. 1B
H350
GHS08
Dgr
H350
M
648-076-00-X
Pitch, coal tar-petroleum; Pitch Residues;
[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40oC to 180oC (140oF to 356oF). Composed; primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]
269-109-0
68187-57-5
Carc. 1B
H350
GHS08
Dgr
H350
M
648-077-00-5
Phenanthrene, distn. residues; Heavy Anthracene Oi Redistillate;
[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644oF to 788oF). It consists predominantly of phenanthrene, anthracene and carbazole.]
310-169-5
122070-78-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-078-00-0
Distillates (coal tar), upper, fluorene-free; Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]
284-899-7
84989-10-6
Carc. 1B
H350
GHS08
Dgr
H350
M
648-079-00-6
Anthracene oil; Anthracene oil;
[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC to 400 oC (572oF to 752oF). Composed primarily of phenanthrene, anthracene and carbazole.]
292-602-7
90640-80-5
Carc. 1B
H350
GHS08
Dgr
H350
M
648-080-00-1
Residues (coal tar), creosote oil distn.; Wash Oil Redistillate;
[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 o C to 330 o C (518 oF to 626 oF). It consists predomi nantly of dinuclear aromatic and heterocyclic hydrocarbons.]
295-506-3
92061-93-3
Carc. 1B
H350
GHS08
Dgr
H350
M
648-081-00-7
Tar, coal; Coal tar;
[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydrocarbons, phenolic compounds, nitrogen bases and thiophene.]
232-361-7
8007-45-2
Carc. 1A
H350
GHS08
Dgr
H350
648-082-00-2
Tar, coal, high-temp.; Coal tar; [The condensation product obtained by cooling, to approxi mately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]
266-024-0
65996-89-6
Carc. 1A
H350
GHS08
Dgr
H350
648-083-00-8
Tar, coal, low-temp.; Coal oil;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]
266-025-6
65996-90-9
Carc. 1A
H350
GHS08
Dgr
H350
648-084-00-3
Distillates (coal), coke-oven light oil, naphthalene cut; Naphthalene Oil;
[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298oF).]
285-076-5
85029-51-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-085-00-9
Distillates (coal tar), naphthalene oils; Naphthalene Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compound and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392oF to 482oF).]-
283-484-8
84650-04-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-086-00-4
Distillates (coal tar), naph thalene oils, naphthalene-low; Naphthalene Oil Redistillate; [A complex combination of hydrocarbons obtained by crys tallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]
284-898-1
84989-09-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-087-00-X
Distillates (coal tar), naphthalene oil crystn. mother liquor; Naphthalene Oil Redistillate;
[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]
295-310-8
91995-49-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-088-00-5
Extract residues (coal), naphthalene oil, alk.; Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]
310-166-9
121620-47-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-089-00-0
Extract residues (coal), naphthalene oil, alk., naphthalene-low;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]
310-167-4
121620-48-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-090-00-6
Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;
Naphthalene Oil Extract Residue;
[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]
292-612-1
90640-90-7
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-091-00-1
Extract residues (coal), naphthalene oil alk., distn. overheads;
Naphthalene Oil Extract Residue;
[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]
292-627-3
90641-04-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-092-00-7
Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437oF to 491 oF).]
309-985-4
101896-27-9
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-093-00-2
Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction; Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).]
309-972-3
101794-91-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-094-00-8
Distillates (coal tar), naphthalene oils, acid exts.; Methylnaphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446oF to 491oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]
295-309-2
91995-48-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-095-00-3
Extract residues (coal), naphthalene oil alk., distn. residues; Methylnaphthalene Oil Extract Residue; [The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428oF to 572oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]
292-628-9
90641-05-7
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-096-00-9
Extract oils (coal), acidic, tar-base free;
Methylnaphthalene Oil Extract Residue; [The extract oil boiling in the range of approximately 220 oC to 265 oC (428oF to 509oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]
284-901-6
84989-12-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-097-00-4
Distillates (coal tar), benzole fraction, distn. residues;
Wash Oil;
[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150o C to 300 oC (302oF to 572oF) or a semi-solid or solid with a melting point up to 70 oC (158oF). It is composed primarily of naphthalene and alkyl naphthalenes.]
310-165-3
121620-46-0
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-098-00-X
Creosote oil, acenaphthene fraction;
Wash Oil; [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 o C to 280 o C (464oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]
292-605-3
90640-84-9
Carc. 1B
H350
GHS08
Dgr
H350
M
648-099-00-5
Creosote oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392oF to 617oF).]
263-047-8
61789-28-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-100-00-9
Creosote oil, high-boiling distillate;
Wash Oil;
[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41oF).]
274-565-9
70321-79-8
Carc. 1B
H350
GHS08
Dgr
H350
M
648-101-00-4
Creosote;
[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]
232-287-5
8001-58-9
Carc. 1B
H350
GHS08
Dgr
H350
648-102-00-X
Extract residues (coal), creosote oil acid;
Wash Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482oF to 536oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]
310-189-4
122384-77-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-103-00-5
Anthracene oil, anthracene paste;
Anthracene Oil Fraction;
[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]
292-603-2
90640-81-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-104-00-0
Anthracene oil, anthracene-low; Anthracene Oil Fraction;
[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]
292-604-8
90640-82-7
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-105-00-6
Residues (coal tar), anthracene oil distn.; Anthracene Oil Fraction;
[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644oF to 752oF). It consists predominantly of tri-and polynuclear aromatic and heterocyclic hydrocarbons.]
295-505-8
92061-92-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-106-00-1
Anthracene oil, anthracene paste, anthracene fraction; Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626oF to 662oF). It contains chiefly anthracene, carbazole and phenanthrene.]
295-275-9
91995-15-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-107-00-7
Anthracene oil, anthracene paste, carbazole fraction; Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distil lation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662oF to 680 oF). It contains chiefly anthracene, carbazole and phenanthrene.]
295-276-4
91995-16-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-108-00-2
Anthracene oil, anthracene paste, distn. lights;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 oC to 340 oC (554oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.]
295-278-5
91995-17-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-109-00-8
Tar oils, coal, low-temp.; Tar Oil, high boiling;
[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320oF to 644oF).]
309-889-2
101316-87-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-110-00-3
Extract residues (coal), low temp. coal atar alk.;
[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]
310-191-5
122384-78-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-111-00-9
Phenols, ammonia liquor ext.; Alkaline Extract;
[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292oF)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]
284-881-9
84988-93-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-112-00-4
Distillates (coal tar), light oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-610-0
90640-88-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-113-00-X
Extracts, coal tar oil alk.; Alkaline Extract;
[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
266-017-2
65996-83-0
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-114-00-5
Distillates (coal tar), naphthalene oils, alk. exts.; Alkaline Extract;
[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-611-6
90640-89-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-115-00-0
Extract residues (coal), tar oil alk., carbonated, limed;
Crude Phenols; [The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]
292-629-4
90641-06-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-116-00-6
Tar acids, coal, crude; Crude Phenols;
[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]
266-019-3
65996-85-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-117-00-1
Tar acids, brown-coal, crude; Crude Phenols;
[An acidified alkaline extract of brown coal tar distillate.
Composed primarily of phenol and phenol homologs.]
309-888-7
101316-86-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-118-00-7
Tar acids, browncoal gasification;
Crude Phenols;
[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]
295-536-7
92062-22-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-119-00-2
Tar acids, distn. residues; Distillate Phenols;
[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140oF to 176oF).]
306-251-5
96690-55-0
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-120-00-8
Tar acids, methylphenol fraction;
Distillate Phenols;
[The fraction of tar acid rich in 3-and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-892-9
84989-04-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-121-00-3
Tar acids, polyalkylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437oF to 608oF). Composed primarily of polyalkylphenols.]
284-893-4
84989-05-9
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-122-00-9
Tar acids, xylenol fraction; Distillate Phenols;
[The fraction of tar acids, rich in 2,4-and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-895-5
84989-06-0
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-123-00-4
Tar acids, ethylphenol fraction; Distillate Phenols;
[The fraction of tar acids, rich in 3-and 4-ethylphenol, recovered by distillation of low-temperature coal tar rude tar acids.]
284-891-3
84989-03-7
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-124-00-X
Tar acids, 3,5-xylenol fraction; Distillate Phenols;
[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]
284-896-0
84989-07-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-125-00-5
Tar acids, residues, distillates, first-cut;
Distillate Phenols;
[The residue from the distillation in the range of 235 oC to 355 oC (481oF to 697oF) of light carbolic oil.]
270-713-1
68477-23-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-126-00-0
Tar acids, cresylic, residues; Distillate Phenols;
[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176oF). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]
271-418-0
68555-24-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-127-00-6
Phenols, C9-11; Distillate Phenols
293-435-2
91079-47-9
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-128-00-1
Tar acids, cresylic; Distillate Phenols;
[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). It contains chiefly phenols and pyridine bases.]
295-540-9
92062-26-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-129-00-7
Tar acids, brown-coal, C2-alkylphenol fraction;
Distillate Phenols;
[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). Composed primarily of m-and p-ethylphenol as well as cresols and xylenols.]
302-662-9
94114-29-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-130-00-2
Extract oils (coal), naphthalene oils;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali- washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-623-1
90641-00-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-131-00-8
Tar bases, quinoline derivs.; Distillate Bases
271-020-7
68513-87-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-132-00-3
Tar bases, coal, quinoline derivs. fraction;
Distillate Bases
274-560-1
70321-67-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-133-00-9
Tar bases, coal, distn. residues; Distillate Bases;
[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of oal tars. I contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]
295-544-0
92062-29-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-134-00-4
Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;
Heat Treatment Products; [The oil obtained from the heat treatment of a polyethylene/ polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).]
309-745-9
100801-63-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-135-00-X
Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158oF to 248oF).]
309-748-5
100801-65-8
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-136-00-5
Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils.
It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410oF).]
309-749-0
100801-66-9
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-137-00-0
Extract residues (coal), tar oil alk., naphthalene distn. residues; Naphthalene Oil Extract Residue;
[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]
277-567-8
73665-18-6
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-138-00-6
Creosote oil, low-boiling distillate;
Wash Oil;
[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).]
274-566-4
70321-80-1
Carc. 1B
H350
GHS08
Dgr
H350
M
648-139-00-1
Tar acids, cresylic, sodium salts, caustic solns.; Alkaline Extract
272-361-4
68815-21-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-140-00-7
Extract oils (coal), tar base; Acid Extract;
[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]
266-020-9
65996-86-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-141-00-2
Tar bases, coal, crude; Crude Tar Bases;
[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]
266-018-8
65996-84-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
JM
648-142-00-8
Residues (coal), liq. solvent extn.;
[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]
302-681-2
94114-46-2
Carc. 1B
H350
GHS08
Dgr
H350
M
648-143-00-3
Coal liquids, liq. solvent extn. soln.;
[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]
302-682-8
94114-47-3
Carc. 1B
H350
GHS08
Dgr
H350
M
648-144-00-9
Coal liquids, liq. solvent extn.; [The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]
302-683-3
94114-48-4
Carc. 1B
H350
GHS08
Dgr
H350
M
648-145-00-4
Tar brown-coal;
[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one-to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one-and two-ring phenols boiling in the range of approximately 150oC to 360 oC (302oF to 680oF).]
309-885-0
101316-83-0
Carc. 1A
H350
GHS08
Dgr
H350
648-146-00-X
Tar, brown-coal, low-temp.;
[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]
309-886-6
101316-84-1
Carc. 1A
H350
GHS08
Dgr
H350
648-147-00-5
Light oil (coal), coke-oven; Crude benzole;
[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1 292oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]
266-012-5
65996-78-3
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-148-00-0
Distillates (coal), liq. solvent extn., primary;
[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC 86 oF to 572 oF).
Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]
302-688-0
94114-52-0
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-149-00-6
Distillates (coal), solvent extn., hydrocracked;
[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 300o C (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-689-6
94114-53-1
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-150-00-1
Naphtha (coal), solvent extn., hydrocracked;
[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86oF to 356oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-690-1
94114-54-2
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-151-00-7
Gasoline, coal solvent extn., hydrocracked naphtha;
[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]
302-691-7
94114-55-3
Carc. 1B
H350
GHS08
Dgr
H350
648-152-00-2
Distillates (coal), solvent extn., hydrocracked middle;
[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 o C to 300 oC (356oF to 572oF. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]
302-692-2
94114-56-4
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-153-00-8
Distillates (coal), solvent extn., hydrocracked hydrogenated middle;
[Distillate from the hydroge nation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 F to 536oF). Composed primarily of hydrogenated two-ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]
302-693-8
94114-57-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
648-154-00-3
Fuels, jet aircraft, coal solvent extn.,hydrocracked hydro genated;
[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180oC to 225oC (356oF to 473oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]
302-694-3
94114-58-6
Carc. 2
H351
GHS08
Wng
H350
648-155-00-9
Fuels, diesel, coal solvent extn., hydrocracked hydrogenated; [Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200oC to 280oC (392oF to 536oF). Composed primarily of hydrogenated two-ring hydrocarbons andtheir alkylderivatives having carbon numbers predominantly in the range of C11 through C14.]
302-695-9
94114-59-7
Carc. 2
H351
GHS08
Wng
H350
648-156-00-4
Light oil (coal), semi-coking process; Fresh oil; [The volatile organic liquid condensed from the gasevolved in the low-temperature (less than 700 oC (1 292oF)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]
292-635-7
90641-11-5
Carc. 1B Muta. 1B
H350
H340
GHS08
Dgr
H350
H340
J
649-001-00-3
Extracts (petroleum), light naphthenic distillate solvent
265-102-1
64742-03-6
Carc. 1B
H350
GHS08
Dgr
H350
649-002-00-9
Extracts (petroleum), heavy paraffinic distillate solvent
265-103-7
64742-04-7
Carc. 1B
H350
GHS08
Dgr
H350
649-003-00-4
Extracts (petroleum), light paraffinic distillate solvent
265-104-2
64742-05-8
Carc. 1B
H350
GHS08
Dgr
H350
649-004-00-X
Extracts (petroleum), heavy naphthenic distillate solvent
265-111-0
64742-11-6
Carc. 1B
H350
GHS08
Dgr
H350
649-005-00-5
Extracts (petroleum), light vacuum gas oil solvent
295-341-7
91995-78-7
Carc. 1B
H350
GHS08
Dgr
H350
649-006-00-0
hydrocarbons C26-55, arom-rich
307-753-7
97722-04-8
Carc. 1B
H350
GHS08
Dgr
H350
649-007-00-6
fatty acids, tall-oil, reaction products with iminodiethanol and boric acid
400-160-5
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
649-008-00-1
Residues (petroleum), atm. tower;
Heavy Fuel oil;
[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approxi mately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-045-2
64741-45-3
Carc. 1B
H350
GHS08
Dgr
H350
649-009-00-7
Gas oils (petroleum), heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-058-3
64741-57-7
Carc. 1B
H350
GHS08
Dgr
H350
649-010-00-2
Distillates (petroleum), heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260oC to 500oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-063-0
64741-61-3
Carc. 1B
H350
GHS08
Dgr
H350
649-011-00-8
Clarified oils (petroleum), catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350oC (662oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-064-6
64741-62-4
Carc. 1B
H350
GHS08
Dgr
H350
649-012-00-3
Residues (petroleum), hydrocracked; Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approxi mately 350oC (662 oF).]
265-076-1
64741-75-9
Carc. 1B
H350
GHS08
Dgr
H350
649-013-00-9
Residues (petroleum), thermal cracked; Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-081-9
64741-80-6
Carc. 1B
H350
GHS08
Dgr
H350
649-014-00-4
Distillates (petroleum), heavy thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-082-4
64741-81-7
Carc. 1B
H350
GHS08
Dgr
H350
649-015-00-X
Gas oils (petroleum), hydro-treated vacuum; Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230oC to 600oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-162-9
64742-59-2
Carc. 1B
H350
GHS08
Dgr
H350
649-016-00-5
Residues (petroleum), hydrodesulfurized atmospheric tower; Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-181-2
64742-78-5
Carc. 1B
H350
GHS08
Dgr
H350
649-017-00-0
Gas oils (petroleum), hydrodesulfurized heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-189-6
64742-86-5
Carc. 1B
H350
GHS08
Dgr
H350
649-018-00-6
Residues (petroleum), steam-cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-memberedcondensed ring aromatic hydrocarbons.]
265-193-8
64742-90-1
Carc. 1B
H350
GHS08
Dgr
H350
649-019-00-1
Residues (petroleum), atmospheric;
Heavy Fuel oil;
[A complex residuum from atmospheric distillation of crude oil.
It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approxi mately 200oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-777-3
68333-22-2
Carc. 1B
H350
GHS08
Dgr
H350
649-020-00-7
Clarified oils (petroleum), hydrodesulfurized catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-782-0
68333-26-6
Carc. 1B
H350
GHS08
Dgr
H350
649-021-00-2
Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
269-783-6
68333-27-7
Carc. 1B
H350
GHS08
Dgr
H350
649-022-00-8
Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260oC to 500 oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-784-1
68333-28-8
Carc. 1B
H350
GHS08
Dgr
H350
649-023-00-3
Fuel oil, residues-straight-run gas oils, high-sulfur;
Heavy Fuel oil
270-674-0
68476-32-4
Carc. 1B
H350
HS08
Dgr
H350
649-024-00-9
Fuel oil, residual; Heavy Fuel oil;
[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]
270-675-6
68476-33-5
Carc. 1B
H350
GHS08
Dgr
H350
649-025-00-4
Residues (petroleum), catalytic reformer fractionator residue distn.;
Heavy Fuel oil;
[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399oC (750oF).]
270-792-2
68478-13-7
Carc. 1B
H350
GHS08
Dgr
H350
649-026-00-X
Residues,(petroleum), heavy coker gas oil and vacuum gas oil;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predomi nantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-796-4
68478-17-1
Carc. 1B
H350
GHS08
Dgr
H350
649-027-00-5
Residues (petroleum), heavy coker and light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-983-0
68512-61-8
Carc. 1B
H350
GHS08
Dgr
H350
649-028-00-0
Residues(petroleum), light vacuum;
Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-984-6
68512-62-9
Carc. 1B
H350
GHS08
Dgr
H350
649-029-00-6
Residues (petroleum), steam-cracked light;
Heavy Fuel oil;
[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101oC to 555 oC (214 oF to 1030oF).]
271-013-9
68513-69-9
Carc. 1B
H350
GHS08
Dgr
H350
649-030-00-1
Fuel oil, No 6; Heavy Fuel oil;
[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]
271-384-7
68553-00-4
Carc. 1B
H350
GHS08
Dgr
H350
649-031-00-7
Residues (petroleum), topping plant, low-sulfur;
Heavy Fuel oil;
[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]
271-763-7
68607-30-7
Carc. 1B
H350
GHS08
Dgr
H350
649-032-00-2
Gas oils (petroleum), heavy atmospheric;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121oC to 510 oC (250 oF to 950oF).]
272-184-2
68783-08-4
Carc. 1B
H350
GHS08
Dgr
H350
649-033-00-8
Residues(petroleum), coker scrubber, Condensed-ring-arom.-contg.; Heavy Fuel oil; [A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed rind aromatic hydrocarbons.]
272-187-9
68783-13-1
Carc. 1B
H350
GHS08
Dgr
H350
649-034-00-3
Distillates (petroleum), petroleum residues vacuum; Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]
273-263-4
68955-27-1
Carc. 1B
H350
GHS08
Dgr
H350
649-035-00-9
Residues (petroleum), steam-cracked, resinous;
Heavy Fuel oil;
[A complex residuum from the distillation of steam-cracked petroleum residues.]
273-272-3
68955-36-2
Carc. 1B
H350
GHS08
Dgr
H350
649-036-00-4
Distillates (petroleum), intermediate vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250oC to 545oC (482oF to 1013oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
274-683-0
70592-76-6
Carc. 1B
H350
GHS08
Dgr
H350
649-037-00-X
Distillates (petroleum), light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545oC (482oF to 1013 oF).]
274-684-6
70592-77-7
Carc. 1B
H350
GHS08
Dgr
H350
649-038-00-5
Distillates (petroleum), vacuum; Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
274-685-1
70592-78-8
Carc. 1B
H350
GHS08
Dgr
H350
649-039-00-0
Gas oils (petroleum), hydrodesulfurized coker heavy vacuum; Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304oC to 548oC (579oF to 1018oF). Likely to contain 5 % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
285-555-9
85117-03-9
Carc. 1B
H350
GHS08
Dgr
H350
649-040-00-6
Residues (petroleum), steam-cracked, distillates;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]
292-657-7
90669-75-3
Carc. 1B
H350
GHS08
Dgr
H350
649-041-00-1
Residues (petroleum), vacuum, light;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]
292-658-2
90669-76-4
Carc. 1B
H350
GHS08
Dgr
H350
649-042-00-7
Fuel oil, heavy, high-sulfur; Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
295-396-7
92045-14-2
Carc. 1B
H350
GHS08
Dgr
H350
649-043-00-2
Residues (petroleum), catalytic cracking;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200oC (392oF).]
295-511-0
92061-97-7
Carc. 1B
H350
GHS08
Dgr
H350
649-044-00-8
Distillates (petroleum), intermediate catalytic cracked, thermally degraded;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 C (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]
295-990-6
92201-59-7
Carc. 1B
H350
GHS08
Dgr
H350
649-045-00-3
Residual oils (petroleum); Heavy Fuel oil;
[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]
298-754-0
93821-66-0
Carc. 1B
H350
GHS08
Dgr
H350
649-046-00-9
Residues, steam cracked, thermally treated;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180oC (356oF).]
308-733-0
98219-64-8
Carc. 1B
H350
GHS08
Dgr
H350
649-047-00-4
Distillates (petroleum), hydrodesulfurized full-range middle; Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150oC to 400oC (302 oF to 752 oF).]
309-863-0
101316-57-8
Carc. 1B
H350
GHS08
Dgr
H350
649-048-00-X
Residues (petroleum), catalytic reformer fractionator;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4-or 6-membered condensed ring aromatic hydrocarbons.]
265-069-3
64741-67-9
Carc. 1B
H350
GHS08
Dgr
H350
649-049-00-5
Petroleum; Crude oil;
[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]
232-298-5
8002-05-9
Carc. 1B
H350
GHS08
Dgr
H350
649-050-00-0
Distillates (petroleum), light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]
265-051-5
64741-50-0
Carc. 1A
H350
GHS08
Dgr
H350
649-051-00-6
Distillates(petroleum), heavy paraffinic;
Unrefined ormildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]
265-052-0
64741-51-1
Carc. 1A
H350
GHS08
Dgr
H350
649-052-00-1
Distillates (petroleum), light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-053-6
64741-52-2
Carc. 1A
H350
GHS08
Dgr
H350
649-053-00-7
Distillates (petroleum), heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-054-1
64741-53-3
Carc. 1A
H350
GHS08
Dgr
H350
649-054-00-2
Distillates (petroleum), acid-treated heavy naphthenic; Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-117-3
64742-18-3
Carc. 1A
H350
GHS08
Dgr
H350
649-055-00-8
Distillates (petroleum), acid-treated light naphthenic; Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-118-9
64742-19-4
Carc. 1A
H350
GHS08
Dgr
H350
649-056-00-3
Distillates (petroleum), acid-treated heavy paraffinic; Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons btained as a raffinate from a sulfuric acid process. It consists predomi nantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100oF (19cSt at 40 oC).]
265-119-4
64742-20-7
Carc. 1A
H350
GHS08
Dgr
H350
649-057-00-9
Distillates (petroleum), acid-treated light paraffinic; Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oi having aviscosity of less than 100 SUS at 100 oF (19cSt at 40oC).]
265-121-5
64742-21-8
Carc. 1A
H350
GHS08
Dgr
H350
649-058-00-4
Distillates (petroleum), chemically neutralized heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained from a treating proces to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]
265-127-8
64742-27-4
Carc. 1A
H350
GHS08
Dgr
H350
649-059-00-X
Distillates (petroleum), chemically neutralized light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-128-3
64742-28-5
Carc. 1A
H350
GHS08
Dgr
H350
649-060-00-5
Distillates (petroleum), chemically neutralized heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-135-1
64742-34-3
Carc. 1A
H350
GHS08
Dgr
H350
649-061-00-0
Distillates (petroleum), chemically neutralized light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-136-7
64742-35-4
Carc. 1A
H350
GHS08
Dgr
H350
649-062-00-6
Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free; Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]
270-755-0
68477-73-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-063-00-1
Gases (petroleum), catalytic cracker;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-756-6
68477-74-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-064-00-7
Gases (petroleum), catalytic cracker, C1-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydro carbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]
270-757-1
68477-75-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-065-00-2
Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]
270-758-7
68477-76-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-066-00-8
Gases (petroleum), catalytic reformer, C1-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]
270-760-8
68477-79-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-067-00-3
Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed; Petroleum gas;
[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]
270-765-5
68477-83-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-068-00-9
Gases (petroleum), C4-rich; Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-767-6
68477-85-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-069-00-4
Gases (petroleum), deethanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]
270-768-1
68477-86-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-070-00-X
Gasespetroleum),deisobutanizer tower overheads; Petroleum gas;
[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C3 through C4.]
270-769-7
68477-87-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-071-00-5
Gases (petroleum), depropanizer dry, propene-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene withsome ethane and propane.]
270-772-3
68477-90-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-072-00-0
Gases (petroleum), depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-773-9
68477-91-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-073-00-6
Gases (petroleum), gas recovery plant depropanizer overheads; Petroleum gas;
[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]
270-777-0
68477-94-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-074-00-1
Gases (petroleum), Girbotol unit feed;
Petroleum gas;
[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C2 through C4.]
270-778-6
68477-95-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-075-00-7
Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;
Petroleum gas
270-782-8
68477-99-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-076-00-2
Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-802-5
68478-21-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-077-00-8
Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-803-0
68478-22-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-078-00-3
Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater; Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]
270-804-6
68478-24-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-079-00-9
Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-806-7
68478-26-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-080-00-4
Tail gas (petroleum), saturate gas plant mixed stream, C4-rich; Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]
270-813-5
68478-32-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-081-00-X
Tail gas (petroleum), saturate gas recovery plant, C1-2-rich; Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, Predominantly methane and ethane.]
270-814-0
68478-33-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-082-00-5
Tail gas (petroleum), vacuum residues thermal cracker; Petroleum gas;
[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-815-6
68478-34-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-083-00-0
Hydrocarbons, C3-4-rich, petroleum distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]
270-990-9
68512-91-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-084-00-6
Gases (petroleum), full-range straight-run naphtha dehexanizer off; petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-000-8
68513-15-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-085-00-1
Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;
Petroleum gas;
[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]
271-001-3
68513-16-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-086-00-7
Gases (petroleum), light straight-run naphtha stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-002-9
68513-17-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-087-00-2
Residues (petroleum), alkylation splitter, C4-rich;
Petroleum gas;
[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 o C to 27.8 o C (11 oF to 82 oF).]
271-010-2
68513-66-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-088-00-8
Hydrocarbons, C1-4; Petroleum gas;
[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus164 o C to minus 0.5 o C (– 263 oF to 31 oF).]
271-032-2
68514-31-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-089-00-3
Hydrocarbons, C1-4, sweetened; Petroleum gas;
[A complex combination of hydrocarbons obtaine by subjectin hydrocarbon gases to a sweetening process to convert mercaptans o to remove acidc impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately –
164o C to - 0.5 oC (– 263 oF to 31 oF).]
271-038-5
68514-36-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-090-00-9
Hydrocarbons, C1-3; Petroleum gas;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approxi mately minus 164 o C to minus 42 oC (– 263 oF to - 44 oF).]
271-259-7
68527-16-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-091-00-4
Hydrocarbons, C1-4, debutanizer fraction;
Petroleum gas
271-261-8
68527-19-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-092-00-X
Gases (petroleum), C1-5, wet; Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil.
It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
271-624-0
68602-83-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-093-00-5
Hydrocarbons, C2-4; Petroleum gas
271-734-9
68606-25-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-094-00-0
Hydrocarbons, C3; Petroleum gas
271-735-4
68606-26-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-095-00-6
Gases (petroleum), alkylation feed;
Petroleum gas;
[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
271-737-5
68606-27-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-096-00-1
Gases (petroleum), depropanizer bottoms fractionation off; Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]
271-742-2
68606-34-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-097-00-7
Gases (petroleum), refinery blend;
Petroleum gas;
[A complex combination obtained from various processes.
It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-183-7
68783-07-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-098-00-2
Gases (petroleum), catalytic cracking;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
272-203-4
68783-64-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-099-00-8
Gases (petroleum), C2-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (– 60oF to - 30oF).]
272-205-5
68783-65-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-100-00-1
Gases (petroleum), crude oil fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-871-7
68918-99-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-101-00-7
Gases (petroleum), dehexanizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the Fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-872-2
68919-00-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-102-00-2
Gases (petroleum), light straight run gasoline fractionation stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-878-5
68919-05-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-103-00-8
Gases (petroleum), naphtha unifiner desulfurization stripper off;
Petroleum gas;
[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-879-0
68919-06-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-104-00-3
Gases (petroleum), straight-run naphtha catalytic reforming off; Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]
272-882-7
68919-09-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-105-00-9
Gases(petroleum), fluidized catalytic cracker splitter overheads; Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.]
272-893-7
68919-20-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-106-00-4
Gases (petroleum), straight-run stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-883-2
68919-10-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-107-00-X
Gases (petroleum), catalytic cracked naphtha debutanizer; Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-169-3
68952-76-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-108-00-5
Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-170-9
68952-77-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-109-00-0
Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;
petroleum gas;
[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-175-6
68952-81-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-110-00-6
Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-176-1
68952-82-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-111-00-1
Gases (petroleum, light steam-cracked, butadiene conc.; Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]
273-265-5
68955-28-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-112-00-7
Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the frac tionation of the total effluent.
It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
273-270-2
68955-34-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-113-00-2
Hydrocarbons, C4; Petroleum gas
289-339-5
87741-01-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-114-00-8
Alkanes, C1-4, C3-rich; Petroleum gas
292-456-4
90622-55-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-115-00-3
Gases (petroleum), steam-cracker C3-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (– 94oF to 32oF).]
295-404-9
92045-22-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-116-00-9
Hydrocarbons, C4, steam-cracker distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 o C to 5 o C (10.4 oF to 41oF).]
295-405-4
92045-23-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-117-00-4
Petroleum gases, liquefied, sweetened, C4 fraction; Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]
295-463-0
92045-80-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K S U
649-118-00-X
Hydrocarbons, C4, 1,3-butadiene-and isobutene-free; Petroleum gas
306-004-1
95465-89-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-119-00-5
Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free; Petroleum gas
307-769-4
97722-19-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-120-00-0
Gases (petroleum), amine system feed;
Refinery gas;
[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]
270-746-1
68477-65-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-121-00-6
Gases (petroleum), benzene unit hydrodesulfurizer off;
Refinery gas;
[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]
270-747-7
68477-66-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-122-00-1
Gases (petroleum), benzene unit recycle, hydrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydro carbons having carbon numbers in the range of C1 through C6.]
270-748-2
68477-67-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-123-00-7
Gases (petroleum), blend oil, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-749-8
68477-68-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-124-00-2
Gases (petroleum), catalytic reformed naphtha stripper overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-759-2
68477-77-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-125-00-8
Gases (petroleum), C6-8 catalytic reformer recycle;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-761-3
68477-80-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-126-00-3
Gases (petroleum), C6-8 catalytic reformer;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]
270-762-9
68477-81-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-127-00-9
Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich; Refinery gas
270-763-4
68477-82-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-128-00-4
Gases (petroleum), C2-return stream;
Refinery gas;
[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydroge with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contain predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]
270-766-0
68477-84-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-129-00-X
Gases (petroleum), dry sour, gas-concn.-unit-off;
Refinery gas;
[The complex combination of dry gase from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-774-4
68477-92-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-130-00-5
Gases (petroleum), gas concn. reabsorber distn.;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]
270-776-5
68477-93-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-131-00-0
Gases (petroleum), hydrogen absorber off;
Refinery gas;
[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]
270-779-1
68477-96-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-132-00-6
Gases (petroleum), hydrogen-rich;
Refinery gas;
[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]
270-780-7
68477-97-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-133-00-1
Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-781-2
68477-98-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-134-00-7
Gases (petroleum), recycle, hydrogen-rich;
Refinery gas;
[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
270-783-3
68478-00-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-135-00-2
Gases (petroleum), reformer make-up, hydrogen-rich; Refinery gas;
[Acomplex combination obtained from the reformers. It consists primarily of hydrogen with variou smal amount of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-784-9
68478-01-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-136-00-8
Gases (petroleum), reforming hydrotreater;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-785-4
68478-02-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-137-00-3
Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;
Refinery gas;
[A complex combination obtained fromthe reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
270-787-5
68478-03-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-138-00-9
Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-788-0
68478-04-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-139-00-4
Gases (petroleum), thermal cracking distn.;
Refinery gas;
[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-789-6
68478-05-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-140-00-X
Tail gas (petroleum), catalytic cracker refractionation absorber; Refinery gas;
[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-805-1
68478-25-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-141-00-5
Tail gas (petroleum), catalytic reformed naphtha separator; Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-807-2
68478-27-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-142-00-0
Tail gas (petroleum), catalytic reformed naphtha stabilizer; Refinery gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-808-8
68478-28-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-143-00-6
Tail gas (petroleum), cracked distillate hydrotreater separator; Refinery gas; [A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-809-3
68478-29-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-144-00-1
Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-810-9
68478-30-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-145-00-7
Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]
270-999-8
68513-14-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-146-00-2
Gases (petroleum), reformer effluent high-pressure flash drum off;
Refinery gas;
[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-003-4
68513-18-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-147-00-8
Gases (petroleum), reformer effluent low-pressure flash drum off;
Refinery gas;
[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-005-5
68513-19-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-148-00-3
Gases (petroleum), oil refinery gas distn. off;
Refinery gas;
[A complex combination separatedby distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]
271-258-1
68527-15-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-149-00-9
Gases (petroleum), benzene unit hydrotreater depentanizer overheads; Refinery gas;
[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]
271-623-5
68602-82-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-150-00-4
Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator; Refinery gas;
[A complex combination produced by the fractionation of the overhead products from the catalyticcracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
271-625-6
68602-84-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-151-00-X
Petroleum products, refinery gases;
Refinery gas; [A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-750-6
68607-11-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-152-00-5
Gases (petroleum), hydrocracking low-pressure separator; Refinery gas;
[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-182-1
68783-06-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-153-00-0
Gases (petroleum), refinery; Refinery gas;
[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-338-9
68814-67-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-154-00-6
Gases (petroleum), platformer products separator off;
Refinery gas;
[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
272-343-6
68814-90-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-155-00-1
Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;
Refinery gas;
[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]
272-775-5
68911-58-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-156-00-7
Gases (petroleum), hydrotreated sour kerosine flash drum; Refinery gas;
[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
272-776-0
68911-59-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-157-00-2
Gases (petroleum), distillate unifiner desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]
272-873-8
68919-01-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-158-00-8
Gases (petroleum), fluidized catalytic cracker fractionation off;
Refinery gas;
[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-874-3
68919-02-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-159-00-3
Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;
Refinery gas;
[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]
272-875-9
68919-03-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-160-00-9
Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-876-4
68919-04-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-161-00-4
Gases (petroleum), platformer stabilizer off, light ends fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]
272-880-6
68919-07-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-162-00-X
Gases (petroleum), preflash tower off, crude distn.;
Refinery gas;
[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-881-1
68919-08-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-163-00-5
Gases (petroleum), tar stripper off;
Refinery gas;
[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-884-8
68919-11-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-164-00-0
Gases (petroleum), unifiner stripper off;
Refinery gas;
[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]
272-885-3
68919-12-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-165-00-6
Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]
273-173-5
68952-79-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-166-00-1
Tail gas (petroleum), straight-run naphtha hydrodesulfurizer; Refinery gas;
[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
273-174-0
68952-80-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-167-00-7
Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-269-7
68955-33-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-168-00-2
Gases (petroleum), crude distn. and catalytic cracking;
Refinery gas;
[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-563-5
68989-88-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-169-00-8
Gases (petroleum), gas oil diethanolamine scrubber off; Refinery gas;
[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
295-397-2
92045-15-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-170-00-3
Gases (petroleum), gas oil hydrodesulfurization effluent; Refinery gas;
[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydro carbons having carbon numbers predominantly in the range of C1 through C3.]
295-398-8
92045-16-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-171-00-9
Gases (petroleum), gas oil hydrodesulfurization purge; Refinery gas;
[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
295-399-3
92045-17-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-172-00-4
Gases (petroleum), hydrogenator effluent flash drum off;
Refinery gas;
[A complex combination of gases obtained from flash of the effluents after the hydroge nation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
295-400-7
92045-18-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-173-00-X
Gases (petroleum), naphtha steam cracking high-pressure residual;
Refinery gas;
[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]
295-401-2
92045-19-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-174-00-5
Gases (petroleum), residue visbaking off;
Refinery gas;
[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
295-402-8
92045-20-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-175-00-0
Foots oil (petroleum), acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-225-7
93924-31-3
Flam. Gas 1
Press. Gas
Carc. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340
K U
649-176-00-6
Foots oil (petroleum), clay-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predomi nantly of branched chain hydro carbons with carbon numbers predominantly in the range of C20 through C50.]
300-226-2
93924-32-4
Flam. Gas 1
Press. Gas
Carc. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340
K U
649-177-00-1
Gases (petroleum), C3-4; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (– 60 oF to 30 oF.)]
268-629-5
68131-75-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-178-00-7
Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber; Petroleum gas;
[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-617-2
68307-98-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-179-00-2
Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer; Petroleum gas;
[A complex combination of hydrocarbons from the fractionation stabilization products
from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-618-8
68307-99-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-180-00-8
Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-619-3
68308-00-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-181-00-3
Tail gas (petroleum), cracked distillate hydrotreater stripper;
Petroleum gas;
[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-620-9
68308-01-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-182-00-9
Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-630-3
68308-10-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-183-00-4
Tail gas (petroleum), gas oil catalytic cracking absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-623-5
68308-03-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-184-00-X
Tail gas (petroleum), gas recovery plant;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-624-0
68308-04-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-185-00-5
Tail gas (petroleum), gas recovery plant deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-625-6
68308-05-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-186-00-0
Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of hydrodesul furized naphtha and distillate
hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-626-1
68308-06-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-187-00-6
Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-627-7
68308-07-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-188-00-1
Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-629-8
68308-09-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-189-00-7
Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-631-9
68308-11-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-190-00-2
Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-632-4
68308-12-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-191-00-8
Gases (petroleum), catalytic cracked overheads; Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately –48 oC to 32 oC (– 54 oF to 90oF).]
270-071-2
68409-99-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-193-00-9
Alkanes, C1-2; Petroleum gas
270-651-5
68475-57-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-194-00-4
Alkanes, C2-3; Petroleum gas
270-652-0
68475-58-1
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-195-00-X
Alkanes, C3-4;
petroleum gas
270-653-6
68475-59-2
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-196-00-5
Alkanes, C4-5; Petroleum gas
270-654-1
68475-60-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-197-00-0
Fuel gases; Petroleum gas;
[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]
270-667-2
68476-26-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-198-00-6
Fuel gases, crude oil of distillates;
Petroleum gas;
[A complex combination of light gases produced by distil lation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217o C to - 12 o C (– 423 oF to 10 oF).]
270-670-9
68476-29-9
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-199-00-1
Hydrocarbons, C3-4; Petroleum gas
270-681-9
68476-40-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-200-00-5
Hydrocarbons, C4-5; Petroleum gas
270-682-4
68476-42-6
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-201-00-0
Hydrocarbons, C2-4, C3-rich; Petroleum gas
270-689-2
68476-49-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-202-00-6
Petroleum gases, liquefied; Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately –
40 oC to 80 oC (– 40oF to 176oF).]
270-704-2
68476-85-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K S U
649-203-00-1
Petroleum gases, liquefied, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately–40 o C to 80 o C (– 40 oF to176 oF).]
270-705-8
68476-86-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K S U
649-204-00-7
Gases (petroleum), C3-4, isobutane-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]
270-724-1
68477-33-8
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-205-00-2
Distillates (petroleum), C3-6, piperylene-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]
270-726-2
68477-35-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-206-00-8
Gases (petroleum), butane splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-750-3
68477-69-0
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-207-00-3
Gases (petroleum), C2-3-; Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]
270-751-9
68477-70-3
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-208-00-9
Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon
stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-752-4
68477-71-4
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-209-00-4
Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-754-5
68477-72-5
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-210-00-X
Tail gas (petroleum), isomerized naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-628-2
68308-08-7
Press. Gas
Flam. Gas 1
Carc. 1A Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-211-00-5
Foots oil (petroleum), carbon-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-126-0
97862-76-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-212-00-0
Distillates (petroleum), sweetened middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302 o F to 653oF).]
265-088-7
64741-86-2
Carc. 1B
H350
GHS08
Dgr
H350
N
649-213-00-6
Gas oils (petroleum), solvent-refined;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205oC to 400oC (401oF to 752oF).]
265-092-9
64741-90-8
Carc. 1B
H350
GHS08
Dgr
H350
N
649-214-00-1
Distillates (petroleum), solvent-refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302oF to 653 oF).]
265-093-4
64741-91-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-215-00-7
Gas oils (petroleum), acid-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230oC to 400oC (446oF to 752 oF).]
265-112-6
64742-12-7
Carc. 1B
H350
GHS08
Dgr
H350
N
649-216-00-2
Distillates (petroleum), acid-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-113-1
64742-13-8
Carc. 1B
H350
GHS08
Dgr
H350
N
649-217-00-8
Distillates (petroleum), acid-treated light;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150oC to 290oC (302oF to 554oF).]
265-114-7
64742-14-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-218-00-3
Gas oils (petroleum), chemically neutralized;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446oF to 752 oF).]
265-129-9
64742-29-6
Carc. 1B
H350
GHS08
Dgr
H350
N
649-219-00-9
Distillates (petroleum), chemically neutralized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205oC to 345oC (401oF to 653oF).]
265-130-4
64742-30-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-220-00-4
Distillates (petroleum), clay-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302oF to 653oF).]
265-139-3
64742-38-7
Carc. 1B
H350
GHS08
Dgr
H350
N
649-221-00-X
Distillates (petroleum), hydrotreated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately
205oC to 400oC (401 oF to 752 oF).]
265-148-2
64742-46-7
Carc. 1B
H350
GHS08
Dgr
H350
N
649-222-00-5
Gas oils (petroleum), hydrodesulfurized;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230oC to 400oC (446oF to 752 oF).]
265-182-8
64742-79-6
Carc. 1B
H350
GHS08
Dgr
H350
N
649-223-00-0
Distillates (petroleum), hydrodesulfurized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205oC to 400oC (401oF to 752oF).]
265-183-3
64742-80-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-224-00-6
Fuels, diesel;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163oC to 357oC (325oF to 675oF).]
269-822-7
68334-30-5
Carc. 2
H351
GHS08
Wng
H351
N
649-225-00-1
Fuel oil, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7oC (100oF) to a maximum of 37,9 SUS at 37,7oC (100 oF).]
270-671-4
68476-30-2
Carc. 2
H351
GHS08
Wng
H351
649-226-00-7
Fuel oil, No 4;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 45 SUS at 37,7oC (100oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]
270-673-5
68476-31-3
Carc. 2
H351
GHS08
Wng
H351
649-227-00-2
Fuels, diesel, No 2; Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]
270-676-1
68476-34-6
Carc. 2
H351
GHS08
Wng
H351
649-228-00-8
Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 99oC (650oF to 750 oF).]
270-719-4
68477-29-2
Carc. 1B
H350
GHS08
Dgr
H350
N
649-229-00-3
Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288oC to 371oC (550oF to 700oF).]
270-721-5
68477-30-5
Carc. 1B
H350
GHS08
Dgr
H350
N
649-230-00-9
Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;
Gasoil — unspecified;
[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550oF).]
270-722-0
68477-31-6
Carc. 1B
H350
GHS08
Dgr
H350
N
649-231-00-4
Distillates (petroleum), highly refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]
292-615-8
90640-93-0
Carc. 1B
H350
GHS08
Dgr
H350
N
649-232-00-X
Distillates (petroleum) catalytic reformer, heavy arom. conc.; Gasoil — unspecified; [A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200oC to 300oC (392 oF to 572 oF).]
295-294-2
91995-34-5
Carc. 1B
H350
GHS08
Dgr
H350
N
649-233-00-5
Gas oils, paraffinic; Gasoil — unspecified;
[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190oC to 330oC (374oF to 594oF).]
300-227-8
93924-33-5
Carc. 1B
H350
GHS08
Dgr
H350
N
649-234-00-0
Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;
Gasoil — unspecified
307-035-3
97488-96-5
Carc. 1B
H350
GHS08
Dgr
H350
N
649-235-00-6
Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;
Gasoil — unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-659-6
97675-85-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-236-00-1
Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluent from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having viscosity of 2cSt at 100oC (212oF).]
307-660-1
97675-86-0
Carc. 1B
H350
GHS08
Dgr
H350
N
649-237-00-7
Hydrocarbons, C11-17, solvent-extd. light naphthenic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200oC to 300oC (392oF to 572 oF).]
307-757-9
97722-08-2
Carc. 1B
H350
GHS08
Dgr
H350
N
649-238-00-2
Gas oils, hydrotreated; Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330oC to 340oC (626oF to 644oF).]
308-128-1
97862-78-7
Carc. 1B
H350
GHS08
Dgr
H350
N
649-239-00-8
Distillates (petroleum), carbon-treated light paraffinic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impur ities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]
309-667-5
100683-97-4
Carc. 1B
H350
GHS08
Dgr
H350
N
649-240-00-3
Distillates (petroleum), intermediate paraffinic, carbon-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar consti tuents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-668-0
100683-98-5
Carc. 1B
H350
GHS08
Dgr
H350
N
649-241-00-9
Distillates (petroleum), intermediate paraffinic, clay-treated; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-669-6
100683-99-6
Carc. 1B
H350
GHS08
Dgr
H350
N
649-242-00-4
Alkanes, C12-26-branched and linear
292-454-3
90622-53-0
Carc. 1B
H350
GHS08
Dgr
H350
N
649-243-00-X
Lubricating greases; Grease;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]
278-011-7
74869-21-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-244-00-5
Slack wax (petroleum); Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
265-165-5
64742-61-6
Carc. 1B
H350
GHS08
Dgr
H350
N
649-245-00-0
Slack wax (petroleum), acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
292-659-8
90669-77-5
Carc. 1B
H350
GHS08
Dgr
H350
N
649-246-00-6
Slack wax (petroleum), clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predomi nantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]
292-660-3
90669-78-6
Carc. 1B
H350
GHS08
Dgr
H350
N
649-247-00-1
Slack wax (petroleum), hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
295-523-6
92062-09-4
Carc. 1B
H350
GHS08
Dgr
H350
N
649-248-00-7
Slack wax (petroleum), low-melting;
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-524-1
92062-10-7
Carc. 1B
H350
GHS08
Dgr
H350
N
649-249-00-2
Slack wax (petroleum), low-melting, hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predomi nantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-525-7
92062-11-8
Carc. 1B
H350
GHS08
Dgr
H350
N
649-250-00-8
Slack wax (petroleum), low-melting, carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-155-9
97863-04-2
Carc. 1B
H350
GHS08
Dgr
H350
N
649-251-00-3
Slack wax (petroleum), low-melting, clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impur ities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-156-4
97863-05-3
Carc. 1B
H350
GHS08
Dgr
H350
N
649-252-00-9
Slack wax (petroleum), low-melting, silicic acid-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-158-5
97863-06-4
Carc. 1B
H350
GHS08
Dgr
H350
N
649-253-00-4
Slack wax (petroleum), carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]
309-723-9
100684-49-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-254-00-X
Petrolatum; Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
232-373-2
8009-03-8
Carc. 1B
H350
GHS08
Dgr
H350
N
649-255-00-5
Petrolatum (petroleum), oxidized;
Petrolatum;
[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]
265-206-7
64743-01-7
Carc. 1B
H350
GHS08
Dgr
H350
N
649-256-00-0
Petrolatum (petroleum), alumina-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
285-098-5
85029-74-9
Carc. 1B
H350
GHS08
Dgr
H350
N
649-257-00-6
Petrolatum (petroleum), hydrotreated;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]
295-459-9
92045-77-7
Carc. 1B
H350
GHS08
Dgr
H350
N
649-258-00-1
Petrolatum (petroleum), carbon-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impur ities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-149-6
97862-97-0
Carc. 1B
H350
GHS08
Dgr
H350
N
649-259-00-7
Petrolatum (petroleum), silicic acid-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-150-1
97862-98-1
Carc. 1B
H350
GHS08
Dgr
H350
N
649-260-00-2
Petrolatum (petroleum), clay-treated;
Petrolatum; [A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]
309-706-6
100684-33-1
Carc. 1B
H350
GHS08
Dgr
H350
N
649-261-00-8
Gasoline, natural;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (– 4oF to 248oF).]
232-349-1
8006-61-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-262-00-3
Naphtha;
Low boiling point naphtha; [Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100o C to 200o C (212oF to 392oF).]
232-443-2
8030-30-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-263-00-9
Ligroine;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58oF to 275oF).]
232-453-7
8032-32-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-264-00-4
Naphtha (petroleum), heavy straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149oF to 446oF).]
265-041-0
64741-41-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-265-00-X
Naphtha (petroleum), full-range straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (– 4 oF to 428oF).]
265-042-6
64741-42-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-266-00-5
Naphtha (petroleum), light straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately - 20 oC to 180 oC (– 4oF to 356oF).]
265-046-8
64741-46-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-267-00-0
Solvent naphtha (petroleum), light aliph.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35o C to 160o C (95oF to 320oF).]
265-192-2
64742-89-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-268-00-6
Distillates (petroleum), straight-run light;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately– 88 oC to 99o C (– 127oF to 210oF).]
270-077-5
68410-05-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-269-00-1
Gasoline, vapor-recovery; Low boiling point naphtha;
[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (– 4oF to 384oF).]
271-025-4
68514-15-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-270-00-7
Gasoline, straight-run, topping-plant; Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97oF to 380oF).]
271-727-0
68606-11-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-271-00-2
Naphtha (petroleum), unsweetened; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25oF to 446oF).]
272-186-3
68783-12-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-272-00-8
Distillates (petroleum), light straight-run gasoline frac tionation stabilizer overheads; Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in he range of C3 through C6.]
272-931-2
68921-08-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-273-00-3
Naphtha (petroleum), heavy straight run, arom.-contg.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266oF to 410oF).]
309-945-6
101631-20-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-274-00-9
Naphtha (petroleum), full-range alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194oF to 428oF).]
265-066-7
64741-64-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-275-00-4
Naphtha (petroleum), heavy alkylate;
Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302oF to 428oF).]
265-067-2
64741-65-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-276-00-X
Naphtha (petroleum), light alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 oC to 160 oC (194oF to 320 oF).]
265-068-8
64741-66-8
Carc. 1B Muta. 1B Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-277-00-5
Naphtha (petroleum), isomerization;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]
265-073-5
64741-70-4
Carc. 1B Muta. 1B Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-278-00-0
Naphtha (petroleum), solvent-refined light;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approxi mately 35 oC to 190 oC (95oF to 374oF).]
265-086-6
64741-84-0
Carc. 1B Muta. 1B Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-279-00-6
Naphtha (petroleum), solvent-refined heavy;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194oF to 446oF).]
265-095-5
64741-92-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-280-00-1
Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]
270-088-5
68410-71-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-281-00-7
Raffinates (petroleum), reformer, Lurgi unit-sepd.;
Low boiling point modified naphtha;
[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]
270-349-3
68425-35-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-28-00-2
Naphtha (petroleum), full-range alkylate, butane-contg.;
Low boiling point modified naphta;
[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).]
271-267-0
68527-27-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-283-00-8
Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]
295-315-5
91995-53-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-284-00-3
Naphtha (petroleum),C4-12, butane-alkylate, isooctane-rich; Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95oF to 410oF).]
295-430-0
92045-49-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-285-00-9
Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha; [A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 o C to 99 o C (201 oF to 210 oF).]
295-436-3
92045-55-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-286-00-4
Naphtha (petroleum), isomerisation, C6-fraction;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalyticall isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140oF to 151oF).]
295-440-5
92045-58-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-287-00-X
Hydrocarbons, C6-7, naphtha-cracking, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predomi nantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158oF to 212oF).]
295-446-8
92045-64-2
Carc. 1B
muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-288-00-5
Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65o C to 70o C (149oF to 158oF).]
309-871-4
101316-67-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-289-00-0
Naphtha (petroleum), heavy catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-055-7
64741-54-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-290-00-6
Naphtha (petroleum), light catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 190 oC (– 4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-056-2
64741-55-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-291-00-1
Hydrocarbons, C3-11, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400oF).]
270-686-6
68476-46-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-292-00-7
Naphtha (petroleum), catalytic cracked light distd.;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-185-8
68783-09-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-293-00-2
Distillates (petroleum), naphtha steam cracking-derived, hydro-treated light arom.;
Low boiling point cat-cracked naphtha.;
[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]
295-311-3
91995-50-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-294-00-8
Naphtha (petroleum), heavy catalytic cracked, sweetened; Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to200 oC (140oF to 392oF).]
295-431-6
92045-50-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-295-00-3
Naphtha (petroleum), light catalytic cracked sweetened; Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predomi nantly of hydrocarbons boiling in a range of approximately 35 oC to 210 oC (95oF to 410oF).]
295-441-0
92045-59-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-296-00-9
Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predomi nantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266oF to 410oF).]
295-794-0
92128-94-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-297-00-4
Hydrocarbons, C8-12, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approxi mately 140 oC to 210 oC (284oF to 410oF).]
309-974-4
101794-97-2
Carc. 1B
Muta. 1B A
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-298-00-X
Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened; Low boiling point cat-cracked naphtha
309-987-5
101896-28-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-299-00-5
Naphtha (petroleum), light catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190o C (95oF to 374oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol.% or more benzene.]
265-065-1
64741-63-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-300-00-9
Naphtha (petroleum), heavy catalytic reformed;
Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194oF to 446oF).]
265-070-9
64741-68-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-301-00-4
Distillates (petroleum), catalytic reformed depentanizer;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC (–57oF to 145oF).]
270-660-4
68475-79-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-302-00-X
Hydrocarbons, C2-6, C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha
270-687-1
68476-47-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-303-00-5
Residues (petroleum), C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha;
[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
270-794-3
68478-15-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-304-00-0
Naphtha (petroleum), light catalytic reformed, arom.-free; Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approxi mately 35o C to 120o C (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]
270-993-5
68513-03-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-305-00-6
Distillates (petroleum), catalytic reformed straight-run naphtha overheads;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-008-1
68513-63-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-306-00-1
Petroleum products, hydrofiner-powerformer reformates;
Low boiling point cat-reformed naphtha;
[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80oF to 410oF).]
271-058-4
68514-79-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-307-00-7
Naphtha (petroleum), full-range reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35o C to 230 oC (95oF to 446oF).]
272-895-8
68919-37-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-308-00-2
Naphtha (petroleum), catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90oF to 430oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]
273-271-8
68955-35-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-309-00-8
Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;-Low boiling point cat-reformed naphtha;
[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320oF to 356oF).]
285-509-8
85116-58-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-310-00-3
Aromatic hydrocarbons, C8, catalytic reforming-derived;
Low boiling point cat-reformed naphtha
295-279-0
91995-18-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-311-00-9
Aromatic hydrocarbons, C7-12, C8-rich;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266oF to 392oF).]
297-401-8
93571-75-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-312-00-4
Gasoline, C5-11, high-octane stabilised reformed;
Low boiling point cat-reformed naphtha; -
[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approxi mately 45 oC to 185 oC (113oF to 365 oF).]
297-458-9
93572-29-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-313-00-X
Hydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction; Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248oF to380oF) and C9 and higher aromatic hydrocarbons.]
297-465-7
93572-35-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-314-00-5
Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 125 oC (94oF to 257oF), benzene and toluene.]
297-466-2
93572-36-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-315-00-0
Foots oil (petroleum), silicic acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-127-6
97862-77-6
Carc. 1B
H350
H304
GHS08
Dgr
H350
H304
L
649-316-00-6
Naphtha (petroleum), light thermal cracked;
Low boiling point thermally cracked naphtha;
[A complexcombination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately - 10 oC to 130 oC (14oF to 266oF).]
265-075-6
64741-74-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-317-00-1
Naphtha (petroleum), heavy thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65o C to 220 oC (148oF to 428oF).]
265-085-0
64741-83-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-318-00-7
Distillates (petroleum), heavy arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]
267-563-4
67891-79-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-319-00-2
Distillates (petroleum), light arom.;
Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]
267-565-5
67891-80-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
HS08
Dgr
H350
H340
H304
P
649-320-00-8
Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;
Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816o C (1 500oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400oF).]
270-344-6
68425-29-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-321-00-3
Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 o C (1 500oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]
270-658-3
68475-70-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-322-00-9
Distillates (petroleum), thermal cracked naphtha and gas oil; Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approxi mately 33 o C to 60 o C (91 oF to 140 oF).]
271-631-9
68603-00-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-323-00-4
Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;
Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33o C to 184 o C (91oF to 363 oF).]
271-632-4
68603-01-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-324-00-X
Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predomi nantly isoamylenes such as 2-methyl-1-buteneand 2-methyl-2-butene and boiling in the rangeof approximately 31o C to 40o C (88oF to 104oF).]
271-634-5
68603-03-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-325-00-5
Distillates (petroleum), light thermal cracked, debutanized arom.;
Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]
273-266-0
68955-29-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-326-00-0
Naphtha (petroleum), light thermal cracked, sweetened;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate From the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 o C (68 oF to 212 oF).]
295-447-3
92045-65-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-327-00-6
Naphtha (petroleum), hydrotreated heavy;
Low boiling point ydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65o C to 230o C (149oF to 446oF).]
265-150-3
64742-48-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-328-00-1
Naphtha (petroleum), hydrotreated light;
Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction With hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20o C to 190o C (– 4oF to 374oF).]
265-151-9
64742-49-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-329-00-7
Naphtha (petroleum), hydrodesulfurized light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in The range of approximately - 20o C to 190o C (– 4oF to 374oF).]
265-178-6
64742-73-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-330-00-2
naphtha (petroleum), hydrodesulphurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90o C to 230o C (194oF to 446 oF).]
265-185-4
64742-82-1
Carc. 1B
Muta. 1B
STOT RE 1
Asp. Tox. 1
H350
H340
H372 (central nervous system)
H304
GHS08
Dgr
H350
H340
H372 (central nervous system)
H304
P
649-331-00-8
Distillates (petroleum), hydrotreated middle, intermediate boiling;
Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127o C to 188o C (262oF to 370oF).]
270-092-7
68410-96-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-332-00-3
Distillates (petroleum), light distillate hydrotreating process, low-boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 o C to 194 o C (37 oF to 382 oF).]
270-093-2
68410-97-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-333-00-9
Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (– 57oF to 155oF).]
270-094-8
68410-98-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-334-00-4
Solvent naphtha (petroleum), light arom., hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approxi mately 135 oC to 210 oC (275oF to 410oF).]
270-988-8
68512-78-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-335-00-X
Naphtha (petroleum), hydrodesulfurized thermal cracked light; Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73oF to 383oF).]
285-511-9
85116-60-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-336-00-5
Naphtha (petroleum), hydrotreated light, cycloalkane-contg.; Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately - 20o C to 190 oC (– 4oF to 374oF).]
285-512-4
85116-61-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-337-00-0
Naphtha (petroleum),heavy steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha
295-432-1
92045-51-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-338-00-6
Naphtha (petroleum), hydrodesulfurized full-range;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86oF to 482oF).]
295-433-7
92045-52-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-339-00-1
Naphtha (petroleum), hydrotreated light steam-cracked;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35o C to 190 oC (95oF to 374oF).]
295-438-4
92045-57-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-340-00-7
Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distallation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230o C (86oF to 446oF).]
295-443-1
92045-61-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-341-00-2
Solvent naphtha (petroleum), hydrotreated light naphthenic; Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approxi mately 73o C to 85o C (163 oF to 185 oF).]
295-529-9
92062-15-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-342-00-8
Naphtha (petroleum), light steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons produced from the separation and subsequent Hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50o C to 200o C (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts ofsulfur and oxygenated compounds.]
296-942-7
93165-55-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-343-00-3
Hydrocarbons, C6-11, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-852-0
93763-33-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-344-00-9
Hydrocarbons, C9-12, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-853-6
93763-34-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-345-00-4
stoddard solvent;
Low boiling point naphtha —
unspecified;
[A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 oC to 204,4 o C (300oF to 400oF).]
232-489-3
8052-41-3
Carc. 1B
Muta. 1B
STOT RE 1
Asp. Tox. 1
H350
H340
H372 (central nervous system)
H304
GHS08
Dgr
H350
H340
H372 (central nervous system)
H304
P
649-346-00-X
Natural gas condensates (petroleum);
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]
265-047-3
64741-47-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-347-00-5
Natural gas (petroleum), raw liq. mix; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]
265-048-9
64741-48-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-348-00-0
Naphtha (petroleum), light hydrocracked;
Low boiling naphtha — unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approxi mately - 20 o C to 180 o C (– 4 oF to 356 oF).]
265-071-4
64741-69-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-349-00-6
Naphtha (petroleum), heavy hydrocracked;
Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148oF to 446oF).]
265-079-8
64741-78-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-350-00-1
Naphtha (petroleum) sweetened;
Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately - 10o C to 230o C (14oF to 446oF).]
265-089-2
64741-87-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-351-00-7
Naphtha(petroleum), acid-treated;
Low boilingpoint naphtha -unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 o C to 230 o C (194 oF to 446 oF).]
265-115-2
64742-15-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-352-00-2
Naphtha (petroleum), chemically neutralized heavy;
Low boilingpoint naphtha — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65o C to 230o C (149oF to 446oF).]
265-122-0
64742-22-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-353-00-8
Naphtha (petroleum), chemically neutralized light;
Low boilingpoint naphtha -unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 190o C (–4 oF to 374 oF).]
265-123-6
64742-23-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-354-00-3
Naphtha (petroleum), catalytic dewaxed;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35o C to 230 oC (95oF to 446oF).]
265-170-2
64742-66-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-355-00-9
Naphtha (petroleum), light steam-cracked;
Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (– 4oF to 374oF). This stream is likely to contain 10 vol.% or more benzene.]
265-187-5
64742-83-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-356-00-4
Solvent naphtha (petroleum), light arom.;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275oF to 410oF).]
265-199-0
64742-95-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-357-00-X
Aromatic hydrocarbons, C6-10, acid-treated, neutralized;
Low boiling point naphtha — unspecified
268-618-5
68131-49-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-358-00-5
Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons from the distil lation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]
270-725-7
68477-34-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-359-00-0
Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;
Low boiling point naphtha- unspecified;
[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-735-1
68477-50-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-360-00-6
Distillates (petroleum), steam-cracked, C5-12 fraction;
Low boiling point naphtha -unspecified;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-736-7
68477-53-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-361-00-1
Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction; Low boiling point naphtha -unspecified
270-738-8
68477-55-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-362-00-7
Extracts (petroleum), cold-acid, C4-6; Low boiling point naphtha — unspecified; [A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
270-741-4
68477-61-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-363-00-2
Distillates (petroleum), depentanizer overheads;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C4 through C6.]
270-771-8
68477-89-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-364-00-8
Residues (petroleum), butane splitter bottoms;
Low boiling point naphtha -unspecified;
[A complex residuum from the distillation of butane stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C4 through C6.]
270-791-7
68478-12-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-365-00-3
Residual oils (petroleum), deisobutanizer tower;
Low boiling point naphtha -unspecified;
[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-795-9
68478-16-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-366-00-9
Naphtha (petroleum), full-range coker;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43o C to 250o C (110oF-500oF).]
270-991-4
68513-02-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-367-00-4
Naphtha (petroleum), steam-cracked middle arom.;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130o C to 220o C (266oF to 428oF).]
271-138-9
68516-20-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-368-00-X
Naphtha (petroleum), clay-treated full-range straight-run; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons resulting from treatment of full-range straight- run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20o C to 220o C (– 4oF to 429oF).]
271-262-3
68527-21-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-369-00-5
Naphtha (petroleum), clay-treated light straight-run;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200oF to 356oF).]
271-263-9
68527-22-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-370-00-0
Naphtha (petroleum), light steam-cracked arom.;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110o C to 165 o C (230 oF to 329 oF).]
271-264-4
68527-23-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-371-00-6
Naphtha (petroleum),light steam-cracked, debenzenized; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80o C to 218o C (176oF to 424oF).]
271-266-5
68527-26-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-372-00-1
Naphtha (petroleum), arom.-contg.;
Low boilingpoint naphtha — unspecified
271-635-0
68603-08-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-373-00-7
Gasoline, pyrolysis, debutanizer bottoms;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]
271-726-5
68606-10-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-374-00-2
Naphtha (petroleum), light, sweetened;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydro carbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20o C to 100o C (– 4oF to 212 oF).]
272-206-0
68783-66-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-375-00-8
Natural gas condensates;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]
272-896-3
68919-39-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-376-00-3
Distillates (petroleum), naphtha unifiner stripper;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
272-932-8
68921-09-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-377-00-9
Naphtha (petroleum), catalytic reformed light, arom.-free fraction;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66o C to 121o C (151oF to250oF).]
285-510-3
85116-59-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-378-00-4
Gasoline;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260o C (86oF to 500oF).]
289-220-8
86290-81-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-379-00-X
Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues;
Low boiling point naphtha — unspecified
292-698-0
90989-42-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-380-00-5
Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes and boiling in the range of approximately 25 oC to 40 o C (77oF to 104oF).]
295-298-4
91995-38-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-381-00-0
Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam- cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
295-302-4
91995-41-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-382-00-6
Extracts (petroleum), catalytic reformed light naphtha solvent; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212oF to 392oF).]
295-331-2
91995-68-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-383-00-1
Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90o C to 100o C (194oF to 212oF).]
295-434-2
92045-53-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-384-00-7
Naphtha (petroleum), light, C5-rich, sweetened;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35o C (14oF to 95oF).]
295-442-6
92045-60-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-385-00-2
Hydrocarbons, C8-11, naphtha-cracking, toluene cut;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130o C to 205o C (266oF to 401oF).]
295-444-7
92045-62-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-386-00-8
Hydrocarbons, C4-11, naphtha-cracking, arom.-free;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene-and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 o C to 205 o C (86 oF to 401 oF).]
295-445-2
92045-63-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-387-00-3
Naphtha (petroleum), light heat-soaked, steam-cracked;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approxi mately 0o C to 80o C (32oF to 176oF).]
296-028-8
92201-97-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-388-00-9
Distillates (petroleum), C6-rich; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60o C to70o C (140 oF to 158 oF).]
296-903-4
93165-19-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-389-00-4
Gasoline, pyrolysis, hydrogenated;
Low boiling point naphtha-unspecified;
[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20o C to 200o C (68oF to 392oF).]
302-639-3
94114-03-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-390-00-X
Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
305-750-5
95009-23-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-391-00-5
Extracts (petroleum) heavy naphtha solvent, clay-treated; Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 o C to 180 o C (175 oF to 356 oF).]
308-261-5
97926-43-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-392-00-0
Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200o C (203oF to 392oF).]
308-713-1
98219-46-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-393-00-6
Naphtha (petroleum), light steam-cracked, thermally treated;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 o C to 80 o C (95 oF to 176 oF).]
308-714-7
98219-47-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-394-00-1
Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 o C to 130 o C (248 oF to 266 oF).]
309-862-5
101316-56-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-395-00-7
Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80o C to 135o C (176oF to 275oF).]
309-870-9
101316-66-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-396-00-2
Naphtha (petroleum), hydrodesulfurised full-range coker;
Low boiling point naphtha -unspecified;
[A complex ombination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 o C (73 oF to 385 oF).]
309-879-8
101316-76-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-397-00-8
Naphtha (petroleum), sweetened light;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 o C to 130 o C (68 oF to 266 oF).]
309-976-5
101795-01-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-398-00-3
Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]
310-012-0
102110-14-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-399-00-9
Hydrocarbons, C5-rich, dicyclopentadiene-contg.;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30o C to 170o C (86oF to 338oF).]
310-013-6
102110-15-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-400-00-2
Residues (petroleum), steam-cracked light, arom.;
Low boiling point naphtha -unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products of steamcracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40o C (104oF).]
310-057-6
102110-55-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-401-00-8
Hydrocarbons, C≥5, C5-6-rich; Low boiling point naphtha -unspecified
270-690-8
68476-50-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-402-00-3
Hydrocarbons, C5-rich;
Low boiling point naphtha — unspecified
270-695-5
68476-55-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-403-00-9
Aromatic hydrocarbons, C8-10; Low boiling point naphtha -unspecified
292-695-4
90989-39-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304
P
649-404-00-4
Kerosine (petroleum); Straight run kerosine;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150oC to 290oC (320oF to 554oF).]
232-366-4
8008-20-6
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-405-00-X
solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140o C to 220o C (284oF to 428oF).]
265-191-7
64742-88-7
STOT RE 1
Asp. Tox. 1
H372 (central nervous system)
H304
GHS08
Dgr
H372 (central nervous system)
H304
649-406-00-5
Solvent naphtha (petroleum) heavy aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]
265-200-4
64742-96-7
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-407-00-0
Kerosine (petroleum), straight-run wide-cut;
Straight run kerosine;
[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]
295-418-5
92045-37-9
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-408-00-6
Distillates (petroleum), steam-cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]
265-194-3
64742-91-2
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-409-00-1
Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydrocarbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129oC to 194oC (264 oF to 382 oF).]
270-728-3
68477-39-4
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-410-00-7
Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]
270-729-9
68477-40-7
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-411-00-2
Distillates (petroleum), steam-cracked, C8-12 fraction;
Cracked kerosine;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
270-737-2
68477-54-3
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-412-00-8
Kerosine (petroleum), hydrodesulfurized thermal cracked; Cracked kerosine;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predomi nantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120oC to 283oC (284oF to 541oF).]
285-507-7
85116-55-8
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-413-00-3
Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated; Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]
292-621-0
90640-98-5
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-414-00-9
Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich; Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140oC to 200oC (284oF to 392oF).]
292-637-8
90641-13-7
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-415-00-4
Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250oC (212oF to 482oF.]
309-866-7
101316-61-4
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-416-00-X
Distillates (petroleum), catalytic cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predomi nantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-938-8
101631-13-4
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-417-00-5
Solvent naphtha (petroleum), hydrocracked heavy arom.; Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]
309-881-9
101316-80-7
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-418-00-0
Distillates (petroleum), steam-cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-940-9
101631-15-6
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-419-00-6
Distillates (petroleum), alkylate; Kerosine — unspecified;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205oC to 320oC (401oF to 608oF).]
265-074-0
64741-73-7
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-420-00-1
Extracts (petroleum), heavy naphtha solvent;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90oC to 220oC (194 oF to 428 oF).]
265-099-7
64741-98-6
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-421-00-7
Distillates (petroleum), chemically neutralized light; Kerosine — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-132-5
64742-31-0
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-422-00-2
Distillates (petroleum), hydro- treated light;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approxi mately 150 oC to 290 oC (302 oF to 554 oF).]
265-149-8
64742-47-8
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-423-00-8
Kerosine (petroleum), hydrodesulfurized; Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-184-9
64742-81-0
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-424-00-3
Solvent naphtha (petroleum), heavy arom.;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]
265-198-5
64742-94-5
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-425-00-9
Naphtha (petroleum), heavy coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons
having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]
269-778-9
68333-23-3
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-426-00-4
Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98oC to 218oC (208oF to 424oF).]
285-508-2
85116-57-0
Asp. Tox. 1
H304
GHS08-Dgr
H304
649-427-00-X
Kerosine (petroleum), sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]
294-799-5
91770-15-9
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-428-00-5
Kerosine (petroleum), solvent-refined sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]
295-416-4
92045-36-8
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-429-00-0
Hydrocarbons, C9-16, hydrotreated, dearomatized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-854-1
93763-35-0
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-430-00-6
Kerosine (petroleum), solvent-refined hydrodesulfurized; Kerosine — unspecified
307-033-2
97488-94-3
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-431-00-1
Distillates (petroleum), hydrodesulfurized full-range middle coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon
numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]
309-864-6
101316-58-9
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-432-00-7
Solvent naphtha (petroleum), hydrodesulfurized heavy arom.; Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]
309-882-4
101316-81-8
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-433-00-2
Solvent naphtha (petroleum), hydrodesulfurized medium; Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]
309-884-5
101316-82-9
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-434-00-8
Kerosine (petroleum), hydrotreated;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]
309-944-0
101631-19-0
Asp. Tox. 1
H304
GHS08
Dgr
H304
649-435-00-3
Distillates (petroleum), light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
265-060-4
64741-59-9
Carc. 1B
H350
GHS08
Dgr
H350
649-436-00-9
Distillates (petroleum), intermediate catalytic cracked; Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
265-062-5
64741-60-2
Carc. 1B
H350
GHS08
Dgr
H350
649-437-00-4
Distillates (petroleum), light hydrocracked;
Cracked gasoil;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approxi mately 160oC to 320oC (320 oF to 608 oF).]
265-078-2
64741-77-1
Carc. 2
H351
GHS08
Wng
H351
649-438-00-X
Distillates (petroleum), light thermal cracked;
Cracked gasoil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160oC to 370 oC (320oF to 698oF).]
265-084-5
64741-82-8
Carc. 1B
H350
GHS08
Dgr
H350
649-439-00-5
Distillates (petroleum), hydrodesulfurized light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
269-781-5
68333-25-5
Carc. 1B
H350
GHS08
Dgr
H350
649-440-00-0
Distillates (petroleum),light steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]
270-662-5
68475-80-9
Carc. 1B
H350
GHS08
Dgr
H350
649-441-00-6
Distillates (petroleum), cracked steam-cracked petroleum distillates;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]
270-727-8
68477-38-3
Carc. 1B
H350
GHS08
Dgr
H350
649-442-00-1
Gas oils (petroleum), steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]
271-260-2
68527-18-4
Carc. 1B
H350
GHS08
Dgr
H350
649-443-00-7
Distillates (petroleum), hydrodesulfurized thermal cracked middle;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400ooC (401oF to 752oF).]
285-505-6
85116-53-6
Carc. 1B
H350
GHS08
Dgr
H350
649-444-00-2
Gas oils (petroleum), thermal-cracked, hydrodesulfurized; Cracked gasoil
295-411-7
92045-29-9
Carc. 1B
H350
GHS08
Dgr
H350
649-445-00-8
Residues (petroleum), hydrogenated steam-cracked naphtha; Cracked gasoil;
[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200oC to 350oC (32 oF to 662 oF).]
295-514-7
92062-00-5
Carc. 1B
H350
GHS08
Dgr
H350
649-446-00-3
Residues (petroleum), steam-cracked naphtha distn.;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]
295-517-3
92062-04-9
Carc. 1B
H350
GHS08
Dgr
H350
649-447-00-9
Distillates (petroleum), light catalytic cracked, thermally degraded;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190oC to 340oC (374oF to 644oF). This stream is likely to contain organic sulfur compounds.]
295-991-1
92201-60-0
Carc. 1B
H350
GHS08
Dgr
H350
649-448-00-4
Residues (petroleum), steam-cracked heat-soaked naphtha; Cracked gasoil;
[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]
297-905-8
93763-85-0
Carc. 1B
H350
GHS08
Dgr
H350
649-449-00-X
Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]
307-662-2
97675-88-2
Carc. 2
H351
GHS08
Wng
H351
649-450-00-5
Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]
308-278-8
97926-59-5
Carc. 1B
H350
GHS08
Dgr
H350
649-451-00-0
Distillates (petroleum), hydrodesulfurized middle coker; Cracked gasoil;
[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydrocarbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]
309-865-1
101316-59-0
Carc. 1B
H350
GHS08
Dgr
H350
649-452-00-6
Distillates (petroleum), heavy steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]
309-939-3
101631-14-5
Carc. 1B
H350
GHS08
Dgr
H350
649-453-00-1
Distillates (petroleum), heavy hydrocracked;
Baseoil — unspecified;
[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]
265-077-7
64741-76-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-454-00-7
Distillates (petroleum), solvent-refined heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-090-8
64741-88-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-455-00-2
Distillates (petroleum), solvent-refined light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-091-3
64741-89-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-456-00-8
Residual oils (petroleum), solvent deasphalted;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-096-0
64741-95-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-457-00-3
Distillates (petroleum), solvent-refined heavy naphthenic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]
265-097-6
64741-96-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-458-00-9
Distillates (petroleum), solvent-refined light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-098-1
64741-97-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-459-00-4
Residual oils (petroleum,) solvent-refined;
Baseoil — unspecified;
[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400oC (752oF).]
265-101-6
64742-01-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-460-00-X
Distillates (petroleum), clay-treated paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-137-2
64742-36-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-461-00-5
Distillates (petroleum), clay-treated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-138-8
64742-37-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-462-00-0
Residual oils (petroleum), clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400oC (752 oF).]
265-143-5
64742-41-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-463-00-6
Distillates (petroleum), clay-treated heavy naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-146-1
64742-44-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-464-00-1
Distillates (petroleum), clay-treated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-147-7
64742-45-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-465-00-7
Distillates (petroleum), hydrotreated heavy naphthenic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-155-0
64742-52-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-466-00-2
Distillates (petroleum), hydrotreated light naphthenic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-156-6
64742-53-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-467-00-8
Distillates (petroleum), hydrotreated heavy paraffinic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-157-1
64742-54-7
Carc. 1B
H350
GHS08
Dgr
H350
L
649-468-00-3
Distillates (petroleum), hydrotreated light paraffinic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-158-7
64742-55-8
Carc. 1B
H350
GHS08
Dgr
H350
L
649-469-00-9
Distillates (petroleum), solvent-dewaxed light paraffinic;
Baseoil — unspecified;
[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-159-2
64742-56-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-470-00-4
Residual oils (petroleum), hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-160-8
64742-57-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-471-00-X
Residual oils (petroleum), solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of ong, branched chain hydrocarbons from a residual oil by solvent crystalli zation. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approxi mately 400 oC (752 oF).]
265-166-0
64742-62-7
Carc. 1B
H350
GHS08
Dgr
H350
L
649-472-00-5
Distillates (petroleum), solvent-dewaxed heavy naphthenic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-167-6
64742-63-8
Carc. 1B
H350
GHS08
Dgr
H350
L
649-473-00-0
Distillates (petroleum), solvent-dewaxed light naphthenic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-168-1
64742-64-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-474-00-6
Distillates (petroleum), solvent-dewaxed heavy paraffinic; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-169-7
64742-65-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-475-00-1
Naphthenic oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-172-3
64742-68-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-476-00-7
Naphthenic oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-173-9
64742-69-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-477-00-2
Paraffin oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-174-4
64742-70-7
Carc. 1B
H350
GHS08
Dgr
H350
L
649-478-00-8
Paraffin oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-176-5
64742-71-8
Carc. 1B
H350
GHS08
Dgr
H350
L
649-479-00-3
Naphthenic oils (petroleum), complex dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removing straight chain
paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-179-1
64742-75-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-480-00-9
Naphthenic oils (petroleum), complex dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-180-7
64742-76-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-481-00-4
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and
solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-736-3
72623-85-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-482-00-X
Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]
276-737-9
72623-86-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-483-00-5
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-738-4
72623-87-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-484-00-0
Lubricating oils;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]
278-012-2
74869-22-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-485-00-6
Distillates (petroleum), complex dewaxed heavy paraffinci; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-613-7
90640-91-8
Carc. 1B
H350
GHS08
Dgr
H350
L
649-486-00-1
Distillates (petroleum), complex dewaxed light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-614-2
90640-92-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-487-00-7
Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-616-3
90640-94-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-488-00-2
Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-617-9
90640-95-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-489-00-8
Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-618-4
90640-96-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-490-00-3
Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by Treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-620-5
90640-97-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-491-00-9
Residual oils (petroleum), hydrotreated solvent dewaxed; Baseoil — unspecified
292-656-1
90669-74-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-492-00-4
Residual oils (petroleum), catalytic dewaxed;
Baseoil — unspecified
294-843-3
91770-57-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-493-00-X
Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]
295-300-3
91995-39-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-494-00-5
Distillates (petroleum), dewaxed light paraffinic, hydrotreated; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]
295-301-9
91995-40-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-495-00-0
Distillates (petroleum), hydrocracked solvent-refined, dewaxed;
Baseoil — unspecified; [A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]
295-306-6
91995-45-8
Carc. 1B
H350
GHS08
Dgr
H350
L
649-496-00-6
Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]
295-316-0
91995-54-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-497-00-1
Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;
Baseoil — unspecified
295-423-2
92045-42-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-498-00-7
Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;
Baseoil — unspecified
295-424-8
92045-43-7
Carc. 1B
H350
GHS08
Dgr
H350
L
649-499-00-2
Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distil lation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]
295-499-7
92061-86-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-500-00-6
Paraffin oils (petroleum), solvent-refined dewaxed heavy; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]
295-810-6
92129-09-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-501-00-1
Lubricating oils (petroleum), base oils, paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]
297-474-6
93572-43-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-502-00-7
Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;
Baseoil — unspecified
297-857-8
93763-38-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-503-00-2
Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;
Baseoil — unspecified
300-257-1
93924-61-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-504-00-8
Distillates (petroleum), solvent-refined hydrotreated heavy; hydrogenated;
Baseoil — unspecified
305-588-5
94733-08-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-505-00-3
Distillates (petroleum), solvent-refined hydrocracked light; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370oC to 450oC (698oF to 842oF).]
305-589-0
94733-09-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-506-00-9
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;
Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370oC to 550 oC (698 oF to 1022oF).]
305-594-8
94733-15-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-507-00-4
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-595-3
94733-16-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-508-00-X
Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified
305-971-7
95371-04-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-509-00-5
Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified
305-972-2
95371-05-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-510-00-0
Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;
Baseoil — unspecified
305-974-3
95371-07-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-511-00-6
Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;
Baseoil — unspecified
305-975-9
95371-08-7
Carc. 1B
H350
GHS08
Dgr
H350
L
649-512-00-1
Distillates (petroleum), hydrocracked solvent-refined light; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predomiantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450oC (698 oF to 842 oF.]
307-010-7
97488-73-8
Carc. 1B
H350
GHS08
Dgr
H350
L
649-513-00-7
Distillates (petroleum), solvent-refined hydrogenated heavy; Baseoil — unspecified; [A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]
307-011-2
97488-74-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-514-00-2
Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;
Baseoil — unspecified
307-034-8
97488-95-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-515-00-8
Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]
307-661-7
97675-87-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-516-00-3
Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]
307-755-8
97722-06-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-517-00-9
Hydrocarbons, C13-27, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).]
307-758-4
97722-09-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-518-00-4
Hydrocarbons, C14-29, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40oC (104oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]
307-760-5
97722-10-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-519-00-X
Hydrocarbons, C27-42, dearomatized;
Baseoil — unspecified
308-131-8
97862-81-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-520-00-5
Hydrocarbons, C17-30, hydrotreated distillates, distn. lights; Baseoil — unspecified
308-132-3
97862-82-3
Carc. 1B
H350
GHS08
Dgr
H350
L
649-521-00-0
Hydrocarbons, C27-45, naphthenic vacuum distn.;
Baseoil — unspecified
308-133-9
97862-83-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-522-00-6
Hydrocarbons, C27-45, dearomatized;
Baseoil — unspecified
308-287-7
97926-68-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-523-00-1
Hydrocarbons, C20-58, hydrotreated;
Baseoil — unspecified
308-289-8
97926-70-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-524-00-7
Hydrocarbons, C27-42, naphthenic;
Baseoil — unspecified
308-290-3
97926-71-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-525-00-2
Residual oils (petroleum), carbon-treated solvent-dewaxed; Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]
309-710-8
100684-37-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-526-00-8
Residual oils (petroleum), clay-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]
309-711-3
100684-38-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-527-00-3
Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]
309-874-0
101316-69-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-528-00-9
Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]
309-875-6
101316-70-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-529-00-4
Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]
309-876-1
101316-71-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-530-00-X
Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]
309-877-7
101316-72-7
Carc. 1B
H350
GHS08
Dgr
H350
L
649-531-00-5
Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;
Distillate aromatic extract (treated);
[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]
272-175-3
68783-00-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-532-00-0
Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;
Distillate aromaticextract (treated); [A complex combination of hydrocarbons obtained as the extractfrom the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
272-180-0
68783-04-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-533-00-6
Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]
272-342-0
68814-89-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-534-00-1
Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]
292-631-5
90641-07-9
Carc. 1B
H350
GHS08
Dgr
H350
L
649-535-00-7
Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350oC to 480oC (662oF to 896oF).
292-632-0
90641-08-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-536-00-2
Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a lightparaffinic distillate solvent extract with hydrogen in the presence of acatalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280oC to 400oC (536 oF to 752 oF).]
292-633-6
90641-09-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-537-00-8
Extracts (petroleum), hydrotreated light paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
295-335-4
91995-73-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-538-00-3
Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
295-338-0
91995-75-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-539-00-9
Extracts(petroleum), light paraffinic distillate solvent, acid-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
295-339-6
91995-76-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-540-00-4
Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]
295-340-1
91995-77-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-541-00-X
Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
295-342-2
91995-79-8
Carc. 1B
H350
GHS08
Dgr
H350
L
649-542-00-5
Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]
296-437-1
92704-08-0
Carc. 1B
H350
GHS08
Dgr
H350
L
649-543-00-0
Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-827-4
93763-10-1
Carc. 1B
H350
GHS08
Dgr
H350
L
649-544-00-6
Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-829-5
93763-11-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-545-00-1
Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-672-2
100684-02-4
Carc. 1B
H350
GHS08
Dgr
H350
L
649-546-00-7
Extracts (petroleum), light paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-673-8
100684-03-5
Carc. 1B
H350
GHS08
Dgr
H350
L
649-547-00-2
Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-674-3
100684-04-6
Carc. 1B
H350
GHS08
Dgr
H350
L
649-548-00-8
Extracts (petroleum), light vacuum gas oil solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-675-9
100684-05-7
Carc. 1B
H350
GHS08
Dgr
H350
L
649-549-00-3
Foots oil (petroleum); Foots oil;
[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predomi nantly of branched chain hydro carbons having carbon numbers predominantly in the range of C20 through C50.]
265-171-8
64742-67-2
Carc. 1B
H350
GHS08
Dgr
H350
L
649-550-00-9
Foots oil (petroleum), hydrotreated; Foots oil
295-394-6
92045-12-0
Carc. 1B
H350
GHS08
Dgr
H350
L
650-002-00-6
turpentine, oil
232-350-7
8006-64-2
Flam. Liq. 3
Acute Tox. 4 * Acute Tox. 4 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H226
H332
H312
H302
H304
H319
H315
H317
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H332
H312
H302
H304
H319
H315
H317
H411
650-003-00-1
fenson (ISO);
4-chlorophenyl benzenesulphonate;
201-274-6
80-38-6
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H302
H319
H411
GHS07
GHS09
Wng
H302
H319
H411
650-004-00-7
norbormide (ISO);
5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicycle [2.2.1] hept-5-ene-2,3-dicarboximide
213-589-6
991-42-4
Acute Tox. 4 *
H302
GHS07
Wng
H302
650-005-00-2
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone
201-501-9
83-79-4
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H335
H315
H400
H410
GHS06
GHS09
Dgr
H301
H319
H335
H315
H410
650-006-00-8
benquinox (ISO);
p-benzoquinone 1-benzoylhydrazone 4-oxime
207-807-9
495-73-8
Acute Tox. 3 * Acute Tox. 4 *
H301
H312
GHS06
Dgr
H301
H312
650-007-00-3
chlordimeform (ISO);
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine
228-200-5
6164-98-3
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H351
H312
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H312
H302
H410
650-008-00-9
drazoxolon (ISO);
4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone
227-197-8
5707-69-7
Acute Tox. 3 * Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
650-009-00-4
chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride
243-269-1
19750-95-9
Carc. 2
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410
650-010-00-X
benzyl violet 4B;
α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonato benzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate
216-901-9
1694-09-3
Carc. 2
H351
GHS08
Wng
H351
650-012-00-0
erionite
—
12510-42-8
Carc. 1A
H350
GHS08
Dgr
H350
650-013-00-6
asbestos
—
—
—
—
—
—
—
12001-28-4
132207-32-0
12172-73-5
77536-66-4
77536-68-6
77536-67-5
12001-29-5
Carc. 1A
STOT RE 1
H350
H372 **
GHS08
Dgr
H350
H372 **
650-014-00-1
diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate
401-770-4
—
Skin Corr. 1B
Acute Tox. 4 *
H314
H302
GHS05
GHS07
Dgr
H314
H302
650-015-00-7
rosin;
colophony
232-475-7
232-484-6
277-299-1
8050-09-7
8052-10-6
73138-82-6
Skin Sens. 1
H317
GHS07
Wng
H317
650-016-00-2
Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]
—
—
Carc. 2
H351
GHS08
Wng
H351
AQR
650-017-00-8
Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]
—
—
Carc. 1B
H350i
GHS08
Dgr
H350i
AR
650-018-00-3
Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid
406-230-1
—
Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H351
H314
H332
H317
H400
H410
GHS02
GHS08
GHS05
GHS07
GHS09
Dgr
H226
H351
H314
H332
H317
H410
650-031-00-4
bis(4-hydroxy-N-methylanilinium) sulphate
200-237-1
55-55-0
Acute Tox. 4 * STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 ** H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 ** H317
H410
650-041-00-9
triasulfuron (ISO);
1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea
—
82097-50-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410
650-042-00-4
Reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates
417-450-2
—
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H315
H317
H412
GHS07
Wng
H319
H315
H317
H412
650-043-00-X
reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate
420-310-3
—
Acute Tox. 4 * Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
650-044-00-5
mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin
420-480-9
158570-99-1
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410
650-045-00-0
Reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate
417-110-3
—
Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H225
H315
H318
H411
GHS02
GHS05
GHS09
Dgr
H225
H315
H318
H411
650-046-00-6
di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates
416-180-2
12222-04-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 ** H411
GHS08
GHS07
GHS09
Wng
H302
H373 ** H411
650-047-00-1
dibenzylphenylsulfonium hexafluoroantimonate
417-760-8
134164-24-2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H372 ** H302
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H372 **
H302
H318
H317
H411
650-048-00-7
reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid
420-070-1
—
Org. Perox. D **** Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A Aquatic Acute 1
H242
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H332
H312
H302
H314
H400
650-049-00-2
2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl
417-960-5
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
650-050-00-8
reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;
1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;
1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers
423-600-8
—
Aquatic Chronic 2
H411
GHS09
H411
650-055-00-5
silver sodium zirconium hydrogenphosphate
422-570-3
155925-27-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

---
Source: https://www.legislation.gov.uk/eur/2018/669 (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-669
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.